cl_id,name,EC_No,CAS_No,cl_classification,sourse,num_of_notifiers,ghs_and_notifiers
1,"α,α,α-trifluoro-p-toluoyl chloride",206-342-9,329-15-7,Skin Corr. 1B,Notified C&L,50.0,H314:50;H318:2;H335:2;H319:1;H290:1;Not classified:1
1,"α,α,α-trifluoro-p-toluoyl chloride",206-342-9,329-15-7,Skin Corr. 1B,Notified C&L,50.0,H314:50;H318:2;H335:2;H319:1;H290:1;Not classified:1
2,"N,N-diethyl-m-anisidine",202-134-7,92-18-2,Acute Tox. 4,Notified C&L,38.0,H302:38
3,"5,9-Anhydro-2,3,4,8-tetradeoxy-8-[[3-(2-hydroxy-1-methylpropyl)oxiranyl]methyl]-3-methyl-[2E,8[2S,3S(1S,2S)]]-L-talonon-2-enonic acid",603-145-3,12650-69-0,Not Classified,Notified C&L,4.0,Not classified:2;H317:1;H302:1
5,Benzyl pivalate,218-251-1,2094-69-1,Not Classified,Notified C&L,25.0,Not classified:25
8,"1H-Indol-3-ol, 5-bromo-4-chloro-, dihydrogen phosphate (ester), disodium salt",600-286-2,102185-33-1,Not Classified,Notified C&L,1.0,Not classified:1
13,"Tetrasodium 6-amino-4-hydroxy-3-[[7-sulphonato-4-[(4-sulphonatophenyl)azo]-1-naphthyl]azo]naphthalene-2,7-disulphonate",218-326-9,2118-39-0,,Notified C&L,35.0,Not classified:35
19,"Sulfuric acid, mono-C9-11-alkyl esters, sodium salts",282-968-6,84501-49-5,Flam. Sol. 1;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,8.0,H302:8;H228:4;H335:4;H412:8;H332:4;H318:8;H315:8
21,Disodium hydrogenorthophosphate,231-448-7,7558-79-4,Not Classified,REACH registration C&L,975.0,Not classified:595;H319:297;H318:84;H315:20;H335:19;H371:4;H332:1;H336:1
25,"Steel manufacture, chemicals",266-048-1,65997-19-5,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 2;STOT SE 3;Carc. 1B;STOT RE 1;Aquatic Chronic 2,Notified C&L,27.0,H301:13;H319:13;H372:13;H335:15;H411:13;H330:13;H317:13;H315:13;H350:13;Not classified:12
30,Triparanol,201-115-0,78-41-1,Acute Tox. 4;Eye Dam. 1,Notified C&L,38.0,H302:38;H318:38
31,3-acetoxymethylen-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,213-485-0,957-68-6,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,73.0,H334:71;H317:71;H335:10;H319:11;H302:1;H341:1;Not classified:1;H315:2;H318:1
32,Phthalimidoacetic acid,225-177-3,4702-13-0,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,7.0,H302:4;H319:6;H315:2;Not classified:1;H335:1
38,Sodium hydrotrimethoxyborate(1-),241-003-9,16940-17-3,Flam. Sol. 1;Water-react. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H261:38;H319:38;H228:38;H335:38;H315:38
39,C.I. Direct Red 83:1,618-677-1,90880-77-6,Not Classified,Notified C&L,3.0,Not classified:3
40,5-(phenylmethoxy)-1H-indole-3-ethylamine monohydrochloride,257-626-4,52055-23-9,Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H319:1;H317:1
41,"1,2-Propanediol, polymer with 2-ethyloxirane",608-680-6,31923-86-1,Not Classified,Notified C&L,6.0,Not classified:6
45,"Amines, C12-18-alkyl",268-953-7,68155-27-1,Acute Tox. 4;Asp. Tox. 1;Skin Corr. 1B;STOT SE 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,46.0,H302:46;H373:46;H335:46;H410:40;H314:46;H304:40;H400:46;H318:5
47,Methyldioctylamine,224-703-9,4455-26-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,45.0,H315:42;H335:38;H319:42;H400:43;H410:4;Not classified:1;H318:1;H314:1;H302:1
51,"(E)-N,N,N',N'-tetramethylbut-2-ene-1,4-diamine",203-879-0,111-52-4,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,38.0,H314:38;H226:38
52,"Titanium, bis(2,6-difluorophenyl)bis[(1,2,3,4,5-.eta.)-1-methyl-2,4-cyclopentadien-1-yl]-",452-580-3,93709-39-8,Expl. 1.1;Flam. Sol. 1;Acute Tox. 3;Aquatic Chronic 4,Notified C&L,84.0,H301:84;H228:84;H413:84;H201:84
54,2-isopropenylaniline,258-008-7,52562-19-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H315:38;H335:38;H319:38
55,Cyclobutanemethanol,224-575-4,4415-82-1,Flam. Liq. 3,Notified C&L,51.0,H226:51;H315:1;H335:1;H319:1
59,"Ergoline-8-carboxylic acid, 8,9-didehydro-6-methyl-",611-233-8,5516-88-1,Skin Sens. 1,Notified C&L,2.0,H317:2
60,"L-Alanine, N-coco acyl derivs., sodium salts",290-478-9,90170-45-9,Not Classified,REACH registration C&L,7.0,Not classified:4;H319:2;H318:1
61,"5-Diazo-2,4,6(1H, 3H, 5H)-pyrimidinetrione",608-591-2,31221-06-4,Acute Tox. 4,Notified C&L,1.0,H302:1
62,"4-[[5-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-2-sulphophenyl]azo]-4,5-dihydro-5-oxo-1-(4-sulphophenyl)-1H-pyrazole-3-carboxylic acid",288-958-8,85946-19-6,Not Classified,Notified C&L,1.0,Not classified:1
63,potassium ethanolate;potassium ethoxide,213-029-0,917-58-8,Self-heat. 1;Skin Corr. 1B,Harmonised C&L,0.0,H314:0;H251:0
65,Sodium benzenethiolate,213-224-0,930-69-8,Skin Corr. 1B,Notified C&L,39.0,H314:39;H302:1;H312:1;H332:1;H318:1
67,1-(3-Chloro-4-hydroxyphenyl)ethanone,620-213-8,2892-29-7,Not Classified,REACH registration C&L,40.0,Not classified:1;H315:39;H302:39;H318:38;H335:38;H319:1
72,"1,2,4-Triazole-3-carboxylic acid",610-450-5,4928-87-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47.0,H315:46;H335:46;H319:46;H302:1
74,"2-(1-methylethoxy)-1,2-diphenylethan-1-one",229-677-2,6652-28-4,Not Classified,Notified C&L,1.0,Not classified:1
76,"Distillates (petroleum), chemically neutralized light;Kerosine - unspecified;[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-132-5,64742-31-0,Asp. Tox. 1,Harmonised C&L,0.0,H304:0
77,4-methylpyrimidin-2-ylamine,203-591-5,108-52-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H315:46;H335:45;H319:46
78,C.I. Disperse Violet 5,615-397-1,71775-53-6,Not Classified,Notified C&L,1.0,Not classified:1
83,"1,3-Dioxolan-2-one, polymer with 1,4-butanediol and 1,6-hexanediol",604-682-6,149295-53-4,Not Classified,Notified C&L,5.0,Not classified:5
85,"Walnut, Juglans regia, ext.",281-688-1,84012-43-1,Flam. Liq. 3,Notified C&L,1498.0,H226:1436;Not classified:61;H225:2;H319:1
87,[2H4]ethylene,211-675-8,683-73-8,Flam. Gas 1;Press. Gas (Liq.);STOT SE 3,Notified C&L,84.0,H220:84;H336:84;H280:84
89,Enalaprilat,278-459-3,76420-72-9,Acute Tox. 4,Notified C&L,40.0,H302:38;H318:1;H361:2
92,{[2-(6-amino-9H-purin-9-yl)ethoxy]methyl}phosphonic acid,600-789-7,106941-25-7,Acute Tox. 3,Notified C&L,39.0,H301:38;H315:1;H302:1;H373:1
93,zinc oxide,215-222-5,1314-13-2,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H400:0
98,"Boric acid (H3BO3), reaction products with diethanolamine, compds. with diethanolamine and ethanolamine",294-256-2,91696-96-7,Not Classified,Notified C&L,9.0,Not classified:8;H319:1
100,(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoic acid,406-310-6,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,5.0,H315:2;H335:2;H319:2;Not classified:3
102,Tetrabutylammonium nitrite,247-749-1,26501-54-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,72.0,H315:72;H335:72;H319:72
105,"Alcohols, C11-14-branched and linear",287-812-0,85586-10-3,Not Classified,Notified C&L,6.0,Not classified:6
109,C.I. Direct Blue 77,618-325-7,89998-31-2,Not Classified,Notified C&L,1.0,Not classified:1
111,Trisodium 5-[[2-amino-4-[[4-[2-(4-nitro-2-sulphonatophenyl)vinyl]-3-sulphonatophenyl]azoxy]phenyl]azo]naphthalene-1-sulphonate,292-378-0,90604-82-3,Not Classified,Notified C&L,3.0,Not classified:3
114,"3-chloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepin-11-ol 5,5-dioxide",247-944-1,26723-60-4,Not Classified,REACH registration C&L,1.0,Not classified:1
116,"5-[[4-[(4-sulphophenyl)azo]phenyl]azo]salicylic acid, sodium salt",286-202-1,85188-12-1,,Notified C&L,33.0,Not classified:33
117,"4,4'-(1,3,4-oxadiazole-2,5-diyl)dianiline",219-373-8,2425-95-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H315:39;H335:38;H319:39
119,Disisomicin pentakis(sulphate),258-414-4,53179-09-2,Acute Tox. 4;Acute Tox. 4;Repr. 1B,Notified C&L,40.0,H360:40;H312:39;H332:39
125,Exo-2-bornanamine,230-647-6,7242-92-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H315:39;H335:39;H226:39;H319:39
126,m-bis(epoxyethyl)benzene,240-854-3,16832-59-0,Not Classified,Notified C&L,55.0,Not classified:55
128,"1-Propanone, 3-(dimethylamino)-1-(3-methoxyphenyl)-2-methyl-",606-357-4,197145-37-2,Not Classified,Notified C&L,2.0,Not classified:2
129,"N-[2-[(2,6-dicyano-p-tolyl)azo]-5-(diethylamino)phenyl]methanesulphonamide",269-887-1,68385-96-6,Not Classified,REACH registration C&L,28.0,Not classified:28
136,3-methylcrotonic acid,208-782-7,541-47-9,Skin Corr. 1C,REACH registration C&L,167.0,H314:36;H315:131;H318:77;H335:131;H290:1
141,4-chloro-6-fluoro-2-methylquinoline,242-403-6,18529-01-6,,Notified C&L,5.0,H315:5;H335:5;H319:5;H302:1
142,2-bromobenzyl alcohol,242-719-4,18982-54-2,Acute Tox. 4;Eye Irrit. 2,Notified C&L,40.0,H302:38;H319:40;H315:2;H335:2
144,O-phosphoserine,206-986-0,407-41-0,Skin Corr. 1;Eye Dam. 1,REACH registration C&L,41.0,H318:3;H314:3;Not classified:38
145,N-2-hydroxyethylacetamide,205-530-8,142-26-7,Not Classified,REACH registration C&L,78.0,Not classified:19;H315:52;H318:59;H335:52
146,"4,4,4-trifluoro-1-(4-methylphenyl)butane-1,3-dione",615-712-2,720-94-5,Acute Tox. 4;Skin Sens. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,2.0,H302:1;H410:1;H411:1;H318:1;H317:1;H400:1;H315:1;H335:1;H319:1
147,"Benzenesulfonic acid, 4-C10-14-alkyl derivs., compds. with ethanolamine",289-090-2,85995-82-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,7.0,H315:6;H319:3;H302:2;H318:3;Not classified:1;H412:1
149,1-fluoronaphthalene,206-287-0,321-38-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,55.0,H315:51;H335:50;H319:51;Not classified:3;H302:2;H351:1;H410:1;H400:1;H227:1
151,"2-(4,5-dibromo-3,6-dihydroxy-2,7-dinitroxanthen-9-yl)-benzoic acid, disodium salt",208-943-1,548-24-3,Not Classified,Notified C&L,4.0,Not classified:3;H318:1
153,Cadmium oxalate,212-408-8,814-88-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1.0,H302:1;H312:1;H410:1;H332:1;H400:1
155,Isomethadone Nitrile,613-110-4,6293-01-2,Acute Tox. 3;Acute Tox. 3,Notified C&L,1.0,H301:1;H331:1
160,1-Methoxy-4-(4-trans-pentylcyclohexyl)-benzene,617-645-4,84952-30-7,Aquatic Chronic 4,Notified C&L,1.0,H413:1;Not classified:1
172,"1,4-bis(1,2-dibromoethyl)benzene",246-936-5,25393-98-0,Skin Irrit. 2;STOT SE 3,Notified C&L,39.0,H315:38;H335:38;H318:1;H314:1
175,"Benzene,1,1 Methylenebis Isocyanato Homopolymer",609-645-8,39310-05-9,Resp. Sens. 1,Notified C&L,163.0,H334:153;H317:48;H335:48;H319:48;H315:48;H332:48;H351:23;H373:23;Not classified:10
176,Didecyl adipate,203-349-9,105-97-5,Not Classified,Notified C&L,4.0,Not classified:4
181,3-Hydroxybenzenethiol,609-803-6,40248-84-8,Skin Sens. 1;Eye Dam. 1,Notified C&L,41.0,H317:38;H318:39;H314:2;H312:1;H302:1;H332:1;H315:1;H319:1
183,Nonivamide,219-484-1,2444-46-4,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Resp. Sens. 1,Notified C&L,1509.0,H317:1335;H315:1503;H318:1294;H301:1295;H334:1294;H335:210;H319:210;Not classified:5;H300:1
186,"Distillates (petroleum), solvent-refined light naphthenic;Baseoil - unspecified;[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-098-1,64741-97-5,Carc. 1B,Harmonised C&L,0.0,H350:0
191,Methyl 3-(bromomethyl)benzoate,419-100-4,1129-28-8,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,Notified C&L,1.0,H290:1;H318:1;H314:1
193,o-(trifluoromethyl)phenethylamine,212-262-5,774-18-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H335:1;H312:1;H302:1;H319:1;H315:1;H332:1
199,"16-nitroviolanthrene-5,10-dione",204-898-7,128-60-9,Not Classified,REACH registration C&L,12.0,Not classified:12
204,"Gasoline, natural;Low boiling point naphtha;[A complex combination of hydrocarbons separated from natural gas by processes such as refrigeration or absorption. It consists predominantly of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C",232-349-1,8006-61-9,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0.0,H304:0;H340:0;H350:0
206,"imazalil sulphate (ISO) powder;1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate;imazalil sulphate (ISO), aqueous solution",261-351-5,58594-72-2,,,0.0,H317:0;H410:0;H302:0;H314:0;H400:0
207,2-(phenylthio)ethanol,211-828-9,699-12-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H335:1;H312:1;H302:1;H319:1;H315:1;H332:1
208,"Fatty acids, C6-19-branched, calcium salts, overbased",271-376-3,68551-41-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,853.0,H315:713;H319:687;Not classified:118;H413:2;H361:1
209,"Alkenes, C13-14, hydroformylation products, distn. residues",292-429-7,90622-29-0,Not Classified,REACH registration C&L,1.0,Not classified:1
211,5-hydroxytryptophan,200-284-8,56-69-9,Acute Tox. 4;Acute Tox. 4,Notified C&L,2.0,H332:1;H302:2;H226:1;H319:1
214,(E)-3'-hydroxy-4'-methoxycinnamic acid,247-071-6,25522-33-2,Not Classified,Notified C&L,2.0,Not classified:1;H315:1;H335:1;H319:1
222,Ethyl 3-oxopiperidine-4-carboxylate hydrochloride,276-806-3,72738-09-1,,Notified C&L,1.0,H315:1;H335:1;H319:1
223,"Quaternary ammonium compounds, benzyl(hydrogenated tallow alkyl)dimethyl, chlorides, compds. with bentonite and bis(hydrogenated tallow alkyl)dimethylammonium chlorides",275-125-9,71011-25-1,Eye Irrit. 2,Notified C&L,80.0,H319:48;Not classified:32
225,"2,3,4,5,6-pentabromostyrene",258-359-6,53097-59-9,Eye Irrit. 2,Notified C&L,38.0,H319:38
226,"1-Propene, chlorinated, epoxidized, distn. residues",304-800-3,94279-54-6,Flam. Liq. 2;Met. Corr. 1;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 2;Muta. 1B;Carc. 1B;Repr. 1B,Notified C&L,84.0,H290:83;H317:84;H360:84;H340:84;H319:83;H315:84;H330:84;H225:84;H311:84;H350:84;H301:84;H361:1;H320:1
232,p-(1-piperazinyl)phenol,260-289-6,56621-48-8,Not Classified,REACH registration C&L,47.0,Not classified:2;H315:41;H335:40;H319:41;H314:4;H302:4
234,"Resin acids and Rosin acids, esters with ethylene glycol",270-986-7,68512-65-2,Not Classified,Notified C&L,1.0,Not classified:1
235,"2-(2,6-diethyl-4-methyl-phenyl)propanediamide",452-330-3,,Acute Tox. 4;Repr. 2,REACH registration C&L,1.0,H361:1;H302:1
239,Thiocolchicine,220-346-8,2730-71-4,Acute Tox. 2;Eye Dam. 1;Acute Tox. 1;Muta. 1B,Notified C&L,40.0,H340:40;H330:40;H300:40;H318:40;H225:1
240,Isobutyl laurate,253-675-0,37811-72-6,Not Classified,REACH registration C&L,46.0,Not classified:13;H413:33
241,Methyl hydrogen azelate,218-275-2,2104-19-0,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H315:1;H335:1;H319:1
242,cobalt dinitrate,233-402-1,10141-05-6,Skin Sens. 1;Resp. Sens. 1;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1B;Repr. 1B,Harmonised C&L,0.0,H410:0;H317:0;H341:0;H360:0;H400:0;H350:0;H334:0
244,"Riboflavin 5'-(trihydrogen diphosphate), 5'→5'-ester with adenosine, disodium salt",282-733-8,84366-81-4,Not Classified,Notified C&L,4.0,Not classified:4
246,"(Z,Z)-cycloocta-1,5-diene",216-291-4,1552-12-1,Flam. Liq. 3;Acute Tox. 4;Asp. Tox. 1;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,58.0,H226:58;H302:58;H304:38;H411:42;H332:38;H413:16;H317:4;H335:4;H319:4;H315:4
247,"Benzene-1,3-dicarbonitrile",210-933-7,626-17-5,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,138.0,H317:1;H412:1;H302:138;H332:40;H373:1
250,tert-butylcyclohexane,221-652-4,3178-22-1,Flam. Liq. 3,Notified C&L,45.0,H226:45;Not classified:2
253,"4H-Pyrido[1,2-a]pyrimidin-4-one, 3-(2-chloroethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-",603-382-2,130049-82-0,Not Classified,Notified C&L,3.0,Not classified:2;H332:1;H302:1
254,"trisodium [2-{[{[3-{[4-({2-[2-(ethenylsulfonyl)ethoxy]ethyl}amino)-6-fluoro-1,3,5-triazin-2-yl]amino}-2-(hydroxy-kO)-5-sulfophenyl]diazenyl-kN2}(phenyl)methyl]diazenyl-kN1}-4-sulfobenzoato(5-)-kO]cuprate(3-)",402-020-9,,Not Classified,REACH registration C&L,22.0,Not classified:22
256,4-[[5-(carbamoyl)-2-methoxyphenyl]azo]-3-hydroxy-N-phenylnaphthalene-2-carboxamide,268-171-6,68016-05-7,Not Classified,Notified C&L,1.0,Not classified:1
259,O-benzyl-D-serine,233-916-6,10433-52-0,Not Classified,Notified C&L,2.0,Not classified:1;H315:1;H335:1;H319:1
260,Isobutyraldehyde oxime,205-779-2,151-00-8,Acute Tox. 3;Acute Tox. 4;Acute Tox. 4,Notified C&L,1.0,H332:1;H312:1;H301:1
265,"1,3-Dioxolane-4-methanol, 2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-, 4-(4-methylbenzenesulfonate), (2R,4R)-rel-",601-280-2,113770-65-3,Not Classified,Notified C&L,1.0,Not classified:1
274,ethylbenzene,202-849-4,100-41-4,Flam. Liq. 2;Acute Tox. 4;Asp. Tox. 1;STOT RE 2,Harmonised C&L,0.0,H332:0;H304:0;H225:0;H373:0
275,"Reaction product of Hexamethylene diisocyanate, oligomers with Mercaptopropyltrimethoxysilane",924-669-1,,Skin Sens. 1A,REACH registration C&L,6.0,H317:6
281,Alprostadil,212-017-2,745-65-3,Acute Tox. 3;Repr. 2,Notified C&L,71.0,H361:41;H301:71;H360:1
286,"4'-(hexyloxy)[1,1'-biphenyl]-4-carbonitrile",255-358-2,41424-11-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40.0,H335:38;H312:38;H319:39;H315:39;H332:38;H413:1;Not classified:1
288,4-[3-(1-naphthylamino)propyl]morpholine,226-033-2,5235-82-5,Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,4.0,H411:4;H317:4;H319:4
289,Ethyl nicotinate,210-370-7,614-18-6,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,REACH registration C&L,1447.0,H318:138;H335:139;H314:10;H319:1308;H315:131;H334:15;Not classified:2;H317:1
290,"2-[2-(8-heptadecenyl)-4,5-dihydro-1H-imidazol-1-yl]ethyl oleate",280-038-4,82799-41-5,Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Aquatic Acute 1,Notified C&L,22.0,H318:22;H400:22;H314:22;H302:22
291,"Lecithins, egg yolk",297-639-2,93685-90-6,Not Classified,Notified C&L,36.0,Not classified:36
293,"N,N''-ethylenebis[N'-[2-methyl-5-[[(octadecylamino)carbonyl]amino]phenyl]urea]",303-345-8,94166-50-4,Not Classified,REACH registration C&L,4.0,Not classified:4
294,"Distillates (coal tar), light oils, acid exts.; Light Oil Extract Residues, high boiling;[This oil is a complex reaction mass of aromatic hydrocarbons, primarily indene, naphthalene, coumarone, phenol, and o-, m- and p-cresol and boiling in the range of 140°C to 215°C (284°F to 419°F).]",292-609-5,90640-87-2,Muta. 1B;Carc. 1B,Harmonised C&L,0.0,H340:0;H350:0
297,"Silicic acid (H2SiO3), disodium salt, nonahydrate",603-903-3,13517-24-3,Skin Corr. 1B;STOT SE 3,Notified C&L,69.0,H335:43;H314:68;H290:2;H315:1;H302:3;H318:1
298,4-({[4-(acryloyloxy)butoxy]carbonyl}oxy)benzoic acid,608-403-9,297132-04-8,Skin Sens. 1;Eye Irrit. 2,Notified C&L,84.0,H317:84;H319:84
299,Tris(4-methoxyphenyl)phosphine,212-723-0,855-38-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H315:44;H335:43;H319:44;H302:1
301,"1,3-bis(chloromethyl)benzene",210-932-1,626-16-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3,Notified C&L,45.0,H335:40;H302:45;H319:40;H330:43;H315:40;H410:5;H314:5;H400:5;H290:1;H318:1;Not classified:1
305,"Fatty acids, coco, ammonium salts",263-068-2,61789-55-7,Not Classified,Notified C&L,3.0,Not classified:3
307,"1-FLUORO-2,4-DIMETHOXYBENZENE",605-794-8,17715-70-7,Acute Tox. 4,Notified C&L,39.0,H302:38;H315:1;H335:1;H319:1
308,"Reaction products of N,N'-ethane-1,2-diylbis(1,3-propanediamine), cyclohexane, peroxidized 4-butylamino-2,2,6,6-tetramethylpiperidine and 2,4,6-trichloro-1,3,5-triazine",425-020-0,,Not Classified,REACH registration C&L,86.0,Not classified:86
319,"1,4-dinitrosobenzene",203-272-0,105-12-4,Acute Tox. 4,Notified C&L,69.0,H302:69;H314:13
320,"Glucosidase, exo-1,3-β-",232-968-7,9073-49-8,,Notified C&L,2.0,H334:2
325,Tetrahydrogen [μ12-[orthosilicato(4-)-O:O:O:O':O':O':O'':O'':O'':O''':O''':O''']]tetracosa-μ-oxododecaoxododecamolybdate(4-),234-718-2,12027-12-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38.0,H335:38;H312:38;H302:38;H319:38;H315:38;H332:38
326,(R)-o-[[(1-phenylethyl)amino]carbonyl]benzoic acid,244-570-0,21752-35-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H315:39;H335:38;H319:39
327,4-bromophenyl cyclopropyl ketone,230-130-5,6952-89-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H335:2;H312:2;H302:2;H319:2;H315:2
329,"Fatty acids, C6-19-branched, manganese salts",271-377-9,68551-42-8,Skin Irrit. 2,Notified C&L,106.0,H315:104;H413:2;H335:1;H312:1;H302:1;H319:1;H332:1
330,"coumaphos (ISO);O-3-chloro-4-methylcoumarin-7-yl O,O-diethyl phosphorothioate",200-285-3,56-72-4,Acute Tox. 2;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H300:0;H312:0;H400:0
336,"S-[11β,17-dihydroxypregn-4-ene-3,20-dione] 21-(thiopivalate)",259-706-4,55560-96-8,Skin Sens. 1;Aquatic Chronic 4,Notified C&L,2.0,H317:2;H413:1
337,"3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-inden-5-yl propionate",266-829-7,67634-24-6,Aquatic Chronic 2,Notified C&L,297.0,H411:297
339,"[6aS-(6aα,8β,9aα)]-2,3,6a,8,9a-hexahydro-8-hydroxy-4-methoxycyclopenta[c]furo[3',2':4,5]furo[2,3-h][1]benzopyran-1,11-dione",241-832-6,17878-54-5,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2;Carc. 1B,Notified C&L,38.0,H330:38;H310:38;H300:38;H350:38
341,"3,3'-[butane-1,4-diylbis(oxy)]bispropiononitrile",242-485-3,18664-94-3,Not Classified,Notified C&L,83.0,Not classified:83
343,Boron orthophosphate,236-337-7,13308-51-5,Acute Tox. 4;Repr. 1B,REACH registration C&L,56.0,H360:12;H302:12;H315:43;H335:42;H319:43;Not classified:1
346,m-aminobenzamide,222-586-9,3544-24-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H315:46;H335:45;H302:40;H319:46
347,"Silver zeolite (Zeolite, LTA framework type, ion exchanged with silver and ammonium ions)",,130328-18-6,Not Classified,Notified C&L,1.0,Not classified:1
349,"diethyl 1,4-cyclohexanedicarboxylate",417-310-0,72903-27-6,Aquatic Chronic 2,Harmonised C&L,0.0,H411:0
354,Benzylmalonic acid,210-491-5,616-75-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H315:39;H335:38;H319:39
355,β-methylaziridine-1-propiononitrile,223-798-4,4078-19-7,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Acute Tox. 3,REACH registration C&L,85.0,H301:85;H311:85;H317:85;H331:85;H319:83
356,"Lubricating oils (petroleum), C",309-875-6,101316-70-5,Carc. 1B,Harmonised C&L,0.0,H350:0
358,"4-hydroxydinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 4-oxide",252-425-8,35193-63-6,Not Classified,Notified C&L,2.0,Not classified:1;H315:1;H335:1;H319:1
362,Iron (III) tris(4-methylbenzenesulfonate),420-960-8,77214-82-5,Eye Dam. 1,Harmonised C&L,0.0,H318:0
363,"1,1-dimethylprop-3-ynylamine",221-029-7,2978-58-7,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,186.0,H225:130;H302:130;H314:130;H318:86;Not classified:55;H334:40;H317:4;H301:1;H319:1;H311:1;H335:1;H331:1;H315:1
367,"4-trans-Butyl-4'-trans-propyl-[1,1'-bicyclohexyl]",619-232-4,96624-52-1,Not Classified,REACH registration C&L,1.0,Not classified:1
368,"1,2-diacetoxybut-3-ene",421-720-5,18085-02-4,Acute Tox. 4,Harmonised C&L,0.0,H302:0
370,4-phenylbutylamine,236-186-7,13214-66-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H315:39;H335:38;H319:39;H314:5
373,"[(4S,5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzenesulfonate",416-360-0,162221-28-5,Skin Sens. 1,Harmonised C&L,0.0,H317:0
376,Sodium 1-methyl 9-(sulphooxy)octadecanoate,205-389-2,139-99-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,18.0,H315:18;H318:17;H319:1
377,3'-deoxyadenosine,200-791-4,73-03-0,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H301:39;H335:38;H319:39;H315:39;H311:1;H331:1
378,N-methyl-p-toluidine,210-769-6,623-08-5,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0.0,H301:0;H373:0;H311:0;H412:0;H331:0
379,Dimethyl 4-hydroxyisophthalate,227-803-0,5985-24-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
380,"Poly(oxy-1,2-ethanediyl), α-sulfo-ω-(decyloxy)-, ammonium salt (1:1)",610-821-1,52286-19-8,Not Classified,Notified C&L,80.0,Not classified:59;H315:21;H319:20;H318:1
383,α-bromo-o-fluorotoluene,207-169-1,446-48-0,Skin Corr. 1B;STOT SE 3,Notified C&L,49.0,H314:49;H335:41;H318:1;H290:1;H319:2
384,"Reaction mass of 4-(9-amino-1,4-dioxo-2,4-dihydro-1H-benzo[f]heteropolycycle-3-yl)-N-[3-(dimethylamino)propyl]benzensulfonamide and 4,4'-(3,6-dioxo-2,3,5,6-tetrahydroheteropolycycle-1,4-diyl)bis{N-[3-(dimethylamino)propyl]benzenesulfonamide}",473-450-2,,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1.0,H317:1;H410:1;H400:1
386,(Z)-3-methylpent-2-en-4-yn-1-ol,228-168-2,6153-05-5,Flam. Liq. 3;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,2.0,H225:1;H301:2;H318:2;H314:2;H226:2
390,"Trisodium 7-[[4-[(4-aminophenyl)azo]phenyl]azo]naphthalene-1,3,5-trisulphonate",270-027-2,68400-38-4,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1.0,H302:1;H412:1
391,"Formaldehyde, polymer with 2-methyloxirane, oxirane and phenol",607-563-7,25134-86-5,Aquatic Chronic 3,Notified C&L,55.0,H412:55
392,Acetonyl acetate,209-746-3,592-20-1,Not Classified,Notified C&L,141.0,Not classified:140;H315:1;H319:1
393,"Poly(oxy-1,2-ethanediyl), a-(1-oxohexadecyl)-[?]-hydroxy-",618-403-0,9004-94-8,Not Classified,Notified C&L,44.0,Not classified:44
394,"1-[7-(dimethylamino)-4-methyl-2-oxo-2H-1-benzopyran-3-yl]-1H-pyrrole-2,5-dione",259-499-0,55145-14-7,Skin Irrit. 2;STOT SE 3,Notified C&L,38.0,H315:38;H335:38
396,"2-methyl-1,4-dioxaspiro[4.5]decane",225-213-8,4722-68-3,Acute Tox. 4,Notified C&L,38.0,H302:38
397,"Acid chlorides, coco, reaction products with protein hydrolyzates",614-840-6,68952-15-8,Not Classified,Notified C&L,31.0,Not classified:31
401,"2,2,4,4-tetramethyl-7-oxa-3,20-diazadispiro[5.1.11.2]henicosan-21-one hydrochloride",277-620-5,73833-37-1,Eye Dam. 1,Notified C&L,34.0,H318:34
408,2-cyclohexylpropan-1-ol,226-632-9,5442-00-2,Not Classified,Notified C&L,88.0,Not classified:88
413,3-aminobutyric acid,208-783-2,541-48-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H315:38;H335:38;H319:38
416,Ethyl (phenylsulphonyl)acetate,231-516-6,7605-30-3,Acute Tox. 4,Notified C&L,40.0,H302:38;H315:2;H319:2;H335:1
417,"2-methyl-m-phenylenediamine;2,6-toluenediamine",212-513-9,823-40-5,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Muta. 2;Aquatic Chronic 2,Harmonised C&L,0.0,H302:0;H312:0;H341:0;H411:0;H317:0
422,"1,3-dioxolane-2-propan-1-ol",286-766-9,85391-14-6,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H315:1;H335:1;H319:1
424,"Propylene carbonate, oligomeric reaction products with 2-methylpentane-1,5-diamine",500-307-4,119499-55-7,,Notified C&L,1.0,Not classified:1
425,5-Fluoro-2-nitrobenzoic acid methyl ester,609-664-1,393-85-1,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,4.0,H412:3;H317:3;H315:1;H335:1;H319:1
427,cyclohexanone,203-631-1,108-94-1,Flam. Liq. 3;Acute Tox. 4,Harmonised C&L,0.0,H226:0;H332:0
428,"Montan wax, ester with methylated hexamethylolmelamine",297-870-9,93763-50-9,Not Classified,Notified C&L,6.0,Not classified:6
429,"Hydrocarbons, C5-7, C6-rich, ethylene manuf. by-products",294-557-9,91723-50-1,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Repr. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,72.0,H301:9;H319:36;H372:27;H311:9;H335:27;H410:18;H317:18;H331:18;H361:54;H400:18;H225:9;H340:18;H315:18;H350:18;H304:18;H336:18;H312:27;H373:27;H332:18;H411:36;H302:18;H226:9
430,Leptospermum scoparium branch/leaf oil,434-370-3,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H302:1;H319:1
434,"N,N-bis(1-methylethyl)formamide",220-284-1,2700-30-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2.0,H302:2;H312:2;H332:2
438,"2,2,4-trimethyl-4-phenyl-butane-nitrile",422-580-8,75490-39-0,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0.0,H302:0;H411:0
439,"1-Methyl-1H-pyrazol-4-boronic acid, pinacol ester",616-293-9,761446-44-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,54.0,H315:53;H302:53;H335:52;H319:54;H332:2;H312:1
442,"Fatty acids, C8-18",292-769-6,90990-08-2,Skin Corr. 1C;Eye Dam. 1,REACH registration C&L,121.0,H318:113;H314:72;H315:41;Not classified:8
443,"6-propyl-1,3,5-triazine-2,4-diamine",227-737-2,5962-23-2,Not Classified,Notified C&L,1.0,Not classified:1
446,"diuron (ISO);3-(3,4-dichlorophenyl)-1,1-dimethylurea",206-354-4,330-54-1,Acute Tox. 4;Carc. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H302:0;H373:0;H410:0;H351:0;H400:0
448,Iron selenide,215-177-1,1310-32-3,,Notified C&L,4.0,H301:4;H373:4;H410:4;H331:4;H400:4
450,Thixatrol SR,603-123-3,126162-16-1,Skin Irrit. 2,Notified C&L,31.0,H315:31;H319:9
455,3-(methylthio)propyl butyrate,240-680-8,16630-60-7,Not Classified,Notified C&L,92.0,Not classified:81;H315:11;H335:11;H319:11
457,(±)-trans-4-(4-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine,415-550-0,109887-53-8,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0.0,H302:0;H318:0;H411:0
459,Barium strontium niobate,253-383-3,37185-09-4,,Notified C&L,4.0,H302:4;H332:4
460,"1,3,3-trimethyl-2-[2-(1-methyl-2-phenyl-1H-indol-3-yl)vinyl]-3H-indolium chloride",225-097-9,4657-00-5,Acute Tox. 3;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,39.0,H301:26;H318:39;H410:26;H400:26;H302:13;H411:12;H315:1
463,Dibenzyltoluene,248-097-0,26898-17-9,Asp. Tox. 1;Aquatic Chronic 4,Notified C&L,266.0,H304:215;H413:217;H411:38;H410:11;H400:11
465,"Gases (petroleum), fluidized catalytic cracker fractionation off;Refinery gas;[A complex combination produced by the fractionation of the overhead product of the fluidized catalytic cracking process. It consists of hydrogen, hydrogen sulfide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]",272-874-3,68919-02-8,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0.0,H220:0;H340:0;H350:0;Not classified:0
466,"1,3,3-trimethyl-2-[[methyl(p-tolyl)hydrazono]methyl]-3H-indolium hydrogen sulphate",281-429-2,83949-69-3,Acute Tox. 4;Eye Irrit. 2,Notified C&L,2.0,H302:2;H319:2
467,Diethyl cinnamylidenemalonate,246-899-5,25364-76-5,Acute Tox. 4,Notified C&L,38.0,H302:38
469,"6-chloro-1,3-dimethyluracil",230-205-2,6972-27-6,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,10.0,H315:10;H318:2;H335:7;H319:8
476,2-amino-4-(trifluoromethyl)benzonitrile,216-047-7,1483-54-1,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3,Notified C&L,3.0,H301:3;H319:3;H311:3;H331:3;H315:3;H335:2
477,"Oils, fish, bisulfited, ammonium salts",272-500-9,68855-96-9,Not Classified,Notified C&L,3.0,Not classified:3
481,3-methoxy-4-nitrobenzyl alcohol,279-593-5,80866-88-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H315:39;H335:39;H319:39
482,Clove leaf oil,616-969-3,8015-97-2,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1,Notified C&L,4.0,H315:2;H302:3;H317:3;H312:1;H319:2;H335:1;H334:1;H304:2;Not classified:1
484,"2-Imidazolidinone, 4,5-dimethoxy-1,3-bis(methoxymethyl)-",617-698-3,85306-00-9,Skin Sens. 1,Notified C&L,1.0,H317:1
486,"4'-butoxy[1,1'-biphenyl]-4-carbonitrile",258-123-2,52709-87-2,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39.0,H335:38;H410:38;H318:38;H315:39;H400:38;H319:1
489,"9-Octadecenoic acid (Z)-, 2-methylpropyl ester, sulfated, sodium salts",294-020-9,91672-16-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1.0,H315:1;H318:1
491,Gadolinium trihydroxide,240-516-5,16469-18-4,Not Classified,Notified C&L,2.0,Not classified:2
497,Alpha-chloro-2-methyl-3-nitrotoluene,262-249-3,60468-54-4,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,41.0,H318:39;H314:41;H335:38;H290:1
502,1-(2-methoxypropoxy)propan-2-ol,236-547-9,13429-07-7,,Notified C&L,304.0,Not classified:304
511,4-CHLORO-3-METHYLBENZOIC ACID,616-415-0,7697-29-2,,Notified C&L,8.0,H319:8;H315:8;H335:7
515,"Soaps, stocks, safflower-oil, acidulated, hydrogenated",296-509-2,92704-73-9,Not Classified,Notified C&L,1.0,Not classified:1
522,Cyclopropyl methyl ketone,212-146-4,765-43-5,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,242.0,H302:160;H314:5;H225:209;H318:156;H319:41;H301:41;H335:4;H315:8
526,3-methylbutyronitrile,210-884-1,625-28-5,Flam. Liq. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H319:41;H335:40;H301:41;H315:41;H226:41;H311:1;H331:1
529,N-[3-(dimethoxymethylsilyl)propyl]ethylenediamine,221-336-6,3069-29-2,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1A;Eye Dam. 1,REACH registration C&L,455.0,H315:98;H302:70;H317:307;H318:324;H314:135;H301:32;H412:24;Not classified:1;H319:1;H290:1;H411:1
531,2-chlorobenzaldehyde;o-chlorobenzaldehyde,201-956-3,89-98-5,Skin Corr. 1B,Harmonised C&L,0.0,H314:0
532,2-ethylideneundec-10-en-1-al,276-965-9,72894-14-5,Skin Irrit. 2,Notified C&L,88.0,H315:88
533,"4-[4-(3,4-Difluorophenyl)-cyclohexyl]-cyclohexanone",605-495-2,167948-98-3,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2.0,H410:2;H400:2
536,Ditridecyl maleate,263-208-2,61791-92-2,Not Classified,REACH registration C&L,22.0,Not classified:21;H319:1;H315:1
542,2-(2-(2-Phenylpropan-2-yl)-2H-tetrazol-5-yl)phenylboronic acid,617-572-8,844681-82-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H335:1
545,Diphenyllead dichloride,218-325-3,2117-69-3,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39.0,H373:39;H302:39;H410:39;H400:39;H332:39;H360:39
550,"S,S-dimethyl carbonodithioate",617-931-9,868-84-8,Acute Tox. 4,Notified C&L,40.0,H302:40;H226:1;H332:1
553,"α,α,α-trifluoro-3-tolyl isocyanate",206-341-3,329-01-1,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1A;Eye Dam. 1;Acute Tox. 1;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,47.0,H330:45;H317:41;H335:46;H411:2;H311:3;H315:47;H318:2;H302:44;H226:44;H334:44;H319:6;H332:1;H331:1;H301:1
556,Hexafluoroacetone,211-676-3,684-16-2,Press. Gas (Liq.);Skin Corr. 1A,Notified C&L,159.0,H330:157;H314:110;H280:110;H370:47;H372:47;H301:88;H310:47;H360:86;H315:49;H318:47;H311:41;Not classified:2;H319:2;H335:2
562,"Sulphamic acid, sodium salt",247-584-5,26288-34-6,Not Classified,Notified C&L,3.0,Not classified:3
564,"Cyclohex-1,3-ylenediamine",222-194-8,3385-21-5,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1,Notified C&L,2.0,H314:2;H302:2;H318:1;H312:1;H332:1
567,"1-Propene, 2-methyl-, chlorinated, epoxidized, distn. residues",304-801-9,94279-55-7,Flam. Liq. 3;Met. Corr. 1;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 2;Muta. 1B;Carc. 1B,Notified C&L,84.0,H330:84;H317:84;H319:83;H340:84;H350:84;H311:84;H301:84;H290:83;H315:84;H226:84;H320:1;H331:1
568,"Boric acid (H3BO3), reaction products with 2-amino-2-methyl-1-propanol",294-255-7,91696-95-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
573,N-(4-amino-2-chloro-5-methylphenyl)benzamide,204-456-3,121-22-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H319:2;H315:2;H335:2
575,Potassium 5-oxo-L-prolinate,225-373-9,4810-50-8,Not Classified,Notified C&L,1.0,Not classified:1
576,2-nitrobenzenesulphonic acid,201-311-6,80-82-0,,Notified C&L,34.0,Not classified:33;H314:1;H318:1
577,Sodium dihydrogenorthophosphate,231-449-2,7558-80-7,Not Classified,REACH registration C&L,643.0,Not classified:585;H319:58;H315:49;H335:48;H318:1
581,"[N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κN][(1,2,3,4-η)-1,3-pentadiene]-titanium",419-840-8,169104-71-6,Flam. Sol. 1;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0.0,H314:0;H413:0;H228:0;H317:0
584,"1H-Imidazole-1-ethanol, 4,5-dihydro-, 2-C15-17-unsatd. alkyl derivs.",273-051-1,68937-01-9,,Notified C&L,60.0,H314:56;Not classified:4
589,"Collagens, hydrolyzates",295-635-5,92113-31-0,Not Classified,Notified C&L,93.0,Not classified:83;H317:10
594,Trimethyloctylammonium dimethyl phosphate,285-814-6,85153-34-0,Not Classified,Notified C&L,1.0,Not classified:1
596,2-methylpent-2-ene,210-883-6,625-27-4,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,73.0,H225:73;H304:51;H319:22;H315:22;H335:22;H336:8
597,p-bis(epoxyethyl)benzene,240-853-8,16832-58-9,Not Classified,Notified C&L,55.0,Not classified:55
598,N-[3-(methoxydimethylsilyl)propyl]ethylenediamine,221-337-1,3069-33-8,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,1.0,H314:1;H302:1;H318:1
600,sec-butylurea,211-709-1,689-11-2,Acute Tox. 4;Skin Sens. 1,Notified C&L,38.0,H302:38;H317:38
601,Methyl 4-methyl-3-[[(1-oxo-2-(propylamino)propyl]amino]-2-thenoate monohydrochloride,245-957-7,23964-57-0,Acute Tox. 4;Eye Irrit. 2,Notified C&L,193.0,H319:186;H302:152;H315:41;H335:50;H312:10;H332:11;H412:12
602,ALIPHATIC POLYSULPHIDE POLYMER,614-671-8,68611-50-7,Aquatic Chronic 3,Notified C&L,173.0,H412:134;H411:35;H319:34;H315:34;H335:34;Not classified:4;H229:1;H223:1
604,"1H-Tetrazol-5-amine-, N-1H-tetrazol-5-yl-, monoammonium salt",485-280-6,,Flam. Sol. 1;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1.0,H319:1;H228:1;H412:1
608,Alpha-methylcyclopropanemethanol,212-145-9,765-42-4,Flam. Liq. 3,Notified C&L,41.0,H226:41
609,Disodium 2-[(1-hydroxy-4-sulphonato-2-naphthyl)azo]benzoate,229-070-2,6408-82-8,Not Classified,Notified C&L,9.0,Not classified:9
610,"1,2,5-trimethylpyrrole",213-225-6,930-87-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H315:39;H226:39;H335:38
611,"2,2,2-trifluoroethyl acrylate",206-987-6,407-47-6,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,46.0,H312:38;H302:38;H319:45;H335:44;H332:38;H315:45;H225:45;H411:1;H226:1
615,Triethyltin chloride,213-616-1,994-31-0,,Notified C&L,4.0,H330:4;H410:4;H400:4;H310:4;H300:4
616,3-(dimethylamino)propyl acrylate,242-402-0,18526-07-3,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,38.0,H312:38;H314:38;H302:38;H332:38
621,"2-Propenoic acid, polymer with butyl 2-propenoate and ethenylbenzene",607-751-9,25586-20-3,Not Classified,Notified C&L,6.0,Not classified:6
622,Transglutaminase,616-952-0,80146-85-6,Resp. Sens. 1,Notified C&L,33.0,H334:33
623,"Methyl 1,2,4-triazole-3-carboxylate",610-451-0,4928-88-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H319:43;H315:43;H335:43
625,"Wheat, ext.",281-689-7,84012-44-2,Not Classified,REACH registration C&L,150.0,Not classified:72;H317:78
628,"Tricyclo(3.3.1.1'3,7)decane-1-carbonyl chloride",218-252-7,2094-72-6,Skin Corr. 1B,REACH registration C&L,47.0,H314:47;H318:2;H312:1;H302:1;H332:1;H290:1;H341:1
632,"Disodium [[4-[bis[4-[(sulphonatophenyl)amino]phenyl]methylene]cyclohexa-2,5-dien-1-ylidene]amino]benzenesulphonate",249-352-9,28983-56-4,Not Classified,REACH registration C&L,2137.0,Not classified:2093;H319:44;H315:44;H302:40;H335:44
633,"Isooctanoic acid, mixed esters with dipentaerythritol, heptanoic acid, octanoic acid and pentaerythritol",282-967-0,84501-48-4,Not Classified,Notified C&L,41.0,Not classified:41
635,(E)-hex-3-enyl isobutyrate,283-582-0,84682-20-2,Not Classified,Notified C&L,88.0,Not classified:88
636,Fluindione,213-484-5,957-56-2,Not Classified,Notified C&L,1.0,Not classified:1
637,Titanium trioxide,215-698-4,1344-55-4,Not Classified,Notified C&L,1.0,Not classified:1
638,5-bromothiophene-2-carbaldehyde,225-176-8,4701-17-1,,Notified C&L,9.0,H319:9;H315:9;H335:9;H312:1;H302:1;H332:1
646,Hydroxyaluminium bis(2-ethylhexanoate),250-322-2,30745-55-2,Not Classified,Notified C&L,5.0,Not classified:4;H319:1;H315:1;H228:1
648,1-(4-methyl-2-nitrophenylazo)-2-naphthol,219-372-2,2425-85-6,Not Classified,REACH registration C&L,567.0,Not classified:403;H413:83;H410:80;H318:80;H400:38;H335:1
649,"Bis(2,4-dichlorophenyl) carbonate",247-748-6,26496-99-1,Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,2.0,H411:1;H317:2;H412:1
650,"7-aminonaphthalene-1,3,5-trisulphonic acid",248-394-5,27310-25-4,Skin Corr. 1C;Eye Dam. 1,REACH registration C&L,2.0,H314:1;H318:1;Not classified:1
651,Trifluoromethanesulphonyl chloride,207-009-0,421-83-0,Skin Corr. 1B,REACH registration C&L,51.0,H314:51;H290:1;H318:1;H335:1
655,Germanium tetraiodide,236-613-7,13450-95-8,Skin Corr. 1B;Eye Dam. 1,Notified C&L,42.0,H314:42;H318:38
659,"Pentasodium 4-hydroxy-5-[[4-[[[[5-hydroxy-7-sulphonato-6-[[2-sulphonato-4-[(4-sulphonatophenyl)azo]phenyl]azo]-2-naphthyl]amino]carbonyl]amino]-5-methoxy-o-tolyl]azo]naphthalene-2,7-disulphonate",277-180-4,72987-21-4,Not Classified,Notified C&L,9.0,Not classified:9
662,"11β,17,21-trihydroxypregna-1,4-diene-3,20-dione 21-(dihydrogen phosphate)",206-120-1,302-25-0,Repr. 1B,REACH registration C&L,3.0,H360:1;H361:2;H373:1
667,"[S-(R*,R*)]-2,2'-(ethylenediimino)dibutan-1-ol dihydrochloride",213-970-7,1070-11-7,Repr. 1B,Notified C&L,43.0,H360:42;H319:2;H315:2;H335:1
670,"1,3,3-trimethyl-2-[[methyl(p-tolyl)hydrazono]methyl]-3H-indolium dihydrogen phosphate",281-428-7,83949-68-2,Acute Tox. 4;Eye Irrit. 2,Notified C&L,2.0,H319:2;H302:2
671,(methoxymethyl)diphenylphosphine oxide,224-704-4,4455-77-0,Acute Tox. 4,Notified C&L,43.0,H302:43
674,"Alcohols, C12-15, branched and linear, ethoxylated",500-294-5,106232-83-1,Aquatic Acute 1;Aquatic Chronic 3,Notified C&L,292.0,H410:83;H412:97;H400:196;H302:147;H318:209;Not classified:5
679,5-methyl-2-nitroanisole,253-975-1,38512-82-2,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39.0,H319:39;H302:39
680,"1-Propanesulfonic acid, 3-chloro-2-hydroxy-, monosodium salt, reaction products with 2-heptyl-4,5-dihydro-1H-imidazole-1-ethanol",271-863-0,68610-39-9,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,16.0,H319:16;H412:15;H315:1
681,"2,3-dichlorobenzoic acid",200-039-5,50-45-3,Acute Tox. 4;Eye Irrit. 2A;Aquatic Chronic 4,REACH registration C&L,144.0,H319:139;H302:97;H413:1;H412:92;H315:46;H335:45;H312:3;H332:3;H317:3;H400:1
685,"trans-2,4'-vinylenedipyridine",238-866-9,14802-41-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
686,"Beta,beta-styrenedicarbonitrile",220-283-6,2700-22-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43.0,H312:42;H302:42;H319:43;H335:42;H332:42;H315:43;H301:1
687,"1-ethyl-2-methylnaphtho[1,2-d]thiazolium toluene-p-sulphonate",256-017-0,42952-29-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
688,2-fluoro-6-trifluoromethylpyridine,428-100-3,94239-04-0,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0.0,H412:0;H302:0;H226:0;H332:0
689,Pancreatic extracts,232-500-1,8054-41-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3;Aquatic Acute 1,Notified C&L,1.0,H302:1;H335:1;H400:1;H315:1;H334:1;H318:1
690,Trisodium hexachlororhodate,239-047-9,14972-70-4,Acute Tox. 4;Eye Irrit. 2,Notified C&L,40.0,H319:39;H302:38;H335:1;H315:1;H290:2;H318:1
691,"Phosphoric acid, octadecyl ester",254-466-7,39471-52-8,Not Classified,REACH registration C&L,118.0,Not classified:57;H314:39;H319:22;H315:3
692,Cobalt oxalate,212-409-3,814-89-1,Skin Sens. 1B;Repr. 1B;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,8.0,H411:1;H360:1;H317:3;H400:2;H312:5;H302:5;H341:1;H410:1
694,Isovaleramide,208-781-1,541-46-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H335:1
695,"20,20-Ethylenedioxy-17-hydroxy-1,4,6-pregnatrien-3-one",618-972-5,93771-36-9,Not Classified,Notified C&L,1.0,Not classified:1
698,"(7aS,13aR,13bR,13cS)-dodecahydro-1H,5H,10H-dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one 4-oxide",605-514-4,16837-52-8,Acute Tox. 4,Notified C&L,196.0,H302:196
701,"3,4,5,6,7,8,9,10,11,12,13,14-dodecahydro-2H-cyclododeca[b]pyran",251-090-5,32539-83-6,Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,64.0,H410:64;H319:64;H315:64;H400:64
708,"4-(tert-butyl)-N-sec-butyl-2,6-dinitroaniline",251-607-4,33629-47-9,Acute Tox. 4;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,131.0,H410:131;H361:1;H302:128;H400:131;H319:130;H341:127;H335:3;H311:3;H315:3
710,"Fatty acids, montan-wax, mixed esters with adipic acid and trimethylolpropane",615-938-1,73246-99-8,Not Classified,Notified C&L,36.0,Not classified:36
712,1-[4-(2-methoxyethoxy)phenyl]piperazine,610-679-0,515160-72-2,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H335:1
713,"slimes and sludges, copper electrolyte refining, decopperised",305-433-1,94551-87-8,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1A,Harmonised C&L,0.0,H317:0;H372:0;H410:0;H400:0;H350:0;H360:0;H341:0;H334:0
714,Bis(6-methylheptyl) adipate,203-348-3,105-96-4,Not Classified,Notified C&L,1.0,Not classified:1
716,(Trifluoromethyl)trimethylsilane,617-210-9,81290-20-2,Flam. Liq. 2,Notified C&L,50.0,H225:50;H319:8;H315:8;H335:8
718,Undec-10-enonitrile,258-413-9,53179-04-7,,Notified C&L,1287.0,H411:1286;H315:1287;H318:1286;H400:1
720,"Fatty acids, C16-18, tetraesters with pentaerythritol",293-029-5,91050-82-7,Not Classified,REACH registration C&L,23.0,Not classified:23
724,tert-butyl alaninate hydrochloride,236-497-8,13404-22-3,Not Classified,Notified C&L,3.0,Not classified:1;H319:2;H315:2;H335:2
725,(methylthio)acetic acid,219-483-6,2444-37-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H319:45;H315:45;H335:45
727,Dipotassium dihydrogen ethylenediaminetetraacetate,217-895-0,2001-94-7,Acute Tox. 4;STOT RE 2,REACH registration C&L,69.0,H373:13;H332:18;H319:47;H302:25;H412:25;H315:20;H317:20;H335:20;Not classified:4
733,Noscapine,204-899-2,128-62-1,Acute Tox. 4,REACH registration C&L,200.0,H302:200;H317:2;H334:2;H332:1
737,"Propanenitrile, 3-[[4-[2-[5,6(or 6,7)-dichloro-2-benzothiazolyl]diazenyl]-3-methylphenyl]ethylamino]-",616-631-5,78564-86-0,Not Classified,Notified C&L,2.0,Not classified:2
738,"6-(2-chlorophenyl)-1,3,5-triazine-2,4-diamine",249-587-7,29366-77-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38.0,H319:38;H302:38
739,"Cinnamomum loureirii, ext.",307-474-0,97659-68-2,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1342.0,H312:1342;H319:1341;H315:1342;H317:1342
741,"3,6-dihydro-4-methyl-2-phenyl-2H-pyran",262-187-7,60335-71-9,Aquatic Chronic 3,Notified C&L,1408.0,H412:1296;Not classified:112
743,"octyl 3,4,5-trihydroxybenzoate",213-853-0,1034-01-1,Acute Tox. 4;Skin Sens. 1,Harmonised C&L,0.0,H302:0;H317:0
744,"1-cyclohexyl-1H-pyrrole-2,5-dione",216-630-6,1631-25-0,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1A;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,49.0,H317:4;H319:49;H335:48;H400:4;H301:5;H315:49;H412:4;H330:1
745,"(2R)-Oxiranecarboxylic acid, methyl ester",601-036-5,111058-32-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H315:39;H335:39;H341:1;H351:1
748,Styleze W-20,437-650-3,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1.0,H410:1;H400:1
749,"Ethanol, 2-[2-[2-[2-(4-nonylphenoxy)ethoxy]ethoxy]ethoxy]-, branched",294-139-6,91673-24-4,Flam. Gas 2,Notified C&L,1.0,H221:1
751,"4-[4-[[2,5-dimethoxy-4-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonic acid",246-813-6,25311-20-0,Not Classified,Notified C&L,2.0,Not classified:2
754,"Ethane-1,2-disulphonic acid, compound with 2-chloro-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine (1:1)",215-019-1,1257-78-9,Acute Tox. 4,Notified C&L,38.0,H302:38
755,"prochloraz (ISO);N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]-1H-imidazole-1-carboxamide",266-994-5,67747-09-5,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H302:0;H400:0
756,Thallium hydrogen carbonate,249-868-4,29809-42-5,Acute Tox. 2;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,38.0,H373:38;H330:38;H411:38;H300:38
759,p-fluorophenyl 4-piperidyl ketone hydrochloride,247-070-0,25519-78-2,Acute Tox. 3;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,4.0,H412:1;H317:2;H301:2;H318:2;H319:2;H315:3;H335:2;H312:1;H302:1;H332:1
761,Adenosine 5'-triphosphate,200-283-2,56-65-5,Not Classified,Notified C&L,2.0,Not classified:2
768,"Quaternary ammonium compounds, benzyl(hydrogenated tallow alkyl)dimethyl, chlorides, compds. with hectorite",275-126-4,71011-26-2,Not Classified,Notified C&L,310.0,Not classified:310
772,triethyl phosphate,201-114-5,78-40-0,Acute Tox. 4,Harmonised C&L,0.0,H302:0
778,4-(4-nitrophenylazo)-1-naphthol,226-129-4,5290-62-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H319:43;H315:43;H335:42;H312:1;H302:1;H332:1
779,1-(4-bromophenyl)-2-chloroethan-1-one,224-134-6,4209-02-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
780,"2,2',3,3',5,5',6,6'-octafluoro-1,1'-biphenyl",223-418-7,3883-86-1,Not Classified,Notified C&L,4.0,Not classified:3;H319:1;H315:1;H335:1
783,"Bis(1,2,2,6,6-pentamethyl-4-piperidyl) sebacate",255-437-1,41556-26-7,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1428.0,H410:1275;H317:1286;H400:1244;Not classified:104;H318:32;H411:10;H319:1;H315:1
784,2-methyl-1H-indole-3-ethylamine,220-347-3,2731-06-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H319:2;H315:2;H335:1
786,"Amides, vegetable-oil, N,N-bis(hydroxyethyl)",268-952-1,68155-26-0,Not Classified,REACH registration C&L,476.0,Not classified:444;H411:1;H314:1;H319:20;H315:31;H318:11
787,methyl-3-methoxyacrylate,412-900-4,5788-17-0,Skin Sens. 1,Harmonised C&L,0.0,H317:0
788,pethoxamide (ISO);2-chloro-N-(2-ethoxyethyl)-N-(2-methyl-1-phenylprop-1-enyl)acetamide,600-765-6,106700-29-2,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H302:0;H317:0;H400:0
789,O-ethyl O-4-nitrophenyl phenylphosphonothioate;EPN,218-276-8,2104-64-5,Acute Tox. 2;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H310:0;H410:0;H300:0;H400:0
792,Sodium 4-(2-hydroxynaphth-1-ylazo)-3-methylbenzenesulphonate,227-458-6,5850-86-2,STOT RE 1;Aquatic Chronic 3,REACH registration C&L,16.0,H372:13;H412:13;Not classified:3
793,"m-xylene-α,α'-diol",210-934-2,626-18-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,41.0,H319:40;H302:40;H315:2;H335:2
794,"Reaction product of m-tolylidene diisocyanate (247-722-4) and cyclohexylamine (203-629-0) and cyclohex-1,2-ylenediamine (211-776-7) and (Z)-octadec-9-enylamine (204-015-5)",924-067-9,,Not Classified,Notified C&L,1.0,Not classified:1
797,Cyclohexyl butyrate,216-290-9,1551-44-6,Not Classified,Notified C&L,236.0,Not classified:236
802,1-(3-methylpyrazinyl)ethan-1-one,245-889-8,23787-80-6,Acute Tox. 4,Notified C&L,1453.0,H302:1378;H319:77;H315:77;H335:75
804,"Fatty acids, rape-oil, hydrogenated, magnesium salts",294-323-6,91697-61-9,Not Classified,Notified C&L,1.0,Not classified:1
805,"[2R*(4R*,8R*)]-(±)-3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-benzopyran-6-ol",218-197-9,2074-53-5,Skin Sens. 1B,Notified C&L,20.0,H317:13;Not classified:7
812,"Cellulose, 2-hydroxypropyl methyl ether, acetate hydrogen butanedioate",615-255-9,71138-97-1,Not Classified,Notified C&L,22.0,Not classified:22
815,Nordazepam,214-123-4,1088-11-5,Not Classified,REACH registration C&L,47.0,Not classified:4;H302:42;H331:1;H311:1;H301:1;H373:1
816,"2,4-dinonylphenol",205-310-1,137-99-5,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,54.0,H315:54;H317:54;H412:54
820,(2S)-2-amino-5-(tert-butoxy)-5-oxopentanoic acid,607-337-8,2419-56-9,Not Classified,Notified C&L,2.0,Not classified:1;H319:1;H315:1;H335:1
822,"Ethanedioic acid, potassium salt, hydrate (2:1:2)",612-064-2,6100-20-5,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A,Notified C&L,48.0,H312:46;H314:38;H302:46;H332:2;H301:2;H331:1;H311:1
825,"4-[[4-[[(4,6-dimethyl-2-pyrimidinyl)amino]sulphonyl]phenyl]amino]-4-oxoisocrotonic acid",253-551-6,37560-05-7,Not Classified,Notified C&L,1.0,Not classified:1
828,"Castor oil, dehydrated",264-705-7,64147-40-6,Not Classified,REACH registration C&L,192.0,Not classified:191;H413:1
829,[No public or meaningful name is available],471-080-6,,Not Classified,Notified C&L,31.0,Not classified:31
831,"Oils, fish, bisulfited, sodium salts",272-501-4,68855-97-0,Skin Irrit. 2,Notified C&L,48.0,H315:32;Not classified:16
832,3-(Methylthio)hexyl acetate,610-722-3,51755-85-2,Not Classified,Notified C&L,128.0,Not classified:88;H315:40;H319:1
833,CGX ANUCA 0386,456-830-2,,Not Classified,REACH registration C&L,84.0,Not classified:84
837,"Benzenamine, 3-chloro-2,6-dimethyl-, hydrochloride (1:1)",615-791-3,72725-98-5,,Notified C&L,5.0,H319:5;H315:5;H302:5;H335:5;H312:1;H332:1
839,"4,4'-bis[[4-(2-methoxyethoxy)-6-[methyl(2-sulphoethyl)amino]-1,3,5-triazin-2-yl]amino]stilbene-2,2'-disulphonic acid, sodium salt",285-886-9,85154-05-8,Not Classified,Notified C&L,1.0,Not classified:1
844,"Phenol, 2,2'-polythiobis[4-C8-30-alkyl derivs., calcium salts, overbased",291-829-9,90480-91-4,Not Classified,Notified C&L,517.0,Not classified:448;H413:69
848,1-phenylcyclopropanecarboxylic acid,228-090-9,6120-95-2,,Notified C&L,7.0,H319:7;H315:7;H335:6
849,"Silicic acid, barium salt",235-746-8,12650-28-1,Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,2.0,H314:1;H302:2;H332:2;H373:1;H410:1;Not classified:1;H360:1
856,5-fluoro-2-nitrophenol,207-168-6,446-36-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47.0,H312:43;H302:47;H319:46;H335:45;H332:43;H315:46
858,Diethylbenzylidene malonate dimethicone,606-621-9,207574-74-1,Acute Tox. 2;Aquatic Chronic 4,Notified C&L,76.0,H330:52;H413:52;H412:24
859,"Furan-3,4-diyldimethanol",238-505-5,14496-24-3,Eye Dam. 1,Notified C&L,38.0,H318:38
861,"Fatty acids, tall-oil, compds. with triethanolamine",268-638-4,68132-46-7,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,41.0,H315:31;H318:2;H319:30;Not classified:9
862,4-methoxybenzyl alcohol,203-273-6,105-13-5,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,1894.0,H319:75;H315:85;H317:1806;H302:1859;H318:1816;H335:45;H411:1
864,"2,2-bis(hydroxymethyl)propane-1,3-diyl didocosanoate",269-495-0,68258-72-0,Not Classified,REACH registration C&L,4.0,Not classified:4
866,Ammonium iodide,234-717-7,12027-06-4,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,54.0,H319:49;H315:48;H335:46;Not classified:4;H302:1
867,Trimethyl(1-methylethoxy)silane,217-372-7,1825-64-5,Flam. Liq. 2,Notified C&L,38.0,H225:38
868,crimidine (ISO);2-chloro-6-methylpyrimidin-4-yldimethylamine,208-622-6,535-89-7,Acute Tox. 2,Harmonised C&L,0.0,H300:0
869,"Formaldehyde, oligomeric reaction products with nonylphenol and triethylenetetramine",921-545-9,,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,1.0,H315:1;H317:1;H318:1
874,"Fatty acids, castor-oil, hydrogenated",263-131-4,61790-39-4,Not Classified,Notified C&L,40.0,Not classified:40
875,"difenoconazole (ISO); 1-({2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole; 3-chloro-4-[(2RS,4RS;2RS,4SR)-4-methyl-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-2-yl]phenyl 4-chlorophenyl ether",601-613-1,119446-68-3,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,186.0,H410:182;H319:125;H302:186;H400:183;H332:39;H318:5;H304:1;H336:1;H335:1;H315:1;H226:1;H330:1
876,Trimethylsilyl benzenesulphonate,241-833-1,17882-06-3,Flam. Liq. 2,Notified C&L,38.0,H225:38
879,Magnesium sulphide,234-771-1,12032-36-9,Self-heat. 2;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,42.0,H302:38;H314:38;H252:38;H400:38;H311:38;H319:4;H315:4;H261:4;H335:4
880,Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate,608-053-7,27143-07-3,,Notified C&L,2.0,H315:1;H413:1
881,(2-hydroxyethyl)ammonium dodecylsulfate,225-214-3,4722-98-9,Skin Irrit. 2;Eye Dam. 1,Notified C&L,3.0,H315:3;H318:2;H319:1
882,"Benzene, 1-butyl-4-chloro-",604-986-9,15499-27-1,,Notified C&L,1.0,H312:1;H302:1;H332:1
884,"Gonadotropin, chorionic",232-660-2,9002-61-3,Repr. 2,Notified C&L,115.0,H361:40;H372:51;H360:51;H317:24;H334:24;H332:24;H319:1;H315:1;H335:1
886,(E)-hex-4-en-1-ol,213-188-6,928-92-7,Eye Irrit. 2,Notified C&L,39.0,H319:39
887,Sodium [3-hydroxy-4-[(1-hydroxy-5-sulpho-2-naphthyl)azo]naphthalene-1-sulphonato(4-)]chromate(1-),289-530-3,89899-25-2,Aquatic Chronic 2,REACH registration C&L,2.0,H411:2
895,Isometheptene,207-959-6,503-01-5,Flam. Liq. 3;Acute Tox. 4;Eye Irrit. 2;STOT SE 3,REACH registration C&L,1.0,H319:1;H302:1;H226:1;H335:1
896,Dicycloverine,201-009-4,77-19-0,Acute Tox. 4,REACH registration C&L,1.0,H302:1
898,4-aminophenylacetonitrile,222-587-4,3544-25-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,44.0,H312:43;H302:43;H332:43;H319:5;H335:5;H315:5;H331:1;H311:1;H301:1
902,"Lubricating oils (petroleum), C",309-874-0,101316-69-2,Carc. 1B,Harmonised C&L,0.0,H350:0
903,N-[3-(dimethylamino)propyl]isooctadecan-1-amide,267-101-1,67799-04-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,442.0,H315:442;H318:442
904,"1,4-Benzenedicarbonyl dichloride, polymer with 1,4-benzenediamine",607-870-6,26125-61-1,Not Classified,Notified C&L,102.0,Not classified:102
905,"2,7,11-trimethyl-13-(2,6,6-trimethylcyclohex-1-en-1-yl)tridecahexaen-2,4,6,8,10,12-al",415-770-7,1638-05-7,Skin Sens. 1;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0.0,H373:0;H317:0;H412:0
910,"α,α,α-trifluoro-3-nitrotoluene",202-670-1,98-46-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3,Notified C&L,80.0,H330:78;H302:78;H319:79;H335:74;H315:79;H312:4;H301:2;H311:1;H331:1
913,C.I. Pigment Red 184,619-430-0,99402-80-9,Not Classified,Notified C&L,176.0,Not classified:176
914,2-oxoimidazolidine-1-carbonyl chloride,236-185-1,13214-53-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H315:39;H335:38
916,"N-(2-methylsulfinyl-1,1-dimethyl-ethyl)-N'-{2-methyl-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl}phthalamide",609-338-9,371771-07-2,Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,2.0,H411:2;H302:2
918,"(2,5-dimethyl-4-oxofuran-3-yl) acetate",609-950-6,4166-20-5,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1198.0,H411:1158;H317:1158;H302:40
920,4-phenylbut-1-ene,405-980-7,768-56-9,Skin Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H315:0
922,Disodium glycerol phosphate,215-613-0,1334-74-3,Not Classified,Notified C&L,51.0,Not classified:51
923,4-hydroxy-α-[(methylamino)methyl]benzyl alcohol hydrochloride,227-804-6,5985-28-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H319:2;H315:2;H335:2
924,1-[[4-[(4-aminophenyl)methyl]phenyl]amino]-3-phenoxypropan-2-ol,269-936-7,68391-25-3,Not Classified,Notified C&L,22.0,Not classified:22
928,"5,7-Dimethoxy[1,2,4]triazolo[1,5-a]pyrimidin-2-amine",603-562-0,13223-43-3,Acute Tox. 4,Notified C&L,136.0,H302:80;Not classified:56
929,Tris(2-hydroxyethyl)ammonium dodecylsulfate,205-388-7,139-96-8,Skin Irrit. 2;Eye Dam. 1,Notified C&L,125.0,H315:123;H318:99;H319:24;H400:2;H412:1;H302:1
933,"(5α)-7,8-didehydro-4,5-epoxy-3,14-dihydroxymorphinan-6-one",282-186-5,84116-46-1,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1,Notified C&L,1.0,H302:1;H317:1;H334:1;H332:1
935,T-159,485-120-5,,Not Classified,Notified C&L,1.0,Not classified:1
936,6-amino-5-nitrosouracil,226-633-4,5442-24-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H315:39;H335:38;H228:1
937,Praseodymium nitride,247-244-6,25764-09-4,,Notified C&L,4.0,H319:4;H315:4;H335:4
938,"Distillates (petroleum), solvent-refined heavy naphthenic;Baseoil - unspecified;[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-097-6,64741-96-4,Carc. 1B,Harmonised C&L,0.0,H350:0
945,Sodium dimethylnaphthalenesulphonate,248-301-8,27178-87-6,Eye Irrit. 2,Notified C&L,25.0,H319:25
947,2-propylvaleronitrile,236-338-2,13310-75-3,Flam. Liq. 3;Acute Tox. 4,REACH registration C&L,3.0,H302:2;H226:2;H301:1
948,2-bromopyridine 1-oxide hydrochloride,279-594-0,80866-91-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H319:42;H315:42;H335:42
950,2-(4-(Methylthio)phenyl)acetonitrile,609-576-3,38746-92-8,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,3.0,H411:1;H302:1;H413:1;H319:1;H315:1;H335:1
951,Isotridecan-1-ol,248-469-2,27458-92-0,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,5159.0,H410:4664;H315:4530;H400:4936;H319:443;Not classified:178;H411:8
955,Anthracene-9-carbonitrile,214-909-7,1210-12-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,44.0,H312:42;H302:42;H332:42;H319:5;H335:4;H315:5;H311:2;H331:2;H301:2
956,"2,2,2-trichloro-1,1-dimethylethyl chloroformate",266-293-4,66270-36-8,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,38.0,H314:38;H331:38;H311:38;H301:38
961,2-hydroxyethylammonium hydrogen sulphite,236-546-3,13427-63-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H319:2;H315:2
962,"Montan wax, ext.",297-871-4,93763-51-0,Not Classified,Notified C&L,33.0,Not classified:33
963,5-(aminomethyl)isoxazol-3-ol hydrate,220-430-4,2763-96-4,Acute Tox. 3,Notified C&L,195.0,H301:157;H300:38;H331:1;H311:1
964,"Benzoic acid, 4-chloro-3-methyl-, methyl ester",618-736-1,91367-05-4,,Notified C&L,1.0,H331:1;H311:1;H301:1
968,"Soaps, stocks, fish-oil, acidulated",285-567-4,85117-16-4,Not Classified,Notified C&L,1.0,Not classified:1
971,"2,5-dimethylhexane",209-745-8,592-13-2,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H304:0;H336:0;H410:0;H400:0;H315:0;H225:0
972,5-formylsalicylic acid,210-492-0,616-76-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4.0,H319:4;H315:4;H335:3
973,Dextropropoxyphene,207-420-5,469-62-5,Acute Tox. 3;Aquatic Acute 1,Notified C&L,41.0,H301:40;H400:38;H411:1;H362:1;H302:1;H330:1;H311:1
980,"2,4-Pentanedione, peroxide",253-384-9,37187-22-7,Org. Perox. D;Skin Sens. 1;Eye Irrit. 2,Notified C&L,112.0,H319:74;H317:54;H242:74;H314:38;H315:20
982,[No public or meaningful name is available],803-806-8,530-40-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H302:38;H335:38
983,(1-cyclohexen-1-yloxy)trimethylsilane,229-675-1,6651-36-1,Flam. Liq. 3,Notified C&L,45.0,H226:45;H319:1;H315:1;H335:1
984,"2,4,6-trichloro-3,5-dimethylphenol",230-206-8,6972-47-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38.0,H315:38;H302:38;H335:38;H318:38
987,Glipizide,249-427-6,29094-61-9,Not Classified,Notified C&L,44.0,Not classified:43;H341:1;H317:1;H361:1
995,"tebuconazole (ISO);1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol",403-640-2,107534-96-3,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0.0,H410:0;H361:0;H302:0;H400:0
996,trans-(±)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexan-1-ol hydrochloride,252-950-2,36282-47-0,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,133.0,H411:123;H302:59;H301:75;H319:9;H412:7;H315:3;H332:5;H336:3;Not classified:1;H311:2;H312:1;H331:1;H361:1
997,C.I. Acid Yellow 184,612-840-0,61968-07-8,,Notified C&L,1.0,H319:1
999,"Protein hydrolyzates, silk, reaction products with cocoyl chloride",500-711-0,162353-73-3,Not Classified,Notified C&L,17.0,Not classified:17
1001,N-methylmaleimide,213-226-1,930-88-1,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1,Notified C&L,51.0,H314:51;H302:47;H317:51;H330:4;H311:4;H301:4;H312:1;H332:1;H318:1
1002,Phenylsulphonylacetonitrile,231-515-0,7605-28-9,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,45.0,H331:39;H311:39;H301:40;H312:5;H302:5;H319:6;H335:5;H332:5;H315:6
1004,L-(-)2-amino-3-ureidopropionic acid,216-046-1,1483-07-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
1008,"1-Tridecanamine, N-tridecyl, branched, reaction products with carbon disulfide 2-ethyl-N-(2-ethylhexyl)-1-hexanamine and molybdenum oxide (MoO3)",616-754-4,799241-27-3,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,2.0,H411:2;H315:2
1009,N-(3-nitrophenyl)-3-(phosphonooxy)naphthalene-2-carboxamide,233-014-2,10019-03-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
1010,"Rosin, polymer with bisphenol A, formaldehyde and glycerol",614-320-9,68152-70-5,Not Classified,Notified C&L,7.0,Not classified:7
1011,phenol;carbolic acid;monohydroxybenzene;phenylalcohol,203-632-7,108-95-2,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3;Muta. 2;STOT RE 2,Harmonised C&L,0.0,H373:0;H314:0;H331:0;H311:0;H301:0;H341:0
1015,"3-butene-1,2-diol",207-835-1,497-06-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38.0,H312:38;H302:38;H332:38
1017,"1,2-benzisothiazol-3(2H)-one, sodium salt",261-184-8,58249-25-5,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1,Notified C&L,220.0,H314:136;H302:158;H317:158;H318:83;Not classified:62;H400:36;H319:22;H335:22
1018,Tris(isooctadecanoato-O)(propan-2-olato)titanium,262-774-8,61417-49-0,Not Classified,REACH registration C&L,202.0,Not classified:77;H335:125;H319:73;H315:73;H361:1
1020,"[2,6-Dichloro-4-(trifluoromethyl)phenyl]hydrazine",617-847-2,86398-94-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,43.0,H312:38;H302:42;H319:43;H335:43;H332:38;H315:43;H351:38
1023,Lithium [2H4]tetrahydroborate(1-),239-291-6,15246-28-3,Water-react. 1;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,39.0,H314:39;H260:39;H331:39;H311:39;H301:39
1030,"2,4,5-trimethyl-3-furanilide",249-194-0,28730-17-8,Acute Tox. 4,Notified C&L,194.0,H302:194
1032,Chloronaphthalene,247-120-1,25586-43-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
1033,Diiron phosphide,215-178-7,1310-43-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,210.0,H319:210;H315:210;H335:210
1036,(cyanomethyl)urea,227-736-7,5962-07-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H312:1;H302:1;H319:1;H335:1;H332:1;H315:1
1037,"[N,N',N''-tris[3-(dimethylamino)propyl]-29H,31H-phthalocyaninetrisulphonamidato(2-)-N29,N30,N31,N32]copper",251-539-5,33481-16-2,Not Classified,Notified C&L,18.0,Not classified:13;H411:5
1039,Potassium Trifluoromethanesulfonate,608-334-4,2926-27-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H319:44;H315:44;H335:43
1043,C.I. Acid Red 343,612-538-9,61847-61-8,Not Classified,Notified C&L,2.0,Not classified:2
1044,"Gases (petroleum), distillate unifiner desulfurization stripper off;Refinery gas;[A complex combination stripped from the liquid product of the unifiner desulfurization process. It consists of hydrogen sulfide, methane, ethane, and propane.]",272-873-8,68919-01-7,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0.0,Not classified:0;H350:0;H220:0;H340:0
1046,"Phosphorous trichloride, reaction products with 1,1'-biphenyl and 2,4-bis(1,1-dimethylethyl)phenol",432-130-2,119345-01-6,Not Classified,REACH registration C&L,4.0,Not classified:2;H413:2
1047,2-chlorobenzylamine,201-955-8,89-97-4,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,97.0,H312:39;H314:97;H302:39;H335:3;H318:2;H332:1
1050,Ethynylenebis[trimethylstannane],218-324-8,2117-50-2,Flam. Sol. 1;Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39.0,H330:39;H410:39;H400:39;H228:38;H310:39;H300:39
1062,"2-[10-(acetyloxy)-9a,11a-dimethyl-7-oxo-3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl]-2-oxoethyl acetate",607-277-2,23825-05-0,Not Classified,REACH registration C&L,2.0,Not classified:2
1063,N-acetyl-N-methylacetamide,214-207-0,1113-68-4,Eye Irrit. 2,Notified C&L,38.0,H319:38
1066,3-(trifluoromethyl)benzoyl fluoride,206-340-8,328-99-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
1068,"Tris(2,3-dichloropropyl) phosphate",201-117-1,78-43-3,Carc. 2;Aquatic Chronic 2,Notified C&L,38.0,H411:38;H351:38
1069,"cis-1-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine",267-745-3,67914-61-8,,Notified C&L,1.0,H411:1;H341:1;H301:1
1070,"2,2-bis(hydroxymethyl)-1,3-propanediyl dioleate",246-665-2,25151-96-6,Not Classified,REACH registration C&L,28.0,Not classified:28
1078,"Octadecanoic acid, reaction products with acetic anhydride and diethylenetriamine",283-052-9,84539-63-9,,Notified C&L,3.0,H412:2;H318:2;Not classified:1
1079,6-hydroxyindole,417-020-4,2380-86-1,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H302:0;H317:0;H318:0
1083,1-((tert-butoxycarbonyl)amino)cyclopropanecarboxylic acid,618-224-8,88950-64-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H319:41;H315:41;H335:41;H302:2
1086,"Glass, oxide, chemicals",266-046-0,65997-17-3,Carc. 1B,REACH registration C&L,1258.0,H350:144;Not classified:911;H319:154;H315:99;H351:98;H335:104;H373:9;H302:1;H410:1;H400:1;H332:1;H360:1
1087,1-(mercaptomethyl)cyclopropylacetic acid,420-240-3,162515-68-6,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0.0,H312:0;H302:0;H317:0;H314:0;H411:0
1088,4-heptadecylidene-3-hexadecyloxetan-2-one,233-347-3,10126-68-8,Not Classified,Notified C&L,20.0,Not classified:20
1092,"Oxybis(methyl-2,1-ethanediyl) diacrylate",260-754-3,57472-68-1,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,3296.0,H315:3290;H317:3286;H318:3283;Not classified:6;H319:6;H302:1;H335:1
1093,2-ethylhexyl methacrylate,211-708-6,688-84-6,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,843.0,H317:702;H319:354;H335:332;H315:354;H412:247;H411:2;H361:2
1100,"Amines, C12-14-tert-alkyl, mono-Me phosphates",268-955-8,68155-35-1,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,Notified C&L,3.0,H312:2;H314:2;H302:2;H318:2;Not classified:1
1101,1-bromotetrafluoro-2-iodoethane,207-008-5,421-70-5,,Notified C&L,5.0,H319:5;H315:5;H335:4
1102,3-Fluoro-4-hydroxybenzoic Acid Hydrate,609-056-6,350-29-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,46.0,H315:46;H302:39;H335:45;H318:39;H319:7
1106,"2-Propenoic acid, 2-methyl-, methyl ester, polymer with 2-methoxyethyl 2-propenoate and tris(1-methylethyl)silyl 2-propenoate",605-442-3,166441-77-6,Not Classified,Notified C&L,22.0,Not classified:22
1108,"1-5-diamino-2-bromo-4,8-dihydroxyanthraquinone",248-395-0,27312-17-0,Not Classified,Notified C&L,18.0,Not classified:18
1109,"Isooctadecanoic acid, mono-, di- and triesters with triglycerol",291-548-1,90431-25-7,Not Classified,Notified C&L,12.0,Not classified:12
1111,4-(trifluoromethoxy)benzoic acid,206-352-3,330-12-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47.0,H319:47;H315:47;H335:46;H312:1;H302:1;H332:1
1121,2-butoxyethyl α-phenylpiperidine-1-acetate hydrobromide,262-318-8,60595-56-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1.0,H312:1;H302:1;H319:1;H332:1;H315:1
1122,Trioctylsilane,242-559-5,18765-09-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,38.0,H319:38;H315:38
1123,"3,3-[(2,2-dimethylpropane-1,3-diyl)bis(oxy)]-17α-hydroxyestr-5(10)-ene-17-carbonitrile",304-925-3,94291-97-1,Repr. 2;Lact.;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1.0,H410:1;H361:1;H362:1;H400:1
1124,"Vinca minor, ext.",281-686-0,84012-41-9,Flam. Liq. 3,Notified C&L,1.0,H226:1
1129,"Bis[stilbene-α,β-dithiolato(2-)]nickel",249-353-4,28984-20-5,Skin Sens. 1;Resp. Sens. 1;Carc. 1A,Notified C&L,1.0,H350:1;H317:1;H334:1
1130,"[S-(R*,S*)]-2-methyl-2-(4-methylcyclohex-3-enyl)oxirane",248-839-3,28098-67-1,,Notified C&L,1.0,Not classified:1
1132,4-Fluorophenyl chloroformate,609-545-4,38377-38-7,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,40.0,H314:40;H331:40;H311:40;H301:40;H335:1;H227:1
1133,Trifluoroacetic trifluoroacetohydroxamic anhydride,211-677-9,684-78-6,Skin Corr. 1B;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H319:2;H314:1;H335:1;H315:1
1139,4-methoxy-1-naphthonitrile,227-734-6,5961-55-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,42.0,H312:42;H302:42;H332:42
1144,Flunisolide,222-193-2,3385-03-3,Acute Tox. 1,Notified C&L,42.0,H300:41;H310:1;H351:1;H361:2;H302:1;H373:1;H360:1
1148,"1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]propoxy]-3-methoxyphenyl]ethanone",603-745-5,133454-47-4,Acute Tox. 2,Notified C&L,42.0,H300:38;H410:2;H301:3;H361:1
1152,Dipotassium butyl phosphate,247-585-0,26290-70-0,Not Classified,Notified C&L,2.0,Not classified:2
1153,"Silicic acid (H4SiO4), zirconium(4+) salt (1:1), reaction products with sodium hydroxide",304-802-4,94279-56-8,Acute Tox. 4;Skin Corr. 1A,Notified C&L,1.0,H312:1;H314:1;H302:1
1154,"2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolane-4-methanol",283-585-7,84682-23-5,Repr. 2;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,1.0,H373:1;H361:1;H412:1
1156,2-ethylphenol,201-958-4,90-00-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,462.0,H312:184;H302:300;H332:180;H314:167;H315:114;H335:115;H318:170;H310:10;H300:10
1157,"Reaction mass of bis(N-decyl-N,N-dimethyldecan-1-aminium) carbonate and N-decyl-N,N-dimethyldecan-1-aminium hydrogen carbonate",451-900-9,894406-76-9,Acute Tox. 3;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,15.0,H411:15;H314:15;H301:15;H400:15
1158,"Lauric acid, compound with 2-aminoethanol (1:1)",240-852-2,16830-40-3,Not Classified,Notified C&L,1.0,Not classified:1
1160,Loperamide,258-416-5,53179-11-6,Acute Tox. 3,REACH registration C&L,7.0,H301:7
1163,2-(2-Methyl-5-nitroanilino)-4-(3-pyridyl)pyrimidine,604-858-2,152460-09-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
1165,"[ethylenebis[nitrilobis(methylene)]]tetrakisphosphonic acid, sodium salt",244-742-5,22036-77-7,Not Classified,REACH registration C&L,50.0,Not classified:50
1168,Strontium silicate(1:1),236-616-3,13451-00-8,Not Classified,Notified C&L,17.0,Not classified:17
1170,"Phosphine, 1,1'-[(1S)-[1,1'-binaphthalene]-2,2'-diyl]bis[1,1-diphenyl-",616-305-2,76189-56-5,,Notified C&L,7.0,H319:6;H315:6;H335:5;H413:1
1173,"Gas oils, hydrotreated;Gasoil - unspecified;[A complex combination of hydrocarbons obtained from the redistillation of the effluents from the treatment of paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",308-128-1,97862-78-7,Carc. 1B,Harmonised C&L,0.0,H350:0
1174,"4''-Ethyl-2'-fluor-4-propyl-1,1':4',1''-terphenyl",619-171-3,95759-44-7,Not Classified,REACH registration C&L,1.0,Not classified:1
1177,"Phosphoric acid, isodecyl ester, potassium salt",269-889-2,68389-40-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,8.0,H319:6;H315:6;Not classified:2
1178,Calcium dilactate,212-406-7,814-80-2,Eye Irrit. 2,REACH registration C&L,87.0,H320:1;H319:79;Not classified:7;H315:1;H335:1
1180,Cyclopentene,205-532-9,142-29-0,Flam. Liq. 2;Acute Tox. 4;Asp. Tox. 1;Acute Tox. 4;Skin Irrit. 2,REACH registration C&L,167.0,H312:167;H302:167;H304:136;H315:155;H225:167;H319:25;H335:22;H412:27;H332:5;H336:5
1183,2-ethylhexyl hydrogen -2-ethylhexylphosphonate,238-865-3,14802-03-0,Skin Irrit. 2;Eye Dam. 1,Notified C&L,27.0,H315:26;H318:21;H290:8;H312:6;H319:6;H302:7;H314:1;H412:1
1185,2-methylpyrrolidine,212-144-3,765-38-8,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1B,Notified C&L,44.0,H302:38;H314:44;H225:44
1186,"Soaps, stocks, peanut-oil, acidulated, hydrogenated",296-507-1,92704-71-7,Not Classified,Notified C&L,1.0,Not classified:1
1187,"Gasoline;Low boiling point naphtha - unspecified;[A complex combination of hydrocarbons consisting primarily of paraffins, cycloparaffins, aromatic and olefinic hydrocarbons having carbon numbers predominantly greater than C",289-220-8,86290-81-5,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0.0,H350:0;H340:0;H304:0
1188,2-ethyl-2-butenal,243-299-5,19780-25-7,Flam. Liq. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H319:42;H335:41;H311:42;H315:42;H226:42
1193,"3-chloro-2,2-dimethylpropaneoic acid",236-848-5,13511-38-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H319:39;H315:39;H335:39;H314:1;H290:1;H318:1
1197,Tamanol 100S,617-062-5,80341-90-8,Not Classified,Notified C&L,1.0,Not classified:1
1201,Pentyl cinnamate,222-478-1,3487-99-8,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2.0,H410:2;H400:2
1205,Lead thiosulphate,236-780-6,13478-50-7,,Notified C&L,5.0,H373:4;H302:5;H410:4;H400:4;H332:5;H360:5;H312:1;H411:1
1207,(±)-α-(trifluoromethyl)benzyl alcohol,206-429-1,340-05-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H319:45;H315:45;H335:43
1208,"2,2-dimethylhexan-3-ol",224-135-1,4209-90-9,,Notified C&L,5.0,H319:4;H315:4;H335:4;H226:1
1209,5-bromopentan-2-one,223-419-2,3884-71-7,Flam. Liq. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H302:1;H319:1;H335:1;H332:1;H227:1;H315:1
1216,promecarb (ISO);3-isopropyl-5-methylphenyl N-methylcarbamate,220-113-0,2631-37-0,Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H301:0;H400:0
1217,Hentetracontane,230-561-9,7194-87-8,Not Classified,Notified C&L,1.0,Not classified:1
1223,4-dimethylaminobenzylidenerhodanine,208-625-2,536-17-4,Acute Tox. 4,Notified C&L,3.0,H302:1;Not classified:1;H319:1;H315:1
1227,"Phenol, 2(or 4)-(2,4-dinitrophenyl)amino-, sulfurized, thiosulfonated",215-455-2,1327-03-3,Not Classified,Notified C&L,38.0,Not classified:38
1228,Naphthalen-1-ethanol,212-260-4,773-99-9,,Notified C&L,5.0,H319:5;H315:5;H335:5
1229,2-isopropylidene-5-methylcyclohexanone,240-070-1,15932-80-6,Acute Tox. 4,Notified C&L,1615.0,H302:1615;H317:25
1232,Cyclopropanecarbohydrazide,230-132-6,6952-93-8,Acute Tox. 3,Notified C&L,39.0,H301:39
1233,"Benzoic acid, 2-amino-4,5-bis(2-methoxyethoxy)-, ethyl ester, hydrochloride",917-647-8,,Not Classified,REACH registration C&L,2.0,Not classified:2
1234,5-methyl-2-[(2-nitrophenyl)amino]thiophene-3-carbonitrile,604-084-5,138564-59-7,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41.0,H410:40;H319:39;H400:39;H302:1
1235,"Quaternary ammonium compounds, trimethylsoya alkyl, chlorides",263-134-0,61790-41-8,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,Notified C&L,41.0,H314:38;H302:41;H318:37;H410:2;H225:1;H400:1
1237,3-Acetyl-5-chloro-thiophene-2-sulfonic acid (3-methoxy-propyl)-amide,928-005-1,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,2.0,H312:2;H302:2;H332:2
1240,"4-trans-Propyl-[1,1-bicyclohexyl]-4-trans-carbonic acid-(4-propylphenyl)ester",619-276-4,97564-42-6,Aquatic Chronic 4,Notified C&L,1.0,Not classified:1;H413:1
1244,o-chlorophenylacetic acid,219-482-0,2444-36-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H319:46;H315:46;H335:45
1245,Indium Tin Oxide,610-589-1,50926-11-9,,Notified C&L,6.0,H335:6;H319:2;H315:2
1246,N-methyltetradecylamine,249-588-2,29369-63-9,Acute Tox. 4;Skin Corr. 1B;STOT SE 3,Notified C&L,1.0,H314:1;H302:1;H335:1
1247,1-(5-methyl-1-phenyl-1H-pyrazol-4-yl)ethan-1-one,228-091-4,6123-63-3,Acute Tox. 4,Notified C&L,43.0,H302:38;H319:5;H315:5;H335:5
1251,"paraquat dimethylsulfate;1,1-dimethyl-4,4'-bipyridinium dimethyl sulphate",218-196-3,2074-50-2,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H330:0;H372:0;H410:0;H319:0;H335:0;H400:0;H311:0;H301:0;H315:0
1252,"1-[(2-butyloctyl)oxy]-3-(3,4-dihydroisoquinolinium-2-yl)propan-2-yl sulfate",470-080-3,,Aquatic Chronic 2,Notified C&L,1.0,H411:1
1253,Bromoicosane,224-277-4,4276-49-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
1254,"16,17-dimethoxyviolanthrene-5,10-dione",204-896-6,128-58-5,Not Classified,REACH registration C&L,96.0,Not classified:55;H319:40;H412:1;H315:1;H335:1
1258,"1-benzyl-1H-pyrrole-2,5-dione",216-631-1,1631-26-1,Skin Corr. 1B;Eye Dam. 1,Notified C&L,48.0,H314:48;H318:41
1261,"Distillates (petroleum), chemically neutralized middle;Gasoil - unspecified;[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-130-4,64742-30-9,Carc. 1B,Harmonised C&L,0.0,H350:0
1266,"Benzoic acid, 2,3,4,5-tetrachloro-6-[[(2,3-dichlorophenyl)amino]carbonyl]-",616-316-2,76280-91-6,,Notified C&L,38.0,Not classified:38
1269,"2',3,4,4'-tetrahydroxychalcone",207-659-5,487-52-5,Not Classified,Notified C&L,2.0,Not classified:2
1270,Dipotassium tin trioxide,235-255-9,12142-33-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,113.0,H319:113;H315:113;H335:113
1271,"2-(2-hexyloxyethoxy)ethanol;DEGHE;diethylene glycol monohexyl ether;3,6-dioxa-1-dodecanol;hexyl carbitol;3,6-dioxadodecan-1-ol",203-988-3,112-59-4,Acute Tox. 4;Eye Dam. 1,Harmonised C&L,0.0,H312:0;H318:0
1273,3-(benzylamino)propanol,225-210-1,4720-29-0,Acute Tox. 4;Eye Dam. 1,Notified C&L,45.0,H302:38;H318:38;H319:7;H315:7;H335:6
1274,Methyl 2-[(2-methylundecylidene)amino]benzoate,267-104-8,67800-80-0,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,92.0,H410:3;H400:3;Not classified:89
1278,"2,2-bis[[(1-oxoisononyl)oxy]methyl]-1,3-propanediyl diisononanoate",298-364-0,93803-89-5,Not Classified,REACH registration C&L,4.0,Not classified:4
1282,"Poly(oxy-1,4-phenylenecarbonyl)",607-862-2,26099-71-8,Not Classified,Notified C&L,2.0,Not classified:2
1284,(R)-β-aminophenethyl alcohol,260-287-5,56613-80-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,12.0,H319:12;H315:12;H335:10
1289,Di-tert-butyldichlorostannane,243-051-6,19429-30-2,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 3,Notified C&L,42.0,H314:42;H331:38;H311:42;H301:42;H318:38;H330:4;H410:4;H400:4
1299,Isophthalaldehyde,210-935-8,626-19-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H319:1;H315:1;H335:1;Not classified:1
1304,"6-dimethylamino-3,3-bis(4-dimethylaminophenyl)phthalide",216-293-5,1552-42-7,Aquatic Chronic 1,REACH registration C&L,200.0,H410:6;H319:99;H315:99;H335:97;Not classified:88;H412:6;H413:1
1307,"Amides, from C16-22 fatty acids and diethylenetriamine",614-751-2,68876-82-4,Skin Corr. 1A;Aquatic Chronic 2,Notified C&L,6.0,H411:6;H314:6
1308,"Lead(2+) 2,4-dinitroresorcinolate",236-498-3,13406-89-8,Unst. Expl.;Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1.0,H373:1;H302:1;H410:1;H332:1;H200:1;H400:1;H360:1
1316,2-(3-carboxy-4-hydroxyphenyl)quinoline-4-carboxylic acid,208-373-3,525-48-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
1317,"(±)-tetrahydro-2,6,6-trimethyl-2-vinyl-2H-pyran",237-550-8,13837-56-4,Flam. Liq. 3;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1287.0,H319:1286;H226:1287;H412:1286
1324,"Orthoboric acid, compound with 1,3,5-triazine-2,4,6-triamine (1:1)",303-196-9,94159-20-3,Not Classified,Notified C&L,1.0,Not classified:1
1326,"2,7-Naphthalenedisulfonic acid, 4-hydroxy-3-[[2-methyl-4-[(2-methylphenyl)azo]phenyl]azo]-, compd. with N-cyclohexylcyclohexanamine",613-436-7,6406-53-7,Not Classified,Notified C&L,5.0,Not classified:5
1328,"Fucus serratus, ext.",303-400-6,94167-02-9,Not Classified,Notified C&L,1.0,Not classified:1
1330,N-[3-(dodecylamino)propyl]glycine,251-993-4,34395-72-7,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,1.0,H412:1;H315:1;H318:1
1337,Sodium 2-aminosulphanilate,221-650-3,3177-22-8,Skin Irrit. 2,REACH registration C&L,1.0,H315:1
1339,Phenalen-1-one,208-945-2,548-39-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H335:1
1345,5-bromo-o-toluidine,254-467-2,39478-78-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42.0,H312:41;H302:42;H319:42;H335:41;H332:42;H315:42
1346,Hexaethyldisiloxane,213-619-8,994-49-0,,Notified C&L,1.0,H319:1;H315:1;H335:1
1347,2-methylvaleryl chloride,226-035-3,5238-27-7,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,43.0,H314:43;H226:43;H318:1
1348,Ethyl 4-phenylpiperidine-4-carboxylate,201-008-9,77-17-8,Acute Tox. 4,Notified C&L,39.0,H302:38;H412:1;H341:1;H301:1;H336:1
1353,"[29H,31H-phthalocyaninetrisulphonyl trichloridato(2-)-N29,N30,N31,N32]copper",248-236-5,27121-30-8,Skin Corr. 1B,REACH registration C&L,4.0,H314:3;Not classified:1
1356,Docosanoyl chloride,606-710-2,21132-76-3,Skin Corr. 1B,Notified C&L,40.0,H314:39;H319:1;H315:1;H335:1
1357,3-methylbut-2-en-1-ol,209-141-4,556-82-1,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1,REACH registration C&L,1767.0,H314:1720;H302:1767;H226:1767;H318:1533;H317:7;H350:5;H319:434;H315:434;H335:43;Not classified:2;H331:1
1358,Cyclopropaneethanamine,613-103-6,62893-54-3,Skin Corr. 1B,Notified C&L,2.0,H314:2;H226:1
1362,"1,1,1,3,3-pentafluorobutane",430-250-1,406-58-6,Flam. Liq. 2,Harmonised C&L,0.0,H225:0
1364,2-(2-hydroxyethoxy)propyl prop-2-enoate; 2-[2-[2-[2-(1-methyl-2-prop-2-enoyloxy-ethoxy)ethoxymethyl]butoxy]ethoxy]propyl 3-(dibutylamino)propanoate,605-658-8,173011-06-8,Skin Sens. 1A,REACH registration C&L,84.0,H317:84
1365,Diammonium N-(phosphonomethyl)glycine,824-599-0,69254-40-6,Aquatic Chronic 2,Notified C&L,89.0,H411:89
1369,"1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, 1,3-dichloro-, sodium salt, dihydrate",610-700-3,51580-86-0,Acute Tox. 4;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,313.0,H302:313;H410:313;H319:313;H335:313;H400:274;H315:1
1371,"Alcohols, cetyl oleyl, ethoxylated, propoxylated",500-305-3,116810-31-2,Not Classified,Notified C&L,1.0,Not classified:1
1373,"Cashew, nutshell liq., polymer with diethylenetriamine and formaldehyde",614-465-8,68413-29-6,Not Classified,Notified C&L,26.0,Not classified:24;H314:2;H312:1;H302:1;H317:1
1377,"Estra-1,3,5,7,9-pentaene-3,17α-diol",229-650-5,6639-99-2,Carc. 1A;Repr. 1A;STOT RE 1,Notified C&L,1.0,H372:1;H350:1;H360:1
1379,5-diethylaminopentan-2-one,203-274-1,105-14-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
1384,"4-[3-[4-hydroxy-5-isopropyl-o-tolyl]-1-oxo-3H-isobenzofuran-3-yl]-6-isopropyl-m-tolylphosphoric acid, sodium salt",249-197-7,28749-63-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H335:1
1388,2-methylcyclopropanecarboxylic acid,249-693-3,29555-02-0,Skin Corr. 1B,Notified C&L,44.0,H314:44
1394,"3,7-dimethylnona-2,6-dienal",255-368-7,41448-29-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1545.0,H319:1544;H315:1545
1395,PERGASCRIPT ORANGE I-G,416-080-9,,Not Classified,Notified C&L,83.0,Not classified:83
1398,Tibolone,227-069-1,5630-53-5,Eye Irrit. 2,Notified C&L,61.0,H319:39;H360:18;H351:18;H361:3;H312:1;H302:1;H332:1;Not classified:1
1399,"Gases (petroleum), heavy distillate hydrotreater desulfurization stripper off;Refinery gas;[A complex combination stripped from the liquid product of the heavy distillate hydrotreater desulfurization process. It consists of hydrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]",272-876-4,68919-04-0,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0.0,Not classified:0;H350:0;H220:0;H340:0
1400,Tetrahexylammonium perchlorate,225-095-8,4656-81-9,Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H319:42;H315:42;H272:42;H335:42
1402,4-nitro-m-cresol,219-952-5,2581-34-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47.0,H312:39;H302:44;H319:47;H335:43;H332:39;H315:47;H411:1
1406,2-fluoro-4-nitrotoluene,215-845-2,1427-07-2,Flam. Sol. 2;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,46.0,H312:45;H302:45;H319:44;H335:43;H332:45;H228:39;H315:44;H331:1;H311:1;H301:1
1407,"Phosphoric acid, decyl ester, compd. with 2-aminoethanol",297-990-1,93776-60-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
1414,Diphenyliodonium chloride,216-049-8,1483-72-3,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H319:45;H315:45;H301:46;H335:44
1421,"Solvent naphtha (petroleum), light arom., hydrotreated;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C",270-988-8,68512-78-7,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0.0,H350:0;H340:0;H304:0
1423,C.I. Acid Brown 362,612-729-7,61931-13-3,Not Classified,Notified C&L,1.0,Not classified:1
1426,Neodymium trihydroxide,240-514-4,16469-17-3,Not Classified,REACH registration C&L,4.0,Not classified:4
1429,"Alkenes, C11-12, hydroformylation products, distn. residues",292-427-6,90622-27-8,Not Classified,REACH registration C&L,1.0,Not classified:1
1430,C.I. Pigment Yellow 115,614-732-9,68814-04-0,Not Classified,Notified C&L,8.0,Not classified:8
1431,2-ethoxybenzylamine,253-672-4,37806-29-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H319:38;H315:38;H335:38;H314:2;H318:1
1433,"α-Cyano-3-phenoxybenzyl-2,2-dichloro-1-(4-ethoxyphenyl)-1-cyclopropanecarboxylate (Cycloprothrin) and preparations containing it",613-404-2,63935-38-6,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39.0,H410:39;H317:39;H400:39;H341:1
1436,Potassium hydro(triisopropoxy)borate,255-747-7,42278-67-1,Acute Tox. 4,Notified C&L,38.0,H302:38
1437,"Quaternary ammonium compounds, bis(hydrogenated tallow alkyl)dimethyl, chlorides, compds. with hectorite",275-128-5,71011-27-3,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,98.0,H412:67;H302:67;H332:67;Not classified:31
1441,"1,3-difluoro-4-nitrobenzene",207-167-0,446-35-5,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48.0,H319:46;H315:45;H301:48;H335:44;H373:4;H330:5;H311:6;H317:1;H372:1;H331:2;H310:2;H412:1;H371:1;H332:1;H411:1
1445,Ethyl 2-(dimethylamino)-1-phenylcyclohex-3-ene-1-carboxylate,241-281-1,17243-69-5,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,85.0,H319:85;H302:85;H412:85
1446,4-aminobenzyl alcohol,210-767-5,623-04-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49.0,H319:49;H315:49;H335:48;H302:6
1449,"reaction product of: 3,5-bis-tert-butylsalicylic acid and aluminiumsulfate",420-310-3,,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H302:0;H400:0
1450,"2-methylpropane-1,3-diol",606-809-0,2163-42-0,Not Classified,Notified C&L,185.0,Not classified:129;H319:56;H315:56;H335:56
1451,2-oxobutanal oxime,924-346-5,,Flam. Liq. 3;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2.0,H319:2;H226:2;H336:2
1454,Lysozyme (chicken egg white),235-747-3,12650-88-3,Resp. Sens. 1,REACH registration C&L,6.0,H334:5;Not classified:1
1458,Ethyldiphenylphosphine oxide,217-068-4,1733-57-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51.0,H319:51;H315:51;H302:51;H335:51
1461,Butyl fluoroacetate,206-739-7,371-49-3,Flam. Liq. 3;Acute Tox. 2;Acute Tox. 2;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 2,Notified C&L,1.0,H330:1;H314:1;H310:1;H300:1;H226:1;H318:1
1462,2-[(3-aminophenyl)sulphonyl] hydrogensulphate,219-668-1,2494-88-4,Not Classified,REACH registration C&L,1.0,Not classified:1
1465,"bromophos (ISO);O-4-bromo-2,5-dichlorophenyl O,O-dimethyl phosphorothioate",218-277-3,2104-96-3,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H302:0;H400:0
1472,trans-1-ethyl-2-methylcyclopentane,213-227-7,930-90-5,Not Classified,Notified C&L,3.0,Not classified:3
1473,2-(octyloxy)ethanol,233-015-8,10020-43-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
1474,"Camphor tree, Cinnamomum camphora formosana, ext.",296-431-9,92704-03-5,Flam. Sol. 2;Acute Tox. 4;STOT SE 2,Notified C&L,66.0,H371:45;H228:45;H332:34;H317:21;H304:21;H410:20;H400:20;H315:21;H226:21;H330:11;H319:1;H335:1;H412:1
1476,"rel-(4aR,5aS,6aS,6bS,9R,9aS,11S,11aS,11bR)-9a,11b-dimethyl-9-(2-methyl-1,3-dioxolan-2-yl)tetradecahydrospiro[cyclopenta[1,2]phenanthro[8a,9-b]oxirene-3,2'-[1,3]dioxolane]-9,11-diol",601-498-8,117899-42-0,STOT RE 2,REACH registration C&L,2.0,H373:2
1478,4-hydroxyfuran-2(5H)-one,208-785-3,541-57-1,,Notified C&L,6.0,H319:6;H315:6;H335:6;H312:1;H302:1;H332:1
1481,7-methylbenz[a]anthracene,219-819-1,2541-69-7,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,39.0,H302:39;H413:38;H312:1;H332:1
1484,"4,7-dihydroindan",231-514-5,7603-37-4,Flam. Liq. 2,Notified C&L,38.0,H225:38
1486,2-(10-oxo-10H-9-oxa-10-phosphaphenanthren-10-ylmethyl)succinic acid,426-480-5,63562-33-4,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0.0,H317:0;H412:0
1487,"3-hydroxy-N-(o-tolyl)-4-[(2,4,5-trichlorophenyl)azo]naphthalene-2-carboxamide",229-440-3,6535-46-2,Skin Sens. 1,REACH registration C&L,590.0,H317:143;Not classified:363;H413:84;H341:1;H412:1
1488,"2,2,3,3,4,4-hexafluoropentane-1,5-diol",206-819-1,376-90-9,Acute Tox. 4,Notified C&L,46.0,H302:45;H319:8;H315:8;H335:7;H312:2;H332:2
1493,"Fatty acids, C18-unsatd., dimers, polymers with C18-unsatd. fatty acid trimers and triethylenetetramine",614-772-7,68911-20-6,Not Classified,Notified C&L,47.0,Not classified:31;H318:16
1498,"O-6-deoxy-α-L-mannopyranosyl-(1→4)-O-β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyl (2α,3β,4α)-2,3,23-trihydroxyurs-12-en-28-oate",240-851-7,16830-15-2,Not Classified,REACH registration C&L,3.0,Not classified:3
1501,Dialuminium cobalt tetraoxide,215-610-4,1333-88-6,Not Classified,Notified C&L,123.0,Not classified:76;H317:47;H319:38;H335:38;H315:38;H351:38;H410:9;H302:9;H400:9
1504,Iron dihydroxide pentakis(sulphate),215-179-2,1310-45-8,Not Classified,Notified C&L,1.0,Not classified:1
1508,"β-Alanine, N-(2-carboxyethyl)-, N-coco alkyl derivs., disodium salts",290-476-8,90170-43-7,Eye Irrit. 2;Aquatic Acute 3,REACH registration C&L,74.0,H319:74;H402:4;H315:1
1511,"(R,S)-2-amino-3,3-dimethylbutane amide",447-860-7,144177-62-8,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;STOT RE 2;Repr. 2,Harmonised C&L,0.0,H373:0;H361:0;H317:0;H319:0;H315:0
1514,N-methyl-4-anisidine,227-735-1,5961-59-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2.0,H312:2;H302:2;H332:2;H319:1;H335:1;H315:1
1519,Pentahydroxy(tetradecanoato)dichromium,265-647-5,65229-24-5,Eye Dam. 1,Notified C&L,47.0,H318:47
1521,Bromovinylmagnesium,217-375-3,1826-67-1,Water-react. 1;Skin Corr. 1B,Notified C&L,65.0,H314:65;H260:39;H225:26
1526,"Urtica dioica, ext.",281-685-5,84012-40-8,Not Classified,Notified C&L,74.0,Not classified:71;H319:1;H317:2;H226:3
1527,HYPOTAURINE,428-720-4,,Not Classified,Notified C&L,6.0,Not classified:6
1528,2-(benzyloxy)acetic acid,608-470-4,30379-55-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H319:44;H315:44;H335:42
1529,Gold cyanide,253-385-4,37187-64-7,,Notified C&L,1.0,H330:1;H410:1;H400:1;H310:1;H300:1
1532,"2,4-Dihydroxy-1,3-cyclobutanediyl)bis[2,3-dihydro-1H-perimidine-4,2,2-triylbis (methylene)] tetrahexanoate",606-723-3,211991-63-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2.0,H319:2;H315:2;H335:2
1533,Isotridecyl dihydrogen phosphate,256-882-4,50977-11-2,Skin Irrit. 2;Eye Dam. 1,Notified C&L,28.0,H315:25;H318:25;Not classified:2;H314:1
1536,"Sulfurous acid, monosodium salt, polymer with formaldehyde and methylphenol",614-154-7,67875-42-7,Aquatic Chronic 3,Notified C&L,33.0,Not classified:33;H412:33
1538,"(S)-ethyl 3-(4,4-difluorocyclohexanecarboxamido)-3-phenylpropanoate",445-820-3,,Aquatic Chronic 3,Notified C&L,1.0,H412:1
1539,4(or 2)-(2-pyridylazo)-3(or 5)-(sodiooxy)phenol,236-339-8,13311-52-9,Not Classified,Notified C&L,2.0,Not classified:2
1544,"3,4-diphenylfuran-2,5-dione",225-370-2,4808-48-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H319:43;H315:43;H335:42
1545,1-methyl-4-(4-methylpentyl)cyclohex-3-ene-1-carbaldehyde,266-314-7,66327-54-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1657.0,H319:1605;H315:1654;H410:35;H400:35;Not classified:3;H302:1;H317:1
1547,Tris(dodecylbenzenesulphonato-O)(propan-2-olato)titanium,262-777-4,61417-55-8,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1,Notified C&L,73.0,H314:55;H302:73;H317:46;H318:71;H315:17;H319:2;H335:2
1550,"1,2-Dimethylpyridinium iodide",617-993-7,872-73-1,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39.0,H319:38;H302:39;H312:1;H332:1
1552,Tungsten diselenide,235-078-7,12067-46-8,,Notified C&L,4.0,H373:4;H410:4;H400:4;H331:4;H301:4
1555,5-nitroanthranilic acid,210-493-6,616-79-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H319:46;H315:46;H335:45
1556,"1,3-diisopropyl-2-(p-nitrobenzyl)isourea",221-027-6,2978-11-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,39.0,H331:38;H311:38;H301:38;H312:1;H302:1;H332:1
1570,1-acetyl-4-(4-hydroxyphenyl)piperazine,267-744-8,67914-60-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,50.0,H319:48;H315:48;H335:47;H302:3;H317:1;H410:1;H400:1;H341:1
1574,sodium dichromate,234-190-3,10588-01-9,Ox. Sol. 2;Acute Tox. 3;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 2;Resp. Sens. 1;Muta. 1B;Carc. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0.0,H312:0;H330:0;H317:0;H372:0;H410:0;H314:0;H272:0;H400:0;H350:0;H301:0;H360:0;H340:0;H334:0
1575,"8-Chloro-11-(1-methyl-piperidin-4-yl)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ol",609-518-7,38089-93-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,5.0,H319:4;H315:4;H335:4;H302:1
1576,"Cement, alumina, chemicals",266-045-5,65997-16-2,Skin Irrit. 2;Eye Dam. 1,Notified C&L,235.0,H315:93;H318:93;H319:88;Not classified:52;H335:3;H317:2;H334:2
1577,"9-(2-carboxylatophenyl)-3,6-bis(ethylamino)-2,7-dimethylxanthylium",246-666-8,25152-49-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
1579,"17-Hydroxy-1,4,6-pregnatriene-3,20-dione",613-906-1,66212-25-7,Not Classified,Notified C&L,1.0,Not classified:1
1581,N-BENZYLOXYPHTHALIMIDE,605-447-0,16653-19-3,Skin Sens. 1;Aquatic Acute 1,Notified C&L,38.0,H317:38;H400:38
1587,(E)-3-ethoxyacrylonitrile,261-181-1,58243-08-6,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H302:38;H319:38;H335:38;H315:38;H226:38
1588,"Trichloro(3,3,3-trifluoropropyl)silane",209-744-2,592-09-6,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,45.0,H314:45;H226:38;H225:7;H290:1;H318:1
1589,Nitrophenyl 3-[[2-hydroxy-3-[(2-methylphenyl)carbamoyl]-1-naphthyl]azo]-4-methoxybenzenesulphonate,276-755-7,72639-39-5,,Notified C&L,38.0,Not classified:38
1594,"1,4-bis(2,3 epoxypropoxy)butane;butanedioldiglycidyl ether",219-371-7,2425-79-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 4,Harmonised C&L,0.0,H312:0;H317:0;H319:0;H332:0;H315:0
1595,3-methylbutyl palmitate,279-864-8,81974-61-0,Not Classified,Notified C&L,6.0,Not classified:6
1598,[3-(chlorocarbonyl)-2-methylphenyl]acetate,433-690-0,167678-46-8,Skin Corr. 1A;Skin Sens. 1,Harmonised C&L,0.0,H314:0;H317:0
1599,1-methylbutylamine,210-886-2,625-30-9,Flam. Liq. 2;Skin Corr. 1B;Eye Dam. 1,Notified C&L,1.0,H314:1;H225:1;H318:1
1601,N-methyl-3-(trimethoxysilyl)propylamine,221-334-5,3069-25-8,Eye Dam. 1,REACH registration C&L,71.0,H318:4;H319:67;H315:69;H335:62
1602,Methyl 2-(nonylideneamino)benzoate,276-963-8,72894-12-3,Not Classified,Notified C&L,88.0,Not classified:88
1603,"5-[3-[(1S)-2-(difluoromethoxy)-1-methylethoxy]-5-[[(5-methyl-2-pyrazinyl)amino]carbonyl]phenoxy]-N,N-dimethyl- 2-pyrazinecarboxamide",600-270-5,1020668-59-0,Acute Tox. 4;Repr. 1B;STOT RE 2;STOT RE 2,Notified C&L,3.0,H373:3;H360:3;H302:3
1611,3-bromo-2-oxopropionic acid,214-206-5,1113-59-3,Skin Corr. 1B,Notified C&L,47.0,H314:47;H290:1;H318:2
1613,CEDARWOOD OIL TEXAS,614-888-8,68990-83-0,Asp. Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,202.0,H410:163;H304:163;H400:162;H319:38;H315:38;H335:38;H411:1;H300:1
1614,potassium 2-amino-2-methylpropionate octahydrate,405-560-3,120447-91-8,Acute Tox. 4;Skin Corr. 1A,Harmonised C&L,0.0,H314:0;H302:0
1617,3-(trichlorovinyl)anilinium chloride,279-862-7,81972-27-2,Acute Tox. 4;STOT SE 3,Notified C&L,2.0,H319:2;H302:2;H335:2
1621,N-{[Dimethoxy(methyl)silyl]methyl}-N-phenylamine,605-838-6,17890-10-7,Muta. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,1.0,H373:1;H411:1;H341:1
1624,Ammonium L-glutamate,231-447-1,7558-63-6,Not Classified,Notified C&L,26.0,Not classified:26
1625,"(2E,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione; ethanol; hydrate; dihydrochloride",607-368-7,24390-14-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,152.0,H319:85;H315:85;H302:122;H335:85;H411:35;H400:45;H360:31;H317:12;H312:2;H361:6;H332:2;H362:4
1626,Vanadium yttrium tetraoxide,236-965-1,13566-12-6,Not Classified,Notified C&L,5.0,Not classified:2;H312:1;H302:1;H319:1;H335:1;H332:3;H315:1
1628,"Boric acid (H3BO3), reaction products with morpholine",294-257-8,91696-97-8,Not Classified,Notified C&L,1.0,Not classified:1
1630,Sodium 3-[[5-[(diethylamino)sulphonyl]-2-methoxyphenyl]azo]-4-hydroxynaphthalene-1-sulphonate,288-422-3,85721-12-6,Not Classified,REACH registration C&L,15.0,Not classified:6;H318:9
1631,"Deca-1,4,9-triene",233-346-8,10124-98-8,Flam. Liq. 3;Aquatic Chronic 2,Notified C&L,38.0,H411:38;H226:38
1633,(3-chloropropoxy)benzene,222-192-7,3384-04-1,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,Notified C&L,38.0,H302:38;H317:38;H335:38;H315:38;H318:38
1639,"5-β-pregnane-3-α,20-α-diol",201-313-7,80-92-2,,Notified C&L,1.0,H302:1
1642,"3,4-dihydro-2,2-dimethyl-4-oxo-2H-pyran-6-carboxylic acid",279-596-1,80866-93-9,Acute Tox. 4,Notified C&L,38.0,H302:38
1644,"Frits, chemicals",266-047-6,65997-18-4,Carc. 2;Repr. 1A;Lact.;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2991.0,H372:1427;H410:1387;H362:1271;H400:1356;H360:2153;H351:1117;H302:725;H332:540;H411:580;H341:683;H318:465;H373:609;H361:166;H412:415;H350:503;H317:219;H334:155;Not classified:205;H312:20;H331:15;H301:16;H319:1;H311:1;H315:1;H314:1
1645,"1,1-diethoxyheptane",211-707-0,688-82-4,Not Classified,Notified C&L,89.0,Not classified:89
1649,"4,4'-(2,3-epoxypropoxy)-2,2'- dimethyl-5,5'-tert-butyldiphenylsulphide",441-520-1,,Not Classified,REACH registration C&L,3.0,Not classified:3
1653,"1,3,5-Triazine-2,4,6-triamine, tris(methoxymethyl)-, tris[(tallow alkyloxy)methyl] derivs.",287-811-5,85586-09-0,Not Classified,Notified C&L,1.0,Not classified:1
1654,Ethyl 4-methyloctanoate,260-051-1,56196-53-3,Not Classified,Notified C&L,1.0,Not classified:1
1657,"reaction mass of substituted dodecyl and/or tetradecyl, diphenyl ethers. The substance is produced by the Friedel Crafts reaction. The catalyst is removed from the reaction product. Diphenyl ether is substituted by C",410-450-3,,Aquatic Chronic 4,Harmonised C&L,0.0,H413:0
1658,"Citric acid, sodium salt",213-618-2,994-36-5,Eye Irrit. 2,Notified C&L,158.0,H319:86;Not classified:72;H315:2;H335:2
1660,"2,2,2-trifluoroethyl trifluoroacetate",206-985-5,407-38-5,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,44.0,H314:44;H225:44;H312:1;H302:1;H332:1;H318:1
1663,4-nitrophenyl dihydrogen phosphate,206-353-9,330-13-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H302:1;H335:1
1664,"1,3-dichloropropane",205-531-3,142-28-9,Flam. Liq. 2,Notified C&L,33.0,H225:26;H226:7;H332:4;Not classified:1;H319:4;H315:4;H335:3;H302:1
1666,"3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,14-pentacosafluorotetradecyl acrylate",251-992-9,34395-24-9,Not Classified,Notified C&L,2.0,Not classified:2
1667,Sodium heptanoate,233-180-6,10051-45-3,Not Classified,Notified C&L,6.0,Not classified:6
1670,"Collagens, hydrolyzates, reaction products with cocoyl chloride, triethanolamine salts",500-714-7,162353-76-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,19.0,H319:18;H315:18;Not classified:1
1672,"Viola tricolor, ext.",281-687-6,84012-42-0,Flam. Liq. 3,Notified C&L,3.0,H226:3;H225:1
1675,2-(2-hydroxyethoxy)ethyl acetate,218-250-6,2093-20-1,Eye Irrit. 2,REACH registration C&L,2.0,H319:2
1677,ROUGE REACTIF DER 7650,415-940-0,,Not Classified,Notified C&L,1.0,Not classified:1
1687,Octachloronaphthalene,218-778-7,2234-13-1,Acute Tox. 4,Notified C&L,43.0,H302:39;Not classified:4;H319:1;H315:1;H335:1
1688,1-anilino-4-hydroxyanthraquinone,242-939-0,19286-75-0,Aquatic Chronic 3,Notified C&L,3.0,H412:2;Not classified:1
1689,"3,5-dimethylhexan-3-ol",224-136-7,4209-91-0,Eye Dam. 1,Notified C&L,43.0,H318:38;H319:5;H315:5;H335:4;H226:1
1696,Tris(2-ethylhexyl) phosphate,201-116-6,78-42-2,Not Classified,REACH registration C&L,624.0,Not classified:238;H315:360;H319:180;H335:31;H332:4;H413:1
1699,"1,1'-(2,6-Pyridinediyl)bis[N-(2-chloro-4,6-dimethylphenyl)ethanimine]",610-133-1,436857-82-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H335:1
1701,"(2aE,4E,5'S,6S,6'R,7S,8E,13S,20R,20bS)-20,20b-dihydroxy-6'-isopropyl-5',6,8,19-tetramethyl-17-oxo-5',6,6',10,11,14,15,17,17a,20,20a,20b-dodecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl 4-O-[(4xi)-4-acetamido-2,4,6-trideoxy-3-O-methyl-alpha-L-threo-hexopyranosyl]-2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranoside",602-966-4,123997-26-2,Acute Tox. 3;Repr. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,40.0,H373:37;H361:38;H410:35;H400:39;H301:39;Not classified:1;H372:1;H362:2
1702,"Polydimethylsiloxane, 3-aminopropyl-terminated",600-723-7,106214-84-0,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,69.0,H315:62;H335:58;H318:62;Not classified:2;H319:3;H411:1;H312:1;H302:1;H314:3;H336:1
1703,"[ethylenebis[nitrilobis(methylene)]]tetrakisphosphonic acid, calcium sodium salt",287-370-9,85480-89-3,Not Classified,REACH registration C&L,56.0,Not classified:5;H319:51;H315:51
1704,2-fluorobenzylamine,201-957-9,89-99-6,Skin Corr. 1B,Notified C&L,48.0,H314:48;H312:1;H302:1;H332:1;H318:1;H319:1;H335:1
1705,"N,N,N',N'-tetramethyltetramethylenediamine",203-878-5,111-51-3,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,39.0,H314:39;H226:39;H318:1
1713,"Amines, C12-14-tert-alkyl, di-Me phosphates",268-954-2,68155-32-8,Not Classified,Notified C&L,35.0,Not classified:35
1720,Chromium potassium bis(sulphate),233-401-6,10141-00-1,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,52.0,H319:52;H315:52;H335:44
1722,Strontium hydrogen phosphate,236-615-8,13450-99-2,Not Classified,REACH registration C&L,293.0,Not classified:293
1724,Dialuminium trioxalate,212-407-2,814-87-9,,Notified C&L,5.0,H312:5;H302:5
1725,(benzimidazol-2-yl)ethanenitrile,224-574-9,4414-88-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44.0,H312:39;H302:43;H319:39;H335:38;H332:39;H315:39;H301:1
1726,Dichlorohexylmethylsilane,238-864-8,14799-94-1,Skin Corr. 1B,Notified C&L,39.0,H314:39;H290:1;H318:1
1732,"2-Propenoic acid, methyl ester, reaction products with 2-ethyl-1-hexanamine and sodium hydroxide",271-865-1,68610-44-6,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 1;Aquatic Chronic 3,REACH registration C&L,30.0,H312:4;H302:4;H412:8;H370:8;H332:4;H315:8;H225:8;H318:24;H331:4;H311:4;H301:4;Not classified:2
1735,"Butane-2,3-dithiol",224-870-8,4532-64-3,Flam. Liq. 3,Notified C&L,1414.0,H226:1414;H319:49;H315:49;H335:48;H302:1
1740,6-methylpyridazin-3(2H)-one monohydrobromide,304-375-4,94248-99-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,89.0,H319:89;H315:89
1742,"1-Butanol, 4-chloro-, 1-methanesulfonate",608-017-0,26910-61-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H335:1
1744,"Benzenemethanesulfonic acid, α,4-dihydroxy-, potassium salt (1:1)",614-953-0,69342-18-3,Not Classified,Notified C&L,1.0,Not classified:1
1745,1-methyl-1-nitrosourea,211-678-4,684-93-5,Flam. Sol. 2;Acute Tox. 3;Carc. 1B;Repr. 1B,Notified C&L,40.0,H350:40;H360:40;H301:40;H228:40;H319:2;H315:2
1750,"Benzenesulfonic acid, C10-60-alkyl derivs., sodium salts",290-641-4,90194-32-4,Eye Irrit. 2,Notified C&L,838.0,H319:838
1756,ucb 22060,446-640-8,,Not Classified,REACH registration C&L,1.0,Not classified:1
1759,"2,16α,20,25-tetrahydroxy-9β-methyl-10α,-19-norlanosta-1,5,23(E)-triene-3,11,22-trione 25-acetate",242-325-2,18444-66-1,Acute Tox. 4,Notified C&L,41.0,H302:41;H312:3
1763,"3,6-bis[2-(dimethylamino)ethoxy]-9H-xanthen-9-one dihydrochloride",259-250-6,54593-27-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H302:38;H335:38
1765,isoprocarb (ISO);2-isopropylphenyl N-methylcarbamate,220-114-6,2631-40-5,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H302:0;H400:0
1768,Octatriacontane,230-560-3,7194-85-6,Not Classified,Notified C&L,6.0,Not classified:6
1774,4-Fluoro-1H-isoindoline hydrochloride,619-606-7,924305-06-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
1775,"[[(2-hydroxyethyl)imino]dimethylene]bisphosphonic acid, sodium salt",244-743-0,22036-78-8,Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,77.0,H314:60;H302:60;H332:60;H318:60;H319:15;H290:12;H412:11;Not classified:2
1779,Sodium tetrahydroborate,241-004-4,16940-66-2,Water-react. 1;Acute Tox. 3;Skin Corr. 1C;Eye Dam. 1;Repr. 1B,REACH registration C&L,765.0,H314:762;H260:520;H301:762;H360:386;H318:422;H311:308;H332:167;H330:45;H331:6;H261:5;Not classified:6
1787,3-fluoro-4-nitrotoluene,207-166-5,446-34-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47.0,H312:45;H302:46;H319:47;H335:46;H332:46;H315:47
1789,Copper(2+) selenite,233-526-6,10214-40-1,,Notified C&L,4.0,H373:4;H410:4;H400:4;H331:4;H301:4
1794,"Extracts (petroleum), cold-acid, C",270-741-4,68477-61-2,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0.0,H350:0;H340:0;H304:0
1795,Dibromotriphenylphosphorane,213-855-1,1034-39-5,Skin Corr. 1B;Eye Dam. 1,Notified C&L,47.0,H314:47;H318:39;H290:1;H312:1;H302:1;H332:1
1796,Disodium succinate,205-778-7,150-90-3,Not Classified,REACH registration C&L,172.0,Not classified:130;H319:42;H315:42;H335:42
1797,"1-(4-chlorophenyl)-1H-pyrrole-2,5-dione",216-632-7,1631-29-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38.0,H315:38;H302:38;H335:38;H318:38
1800,"2-Propyn-1-amine, N,N-diethyl-, sulfate (1:?)",617-623-4,84779-61-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,4.0,H312:4;H412:4;H302:4;H332:4
1802,Nifurtoinol,214-126-0,1088-92-2,Not Classified,Notified C&L,1.0,Not classified:1
1811,"Balsams, copaiba, sulfurized, silver salts",271-373-7,68551-38-2,Flam. Sol. 1,Notified C&L,1.0,H228:1
1813,"3-(1,1,2,2-tetrafluoroethoxy)propene",215-847-3,1428-33-7,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39.0,H312:38;H302:38;H319:38;H335:38;H332:38;H315:38;H225:39
1816,"3,6,9-trioxaundecane-1,11-diol",203-989-9,112-60-7,Not Classified,REACH registration C&L,385.0,Not classified:318;H319:67;H315:1;H335:1
1823,"3,4,5,6-tetrahydrophthalimide",225-211-7,4720-86-9,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,3.0,H319:1;H302:2;Not classified:1
1826,"2,2'-(methylenebis((2,6-dimethyl-4,1-phenylene)oxymethylene))bis oxirane",439-910-1,93705-66-9,Skin Sens. 1;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,7.0,H410:6;H341:6;H317:7;H400:6
1828,N-[4-chloro-2-[(2-chloro-4-nitrophenyl)azo]-5-[(2-hydroxypropyl)amino]phenyl]acetamide,275-721-9,71617-28-2,Skin Sens. 1,Notified C&L,1.0,H317:1
1829,"9-Octadecenoic acid (Z)-, butyl ester, sulfated",283-053-4,84539-64-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
1830,4-hydroxycoumarin,214-060-2,1076-38-6,Not Classified,REACH registration C&L,211.0,Not classified:7;H302:194;H319:65;H315:65;H335:63;H330:2;H311:2
1835,Fluclorolone acetonide,223-010-9,3693-39-8,Repr. 2;Lact.;STOT RE 2,Notified C&L,1.0,H373:1;H361:1;H362:1
1838,4-tert-pentylcyclohexyl acetate,226-631-3,5441-56-5,Not Classified,Notified C&L,9.0,Not classified:9
1842,m-phenylenediacetonitrile,210-936-3,626-22-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44.0,H312:39;H302:39;H319:40;H335:39;H332:38;H315:40;H331:5;H311:5;H301:5
1843,8-amino-4-hydroxynaphthalene-2-sulphonic acid,207-700-7,489-78-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
1846,(R)-5-bromo-3-(1-methyl-2-pyrrolidinyl methyl)-1H-indole,422-390-5,143322-57-0,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0.0,H361:0;H302:0;H317:0;H372:0;H410:0;H400:0;H332:0
1847,(3-bromopropyl)trimethoxysilane,257-453-4,51826-90-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H319:42;H315:42;H335:41;H312:1;H302:1;H332:1
1849,"N,N'-diphenyladipamide",224-706-5,4456-80-8,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38.0,H410:38;H319:38;H400:38
1851,"2-ethynyltetrahydro-2,6,6-trimethyl-2H-pyran",237-551-3,13837-60-0,Flam. Liq. 3,REACH registration C&L,1.0,H226:1
1855,"Extracts (petroleum), heavy naphtha solvent;Kerosine - unspecified;[A complex combination of hydrocarbons obtained as the extract from a solvent extraction process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C",265-099-7,64741-98-6,Asp. Tox. 1,Harmonised C&L,0.0,H304:0
1859,"4-(2-butenylidene)-3,5,5-trimethylcyclohex-2-en-1-one",236-187-2,13215-88-8,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,98.0,H315:2;H302:98;H317:4;H412:4
1861,"Benzene, 1,3-dibromo-2-chloro-5-fluoro-",605-874-2,179897-90-6,,Notified C&L,6.0,H319:6;H315:6;H335:6
1864,Toluenesulphonamide,215-578-1,1333-07-9,Not Classified,REACH registration C&L,20.0,Not classified:20
1869,L-cysteinyl carbamate,218-195-8,2072-71-1,Acute Tox. 4,Notified C&L,1.0,H302:1
1872,"Lead, isononanoate naphthenate complexes",284-577-6,84929-97-5,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,3.0,H373:3;H302:3;H410:3;H400:3;H332:3;H360:3
1875,4-nitroquinoline N-oxide,200-281-1,56-57-5,Carc. 1B,Notified C&L,48.0,H350:44;Not classified:3;H310:1;H330:1;H300:1;H312:1;H302:1;H332:1
1878,4-ethoxysalicylic acid,233-919-2,10435-55-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
1879,Diadenine sulphate,206-286-5,321-30-2,,Notified C&L,12.0,H302:11;H332:5;H312:2;H319:1;H335:1;H315:1;H311:1;H301:1
1881,Diphenyl isophthalate,212-014-6,744-45-6,Not Classified,Notified C&L,5.0,Not classified:3;H319:2;H315:2
1882,"1-Propene, polymer with ethene",618-455-4,9010-79-1,Not Classified,Notified C&L,695.0,Not classified:692;H228:2;H412:1
1885,"Tallow, calcium sodium salt",272-503-5,68856-20-2,Not Classified,Notified C&L,3.0,Not classified:3
1886,"2,2'-[dithiobis(methylene)]bisfuran",224-649-6,4437-20-1,Acute Tox. 4,Notified C&L,1411.0,H302:1347;Not classified:35;H301:25;H319:4;H315:4;H413:1;H226:1;H335:1
1899,Praseodymium trihydroxide,240-513-9,16469-16-2,Not Classified,Notified C&L,2.0,Not classified:2
1903,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with 4,4'-methylenebis(2,6-diethylaniline)",500-306-9,119205-75-3,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,69.0,H411:46;H302:47;H317:46;Not classified:22
1907,Isobutyl furan-2-propionate,203-261-0,105-01-1,Not Classified,Notified C&L,345.0,Not classified:307;H312:38;H302:38
1911,"Poly(oxy-1,2-ethanediyl), .alpha.-[4-(1-phenylethyl)phenyl]-.omega.- hydroxy- (9EO)",608-713-4,32171-27-0,Aquatic Chronic 2,Notified C&L,88.0,H411:59;H412:28;H302:28;H318:28;Not classified:1
1912,"Alkenes, C8-9, hydroformylation products, distn. residues",292-426-0,90622-26-7,Skin Irrit. 2;Aquatic Chronic 4,Notified C&L,28.0,H315:28;H413:28
1923,"Oak, Quercus robur, ext.",275-129-0,71011-28-4,Not Classified,Notified C&L,72.0,Not classified:45;H226:27;H319:1
1926,2-diethylaminoethyl methacrylate,203-275-7,105-16-8,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 4,Harmonised C&L,0.0,H319:0;H315:0;H317:0;H332:0
1928,"Oxirane, 2-methyl-, polymer with oxirane, phenyl ether, polystyrenated",617-318-6,82339-23-9,Not Classified,Notified C&L,1.0,Not classified:1
1932,Pro-Jet 950 NP,416-750-0,,Not Classified,Notified C&L,1.0,Not classified:1
1938,"2-[7-(diethylamino)-2-oxo-2H-1-benzopyran-3-yl]-1,3-dimethyl-1H-benzimidazolium chloride",249-694-9,29556-33-0,Acute Tox. 4;Eye Irrit. 2,Notified C&L,573.0,H319:530;H302:522;Not classified:38;H412:4;H315:1;H335:1;H413:1;H332:1;H411:1
1943,(4-bromophenoxy)trimethylsilane,241-831-0,17878-44-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
1945,Isopropyl methacrylate,225-094-2,4655-34-9,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,4.0,H317:1;H319:2;H335:2;H315:2;H226:3;H330:1;H311:1;H301:2
1946,"2',4'-dimethoxycinnamic acid",230-208-9,6972-61-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
1948,"Alkenes, ethylene-manuf.-by-product dicyclopentadiene-conc., polymers with steam-cracked petroleum distillates",614-303-6,68131-87-3,Not Classified,Notified C&L,73.0,Not classified:73
1949,"(±)-5,6,6a,7-tetrahydro-1,2,9,10-tetramethoxy-6-methyl-4H-dibenzo[de,g]quinoline",227-068-6,5630-11-5,Not Classified,Notified C&L,1.0,Not classified:1
1951,12-wolframosilicic acid,234-719-8,12027-38-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H319:39;H315:38;H335:38;H314:2;H412:1
1955,"9H-thioxanthene-3,6-diamine 10,10-dioxide",233-527-1,10215-25-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
1960,"Ethyl 2-[[[4-(1,1-dimethylethyl)phenyl]methylene]amino]benzoate",302-347-6,94108-09-5,Not Classified,Notified C&L,88.0,Not classified:88
1961,"(2S)-2-Amino-3,3-dimethylbutan-1-ol",601-176-7,112245-13-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H319:41;H315:41;H335:40
1963,"1H,5H-Pyrazolo[1,2-a]pyrazol-1-one, 3-amino-6,7-dihydro-, hydrochloride (1:1)",609-180-0,358360-19-7,Eye Dam. 1,REACH registration C&L,1.0,H318:1
1967,Hept-2-ynoic acid,216-048-2,1483-67-6,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,Notified C&L,1.0,H314:1;H290:1;H318:1
1968,"Octadecanoic acid, reaction products with diethylenetriamine, di-Me sulfate-quaternized",291-707-5,90459-62-4,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,41.0,H315:2;H318:2;H411:39
1970,Zinc carbonate,222-477-6,3486-35-9,Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,262.0,H411:67;H400:157;Not classified:78;H410:89;H413:26;H335:3;H315:1;H302:1
1973,Cyclohexyl formate,224-415-3,4351-54-6,Flam. Liq. 3,Notified C&L,1398.0,H226:1311;Not classified:87
1974,"Methyl (4aS,5aR,6aS,7S,9aS,9bR,10R)-4a,6a-dimethyl-2,5'-dioxo-2,4,4a,4',5a,5',6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3'Hspiro[cyclopenta[1,2]phenanthro[4,4ab]oxirene-7,2'-furan]-10-carboxylate",600-850-8,107724-20-9,,Notified C&L,3.0,H312:1;H361:1;H302:1;H317:1;H332:1;Not classified:1;H373:1;H413:1
1975,"tert-Decanoic acid, oxiranylmethyl ester, reaction products with tetraethylenepentamine",307-229-8,97553-68-9,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,46.0,H411:46;H302:46;H317:46
1980,"2,4,6-tris(pentafluoroethyl)-1,3,5-triazine",212-724-6,858-46-8,Acute Tox. 4,Notified C&L,40.0,H332:39;H312:1;H302:1;H319:1;H315:1;H335:1
1981,methylethylketone peroxide trimer,429-320-2,24748-23-0,Org. Perox. B;Skin Irrit. 2;Skin Sens. 1;Asp. Tox. 1,Harmonised C&L,0.0,H241:0;H315:0;H317:0;H304:0
1982,"2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, calcium salt, [4S-(4α,4aα,5α,5aα,6β,12aα)]-",239-293-7,15251-48-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 2;Lact.;Aquatic Chronic 1,Notified C&L,1.0,H361:1;H410:1;H319:1;H335:1;H362:1;H315:1
1991,"5.alpha.-Pregnane-3,11,20-trione, 5,6.alpha.-epoxy-17-hydroxy-, cyclic 3,20-bis(ethylene acetal)",600-289-9,102213-30-9,Not Classified,REACH registration C&L,2.0,Not classified:2
1992,4-hydroxybenzyl alcohol,210-768-0,623-05-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,190.0,H319:166;H315:48;H335:46;Not classified:24
2000,2-[(p-aminophenyl)sulphonyl]ethyl hydrogensulphate,219-669-7,2494-89-5,Eye Dam. 1,REACH registration C&L,15.0,H318:11;H341:4;H315:4;H314:1;H412:1
2001,"Phosphoric acid, decyl ester, compd. with 2,2',2''-nitrilotris[ethanol]",297-991-7,93776-61-5,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1.0,H315:1;H318:1
2003,2-ethylhexyl 3-mercaptopropionate,256-589-1,50448-95-8,Acute Tox. 4;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,487.0,H410:2;H302:2;H317:2;H400:2;H319:447;H413:38;H315:1
2004,3-(isotridecyloxy)propylamine,256-881-9,50977-10-1,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 1,REACH registration C&L,1.0,H410:1;H314:1;H302:1
2005,Sodium hydrogen 9(or 10)-(sulphonatooxy)octadecanoate,273-422-8,68964-56-7,Not Classified,Notified C&L,1.0,Not classified:1
2009,3-butoxyphenol,242-715-2,18979-72-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
2010,"Santalum austro-caledonicum, ext.",295-223-5,91845-48-6,Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,51.0,H411:3;H315:3;H317:5;Not classified:45;H304:1
2011,Amprolium,204-458-4,121-25-5,Not Classified,Notified C&L,1.0,Not classified:1
2012,"Castoreum, Canadian, ext.",296-432-4,92704-04-6,Not Classified,Notified C&L,11.0,Not classified:11
2013,"Ethyl 2-amino-1,4-dihydro-4-oxopyrimidine-5-carboxylate",239-418-5,15400-53-0,,Notified C&L,5.0,H319:5;H315:5;H335:4
2014,"Aluminum phosphate hydrate, light",613-996-2,66905-65-5,Not Classified,Notified C&L,215.0,Not classified:177;H314:38
2015,"sodium bis[tris(2-hydroxyethyl)ammonium][6-anilino-4'-(4,8-disulfonato-2-naphthylazo)-5'-methyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cuprate(II)",435-240-9,,Aquatic Chronic 3,Harmonised C&L,0.0,H412:0
2019,(R)-4-bromo-α-methylbenzylamine,256-245-0,45791-36-4,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 2,Notified C&L,45.0,H411:39;H314:45;H302:39;H318:1
2020,"4-bromo-3,5-dihydroxybenzamide",236-548-4,13429-12-4,,Notified C&L,4.0,H319:4;H315:4;H335:4
2021,4-hydroxy-3-nitrobenzoic acid,210-494-1,616-82-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H319:45;H315:45;H335:44
2025,"4-(2,6,6-trimethyl-2-cyclohexen-1-yl)butan-2-one",250-657-4,31499-72-6,Not Classified,REACH registration C&L,274.0,Not classified:236;H319:38;H315:38;H335:38
2032,C.I. Reactive Blue 168,615-855-0,72847-57-5,Not Classified,Notified C&L,1.0,Not classified:1
2035,3-tert-butylaniline,226-361-6,5369-19-7,,Notified C&L,10.0,H319:10;H315:10;H302:9;H335:8;H312:5;H332:5;H301:1
2041,"Disilane, chloro Me derivs.",273-054-8,68937-17-7,Flam. Liq. 2;Skin Corr. 1A,REACH registration C&L,1.0,H314:1;H225:1
2042,Platinum dicyanide,209-743-7,592-06-3,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42.0,H330:42;H410:42;H400:42;H310:42;H300:42
2043,"Soaps, stocks, safflower-oil, acidulated",296-508-7,92704-72-8,Not Classified,Notified C&L,1.0,Not classified:1
2047,"Perhydro-1,3,5-trinitro-1,3,5-triazine",204-500-1,121-82-4,Expl. 1.1;Acute Tox. 3;STOT SE 1;STOT RE 2,REACH registration C&L,106.0,H370:57;H201:103;H373:42;H301:106;H372:38;H311:23;H331:23;H315:25;H336:5;H319:7;H335:2;Not classified:1
2053,1-(2-Methyl-5-nitrophenyl)guanidine Nitrate,604-857-7,152460-08-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
2054,"5-ethoxy-1,3-dihydrobenzimidazole-2-thione",611-274-1,55489-15-1,Acute Tox. 4;Skin Sens. 1;STOT RE 2,REACH registration C&L,47.0,H373:2;H302:2;H317:2;H319:45;H315:45;H335:44
2060,Isopropyl 2-methylcrotonate,217-067-9,1733-25-1,Flam. Liq. 3,Notified C&L,272.0,H226:262;H319:38;H315:38;H335:38;Not classified:10
2062,"1,1-dimethoxy-3,5,5-trimethylhexane",276-964-3,72894-13-4,,Notified C&L,1.0,H317:1
2063,2-chloropentane,210-885-7,625-29-6,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0.0,H312:0;H302:0;H225:0;H332:0
2065,"formic acid, copper nickel salt",268-755-0,68134-59-8,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0.0,H317:0;H372:0;H410:0;H400:0;H350:0;H360:0;H341:0;H334:0
2066,Phenyl 2-pyridyl ketone oxime,217-374-8,1826-28-4,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39.0,H315:39;H301:38;H335:38;H318:38;H319:1
2067,4-[(2-hydroxyethyl)amino]-3-nitrophenol,265-648-0,65235-31-6,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,75.0,H411:54;H315:66;H317:62;H302:26;H319:29;H335:12
2070,"(4aR*,8aR*)-1-bromo-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-one hydrochloride",439-750-2,183487-56-1,Acute Tox. 4;Eye Dam. 1;Muta. 2;Aquatic Chronic 3,REACH registration C&L,1.0,H361:1;H302:1;H318:1;H341:1;H412:1
2071,3-hydroxy-p-anisic acid,211-430-5,645-08-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H319:45;H315:45;H335:44
2073,"N,N-dimethyl-α-oxo-1H-indole-3-acetamide",249-429-7,29095-44-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H302:38;H335:38
2079,Denatonium saccharide,623-097-7,90823-38-4,Acute Tox. 4,Notified C&L,38.0,H302:38
2080,3-hydroxy-4-[(4-methyl-2-nitrophenyl)azo]-N-(o-tolyl)naphthalene-2-carboxamide,229-441-9,6535-47-3,Not Classified,Notified C&L,18.0,Not classified:18
2082,"Tar, wood",294-436-0,91722-33-7,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,104.0,H319:104;H315:104;H317:104;H412:93;H312:11;H302:11
2084,Dithiobiuret,208-784-8,541-53-7,Acute Tox. 2;Acute Tox. 2;Acute Tox. 1,Notified C&L,46.0,H310:41;H330:41;H300:46
2088,"diphenamid (ISO);N,N-dimethyl-2,2-diphenylacetamide",213-482-4,957-51-7,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0.0,H302:0;H412:0
2093,cyclohexanol,203-630-6,108-93-0,Acute Tox. 4;Skin Irrit. 2;Acute Tox. 4;STOT SE 3,Harmonised C&L,0.0,H315:0;H302:0;H335:0;H332:0
2096,"2-chloro-1-(3,4-difluorophenyl)ethanone",610-651-8,51336-95-9,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,4.0,H317:1;H319:2;H335:2;H301:1;H315:2;H334:1;H314:2;H312:1;H302:1;H332:1;H290:1;H318:1
2099,"2,2,2-trifluoroethanediol",207-006-4,421-53-4,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H225:38;H319:39;H335:43;H302:42;H315:43;H318:4;Not classified:1;H301:1;H311:1;H331:1
2100,"formothion (ISO);N-formyl-N-methylcarbamoylmethyl O,O-dimethyl phosphorodithioate",219-818-6,2540-82-1,Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0.0,H302:0;H312:0
2104,"3-ethyl-5,6,7,8-tetrahydro-5,5,8,8-tetramethylnaphthalene-2-carbaldehyde",261-182-7,58243-85-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
2110,"Hydrogen [2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][2-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]benzoato(2-)]chromate(1-)",257-791-2,52256-39-0,Not Classified,REACH registration C&L,5.0,Not classified:5
2118,Carbonohydrazide,207-837-2,497-18-7,Skin Sens. 1B,REACH registration C&L,457.0,H317:447;H411:342;H315:357;H302:298;H335:66;H319:76;H240:1;Not classified:1;H332:1;H312:1
2123,"trisodium 2-(cyanoamino)-5-[(E)-2-[4-({4-[(E)-2-(6,8-disulfonaphthalen-2-yl)diazen-1-yl]-2-methoxyphenyl}carbamoyl)phenyl]diazen-1-yl]-6-hydroxypyrimidin-4-olate",402-530-1,,Not Classified,REACH registration C&L,39.0,Not classified:39
2125,Mercaptopurine,200-037-4,50-44-2,Acute Tox. 3,Notified C&L,48.0,H301:42;H319:3;H361:6;H335:4;H302:5;H350:1;H340:1;H315:3;Not classified:2;H341:3;H400:1;H332:1;H351:1
2132,"4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecane-1,2-diol",303-265-3,94159-84-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H335:2;H315:2;H319:2
2136,S-4-(mesyloxy)phenyl methyl(thiocarbamate),614-003-5,66952-49-6,Acute Tox. 3;Aquatic Chronic 2,Notified C&L,127.0,H411:127;H301:127
2137,"2,3- dithiapentane",606-526-2,20333-39-5,Flam. Liq. 1;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3.0,H319:3;H335:2;H224:1;H302:1;H315:3;H225:2
2139,3-aminobenzylamine,412-230-2,4403-70-7,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 2,Harmonised C&L,0.0,H314:0;H411:0;H302:0
2141,1-(6-methoxy-2-naphthyl)propan-1-one,220-285-7,2700-47-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
2143,Sodium N-phenylsulphanilate,228-165-6,6152-67-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47.0,H335:44;H315:45;H319:45;Not classified:2
2146,2-hexyldecan-1-ol,219-370-1,2425-77-6,Not Classified,REACH registration C&L,321.0,Not classified:320;H319:1
2148,N-tridecylnaphthalen-2-amine,260-127-4,56358-18-0,Skin Irrit. 2;Aquatic Chronic 3,Notified C&L,84.0,H412:83;H315:83;H314:1;H302:1;H330:1;H312:1
2151,Altacet,602-916-1,12304-65-3,Not Classified,Notified C&L,1.0,Not classified:1
2154,"Methyl 3-methyl-3-[2-(2,6,6-trimethylcyclohex-2-en-1-yl)vinyl]oxirane-2-carboxylate",267-660-1,67905-40-2,Not Classified,Notified C&L,88.0,Not classified:88
2155,"Gases (petroleum), fluidized catalytic cracker scrubbing secondary absorber off;Refinery gas;[A complex combination produced by scrubbing the overhead gas from the fluidized catalytic cracker. It consists of hydrogen, nitrogen, methane, ethane and propane.]",272-875-9,68919-03-9,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0.0,H220:0;H340:0;H350:0;Not classified:0
2156,Tricyclodecanedimethanol,248-096-5,26896-48-0,Eye Irrit. 2,Notified C&L,673.0,H319:673;H412:177;H335:55;H315:56;H303:1
2158,Diethyl malate,231-444-5,7554-12-3,Not Classified,Notified C&L,89.0,Not classified:89
2165,"1,3,5-Triazine-2,4,6-triamine, hydroxymethyl methoxymethyl derivs.",285-261-0,85049-87-2,Skin Sens. 1,Notified C&L,26.0,H317:25;Not classified:1
2166,1-[2-oxo-2-[[2-[(1-oxooctadecyl)oxy]ethyl]amino]ethyl]pyridinium chloride,238-501-3,14492-68-3,Not Classified,Notified C&L,3.0,Not classified:3
2168,O-isobutyl ethylthiocarbamate,259-869-1,55860-53-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,2.0,H412:2;H315:2;H302:2;H319:2
2169,"Carbonic acid disodium salt, monohydrate",619-709-7,5968-11-6,Eye Irrit. 2,Notified C&L,89.0,H319:84;Not classified:5;H315:1;H332:1
2171,2-methylpropyl (R)-2-hydroxypropanoate,407-770-0,61597-96-4,Eye Irrit. 2,Harmonised C&L,0.0,H319:0
2173,CP cresol-epichlorohydrin-formaldehyde,609-424-6,37382-79-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,17.0,H315:15;H317:15;H319:15;Not classified:2;H412:2
2174,Roxarsone,204-453-7,121-19-7,Not Classified,Notified C&L,92.0,Not classified:52;H410:40;H301:40;H400:40;H331:40;H350:1
2179,"4,4'-Bis[(4-chlorophenyl)sulfonyl]-1,1'-biphenyl",606-971-2,22287-56-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
2181,Naphthacene,202-138-9,92-24-0,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,5.0,H410:4;H400:4;H332:1;H302:1;H312:1
2182,"bis(α,α-dimethylbenzyl) peroxide",201-279-3,80-43-3,Org. Perox. F;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2;Repr. 1B,Harmonised C&L,0.0,H319:0;H411:0;H360:0;H242:0;H315:0
2185,"1,3-Dioxane-5-methanol, 5-ethyl-2,2-dimethyl-",606-629-2,20761-68-6,,REACH registration C&L,31.0,Not classified:31
2187,2-(triphenylphosphoranylidene)acetophenone,212-727-2,859-65-4,,Notified C&L,4.0,H335:4;H315:4;H319:4
2190,"Dibutyl 2,2'-dithiodiacetate",245-954-0,23959-95-7,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38.0,H410:38;H400:38
2191,"Fatty acids, C12-18 and C18-unsatd., reaction products with chloroacetic acid and 2-(dimethylamino)ethanol and N,N-dimethyl-1,3-propanediamine",295-171-3,91845-01-1,Not Classified,Notified C&L,1.0,Not classified:1
2195,Formylcycloheptane,224-279-5,4277-29-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H226:1;H315:1;H319:1
2197,1-[(2-tert-butyl)cyclohexyloxy]-2-butanol,412-300-2,139504-68-0,Aquatic Chronic 2,Harmonised C&L,0.0,H411:0
2200,"2,2'-[1,2-ethanediylbis(oxy)]bis(ethanethiol)",239-044-2,14970-87-7,Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,252.0,H410:15;H301:15;H400:15;H411:227;H302:236;H332:250;H315:2;H319:2
2201,"(2S)-2-(4-(3-Fluorbenzyloxy)-benzylamino)-propanamid, Methan sulfonat",606-485-0,202825-46-5,Acute Tox. 3;Eye Dam. 1;Aquatic Acute 1,Notified C&L,42.0,H318:38;H301:38;H400:38;H361:3;H302:4;Not classified:1;H319:3;H332:1;H335:1;H315:1;H312:1
2202,Methylenebis[diphenylphosphine],218-194-2,2071-20-7,Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:38;H319:39;H315:6
2209,"Sodium bis[3-[[1-(3-chlorophenyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl]azo]-4-hydroxybenzenesulphonamidato(2-)]cobaltate(1-)",277-554-7,73612-40-5,Aquatic Chronic 2,REACH registration C&L,15.0,H411:13;H319:11;H412:1;Not classified:1
2212,"4,4'-Methylenediphenyl diisocyanate, oligomeric reaction products with 2,4'-diisocyanatodiphenylmethane",500-297-1,109331-54-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2;STOT RE 2,REACH registration C&L,26.0,H332:26;H319:26;H351:26;H335:26;H317:26;H334:26;H373:26;H315:26
2213,"5,10,15,20-tetraphenyl-21H,23H-porphine",213-025-9,917-23-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,3.0,H332:3;H302:3;H312:3
2218,phenylhydrazinium sulphate (2:1),257-622-2,52033-74-6,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 3;Muta. 2;Carc. 1B;STOT RE 1;Aquatic Acute 1,Harmonised C&L,0.0,H331:0;H301:0;H372:0;H319:0;H317:0;H400:0;H350:0;H341:0;H315:0;H311:0
2227,Diammonium hexachloroiridate,241-007-0,16940-92-4,Met. Corr. 1;Acute Tox. 4,REACH registration C&L,133.0,H302:50;H290:8;H411:2;H318:2;H317:83;H332:38;H312:38;H335:4;H315:4;H319:6
2228,"Fatty acids, tall-oil, potassium salts",263-136-1,61790-44-1,Not Classified,Notified C&L,202.0,Not classified:193;H314:31;H315:5;H319:9
2229,4-[(4-nitrophenyl)azo]-N-phenylaniline,219-954-6,2581-69-3,Skin Sens. 1,Notified C&L,2.0,H317:2
2230,"2,2,6,6-tetramethyl-4-piperidyl methacrylate",250-718-5,31582-45-3,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 3,Notified C&L,4.0,H412:1;H314:2;H302:2;H315:1;H319:1;H317:1
2231,"(R)-(-)-butane-1,3-diol",228-532-0,6290-03-5,Not Classified,REACH registration C&L,51.0,Not classified:3;H335:47;H315:47;H319:48
2234,Methyl 3-amino-4-hydroxybenzoate,208-627-3,536-25-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4.0,H335:4;H315:4;H319:4
2236,"7-isopropyl-1,4-dimethylazulene",207-701-2,489-84-9,Acute Tox. 4,Notified C&L,231.0,H302:231;H332:1;H319:1;H335:1;H315:1
2237,5-(phenylmethoxy)-1H-indole-3-carbaldehyde,230-134-7,6953-22-6,Skin Sens. 1;Eye Irrit. 2,Notified C&L,128.0,H317:127;H319:128;H335:1;H315:1
2239,"7,9-dimethylspiro[5.5]undecan-3-one",281-129-1,83863-64-3,Skin Irrit. 2,Notified C&L,1400.0,H315:1400;H317:59;H319:1
2240,Norflurazon,248-397-1,27314-13-2,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,197.0,H410:156;H400:196;Not classified:1
2241,"1-(chloromethyl)-3,5-bis(trifluoromethyl)benzene",278-216-1,75462-59-8,Skin Corr. 1B,Notified C&L,46.0,H314:46;H335:2;H319:2;H318:1;H290:1
2244,4-isobutylpyridine,225-376-5,4810-79-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H332:1;H319:1;H335:1;H302:1;H315:1;H312:1
2249,3-nitro-o-phenylenediamine,223-013-5,3694-52-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H335:40;H315:40;H319:40
2250,Bromostyrene,215-617-2,1335-06-4,Not Classified,Notified C&L,16.0,Not classified:16
2251,"Distillates (coal), coal tar-residual pyrolysis oils, naphthalene oils;Redistillates;[The redistillate obtained from the fractional distillation of bituminous coal high temperature tar and pyrolysis residual oils and boiling in the range of approximately 190°C to 270°C (374°F to 518°F). Composed primarily of substituted dinuclear aromatics.]",295-295-8,91995-35-6,Muta. 1B;Carc. 1B,Harmonised C&L,0.0,H340:0;H350:0
2255,"2-(heptadecenyl)-2-oxazoline-4,4-dimethanol",249-355-5,28984-69-2,Aquatic Chronic 3,Notified C&L,143.0,H412:116;Not classified:27
2258,Diguanidinium carbonate,209-813-7,593-85-1,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,301.0,H318:123;H302:301;H412:176;H335:60;H315:65;H319:79;H332:1
2260,2-BROMO-5-FLUOROBENZALDEHYDE,619-047-9,94569-84-3,,Notified C&L,9.0,H335:7;H315:8;H319:8;H331:1;H301:1;H311:1
2261,"3,6,9-triazaundecamethylenediamine;tetraethylenepentamine",203-986-2,112-57-2,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H317:0;H314:0;H302:0;H312:0
2262,3-Chloro-2-fluorobenzaldehyde,617-667-4,85070-48-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47.0,H335:46;H315:47;H319:47;H227:1
2263,Bis(4-nitrophenyl) ether,202-961-3,101-63-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:38;H315:38;H319:38;H341:1
2264,"2,2-dimethylpropane-1,3-diamine",230-819-0,7328-91-8,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,131.0,H317:86;H314:131;H318:87;H302:86;H312:86;H225:1;H226:39;H228:6
2265,"Helichrysum angustifolium, ext.",289-918-2,90045-56-0,Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1599.0,H411:1450;H317:1560;H304:1507;H315:114;H319:112;H410:108;H400:108;H226:157;H334:38;H412:2;H302:1
2270,"1,3-divinylbenzene",203-595-7,108-57-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;Repr. 2;STOT RE 2,Notified C&L,68.0,H319:55;H361:55;H373:55;H226:55;H315:55;H411:13
2271,Yttrium nitride,247-248-8,25764-13-0,Flam. Sol. 1;Skin Corr. 1B,Notified C&L,171.0,H228:171;H314:171
2272,N-methylpyrrol-2-ylacetonitrile,246-248-5,24437-41-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38.0,H332:38;H319:38;H335:38;H302:38;H315:38;H312:38
2273,"Iron, [7,16-dihydrodibenzo[b,i][1,4,8,11]tetraazacyclotetradecinato(2-)-κN5,κN9,κN14,κN18]-, (SP-4-1)-",610-569-2,50792-65-9,,Notified C&L,83.0,Not classified:83
2274,"potassium,sodium 2,4-diamino-3-[4-(2-sulfonatoethoxysulfonyl)phenylazo]-5-[4-(2-sulfonatoethoxysulfonyl)-2-sulfonatophenylazo]-benzenesulfonate",422-980-2,187026-95-5,Eye Dam. 1,Harmonised C&L,0.0,H318:0
2276,"Linden, Tilia argentea, ext.",290-012-4,90063-54-0,Flam. Liq. 3,Notified C&L,512.0,H226:450;Not classified:37;H315:25;H317:25;H319:25
2277,"2-oxocyclohexane-1,1,3,3-tetrapropionic acid",225-833-9,5107-67-5,Not Classified,REACH registration C&L,4.0,Not classified:2;H412:2
2278,4-ethoxy-3-hydroxybenzaldehyde,219-812-3,2539-53-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H302:1;H319:1
2279,Disodium butyl phosphate,264-676-0,64114-42-7,Not Classified,Notified C&L,2044.0,Not classified:2044
2280,"N,N''-bis[[(4-chlorophenyl)amino]iminomethyl]piperazine-1,4-dicarboxamidine dihydrochloride",243-328-1,19803-62-4,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,1.0,H319:1;H335:1;H317:1;H302:1;H413:1;H315:1
2283,"3-Pyridinepropanoic acid, β-oxo-, methyl ester",611-214-4,54950-20-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H332:1;H319:1;H335:1;H302:1;H315:1;H312:1
2284,"[1R-(1α,4β,4aα,6β,8aα)]-octahydro-4,8a,9,9-tetramethyl-1,6-methano-1(2H)-naphthol",227-807-2,5986-55-0,Aquatic Chronic 2,REACH registration C&L,247.0,H411:21;Not classified:226;H319:1;H304:1;H317:1;H315:1
2285,L-tryptophan,200-795-6,73-22-3,Not Classified,REACH registration C&L,89.0,Not classified:87;H335:2;H315:2;H319:2
2286,Dodecafluorocyclohexane,206-591-3,355-68-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
2287,5-chlorosalicylic acid,206-283-9,321-14-2,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,54.0,H335:12;H301:54;H315:52;H319:52;Not classified:2
2292,5-bromo-2-fluorobenzaldehyde,298-056-6,93777-26-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49.0,H335:46;H315:49;H319:49
2295,"Linden, Tilia tomentosa, ext.",303-402-7,94167-04-1,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,1.0,H226:1;H319:1
2296,Chromium boride,235-749-4,12653-55-3,Not Classified,Notified C&L,1.0,Not classified:1
2297,"2-butyl-3-benzofuryl 4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl ketone hydrochloride",243-293-2,19774-82-4,Acute Tox. 4;Acute Tox. 4,Notified C&L,106.0,H332:94;H312:95;H319:6;H361:9;H410:9;H373:10;H315:6;H371:1;H302:2;H362:5;H400:4;H360:1;Not classified:1
2301,Dichloromethyloctylsilane,238-863-2,14799-93-0,Skin Corr. 1B;Eye Dam. 1,Notified C&L,48.0,H314:44;H318:39;Not classified:5;H226:1;H290:2;H335:1
2302,reaction product of: C.I. Leuco Sulfur Black 1 with (3-chloro-2-hydroxypropyl)trimethylammonium chloride,424-510-1,,Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H318:0
2304,3-bromofuran,244-744-6,22037-28-1,Flam. Liq. 2,Notified C&L,47.0,H225:47;H335:6;H315:6;H319:6
2305,"Fatty acids, C16-18, tetraesters with 3,3'-oxybis[1,2-propanediol]",293-026-9,91050-80-5,Not Classified,Notified C&L,8.0,Not classified:8
2307,4-fluorothiophenol,206-737-6,371-42-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,82.0,H335:45;H226:81;H315:80;H319:80;H330:34;H300:39;H317:39;H410:38;H400:38;H310:39;H331:5;H311:1;H301:1;H332:1;H302:2;H312:1;H314:1
2310,"5,10,15,20-tetra(4-pyridyl)-21H,23H-porphine",240-858-5,16834-13-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:38;H315:39;H319:39
2311,"1,3-Undecadien-5-yne",417-840-2,166432-52-6,Skin Sens. 1,Notified C&L,126.0,H317:126;H413:34;H315:34
2313,"1,2-Ethanediamine, N-(5-methoxy-2-nitrophenyl)-, monohydrochloride",415-480-0,86419-69-4,Acute Tox. 4,Notified C&L,1.0,H302:1
2316,"3,9-bis(2,6-di-tert-butyl-4-methylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane",410-290-4,80693-00-1,Aquatic Chronic 4,Harmonised C&L,0.0,H413:0
2317,Tantalum pentabromide,236-618-4,13451-11-1,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,Notified C&L,65.0,H332:42;H314:65;H318:39;H302:64;H312:42;H331:22;H311:22
2319,Bis(2-chloroethyl) phosphonate,213-975-4,1070-42-4,Not Classified,Notified C&L,33.0,Not classified:33
2320,Azidamfenicol,237-552-9,13838-08-9,Acute Tox. 4,Notified C&L,1.0,H302:1
2323,1-ethyl-2-quinolone,258-749-6,53761-50-5,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,38.0,H302:38;H317:38;H319:38
2328,Neryl propionate,203-345-7,105-91-9,Not Classified,Notified C&L,89.0,Not classified:89
2330,2-hexylpyridine,214-454-4,1129-69-7,Acute Tox. 4,Notified C&L,1417.0,H302:1374;H318:48;H301:38;H335:42;H315:42;H332:10;H314:10;H312:10;H319:4;Not classified:1
2331,4-bromophthalic anhydride,201-707-9,86-90-8,Skin Sens. 1;Eye Dam. 1,Notified C&L,5.0,H318:1;H317:1;H315:4;H319:4;H335:3;H302:1
2335,4-amino-5-methyl-1H-pyrimidin-2-one hydrochloride,261-223-9,58366-64-6,Not Classified,Notified C&L,1.0,Not classified:1
2339,"2,4-dichlorophenyl isocyanate",220-040-4,2612-57-9,Skin Corr. 1C;Skin Sens. 1A;Eye Dam. 1;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,45.0,H330:7;H317:40;H314:2;H410:2;H318:2;H400:2;H331:38;H301:42;H319:43;H335:43;H334:42;H315:43;H311:38;H300:1
2340,Methyl (R)-2-chloropropionate,278-658-5,77287-29-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:38;H226:39;H315:39;H319:39
2342,Methyl D-glucoside,246-894-8,25360-07-0,Not Classified,Notified C&L,2.0,Not classified:2
2343,17β-hydroxyandrost-4-en-3-one 3-phenylpropionate,215-014-4,1255-49-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,56.0,H332:56;H351:56;H302:55;H312:55;H360:17;H319:1;H335:1;H315:1
2352,Benzenethiol,203-635-3,108-98-5,Flam. Liq. 4;Acute Tox. 2;Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 1;Repr. 2;STOT SE 2;STOT SE 3;STOT RE 1;Aquatic Acute 1,REACH registration C&L,1665.0,H371:53;H372:52;H330:1664;H319:64;H361:35;H335:59;H300:1406;H410:1324;H400:1324;H310:338;H227:1;H226:1661;H315:1390;H318:1403;H311:1327;H301:259;H314:233;H228:3;Not classified:2
2353,4-(p-tolyloxy)aniline,255-298-7,41295-20-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3.0,H315:3;H319:3;H335:1
2354,"1,1'-dimethyl-4,4'-bipyridinium",225-141-7,4685-14-7,Met. Corr. 1;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 1;STOT SE 3;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,156.0,H301:156;H372:156;H330:156;H319:156;H335:156;H290:156;H410:156;H400:156;H315:156;H311:156
2355,"N,N′-methylenedimorpholine;N,N′-methylenebismorpholine;[formaldehyde released from N,N′-methylenebismorpholine];[MBM]",227-062-3,5625-90-1,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Skin Sens. 1;Acute Tox. 4;Muta. 2;Carc. 1B;STOT RE 2,Harmonised C&L,0.0,H332:0;H317:0;H314:0;H373:0;H318:0;H302:0;H341:0;H350:0;H312:0
2358,(±)-[2-hydroxy-3-(naphthyloxy)propyl]isopropylammonium chloride,222-501-5,3506-09-0,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4,Notified C&L,69.0,H332:67;H302:69;H317:67;H312:67
2359,"Poly[oxy(dimethylsilylene)],alpha-[[3-(2-hydroxyethoxy)propyl]dimethylsilyl]-w-[[[3-(2-hydroxyethoxy)propyl]dimethylsilyl]oxy]-",605-054-4,156327-07-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H315:1;H319:1;Not classified:1
2360,Chloromethylphenylsilane,216-633-2,1631-82-9,Skin Corr. 1B,Notified C&L,39.0,H314:39;H225:1
2362,4-ethoxyphenyl trans-4-propylcyclohexanecarboxylate,266-744-5,67589-39-3,Aquatic Chronic 4,Notified C&L,2.0,H413:1;Not classified:1;H317:1
2366,"SILOXANES AND SILICONES, ETHYL METHYL, METHYL-2-PHENYLPROPYL",614-228-9,68037-77-4,Not Classified,Notified C&L,530.0,Not classified:491;H319:21;H413:18;H335:1;H315:1
2372,Isopropyl 2-ethylhexanoate,266-549-5,67024-46-8,Not Classified,REACH registration C&L,76.0,Not classified:76
2377,cinmethylin (ISO);exo-(±)-1-methyl-2-(2-methylbenzyloxy)-4-isopropyl-7-oxabicyclo(2.2.1)heptane,402-410-9,87818-31-3,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H332:0
2379,"N-(dimethylsilyl)-1,1-dimethylsilylamine",240-072-2,15933-59-2,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,67.0,H335:39;H315:39;H225:67;H319:39;H314:27;H318:23
2380,"Phenol, 2(or 4)-[(2,4-dinitrophenyl)amino]-, sulfurized",215-453-1,1327-01-1,Not Classified,Notified C&L,1.0,Not classified:1
2384,"N,N-dimethylformamide;dimethyl formamide",200-679-5,68-12-2,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;Repr. 1B,Harmonised C&L,0.0,H360:0;H319:0;H332:0;H312:0
2388,4-(DIMETHYLAMINO)-2-BUTENOIC ACID HYDROCHLORIDE,619-362-1,98548-81-3,Eye Irrit. 2,Notified C&L,38.0,H319:38
2393,4-[(4-nitrophenyl)azo]pyrocatechol,212-676-6,843-33-4,,Notified C&L,5.0,H335:4;H315:5;H319:5
2396,"Boric acid (H3BO3), reaction products with ethanolamine and triethanolamine",270-982-5,68512-53-8,Not Classified,REACH registration C&L,40.0,Not classified:12;H315:28;H319:28
2400,"(2E,4E)-hepta-2,4-dien-1-ol",251-535-3,33467-79-7,,Notified C&L,4.0,H315:4;H319:4
2402,"Storax (balsam), American, sapond.",295-226-1,91845-51-1,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,897.0,H412:897;H317:897
2404,(Z)-hept-4-en-1-ol,228-238-2,6191-71-5,Not Classified,Notified C&L,88.0,Not classified:88
2405,"Octadecanoic acid, reaction products with 2-[(2-aminoethyl)amino]ethanol and diethylenetriamine, acetates (salts)",291-702-8,90459-58-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
2407,Tetraaluminium zirconium tetrachloride dodecahydroxide,308-573-1,98106-52-6,Not Classified,Notified C&L,1.0,Not classified:1
2408,Lithium ethylenediamide,241-167-1,17096-24-1,Water-react. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38.0,H319:38;H332:38;H260:38;H335:38;H302:38;H315:38;H312:38
2410,"fenpyroximate (ISO);tert-butyl 4-[({(E)-[(1,3-dimethyl-5-phenoxy-1H-pyrazol-4-yl)methylene]amino}oxy)methyl]benzoate",603-792-1,134098-61-6,Acute Tox. 3;Skin Sens. 1B;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H301:0;H330:0;H317:0;H410:0;H400:0
2413,"Oleic acid, compound with 1-aminopropan-2-ol (1:1)",247-075-8,25525-60-4,Not Classified,Notified C&L,27.0,Not classified:26;H412:1;H319:1
2415,"Ethanol, 2,2'-oxybis-, polymer with 2-methyloxirane and oxirane",610-559-8,50658-23-6,Not Classified,Notified C&L,83.0,Not classified:83
2419,"2S-isopropyl-5R-methyl-1R-cyclohexyl 2,2-dihydroxyacetate",416-810-6,111969-64-3,Eye Dam. 1;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0.0,H373:0;H318:0;H411:0
2420,4-Piperidinecarboxylic acid hydrochloride,611-901-9,5984-56-5,Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,5.0,H412:4;H318:4;H335:1;H315:1;H319:1
2421,3-methoxybenzyl alcohol,230-200-5,6971-51-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H315:2;H302:1;H319:2;H335:1
2425,5-(2-aminoethyl)-4-hydroxypyrocatechol hydrochloride,248-837-2,28094-15-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
2431,Temephos,222-191-1,3383-96-8,Acute Tox. 4;Acute Tox. 3;Aquatic Acute 1,Notified C&L,49.0,H400:46;H302:47;H311:44;H410:8;H373:7;H332:5;H312:3
2432,5-hydroxyoctan-4-one,207-830-4,496-77-5,Not Classified,Notified C&L,88.0,Not classified:88
2440,(nitrooxy)zincio nitrate hexahydrate,600-255-3,10196-18-6,Ox. Sol. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,161.0,H319:161;H335:161;H302:161;H272:161;H315:161;H410:26
2450,2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one,444-860-9,474510-57-1,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H373:0;H400:0
2451,"4-[(2,5-dichlorophenyl)azo]-N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-hydroxynaphthalene-2-carboxamide",230-258-1,6992-11-6,Not Classified,REACH registration C&L,191.0,Not classified:191
2463,"Foots oil (petroleum), carbon-treated;[A complex combination of hydrocarbons obtained by the treatment of Foots oil with activated carbon for the removal of trace constituents and impurities. It consists predominantly of saturated straight chain hydrocarbons having carbon numbers predominantly greater than C",308-126-0,97862-76-5,Carc. 1B,Harmonised C&L,0.0,H350:0
2467,2-Bromo-5-fluoroaniline,600-091-2,1003-99-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H335:43;H315:44;H319:44;H332:5;H302:5;H312:5
2470,"2,7-dihydroxy-1,3,2-benzodioxabismole-5-carboxylic acid",202-742-2,99-26-3,Not Classified,Notified C&L,31.0,Not classified:30;H334:1;H317:1
2473,"1,4-bis(isocyanatomethyl)cyclohexane",233-757-2,10347-54-3,Acute Tox. 4;Acute Tox. 1,Notified C&L,93.0,H302:93;H330:93;H319:38;H335:38;H317:38;H315:38;H312:38
2477,Isopulegyl formate,234-192-4,10588-15-5,Not Classified,Notified C&L,88.0,Not classified:88
2478,1-Hydroxycyclohexanecarboxylic acid ethyl ester,446-570-8,,Aquatic Chronic 3,REACH registration C&L,57.0,H412:57
2482,2-(4'-chlorobenzyl)pyridine,224-412-7,4350-41-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,42.0,H318:38;H315:42;H302:38;H335:38;H319:4
2484,Tri-sec-butylborane,214-209-1,1113-78-6,Pyr. Liq. 1;Pyr. Sol. 1;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,151.0,H412:85;H314:150;H318:86;H250:150;H319:1;H335:1;H224:1;H302:1;H315:1
2488,(±)-4-[1-hydroxy-2-(methylamino)ethyl]pyrocatechol hydrochloride,206-346-0,329-63-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H301:40;H319:39;H335:39;H315:39;H311:39;H300:1
2492,3(or 4)-(4-methylpenten-3-yl)cyclohex-3-ene-1-methyl acetate,276-650-6,72403-67-9,Skin Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1568.0,H411:1301;H315:1301;Not classified:267
2496,Maprotiline hydrochloride,233-758-8,10347-81-6,Acute Tox. 4,Notified C&L,42.0,H302:41;H410:1;H350:1;Not classified:1
2497,"2,6-diamino-3,5-diethyltoluene;4,6-diethyl-2-methyl-1,3-benzenediamine",218-255-3,2095-01-4,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H319:0;H373:0;H400:0;H302:0;H410:0;H312:0
2500,3-Chloro-5-fluoroanisole,606-506-3,202925-08-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H335:38;H315:40;H319:40
2504,"1,2-diphenylethanol",210-374-9,614-29-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H302:1;H319:1
2505,"hexasodium [4,4''-azoxybis(2,2'-disulfonatostilbene-4,4'-diylazo)]-bis[5'-sulfonatobenzene-2,2'- diolato-O(2),O(2),N(1)]-copper(II)",400-020-3,82027-60-9,Aquatic Chronic 2,Harmonised C&L,0.0,H411:0
2512,"2-cyclopentene-1-acetic acid, 3-hydroxy-2-pentyl-, methyl ester acetate",431-400-7,57374-49-9,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H317:0
2513,Benzyldimethyl[3-[(1-oxohexadecyl)amino]propyl]ammonium chloride,265-879-7,65694-09-9,Not Classified,Notified C&L,3.0,Not classified:3
2515,N-octylacrylamide,233-345-2,10124-68-2,Not Classified,Notified C&L,36.0,Not classified:36
2517,1-nitroguanidine,209-143-5,556-88-7,Expl. 1.1,REACH registration C&L,57.0,H201:47;H335:9;H315:10;H319:11;H228:1;H318:1
2518,"2-diethylaminoethanol;N,N-diethylethanolamine",202-845-2,100-37-8,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Harmonised C&L,0.0,H332:0;H314:0;H302:0;H226:0;H312:0
2526,Tributyl borate,211-706-5,688-74-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,501.0,H335:500;H315:501;H302:453;H319:501;H312:446
2527,Magnesium dipropanolate,252-712-8,35754-82-6,Flam. Sol. 1;Eye Irrit. 2,Notified C&L,1.0,H228:1;H319:1
2529,"3-[3-acetyl-4-[3-[(tert-butyl)amino]-2-hydroxypropoxy]phenyl]-1,1-diethyluronium chloride",260-752-2,57470-78-7,Aquatic Chronic 3,Notified C&L,54.0,H412:53;Not classified:1
2530,Styrax tonkinensis,281-683-4,84012-39-5,Not Classified,Notified C&L,151.0,Not classified:47;H319:51;H317:102;H302:50;H412:51;H315:76;H318:2;H225:1;H226:1
2531,Pent-4-yn-2-ol,218-321-1,2117-11-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H335:44;H226:45;H315:45;H319:45;H332:1;H302:1;H312:1
2536,Glycerol,200-289-5,56-81-5,Not Classified,REACH registration C&L,5502.0,Not classified:5443;H319:50;H315:21;H373:5;H372:4;H335:3
2537,"Pteridine-2,4-diol monohydrate",207-652-7,487-21-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,36.0,H302:36;H319:36
2539,5-(p-nitrophenylazo)salicylic acid,218-818-3,2243-76-7,Not Classified,Notified C&L,2086.0,Not classified:2048;H302:38;H319:38
2540,"bis[(1-methylimidazol)-(2-ethyl-hexanoate)], zinc complex",405-635-0,,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H318:0;H410:0;H315:0;H400:0
2543,"1-Piperidinecarboxylic acid, 4-(methylamino)-, ethyl ester",616-013-5,73733-69-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,6.0,H332:2;H302:2;H312:2;H335:4;H315:4;H319:4
2544,Diethylammonium sulphate,247-588-7,26292-53-5,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1A;Eye Dam. 1;Acute Tox. 4;STOT SE 3,Notified C&L,10.0,H332:10;H335:10;H314:10;H318:10;H302:10;H311:10
2549,2-chloro-4-nitrotoluene,204-501-7,121-86-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,47.0,H302:39;H319:43;H411:6;H315:4;H373:4;H301:3;H330:3;H311:3;H332:1;H312:1
2552,5-α-cholestan-3-β-ol,201-315-8,80-97-7,Not Classified,Notified C&L,1.0,Not classified:1
2554,"tetrasodium 5-benzamido-3-(5-(4-fluoro-6-(1-sulphonato-2-naphthylamino)-1,3,5-triazin-2-ylamino)-2-sulphonatophenylazo)-4-hydroxynaphthalene-2,7- disulphonate",400-790-0,85665-97-0,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0.0,H315:0;H317:0;H319:0
2556,"4,9,12,12-tetramethyl-5-oxatricyclo[8.2.0.04,6]dodecane",214-906-0,1209-61-6,Not Classified,Notified C&L,89.0,Not classified:89
2557,2-methylquinolin-8-amine,606-190-7,18978-78-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,87.0,H319:4;H411:84;H335:3;H302:2;H315:4;H301:83;H317:83;H332:1;H312:1
2558,Boswellia frereana extract,616-980-3,8016-36-2,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,265.0,H411:115;H315:118;H317:201;H304:201;H410:86;H400:86;H226:124;Not classified:25;H319:1
2562,Alpha-oxothiophen-2-acetic acid,223-794-2,4075-59-6,Skin Corr. 1B;Eye Dam. 1,Notified C&L,42.0,H314:42;H318:38
2564,"N,N'-(methylenedi-p-phenylene)bis[hexahydro-2-oxo-1H-azepine-1-carboxamide]",258-981-8,54112-23-1,Not Classified,REACH registration C&L,162.0,Not classified:162
2566,"α,α-dimethylphenethyl butyrate",233-221-8,10094-34-5,Skin Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1926.0,H412:30;H315:106;H411:1778;H317:39;Not classified:33
2571,"Walnut, Juglans nigra, ext.",306-252-0,96690-56-1,Not Classified,Notified C&L,37.0,Not classified:37
2578,"2,2,2-trifluoro-N-(trifluoroacetyl)acetamide",206-981-3,407-24-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H315:1;H319:1;H314:1
2579,"Gonadotropin, pregnant mare serum",232-663-9,9002-70-4,Acute Tox. 3,Notified C&L,91.0,H301:39;H360:51;H334:1;H317:1;H332:1
2584,"Benzenesulfonic acid, mono-C10-13-alkyl derivs., compds. with diethanolamine",290-649-8,90194-39-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT RE 2;Aquatic Chronic 3,Notified C&L,114.0,H373:83;H318:86;H302:85;H412:83;H315:114;H319:28
2585,3-nitrobenzamide,211-431-0,645-09-0,,Notified C&L,5.0,H335:4;H315:4;H302:5;H319:4;H332:1;H312:1
2591,Hex-3-en-1-ol,208-860-0,544-12-7,Flam. Liq. 3,Notified C&L,263.0,H226:238;H319:45
2593,Tetraphenylphosphonium chloride,217-890-3,2001-45-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H335:44;H315:45;H319:45;H228:1
2596,"3-(2-CHLOROETHYL)-9-HYDROXY-2-METHYL-4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE HYDROCHLORIDE (1:1)",617-648-0,849727-62-4,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Muta. 2;Aquatic Chronic 2,REACH registration C&L,2.0,H411:2;H314:2;H318:1;H302:2;H341:2
2599,"6,7,8,9-tetrahydro-5H-cyclohepta(b)pyridine",230-568-7,7197-96-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
2601,"1-methyl-2-(2,6-xylyloxy)ethylammonium chloride",226-362-1,5370-01-4,Acute Tox. 4,Notified C&L,49.0,H302:49;H315:2;H319:2;H335:1;H412:2
2603,"Reaction products of di-, tri- and tetra-propoxylated propane-1,2-diol with ammonia",618-561-0,9046-10-0,Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,1235.0,H412:783;H314:1228;H318:716;H304:469;H302:822;H311:515;H335:187;H411:54;H301:57;H312:90;Not classified:5;H317:4;H319:3;H332:2;H315:3;H290:1
2604,"(1,1'-bis(diphenylphosphino)ferrocene)dichloro palladium(II)",615-748-9,72287-26-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H335:44;H315:44;H319:44;H332:2;H302:2;H312:2;H413:1
2607,Acid Blue 284,612-472-0,61814-66-2,Aquatic Chronic 3,Notified C&L,7.0,H412:5;Not classified:2
2609,4-chlorobenzonitrile,210-765-4,623-03-0,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,203.0,H412:159;H319:203;H302:203;H312:81;H311:83;H332:38;H335:39;H315:40;H413:1
2612,"3α,7α-dihydroxy-12-oxo-5β-cholan-24-oic acid",219-542-6,2458-08-4,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1.0,H315:1;H319:1
2614,5-(phenylmethoxy)-1H-indole-2-carboxylic acid,229-652-6,6640-09-1,,Notified C&L,4.0,H335:4;H315:4;H319:4
2615,"2-aminosulfonyl-N,N-dimethylnicotinamide",413-440-7,112006-75-4,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0.0,H412:0;H317:0
2620,"4,4'-Isopropylidenediphenol, ethoxylated, esters with fatty acids, coco",500-303-2,115340-85-7,Muta. 2,REACH registration C&L,9.0,H341:1;Not classified:8
2625,Diethyl(2-ethylaminoethyl)amine,203-264-7,105-04-4,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,39.0,H314:39;H226:39;H318:1
2628,6-nitro-2-benzopyrone,220-341-0,2725-81-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38.0,H302:38;H319:38
2630,"reaction mass of: tetrasodium 3-(1,5-disulfonatonaphthalene-2-ylazo)-4-hydroxy-7-{4-chloro-6-[4-(2-sulfoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino}naphthalene-2-sulfonate;3-(2,5-disulfophenylazo)-4-hydroxy-7-{4-chloro-6-[4-(2-sulfoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino}naphthalene-2-sulfonic acid, sodium salt",429-440-5,,Eye Dam. 1,Harmonised C&L,0.0,H318:0
2638,1-cyclohexylethan-1-one,212-517-0,823-76-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H335:43;H315:43;H319:43
2640,"Amides, from ammonia-1,2-dichloroethane reaction product triethylenetetramine fraction and C18-24 fatty acids, reaction products with 1,6-diisocyanatohexane",287-663-1,85566-54-7,Not Classified,Notified C&L,1.0,Not classified:1
2645,Disodium 4-decyl 2-sulphonatosuccinate,230-818-5,7328-38-3,,Notified C&L,2.0,H318:1;H315:1;H319:1
2647,Guanidinium thiocyanate,209-812-1,593-84-0,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,278.0,H332:269;H314:85;H318:39;H302:271;H412:263;H312:268;H301:6;H402:6;H331:6;Not classified:3;H319:2;H315:2;H335:1
2648,5-AMINO-1-METHYL-1H-TETRAZOLE,611-113-5,5422-44-6,Flam. Sol. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H228:2;H315:2;H319:2
2651,p-bromophenethyl alcohol,225-093-7,4654-39-1,Acute Tox. 4,Notified C&L,41.0,H302:41;H332:1;H319:3;H335:3;H315:3;H312:1
2654,"1,1'-oxybis(4-fluorobenzene)",206-358-6,330-93-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H335:2;H315:2;H319:2
2660,Erythromycin stearate,211-396-1,643-22-1,Skin Sens. 1;Resp. Sens. 1,Notified C&L,105.0,H334:62;H317:62;H319:42;Not classified:1
2661,Rolipram,262-771-1,61413-54-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,64.0,H335:39;H315:39;H319:39;H302:24;H361:1
2664,Dipotassium hexachlororhenate,241-008-6,16940-97-9,Skin Corr. 1B;Eye Dam. 1,Notified C&L,42.0,H314:38;H318:38;H335:4;H315:4;H319:4
2666,"Alcohols, C8-22, distn. residues",292-425-5,90622-25-6,Not Classified,Notified C&L,2.0,Not classified:2
2667,"4,4'-bis[[4-methoxy-6-[(2-sulphoethyl)amino]-1,3,5-triazin-2-yl]amino]stilbene-2,2'-disulphonic acid, sodium salt, compound with 2,2'-iminodiethanol",285-889-5,85154-07-0,Not Classified,Notified C&L,1.0,Not classified:1
2671,"Disodium 8-[[4-(1,1-dimethylethyl)-2-sulphonatophenyl]amino]-9,10-dihydro-1-hydroxy-5-[(1-methylethyl)amino]-9,10-dioxoanthracene-2-sulphonate",280-148-2,83027-45-6,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,9.0,H412:9;H319:9
2675,Di-tert-butyl bicarbamate,240-512-3,16466-61-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,196.0,H335:196;H315:196;H319:196
2680,2-p-tolylethanol,211-824-7,699-02-5,Not Classified,Notified C&L,89.0,Not classified:88;H335:1;H315:1;H319:1
2682,Hex-3-enedioic acid,224-648-0,4436-74-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
2686,(2S)-5-amino-2-[(aminoacetyl)amino]-5-oxopentanoic acid,700-144-0,13115-71-4,Not Classified,Notified C&L,1.0,Not classified:1
2689,Imiprothrin,615-873-9,72963-72-5,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,207.0,H410:207;H400:207;H302:207
2693,C.I. Acid Brown 322,612-727-6,61931-11-1,Not Classified,Notified C&L,2.0,Not classified:2
2698,N-(2-ethylhexyl)naphthalen-2-amine,260-126-9,56358-17-9,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,84.0,H410:83;H315:83;H400:83;H314:1;H302:1;H330:1;H312:1
2701,2-methylbenzylamine,201-952-1,89-93-0,Skin Corr. 1B,Notified C&L,45.0,H314:45;H318:2
2702,2-butyryloxyethyltrimethylammonium iodide,219-666-0,2494-56-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:38;H315:39;H319:39
2705,[2H10]cyclohexanone,257-058-7,51209-49-5,Flam. Liq. 3;Acute Tox. 4,Notified C&L,38.0,H226:38;H332:38
2706,"Urea, N,N-bis(2-hydroxyethyl)-, N'-(hydrogenated tallow alkyl) derivs.",297-000-8,93166-10-0,,Notified C&L,33.0,Not classified:33
2712,Dodecyltrimethoxysilane,221-332-4,3069-21-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,21.0,H335:16;H315:21;H319:21
2714,Pent-3-en-2-one,210-888-3,625-33-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1446.0,H335:1446;H315:1446;H319:1446;H312:1394;H225:160;H311:52;H304:25
2715,"Aluminium, compound with barium (4:1)",235-493-3,12253-23-5,Acute Tox. 4;Acute Tox. 4,Notified C&L,42.0,H302:38;H332:38;H261:4
2716,8-amino-7-methylphenazin-2-ol,202-139-4,92-25-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38.0,H318:38;H315:38;H302:38;H335:38
2717,Decaborane(14),241-711-8,17702-41-9,Flam. Sol. 1;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3,Notified C&L,43.0,H301:39;H330:43;H319:39;H335:39;H228:43;H315:39;H311:39;H310:4;H300:4
2718,2-(aminomethyl)phenol,213-249-7,932-30-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H335:42;H315:42;H319:42;H332:1;H302:1;H312:1
2719,copper(II) methanesulfonate,405-400-2,54253-62-2,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H318:0;H302:0;H400:0
2721,"Fatty acids, C16-22 and C18-unsatd.",270-275-1,68424-13-5,Not Classified,Notified C&L,73.0,Not classified:73
2729,4-methylpyrazole,231-445-0,7554-65-6,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1,Notified C&L,130.0,H314:85;H318:85;H302:130;H312:85;H335:44;H315:45;H319:45
2730,Cyclopentylacetic acid,214-368-7,1123-00-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,200.0,H335:199;H315:200;H319:200
2734,α-hydroxypyridine-3-methanesulphonic acid,225-377-0,4812-14-0,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38.0,H314:38;H318:38
2737,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with octahydro-4,7-methano-lH-indenedimethylamine",500-420-9,158999-25-8,Not Classified,Notified C&L,32.0,Not classified:32;H317:1;H314:1;H302:1;H412:1;H312:1
2738,Deferoxamine mesilate,205-314-3,138-14-7,Not Classified,Notified C&L,9.0,Not classified:4;H319:4;H335:4;H317:5;H334:4;H341:2;H315:4
2740,"Residues (petroleum), heavy coker and light vacuum;Heavy Fuel oil;[A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and light vacuum gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C",270-983-0,68512-61-8,Carc. 1B,Harmonised C&L,0.0,H350:0
2741,"9,10-Anthracenedione, 2,2'-(1,3,4-oxadiazole-2,5-diyl)bis[1-amino-",602-479-7,12227-47-3,Not Classified,Notified C&L,1.0,Not classified:1
2743,"reaction mass of: bis(1S,2S,4S)-(1-benzyl-4-tert-butoxycarboxamido-2-hydroxy-5-phenyl)pentylammonium succinate;isopropyl alcohol",414-810-0,,Eye Dam. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H373:0;H318:0;H400:0
2745,"Nucleotidyltransferase, deoxyribonucleate, RNA-dependent",232-964-5,9068-38-6,Not Classified,Notified C&L,1.0,Not classified:1
2747,"Urea, N,N''-(methylenedi-4,1-phenylene)bis[N'-octadecyl-",610-108-5,43136-14-7,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1.0,H412:1;H317:1
2748,"Pentyl 2-cyano-(3-(6-methoxybenzothiazol-2-ylimino)-2,3-dihydro-1H-isoindol-1-ylidene)acetate",436-060-3,,Not Classified,REACH registration C&L,1.0,Not classified:1
2749,"Pyridinium, 1-(2-benzothiazolyl)-4-(2-oxo-1-pyrrolidinyl)-, chloride (1:1)",606-475-6,202482-12-0,Not Classified,Notified C&L,1.0,Not classified:1
2750,Reactive Red 9707,440-580-6,,Not Classified,Notified C&L,1.0,Not classified:1
2753,Isopropyl 16-methylheptadecanoate,250-651-1,31478-84-9,Not Classified,Notified C&L,38.0,Not classified:38
2756,Diethyl oxalacetate,203-594-1,108-56-5,Acute Tox. 4,Notified C&L,1.0,H302:1
2757,Hydromorphone,207-383-5,466-99-9,Acute Tox. 3,Notified C&L,3.0,H301:3;H361:1;H317:1;H331:1
2758,"2',5'-diethoxybenzanilide",202-137-3,92-22-8,Aquatic Acute 1,Notified C&L,38.0,H400:38
2759,"Fatty acids, C12-20 and C12-20-unsatd., reaction products with diethanolamine, borates (esters)",295-172-9,91845-02-2,Not Classified,Notified C&L,1.0,Not classified:1
2763,Bis(isopropylcyclopentadienyl) Tungsten Dihydride,613-623-3,64561-25-7,Water-react. 1;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,29.0,H314:22;H260:25;H315:29;H319:29;H335:5;H261:4;H226:5;H332:1;H302:1;H413:1;H312:1;H336:1
2765,17β-hydroxyandrost-4-ene-3-one 4-methylvalerate,239-307-1,15262-86-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,57.0,H332:56;H351:56;H302:56;H312:55;H360:17;H361:1;H373:1
2766,Aspergillus oryzae,614-237-8,68038-56-2,Not Classified,Notified C&L,1.0,Not classified:1
2769,5-fluoro-2-nitrotoluene,207-164-4,446-33-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,50.0,H332:47;H319:50;H335:47;H302:47;H315:50;H312:47;Not classified:1
2771,2-methyl-N-(4-sulfamoylphenyl) prop-2-enamide,438-940-2,,Not Classified,Notified C&L,1.0,Not classified:1
2773,"2,4-dimethyl-1H-imidazole",213-221-4,930-62-1,Not Classified,Notified C&L,61.0,Not classified:29;H314:32;H318:14;H302:14
2775,"4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-6-[[(5-methyl-3-phenyl-4-isoxazolyl)carbonyl]amino]-7-oxo-, [2S-(2α,5α,6β)]-, compd. with N,N'-bis(phenylmethyl)-1,2-ethanediamine (2:1)",213-024-3,916-96-1,Skin Sens. 1;Resp. Sens. 1,Notified C&L,24.0,H334:24;H317:24
2776,Adenine,200-796-1,73-24-5,Acute Tox. 3,REACH registration C&L,300.0,H301:290;H302:10;H331:2;H311:2;H315:1;H319:1;H312:1
2781,2-Brommalondialdehyd,606-595-9,2065-75-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48.0,H335:39;H315:39;H319:39;H318:9;H302:8;H300:1;H411:1;Not classified:2
2783,2-methoxy-4-propylcyclohexan-1-ol,245-953-5,23950-98-3,Not Classified,Notified C&L,89.0,Not classified:64;H315:25;H319:25;H335:1
2784,Chromium triformate,248-230-2,27115-36-2,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Acute 2,REACH registration C&L,92.0,H401:4;H319:6;H317:90;H302:4;H315:6;H412:86;H335:2
2786,"reaction mass of: isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-(n)-dodecylphenol;isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-(n)-tetracosylphenol;isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-5,6-didodecyl-phenol. n = 5 or 6",401-680-5,,Aquatic Chronic 4,Harmonised C&L,0.0,H413:0
2789,"Disodium 1-amino-4-(3-amino-4-sulphonatoanilino)-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate",229-735-7,6691-06-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
2792,Ethyl N-(2-ethoxy-2-oxoethyl)glycinate,228-533-6,6290-05-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H335:41;H315:42;H319:42
2794,Bismuth sodium tartrate,250-719-0,31586-77-3,Not Classified,Notified C&L,2.0,Not classified:2
2796,"1,6-naphthalenedisulfonic acid",610-859-9,525-37-1,Skin Corr. 1B;Eye Dam. 1,Notified C&L,33.0,H314:33;H318:33
2798,Hexafluorophosphoric acid,241-006-5,16940-81-1,Skin Corr. 1B,Notified C&L,45.0,H314:45;H301:4;H330:5;H311:4;H310:3;H300:3;H331:2;H318:1
2799,"Amines, tris(hydrogenated tallow alkyl)",263-135-6,61790-42-9,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,35.0,H410:35;H315:35;H400:35
2801,2-Bromo-4-fluoroaniline,619-469-3,1003-98-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47.0,H335:42;H315:47;H319:47;H332:8;H302:9;H312:8
2804,Trihydrogen tetracosa-μ-oxododecaoxo[μ12-[phosphato(3-)-O:O:O:O':O':O':O'':O'':O'':O''':O''':O''']]dodecamolybdate(3-),234-713-5,12026-57-2,Skin Corr. 1B,Notified C&L,17.0,H314:17;H318:1;H272:1;Not classified:1;H290:1;H413:1
2808,"Carbamic acid, N-[(1R)-2-hydroxy-1-phenylethyl]-, 1,1-dimethylethyl ester",600-273-1,102089-74-7,Acute Tox. 4;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,3.0,H412:1;H373:1;H332:1;Not classified:2
2809,1D-chiro-inositol,211-394-0,643-12-9,Not Classified,Notified C&L,3.0,Not classified:3
2810,"Reaction mass of 4-[2-(5-{2-[3-(2-{2,4-dihydroxy-5-[2-(4-hydroxyphenyl)propan-2-yl]phenyl}propan-2-yl)phenyl]propan-2-yl}-2,4-dihydroxyphenyl)propan-2-yl]phenyl 6-diazo-5-oxo-5,6-dihydronaphthalene-1-sulfonate and 1,3-phenylenebis[propane-2,2-diyl(4,6-dihydroxy-3,1-phenylene)propane-2,2-diyl-4,1-phenylene] bis(6-diazo-5-oxo-5,6-dihydronaphthalene-1-sulfonate",433-970-2,,Flam. Sol. 1;Aquatic Chronic 4,Notified C&L,1.0,H228:1;H413:1
2812,5-amino-4-oxovaleric acid,203-414-1,106-60-5,,Notified C&L,1.0,H335:1;H315:1;H319:1
2815,"Sulfonic acids, C16-18-alkane hydroxy and C16-18-alkene, sodium salts",294-430-8,91722-28-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
2817,4-(Methylamino)-3-nitrobenzoic acid,609-904-5,41263-74-5,Not Classified,REACH registration C&L,13.0,Not classified:2;H319:10;H412:1;H302:1;H317:1
2821,Diutan gum,603-019-8,125005-87-0,,Notified C&L,52.0,Not classified:52
2823,NEJI-18,469-880-5,,Not Classified,Notified C&L,1.0,Not classified:1
2824,"Naphthalenesulfonic acid, formaldehyde ammonium salt copolymer",618-625-8,9069-80-1,Eye Irrit. 2,Notified C&L,490.0,H319:457;Not classified:33
2826,"Amines, C14-18 and C16-18-unsatd. alkyl, ethoxylated",614-343-4,68155-39-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,13.0,H318:8;H315:7;H302:7;Not classified:5;H314:1
2828,Guanidinium acetate,209-814-2,593-87-3,Not Classified,Notified C&L,1.0,Not classified:1
2832,"N,N-Diethyl-1,4-phenylendiamin salt",439-010-9,,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1.0,H412:1;H302:1;H319:1
2837,Dihexyl ether,203-987-8,112-58-3,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,40.0,H410:1;H400:1;H317:1;H413:38;H315:1;H319:1
2840,"Cypress, Cupressus funebris, ext., acetate",292-764-9,90990-04-8,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,91.0,H410:90;H400:90;H317:90;H411:1
2841,1H-imidazol-2-amine,231-751-4,7720-39-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
2845,2-fluoroanisole,206-284-4,321-28-8,Flam. Liq. 3,Notified C&L,47.0,H226:47
2848,"4,5-dihydro-2-isoheptadecyl-1H-imidazole-1-ethanol",273-429-6,68966-38-1,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1,Notified C&L,441.0,H314:441;H318:441;H302:441
2849,(cyclopropylmethyl)triphenylphosphonium bromide,238-862-7,14799-82-7,,Notified C&L,4.0,H335:4;H315:4;H319:4
2850,Ammonium pyrrolidine-1-carbodithioate,225-834-4,5108-96-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49.0,H335:47;H315:48;H319:48;H302:2;H332:1;H312:1;Not classified:1
2854,"Phenol, 4-methyl-, reaction products with dicyclopentadiene and isobutylene",271-867-2,68610-51-5,Repr. 2;Aquatic Chronic 4,REACH registration C&L,1033.0,H361:79;H413:276;H335:565;H315:565;H319:565;Not classified:109;H317:115;H314:32
2855,"Hydrazinecarboxylic acid, 2-[(2S)-2-(phenylmethoxy)propylidene]-, 1,1-dimethylethyl ester",606-284-8,192802-28-1,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,10.0,H412:10;H302:10
2858,Calcium bis(nonylphenolate),250-407-4,30977-64-1,Not Classified,Notified C&L,3.0,Not classified:3
2859,Barium bis[6-chloro-4-[(2-hydroxy-1-naphthyl)azo]toluene-3-sulphonate],277-553-1,73612-34-7,Not Classified,Notified C&L,83.0,Not classified:83
2860,"Alcohols, C12-13, ethoxylated, sulfates, sodium salts",500-298-7,110392-50-2,Skin Irrit. 2;Eye Dam. 1,Notified C&L,4.0,H318:4;H314:4;H315:4
2861,Azaserine,204-061-6,115-02-6,Acute Tox. 3;Carc. 2,Notified C&L,38.0,H351:38;H301:38
2862,Tin dibromide,233-087-0,10031-24-0,Skin Corr. 1B;Eye Dam. 1,Notified C&L,44.0,H314:44;H318:40;H290:1
2864,(S)-α-amino-N-2-naphthyl-1H-imidazole-4-propionamide,231-052-4,7424-15-9,,Notified C&L,39.0,Not classified:38;H350:1
2867,"2-methyl-2,3,4,5,6,7,8,9,10,11,12,13-dodecahydro-1H-cyclopentacyclododecene",606-858-8,21890-09-5,Not Classified,REACH registration C&L,3.0,Not classified:3
2869,"Mulberry, Morus alba, ext.",303-403-2,94167-05-2,Not Classified,Notified C&L,1.0,Not classified:1
2871,1-methylpyrrolidin-3-ol,236-189-3,13220-33-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,53.0,H335:50;H315:50;H302:5;H319:50;H314:2;H318:1;H317:1;Not classified:1;H227:1
2873,Ethyl 3-Ethoxyacrylate (cis- and trans- mixture),600-029-4,1001-26-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H335:40;H315:41;H319:41
2876,4-nitrobenzyl chloroformate,224-708-6,4457-32-3,Skin Corr. 1B,REACH registration C&L,43.0,H314:43;H301:1;H311:1;H318:2;H331:1;H332:1;H302:1;H312:1
2877,Disodium maleate,206-738-1,371-47-1,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,REACH registration C&L,358.0,H319:353;H335:332;H317:2;H302:3;H315:332;Not classified:4
2879,Enflurane,237-553-4,13838-16-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,95.0,H335:52;H315:52;H319:94;H336:2;H360:1;H311:1;H226:1;H331:1;H301:1;H373:1
2880,"butyl glycidyl ether;butyl 2,3-epoxypropyl ether",219-376-4,2426-08-6,Flam. Liq. 3;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;STOT SE 3;Muta. 2;Carc. 2;Aquatic Chronic 3,Harmonised C&L,0.0,H332:0;H351:0;H335:0;H317:0;H302:0;H341:0;H412:0;H226:0
2883,4-hydroxy-2-methylnaphthyl benzoate,218-647-4,2211-28-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,1.0,H335:1;H411:1;H315:1;H319:1
2884,4-phenylpiperidine-4-carbaldehyde,230-133-1,6952-94-9,Acute Tox. 3;Eye Irrit. 2,Notified C&L,38.0,H301:38;H319:38
2886,Strontium wolframate,236-617-9,13451-05-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H335:42;H315:38;H319:38
2887,"4-tert-butyl-N,N-dimethylaniline",220-824-6,2909-79-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40.0,H332:39;H319:39;H335:39;H302:39;H315:39;H312:39;Not classified:1
2888,Dibenzofuran-2-sulphonic acid,281-128-6,83863-63-2,,Notified C&L,4.0,H335:4;H315:4;H319:4
2889,"Sulfuric acid, mono-C10-12-alkyl esters, sodium salts",285-260-5,85049-86-1,,Notified C&L,1.0,H315:1;H319:1
2891,2-(diethylamino)ethyl 4-amino-3-butoxybenzoate hydrochloride,227-808-8,5987-82-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,53.0,H335:52;H315:52;H319:52;H332:13;H302:14;H312:13
2892,"N-(4-aminophenyl)benzene-1,4-diamine sulphate (1:1)",258-748-0,53760-27-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1.0,H332:1;H319:1;H302:1;H315:1;H312:1
2893,"4'-trans-pentyl-[1,1'-bicyclohexyl]-4-one",617-638-6,84868-02-0,Skin Corr. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2.0,H314:2;H410:2;H400:2
2894,"Naphtha (petroleum), hydrodesulfurised full-range coker;Low boiling point naphtha - unspecified;[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurised coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",309-879-8,101316-76-1,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0.0,H340:0;H350:0;H304:0
2896,"Oils, butter, Me esters",297-876-1,93763-55-4,Not Classified,Notified C&L,1.0,Not classified:1
2898,"main component 1 (isomer 1): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;main component 1 (isomer 2): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;main component 2: 2,3-bis-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;main component 3: 2,3-bis-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt",422-610-1,,Eye Dam. 1,Harmonised C&L,0.0,H318:0
2903,5-methyl-1H-imidazole-4-methanol,249-740-8,29636-87-1,Eye Irrit. 2,REACH registration C&L,79.0,H319:39;H315:2;H314:38;H302:38;Not classified:2;H335:1
2905,antu (ISO);1-(1-naphthyl)-2-thiourea,201-706-3,86-88-4,Acute Tox. 2;Carc. 2,Harmonised C&L,0.0,H351:0;H300:0
2906,Disodium (Z)-4-(9-octadecenylamino)-4-oxo-2(or 3)-sulphonatobutyrate,261-222-3,58353-68-7,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,105.0,H318:105;H315:83
2907,Geranyl propionate,203-344-1,105-90-8,Not Classified,REACH registration C&L,1665.0,Not classified:1602;H335:39;H315:40;H319:39;H410:13;H400:13;H411:10
2908,"(S)-dichloro[2-[[(2,3-dihydroxypropoxy)hydroxyphosphinyl]oxy]triethylmethylammoniumato]cadmium",265-010-1,64681-08-9,Acute Tox. 3;Acute Tox. 4;Acute Tox. 2;Muta. 1B;Carc. 1B;Repr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38.0,H301:38;H372:38;H330:38;H360:38;H410:38;H400:38;H350:38;H340:38;H312:38
2911,Methyl(6-methyl-2-pyridylmethyl)amine,230-201-0,6971-57-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39.0,H318:39;H315:39;H302:39;H335:39
2915,2-Bromo-4-fluorobenzoic Acid,600-118-8,1006-41-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H335:45;H315:46;H319:46
2918,3-docosenylsuccinic anhydride,261-356-2,58598-42-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
2920,Dimethyl itaconate,210-519-6,617-52-7,Skin Irrit. 2;Skin Sens. 1B,REACH registration C&L,7.0,H315:1;H317:2;Not classified:5;H319:1;H335:1;H314:1;H302:1
2921,"3,4-dimethylanisole",225-142-2,4685-47-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38.0,H318:38;H315:38;H302:38;H335:38
2922,N-(3-acetyl-2-hydroxyphenyl)-4-(4-phenylbutoxy)benzamide,416-150-9,136450-06-1,Aquatic Chronic 4,Harmonised C&L,0.0,H413:0
2923,2-Fluoro-4-hydroxybenzoic acid,613-746-2,65145-13-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3.0,H335:2;H315:3;H319:3
2925,Chloro(diphenyl)silane,216-634-8,1631-83-0,Skin Corr. 1B,Notified C&L,43.0,H314:43;H335:1
2931,"2,3-epoxypropyl neodecanoate",247-979-2,26761-45-5,Skin Sens. 1;Muta. 2;Aquatic Chronic 2,REACH registration C&L,1225.0,H411:1187;H317:1188;H341:297;Not classified:36;H315:15;H412:1;H413:1;H350:1;H335:1;H319:1
2933,"2,2'-(octadecylimino)bisethanol",233-520-3,10213-78-2,Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,223.0,H410:94;H315:202;H400:97;H319:77;H302:126;H335:70;H318:60;H314:3;H412:1;H317:1
2934,"2,5-dimethylhexyne-2,5-diol",205-533-4,142-30-3,Eye Irrit. 2A,REACH registration C&L,241.0,H319:84;H334:130;H317:157
2935,"Soaps, stocks, palm kernel-oil, acidulated, hydrogenated",296-506-6,92704-70-6,Not Classified,Notified C&L,1.0,Not classified:1
2937,"Ethyl acetoacetate, sodium salt",240-071-7,15933-07-0,Flam. Liq. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H227:1;H315:1;H319:1
2939,"(±)-trans-cyclohexane-1,2-diamine hydrochloride",600-815-7,1073144-49-6,Not Classified,REACH registration C&L,2.0,Not classified:2
2944,2-Amino-5-methylthiophene-3-carbonitrile,604-082-4,138564-58-6,Acute Tox. 3;Eye Dam. 1;Repr. 1B,REACH registration C&L,6.0,H360:1;H318:1;H361:1;H301:1;H332:4;H319:4;H335:3;H302:5;H315:4;H312:3
2946,"Dichlorobis(N-propyl-N-(2-(2,4,6-trichlorophenoxy)ethyl)-1H-imidazole-1-carboxymide-N3)-zinc",603-992-9,137001-93-5,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,35.0,H410:35;H400:35;H319:35
2951,5-nitro-2-furoic acid,211-432-6,645-12-5,Eye Irrit. 2,Notified C&L,44.0,H319:40;H341:5;H332:1;H302:1;H315:2;H312:1;H335:1
2954,Methyl (methylthio)acetate,240-683-4,16630-66-3,Flam. Liq. 3,REACH registration C&L,166.0,H226:76;Not classified:90;H332:1;H302:1;H312:1;H335:1;H315:1;H319:1
2958,(E)-hept-2-en-1-ol,251-534-8,33467-76-4,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,43.0,H226:43;H319:43;H335:4;H315:5
2959,Carisoprodol,201-118-7,78-44-4,Acute Tox. 4,Notified C&L,42.0,H302:42
2960,"1,1-dimethoxyoctane",233-018-4,10022-28-3,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1537.0,H411:26;H315:26;H317:26;H319:26;Not classified:1511
2961,Tetraaluminium zirconium trichloride tridecahydroxide,308-574-7,98106-53-7,Not Classified,Notified C&L,37.0,Not classified:37
2962,3-ethoxyacryloyl chloride,228-239-8,6191-99-7,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Resp. Sens. 1,Notified C&L,39.0,H317:38;H314:39;H334:38;H302:38;H226:39;H318:1;H290:1
2969,Methyl cyclopentylideneacetate,254-837-3,40203-73-4,Skin Irrit. 2,REACH registration C&L,129.0,H315:50;Not classified:79
2971,(Z)-tetrahydro-6-(2-pentenyl)-2H-pyran-2-one,247-074-2,25524-95-2,Not Classified,Notified C&L,150.0,Not classified:123;H335:27;H315:27;H319:27
2975,"Octanoic acid, compound with 2-aminoethanol (1:1)",248-838-8,28098-03-5,Not Classified,Notified C&L,86.0,Not classified:55;H315:31;H319:31
2977,"1-phenyldecane-1,3-dione",272-599-9,68892-13-7,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,26.0,H410:4;H400:4;H317:4;Not classified:22
2978,"Pentasodium bis[4-[[6-[[6-anilino-4-chloro-1,3,5-triazin-2-yl]amino]-1-hydroxy-3-sulpho-2-naphthyl]azo]-3-hydroxy-7-nitronaphthalene-1-sulphonato(4-)]chromate(5-)",278-162-9,75268-75-6,Not Classified,Notified C&L,3.0,Not classified:3
2983,TMIP,438-860-8,,Not Classified,Notified C&L,1.0,Not classified:1
2986,MI3,456-600-1,,Not Classified,Notified C&L,1.0,Not classified:1
2987,3-methylpyridine,203-636-9,108-99-6,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1C;Eye Dam. 1;Acute Tox. 4,REACH registration C&L,1908.0,H332:223;H314:1610;H318:1629;H302:1872;H226:1671;H311:1843;H331:1638;H319:179;H335:404;H315:168;H225:156;H412:84;Not classified:36;H336:45;H312:29;H372:1;H370:1
2988,"2-[[3-(3-mercapto-1-oxopropoxy)-2,2-bis[(3-mercapto-1-oxopropoxy)methyl]propoxy]methyl]-2-[(3-mercapto-1-oxopropoxy)methyl]propane-1,3-diyl bis[3-mercaptopropionate]",246-893-2,25359-71-1,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,2.0,H410:1;H400:1;H302:1;H317:1;H315:1;H319:1
2993,"2,7-Naphthalenedisulfonic acid, 4-amino-6-[2-[4-[[[4-[2-(2,4-diaminophenyl)diazenyl]phenyl]amino]sulfonyl]phenyl]diazenyl]-5-hydroxy-3-[2-(4-nitrophenyl)diazenyl]-",615-711-7,72089-20-4,Not Classified,Notified C&L,1.0,Not classified:1
2994,"2-Propenoic acid, 2-methyl-, 2,2-dimethylpropyl ester",607-299-2,2397-76-4,Flam. Liq. 3;Skin Sens. 1,Notified C&L,39.0,H226:38;H317:38;H335:1;H315:1;H319:1
2996,"Zinc O,O,O',O'-tetrabutyl bis(phosphorodithioate)",230-257-6,6990-43-8,Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,19.0,H411:19;H318:18;H302:1;H317:1;H319:1;H315:1
2997,3-(trimethoxysilyl)propyl isocyanate,239-415-9,15396-00-6,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 1;Resp. Sens. 1,REACH registration C&L,201.0,H330:201;H317:136;H314:201;H334:201;H302:201;H312:201;H318:3
3003,"Siloxanes and Silicones, lauryl Me, Me 2-phenylpropyl",614-227-3,68037-76-3,Not Classified,Notified C&L,448.0,Not classified:448
3007,"Methyl 3,4,5-trihydroxybenzoate",202-741-7,99-24-1,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,47.0,H319:45;H335:43;H317:39;H302:47;H315:45
3010,"Foots oil (petroleum), silicic acid-treated;[A complex combination of hydrocarbons obtained by the treatment of Foots oil with silicic acid for removal of trace constituents and impurities. It consists predominantly of straight chain hydrocarbons having carbon numbers predominantly greater than C",308-127-6,97862-77-6,Carc. 1B,Harmonised C&L,0.0,H350:0
3011,[methylenebis(thio)]bisbenzene,222-624-4,3561-67-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H335:40;H315:41;H319:41
3014,"Phosphine, 1,1'-[(1R)-[1,1'-binaphthalene]-2,2'-diyl]bis[1,1-diphenyl-",616-304-7,76189-55-4,,Notified C&L,8.0,H335:5;H315:6;H319:6;H413:1;Not classified:1
3015,"5-Brom-2,3-difluor-alpha-[1-(4-butylcyclohexyl)ethenyl]-benzylalcohol",920-864-0,,Not Classified,Notified C&L,1.0,Not classified:1
3016,Salsalate,209-027-4,552-94-3,Acute Tox. 4;Aquatic Acute 1,Notified C&L,45.0,H400:38;H302:40;H335:4;H315:5;H319:5
3017,"5-(2-Nitro-propenyl)-benzo(1,3)dioxole",611-130-8,5438-41-5,Acute Tox. 3;Aquatic Chronic 4,Notified C&L,39.0,H301:39;H413:39
3019,"Sodium bis[2,4-dihydro-4-[(2-hydroxynitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)]chromate(1-)",274-183-2,69882-08-2,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,92.0,H410:83;H318:83;H302:83;H400:83;H411:7;H319:3;H335:1;H315:1;Not classified:1
3020,Chromium lignosulfonate,618-617-4,9066-50-6,Not Classified,Notified C&L,60.0,Not classified:60
3024,"4,4'-cyclohexylidenebisphenol",212-677-1,843-55-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H335:39;H315:39;H319:39;H361:1;H411:1
3027,Ebastine,635-609-6,90729-43-4,Aquatic Chronic 4,Notified C&L,40.0,H413:39;H302:1
3028,"2,4-dimethylpentan-3-one oxime",214-208-6,1113-74-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
3029,"O-2-(1-H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate",423-020-5,94790-37-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,16.0,H335:9;H315:15;H319:15;H228:5;H412:1;H314:1;H317:1
3033,Isobutyl valerate,234-191-9,10588-10-0,Flam. Liq. 3,Notified C&L,91.0,H226:90;H411:1
3034,"Fatty acids, C9-11-branched, lithium salts",287-818-3,85586-16-9,Not Classified,Notified C&L,7.0,Not classified:7
3036,6-amino-5-[[3-[(ethylphenylamino)sulphonyl]-4-methylphenyl]azo]-4-hydroxynaphthalene-2-sulphonic acid,280-149-8,83027-46-7,,Notified C&L,41.0,Not classified:41
3037,"Fatty acids, C10-20 and C16-18-unsatd., reaction products with triethanolamine, di-Me sulfate-quaternized",295-344-3,91995-81-2,Skin Irrit. 2,Notified C&L,359.0,H315:158;Not classified:93;H335:108;H319:176;H413:20;H411:13;H226:2
3039,"1H-Benzotriazole, methyl-, reaction products with Bu vinyl ether",267-031-1,67762-67-8,Not Classified,Notified C&L,6.0,Not classified:6
3040,3-tert-butyladipic acid,233-759-3,10347-88-3,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,44.0,H302:2;H319:44
3041,3-Chloro-4-fluoroanisole,606-505-8,202925-07-3,,Notified C&L,5.0,H335:4;H315:5;H319:5
3047,Thiazole-4-carbonitrile,215-919-4,1452-15-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H332:1;H319:1;H335:1;H302:1;H315:1;H312:1
3048,"L-α-(aminomethyl)-3,4-dihydroxybenzyl alcohol hydrochloride",206-345-5,329-56-6,Acute Tox. 3,Notified C&L,39.0,H301:39
3050,trilithium-1-hydroxy-7-(3-sulfonatoanilino)-2-(3-methyl-4-(2-methoxy-4-(3-sulfonatophenylazo)phenylazo)phenylazo)naphthalene-3-sulfonate,403-650-7,117409-78-6,Expl. 1.3;Aquatic Chronic 2,Harmonised C&L,0.0,H203:0;H411:0
3051,"1,1'-thiobis(2-naphthol)",241-166-6,17096-15-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
3054,"2-fenazinol, 8-amino-7-methyl-, reaction products with sodium sulfide (Na2(Sx)), thiosulfonated",215-506-9,1327-88-4,Not Classified,Notified C&L,4.0,Not classified:4
3055,Terbium vanadium tetraoxide,236-963-0,13566-09-1,,Notified C&L,4.0,H335:4;H301:4;H315:4;H319:4
3057,2-(diethylamino)ethanethiol,202-846-8,100-38-9,Flam. Liq. 3,Notified C&L,4.0,H226:4;H301:2;H317:2;H314:2;Not classified:1
3059,"Urea, polymer with formaldehyde, phenol and 1,3,5-triazine-2,4,6-triamine",607-643-1,25212-25-3,Skin Sens. 1B,Notified C&L,3.0,H317:3
3061,"Thiourea, N,N'-bis(2-methylphenyl)-, reaction products with N,N'-dibutylthiourea and hexamethylenetetramine",304-805-0,94279-58-0,Not Classified,Notified C&L,1.0,Not classified:1
3066,Potassium laurate,233-344-7,10124-65-9,Not Classified,Notified C&L,18.0,Not classified:14;H315:4;H319:4
3069,3-(1-methylpyrrol-2-yl)pyridine,207-651-1,487-19-4,Not Classified,Notified C&L,2.0,Not classified:1;H335:1;H315:1;H302:1;H319:1
3070,"Hexanedioic acid, mixed hexyl and octyl diesters",291-434-1,90411-58-8,Not Classified,Notified C&L,3.0,Not classified:3
3073,4-Allyloxy-2-hydroxybenzophenone,607-738-8,2549-87-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H335:39;H315:40;H319:40
3075,"3,4-dichloro-α-(trichloromethyl)benzyl acetate",244-573-7,21757-82-4,Aquatic Chronic 4,Notified C&L,1.0,H413:1
3077,Pent-4-en-2-ol,210-887-8,625-31-0,Flam. Liq. 3,Notified C&L,44.0,H226:44
3082,2-ethylhexyl (3-isocyanatomethylphenyl)-carbamate,261-180-6,58240-57-6,Not Classified,Notified C&L,34.0,Not classified:18;H315:16
3083,Dibutyl butylphosphonate,201-119-2,78-46-6,Not Classified,Notified C&L,37.0,Not classified:36;H412:1;H315:1;H319:1
3090,3-nitrobenzophenone,218-819-9,2243-80-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
3093,"N,N,N',N'-tetraethylbut-2-ynylenediamine",203-277-8,105-18-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
3097,1-(5-bromo-2-thienyl)ethan-1-one,226-363-7,5370-25-2,,Notified C&L,7.0,H332:6;H319:6;H302:6;H315:6;H312:6;H335:1
3098,"Dihydrogen bis[monoperoxyphthalato(2-)-O1,OO1]magnesate(2-)",279-013-0,78948-87-5,Org. Perox. E;Skin Corr. 1C;Eye Dam. 1;Acute Tox. 4,REACH registration C&L,51.0,H318:42;H314:4;H242:17;H332:4;H315:47;H335:46;H272:5;H319:9;H312:1
3099,2-chloro-4-nitroaniline,204-502-2,121-87-9,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H302:0
3102,3-amino-p-toluic acid,219-543-1,2458-12-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H335:44;H315:45;H319:45
3104,"2,4-diamino-3,5-diethyltoluene;2,4-diethyl-6-methyl-1,3-benzenediamine",218-256-9,2095-02-5,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H319:0;H373:0;H400:0;H302:0;H410:0;H312:0
3105,Hexadecenylsuccinic acid,258-980-2,54111-93-2,Not Classified,Notified C&L,4.0,Not classified:4
3110,Reaction mass of (E)-3-methylcyclotetradec-5-en-1-one and (Z)-3-methylcyclotetradec-5-en-1-one,452-280-2,259854-70-1,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1291.0,H410:1291;H400:1291;H317:1291
3111,Calcium dipropionate,223-795-8,4075-81-4,Eye Dam. 1,REACH registration C&L,321.0,H318:166;Not classified:152;H311:21;H315:3;H319:2
3120,Trifluoroacetic anhydride,206-982-9,407-25-0,Skin Corr. 1A;Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,102.0,H412:47;H314:102;H332:94;H290:10;H318:2;H410:1;H400:1;H330:1;H331:2;H302:3;H312:3;H319:1;H335:1;H227:1;H315:1
3122,"Hydrochloric acid, reaction products with aniline and nitrobenzene, neutralized",293-970-1,91671-69-1,,Notified C&L,34.0,Not classified:34
3123,"1-Propene, 3-[2-(2-methoxymethylethoxy)methylethoxy]-",616-681-8,79313-21-6,Skin Sens. 1,Notified C&L,44.0,H317:22;Not classified:22
3125,"6α-fluoro-11β,21-dihydroxy-16α-methylpregna-1,4-diene-3,20-dione 21-pivalate",249-504-4,29205-06-9,Acute Tox. 4;Repr. 1A;STOT RE 1;Aquatic Chronic 4,Notified C&L,24.0,H360:24;H413:24;H302:24;H372:24
3126,C.I. Reactive Yellow 15,602-427-3,12226-47-0,,Notified C&L,7.0,Not classified:7
3127,3-(tert-Butyldimethylsilyloxy)glutaric anhydride,618-749-2,91424-40-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:39;H315:39;H319:39;H411:1
3130,Piritramide,206-124-3,302-41-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H335:1;H315:1;H302:2;H319:1;H336:1;H411:1
3132,"Distillates (petroleum), solvent-refined middle;Gasoil - unspecified;[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C",265-093-4,64741-91-9,Carc. 1B,Harmonised C&L,0.0,H350:0
3134,Glutaronitrile,208-861-6,544-13-8,Acute Tox. 3;Acute Tox. 4;Acute Tox. 4,Notified C&L,43.0,H301:43;H332:38;H312:38;H315:1;H319:1
3137,"4-[(3-acetoxypropyl)amino]-2,2-dimethyl-4-oxobutane-1,3-diyl diacetate",302-118-0,94089-18-6,,Notified C&L,270.0,Not classified:270
3140,N-[(triethoxysilyl)methyl]cyclohexylamine,247-744-4,26495-91-0,Flam. Liq. 3,REACH registration C&L,28.0,H226:1;H412:22;H314:5;H302:5;H312:5
3146,Butan-2-one phenylhydrazone,214-452-3,1129-62-0,Not Classified,Notified C&L,88.0,Not classified:88
3147,"2-Bromo-3,5-dinitrobenzoic acid",601-435-4,116529-60-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
3151,Rhodinyl propionate,203-343-6,105-89-5,Not Classified,Notified C&L,88.0,Not classified:88
3153,"Disodium 5,5',7,7'-tetrabromo[2,2'-bi-1H-indole]-3,3'-diyl disulphate",220-287-8,2702-33-2,Not Classified,Notified C&L,1.0,Not classified:1
3154,Furaltadone,205-384-5,139-91-3,Acute Tox. 4,Notified C&L,38.0,H302:38
3156,(Z)-hexadec-11-enyl acetate,251-791-6,34010-21-4,Skin Irrit. 2,Notified C&L,2.0,H315:2
3160,Trimethylsilyl methanesulphonate,233-220-2,10090-05-8,Flam. Liq. 3,Notified C&L,38.0,H226:38
3161,"6-[3-(dimethylamino)propyl]-6,12-dihydro-benzofuro[3,2-c][1]benzoxepin-6-ol",248-465-0,27450-47-1,Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2.0,H410:2;H400:2;H300:2
3162,Panax Ginseng Root Extract,680-299-8,50647-08-0,Not Classified,Notified C&L,67.0,Not classified:36;H318:31;H315:31;H319:31
3163,1-(4-azidophenyl)-2-bromoethan-1-one,260-519-5,57018-46-9,Flam. Sol. 1;Skin Corr. 1B;Skin Sens. 1;Resp. Sens. 1,Notified C&L,38.0,H228:38;H314:38;H334:38;H317:38
3164,Carbonylhydrotris(triphenylphosphine)iridium,241-282-7,17250-25-8,,Notified C&L,5.0,H335:4;H315:5;H302:4;H319:5;H301:1;H311:1;H331:1
3165,lead diazide;lead azide;lead azide [≥ 20 % phlegmatiser],236-542-1,13424-46-9,,,0.0,H332:0;H360:0;H373:0;H400:0;H302:0;H410:0;H200:0
3171,"2,2-dimethylpropyl isocyanate",239-660-1,15592-29-7,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;Resp. Sens. 1;STOT SE 3,Notified C&L,1.0,H332:1;H335:1;H317:1;H334:1;H318:1;H302:1;H226:1;H315:1;H312:1
3172,Dinonyl phthalate,201-560-0,84-76-4,Not Classified,Notified C&L,6.0,Not classified:5;H335:1;H315:1;H319:1
3174,Chromium(3+) neodecanoate,272-062-9,68683-16-9,Skin Sens. 1B,REACH registration C&L,5.0,H317:4;H315:1;H319:1
3175,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with 2,2'-dimethyl-4,4'-methylenebis(cyclohexylamine)",500-304-8,116802-94-9,,Notified C&L,3.0,H311:1;H411:2;H317:2;H314:3;H302:3;H331:1;H332:1;H312:2
3178,Trivinylphosphine,223-136-4,3746-01-8,Flam. Liq. 2;Pyr. Liq. 1,Notified C&L,38.0,H250:38;H225:38
3179,p-(phenylthio)benzaldehyde,214-905-5,1208-88-4,Not Classified,REACH registration C&L,2.0,Not classified:2
3182,"2,3,4,9-tetrahydro-1H-carbazol-3-ol",604-384-6,14384-34-0,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,1.0,H412:1;H302:1
3195,"Methyl 3-[(2S,3R)-2-(4-(benzyloxy)phenyl)-1-(4-fluorophenyl)-4-oxoazetidin-3-yl]propanoate",606-560-8,204589-80-0,Aquatic Chronic 4,Notified C&L,1.0,H413:1
3198,"Cryolite, tripotassium",262-553-6,60996-20-5,Eye Irrit. 2;Acute Tox. 4;Lact.;STOT RE 1;Aquatic Chronic 3,REACH registration C&L,1.0,H362:1;H372:1;H332:1;H319:1;H412:1
3201,3-amino-4-chlorobenzenesulphonamide,249-423-4,29092-34-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H332:1;H319:1;H335:1;H302:1;H315:1;H312:1
3203,"1,1,3,3-tetramethylbutyl isothiocyanate",241-710-2,17701-76-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H332:1;H319:1;H335:1;H302:1;H315:1;H312:1
3207,"1,3-bis(4-nitrophenyl)urea--4,6-dimethylpyrimidin-2-ol (1:1)",206-359-1,330-95-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H335:42;H315:42;H319:42;Not classified:2
3221,"Phenol, 4-dodecyl-, polymer with 1,2-ethanediamine and formaldehyde, compd. with (dibutylamino)methanol",614-183-5,67953-82-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3.0,H315:3;H319:3
3224,"Dihydrogen bis[monoperoxyphthalato(2-)-O1,OO1]magnesate(2-) hexahydrate",617-608-2,84665-66-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,65.0,H335:63;H315:63;H319:62;H312:61;H314:2;H242:3;H332:2;H318:1
3226,"Methyl (2S-trans)-6,8-dideoxy-6-[[(1-methyl-4-propylpyrrolidin-2-yl)carbonyl]amino]-1-thio-D-erythro-α-D-galacto-octopyranoside monohydrochloride",212-726-7,859-18-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,78.0,H335:47;H315:47;H319:47;H410:30;H317:32;H334:2;H412:1
3231,Methyl (4-aminophenyl)carbamate,229-280-4,6465-03-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H302:1;H319:1
3234,"Lubricating oils, used",274-635-9,70514-12-4,Not Classified,REACH registration C&L,14.0,Not classified:7;H304:7
3235,"Octadecane-1,12-diol",220-342-6,2726-73-0,Not Classified,REACH registration C&L,25.0,Not classified:25
3238,"tritosulfuron (ISO) (containing ≤ 0,02% AMTT);1-[4-methoxy-6-(trifluoromethyl)-1,3,5-triazin-2-yl]-3-[2-(trifluoromethyl)benzenesulfonyl]urea (containing ≤ 0,02% AMTT)",604-291-0,142469-14-5,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H400:0;H317:0
3239,Ditetradecyl hydrogen phosphate,229-651-0,6640-03-5,,Notified C&L,1.0,Not classified:1
3240,"4'-octyl[1,1'-biphenyl]-4-carbonitrile",258-120-6,52709-84-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43.0,H332:38;H319:43;H335:42;H315:43;H312:38
3242,"6-(hydroxymethyl)-4-phenyl-3,4-dihydro-2H-chromen-2-ol",700-143-5,959624-24-9,Aquatic Chronic 2,Notified C&L,29.0,H411:29
3246,7-nitro-2-(trifluoromethyl)-10H-phenothiazine,218-192-1,2069-32-1,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,38.0,H302:38;H413:38
3256,N-(2-ethylhexyl)-1-[[3-methyl-4-[(3-methylphenyl)azo]phenyl]azo]naphthalen-2-amine,260-125-3,56358-10-2,Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 4,REACH registration C&L,119.0,H413:9;H315:119;H317:119
3258,"2-((3S,8S)-1,2,3,4,5,6,7,8-octahydro-3,8-dimethylazulen-5-yl)propan-2-ol",207-702-8,489-86-1,Not Classified,Notified C&L,233.0,Not classified:233
3259,Propylene dimyristate,257-057-1,51209-16-6,Not Classified,Notified C&L,1.0,Not classified:1
3261,4-chloro-3-(chlorosulphonyl)benzoic acid,219-667-6,2494-79-3,Acute Tox. 4;Eye Dam. 1,Notified C&L,39.0,H318:38;H302:39;H314:1;H335:1
3265,α-bromo-o-xylene,201-951-6,89-92-9,Skin Corr. 1B,Notified C&L,45.0,H314:45;H330:5;H332:2;H302:2;H312:2;H300:1;H318:1;H310:1
3266,"Benzenesulfonamide, 4-amino-2,5-dichloro-N-methyl-",617-758-9,85776-36-9,Not Classified,Notified C&L,31.0,Not classified:31
3269,"1,1,5,5,5-hexamethyl-3-phenyl-3-[(trimethylsilyl)oxy]trisiloxane",218-320-6,2116-84-9,Not Classified,REACH registration C&L,271.0,Not classified:30;H330:111;H335:127;H315:128;H319:128;H314:1;H413:2
3270,"Butanedioic acid, sulfo-, C-tridecyl ester, branched, disodium salts",298-650-5,93820-69-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
3273,"Oils, fish, sulfated",287-540-2,85536-56-7,Not Classified,Notified C&L,1.0,Not classified:1
3275,Triton DF 12,609-382-9,37281-47-3,Asp. Tox. 1;Skin Irrit. 2;Eye Dam. 1,Notified C&L,1.0,H318:1;H315:1;H304:1
3276,"(2E,4E)-(±)-11-methoxy-3,7,11-trimethyldodeca-2,4-dienoic acid",258-355-4,53092-52-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
3278,"D-Glucitol, 1-deoxy-1-(methylamino)-, hydrochloride (1:1)",927-938-1,35564-86-4,Not Classified,Notified C&L,1.0,Not classified:1
3279,Zirconium tetrahydroxide,238-472-7,14475-63-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H335:43;H315:43;H319:43
3281,Yellow UZ 3217-A,400-090-5,83784-23-0,Aquatic Chronic 4,Notified C&L,37.0,H413:37
3284,methyl 1-aminocyclohexane-1-carboxylate hydrochloride,609-504-0,37993-32-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H302:1;H319:1
3287,2-thiophenebutyric acid,225-090-0,4653-11-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H335:38;H315:42;H319:42;H314:1
3289,2-bromo-5-chlorotoluene,238-503-4,14495-51-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H335:38;H315:43;H319:43
3290,iodine,231-442-4,7553-56-2,Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1,Harmonised C&L,0.0,H400:0;H332:0;H312:0
3291,1-hydroxy-1-cyclohexanecarbonitrile,213-246-0,931-97-5,Acute Tox. 1;Acute Tox. 1;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,98.0,H330:56;H319:56;H300:98;H410:60;H318:56;H310:56;H400:60;H315:56
3295,"3,4-dihydro-1H-2-benzopyran-1-one",225-179-4,4702-34-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H315:2;H319:2;H335:1
3299,[1-(aminocarbonyl)hydrazino]acetic acid,205-311-7,138-07-8,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2.0,H335:2;H301:2;H315:2;H319:2
3301,Soya amine ethoxylate,615-937-6,73246-96-5,Not Classified,Notified C&L,37.0,Not classified:36;H314:1;H318:1;H302:1;H400:1
3303,"Castor oil, hydrogenated, propoxylated",500-301-1,111870-68-9,Not Classified,REACH registration C&L,19.0,Not classified:19
3305,"Chromic acid (H2CrO4), disodium salt, tetrahydrate",600-068-7,10034-82-9,Acute Tox. 3;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 2;Resp. Sens. 1;Muta. 1B;Carc. 1B;Repr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,43.0,H301:43;H372:43;H330:43;H317:43;H314:43;H334:43;H360:43;H350:43;H400:43;H410:43;H340:39;H312:43
3308,Didecyl phthalate,201-561-6,84-77-5,Not Classified,Notified C&L,157.0,Not classified:157
3309,(S)-(+)-Glycidyl benzyl ether,605-380-7,16495-13-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H335:40;H315:46;H319:46;H341:4
3310,"3-Hexanone, 2,2-dimethyl-",611-088-0,5405-79-8,,Notified C&L,4.0,H335:4;H315:4;H319:4
3311,3-phenylpropyl propionate,204-571-9,122-74-7,Not Classified,Notified C&L,272.0,Not classified:234;H335:38;H315:38;H319:38
3312,"(2,6-xylyloxy) acetic acid",603-738-7,13335-71-2,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,80.0,H412:80;H318:80;H302:80
3316,"4-oxo-4-{[(1R,4S,5R,8S,9R,10S,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0^{4,13}.0^{8,13}]hexadecan-10-yl]oxy}butanoic acid",618-170-5,88495-63-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,43.0,H332:40;H302:41;H312:40;H361:1;H317:1;H251:1
3317,Strontium 3-hydroxy-4-[(4-methyl-2-sulphonatophenyl)azo]-2-naphthoate,277-552-6,73612-29-0,Not Classified,REACH registration C&L,186.0,Not classified:186
3319,N-(p-toluoyl)glycine,248-231-8,27115-50-0,Not Classified,Notified C&L,4.0,Not classified:3;H335:1;H315:1;H302:1;H319:1
3322,"Oils, Schinus terebinthifolius",619-090-3,949495-68-5,Not Classified,Notified C&L,268.0,Not classified:174;H411:90;H315:93;H317:94;H304:94;H226:41;H319:13;H410:4;H400:1
3327,"2-ethylhexyl 4-(2,4-dichlorophenoxy)butyrate",231-750-9,7720-36-7,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 2,Notified C&L,1.0,H411:1;H400:1;H302:1;H319:1
3336,1-phenylpiperazinium chloride,218-646-9,2210-93-7,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,43.0,H301:43;H319:42;H311:42;H335:42;H315:42;H331:38
3338,Triammonium diaquaoctachloro-μ-nitridodiruthenate(3-),248-399-2,27316-90-1,Met. Corr. 1;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H290:1;H319:1
3342,"Amides, tallow, hydrogenated, N,N-bis(hydroxyethyl)",268-951-6,68155-23-7,Not Classified,Notified C&L,1.0,Not classified:1
3344,"Lubricating oils (petroleum), used, noncatalytically refined",309-878-2,101316-73-8,Not Classified,Notified C&L,2.0,Not classified:2
3345,Trisodium 12-wolframophosphate,234-716-1,12026-98-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:39;H315:39;H319:39
3347,Aminoguanidinium hydrogen carbonate,219-956-7,2582-30-1,Skin Sens. 1B;Repr. 1B;Aquatic Chronic 2,REACH registration C&L,190.0,H360:101;H411:151;H317:189;H412:38;H315:2;Not classified:1
3349,Tribromo(2H)methane,220-823-0,2909-52-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;Aquatic Chronic 2,Notified C&L,38.0,H319:38;H411:38;H302:38;H315:38;H331:38
3350,"3-methylpentane-1,5-diol",224-709-1,4457-71-0,Eye Irrit. 2,REACH registration C&L,107.0,H319:106;Not classified:1
3351,Phosphodiesterase II,232-965-0,9068-54-6,Resp. Sens. 1,Notified C&L,154.0,H334:116;H335:38;H315:38;H319:38
3353,Octaaluminium zirconium pentachloride tricosahydroxide,308-575-2,98106-54-8,Skin Mild Irrit. 3;Eye Irrit. 2,Notified C&L,3.0,H316:2;H320:2;Not classified:1
3355,"1-Hexen-3-one, 5-hydroxy-5-methyl-1-phenyl-",609-779-7,400752-37-6,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1.0,H319:1;H332:1;H317:1;H226:1;H315:1;H312:1
3357,"Piperazine-2,5-dione",203-411-5,106-57-0,Not Classified,Notified C&L,2.0,Not classified:1;H335:1;H315:1;H319:1
3358,Storax (resin),295-228-2,91845-53-3,Not Classified,Notified C&L,25.0,Not classified:25
3359,"Residues (petroleum), light vacuum;Heavy Fuel oil;[A complex residuum from the vacuum distillation of the residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C",270-984-6,68512-62-9,Carc. 1B,Harmonised C&L,0.0,H350:0
3360,"(±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate ;(±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate",281-291-3,83918-57-4,,,0.0,H317:0;H314:0;H410:0;H400:0;H302:0
3366,"[2-(hydroxymethyl)-1,3-dihydroperimidin-2-yl]methanol",605-770-7,176180-03-3,Acute Tox. 4;Skin Sens. 1B,REACH registration C&L,2.0,H302:2;H317:2
3370,Glutaric anhydride,203-593-6,108-55-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,191.0,H318:188;H315:190;H302:187;H335:114;H312:63;H319:15;Not classified:4;H413:1
3371,"1H-Imidazole-1-ethanamine, 4,5-dihydro-, 2-C12-22-alkyl derivs., diacetates",296-738-8,93028-46-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,3.0,H318:3;H315:3;H302:3
3375,"Acetyl dihydrogen phosphate, lithium potassium salt",304-378-0,94249-01-1,Skin Corr. 1B;Repr. 2,Notified C&L,38.0,H314:38;H361:38
3379,"Fatty acids, C12-18 and C18-unsatd., reaction products with N,N-dimethyl-1,3-propanediamine and triethanolamine",295-173-4,91845-03-3,Skin Sens. 1,Notified C&L,1.0,H317:1
3383,Dimethyl propylphosphonate,242-555-3,18755-43-6,Eye Irrit. 2;Repr. 1B,REACH registration C&L,28.0,H360:28;H319:28
3388,Dodecan-5-one,243-295-3,19780-10-0,Aquatic Chronic 2,Notified C&L,38.0,H411:38
3389,4-fluoroanthranilic acid,207-163-9,446-32-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,52.0,H335:51;H315:52;H319:52
3390,"Oxirane, methyl-, polymer with oxirane, didocosanoate",611-337-3,55963-27-4,Not Classified,Notified C&L,1.0,Not classified:1
3392,3-(p-chlorophenyl)-DL-alanine,231-051-9,7424-00-2,Acute Tox. 3;Skin Sens. 1,Notified C&L,39.0,H301:39;H317:39
3396,"Propanenitrile, 3-[[4-[2-[5,6(or 6,7)-dichloro-2-benzothiazolyl]diazenyl]phenyl]ethylamino]-",616-632-0,78564-87-1,,Notified C&L,2.0,H315:1;Not classified:1
3398,Butynedioic acid,205-536-0,142-45-0,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H335:41;H301:46;H315:41;H319:41;H314:5;H330:4;H311:6;H331:2;H318:1
3401,"Octahydro-4,8a-dimethyl-4a(2H)-naphthol",245-590-2,23333-91-7,Not Classified,Notified C&L,98.0,Not classified:98
3407,"5,6-dihydroxycyclohex-5-ene-1,2,3,4-tetrone, monobarium salt",240-856-4,16833-52-6,Acute Tox. 4;Acute Tox. 4,Notified C&L,38.0,H302:38;H332:38
3408,4-fluoroaniline,206-735-5,371-40-4,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,175.0,H314:135;H373:91;H318:91;H302:172;H400:87;H410:87;H372:34;H319:38;H332:39;H411:33;H317:33;H315:39;H312:39;Not classified:1;H335:2;H301:2;H311:2;H331:2;H412:2
3413,"2-(3,4-dihydroxyphenyl)-7-(β-D-glucopyranosyloxy)-5-hydroxy-4H-1-benzopyran-4-one",226-365-8,5373-11-5,Not Classified,Notified C&L,1.0,Not classified:1
3414,Bis(2-amino-1H-imidazole) sulphate,215-918-9,1450-93-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49.0,H335:48;H315:49;H319:49;H301:1;H311:1;H331:1;H332:1;H302:1;H312:1
3417,"Bis(2,3-epoxypropyl) terephthalate",230-565-0,7195-44-0,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,515.0,H411:515;H315:515;H317:515;H319:515;H335:18
3427,"2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl [1R-[1α[S*(Z)],3β]]-chrysanthemate;pyrethrin I",204-455-8,121-21-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H332:0;H410:0;H400:0;H302:0;H312:0
3431,"Formic acid, compound with 2,2'-oxybis[N,N-dimethylethylamine] (2:1)",257-171-1,51390-19-3,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1,Notified C&L,193.0,H314:185;H318:138;H302:83;H312:83;H336:20;H226:20;H315:8;H319:13;H412:5;H335:5
3434,"1,4-dioxacycloheptadecane-5,17-dione",203-347-8,105-95-3,Not Classified,REACH registration C&L,2050.0,Not classified:1531;H411:476;H315:44;H400:2
3439,2-chlorocyclohexanol,216-339-4,1561-86-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
3442,"4-phenylthiomorpholine 1,1-dioxide",241-675-3,17688-68-5,Acute Tox. 4,Notified C&L,1.0,H302:1
3453,Tanacetum annuum,922-517-9,,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;STOT SE 2;Aquatic Chronic 2,Notified C&L,1.0,H371:1;H304:1;H411:1;H317:1;H226:1;H315:1
3454,"Soybean, flour",614-554-1,68513-95-1,Not Classified,Notified C&L,1.0,Not classified:1
3455,4-methoxyphenyl trans-4-pentylcyclohexanoate,266-746-6,67589-52-0,Aquatic Chronic 4,Notified C&L,1.0,H413:1;Not classified:1
3456,"Ethanedioic acid, ammonium iron(3+) salt (3:3:1), trihydrate",603-647-2,13268-42-3,Acute Tox. 4;Acute Tox. 4,Notified C&L,48.0,H302:48;H312:48;H319:5;H335:5;H315:5
3458,"Adipic acid, polymer with glycerol and 2,2'-oxydiethanol",500-050-8,26760-54-3,Not Classified,Notified C&L,2.0,Not classified:2
3459,"Fatty acids, avocado-oil, isooctadecyl esters",292-767-5,90990-06-0,Not Classified,Notified C&L,2.0,Not classified:2
3461,"Cyclopenta[c]pyrrole-1-carboxylic acid, 2-[(2S)-2-[[(2S)-2-amino-2-cyclohexylacetyl]amino]-3,3-dimethyl-1-oxobutyl]octahydro-, 1,1-dimethylethyl ester, (1S,3aR,6aS",482-250-4,,Skin Sens. 1;STOT RE 1;Aquatic Chronic 2,Notified C&L,1.0,H411:1;H317:1;H372:1
3462,Dichlorophenylsilane,216-635-3,1631-84-1,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,95.0,H314:94;H226:94;Not classified:1
3463,"Alcohols, C16-18, ethoxylated, phosphates",500-295-0,106233-09-4,Eye Dam. 1,REACH registration C&L,483.0,H318:32;H319:453;H315:29;Not classified:5;H314:3
3469,"Tetrahydrocyclobuta[1,2-c:3,4-c']difuran-1,3,4,6-tetraone",224-577-5,4415-87-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H335:39;H315:40;H319:40
3471,"Nickel, compound with Titanium (1:1)",610-765-8,52013-44-2,Not Classified,Notified C&L,1.0,Not classified:1
3473,2-carboxyphenylhydrazinium(1+) chloride,257-869-6,52356-01-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H335:43;H315:43;H319:43
3474,Disodium (Z)-4-[2-[(2-hydroxyethyl)(1-oxooctadec-9-enyl)amino]ethyl] 2-sulphonatosuccinate,287-373-5,85480-92-8,Eye Dam. 1,Notified C&L,5.0,H318:3;H315:1;H319:1;Not classified:1
3479,Ammonium dihydrogen 4-sulphonatophthalate,265-643-3,65229-11-0,Aquatic Chronic 3,Notified C&L,83.0,H412:83
3480,thioglycolic acid,200-677-4,68-11-1,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Harmonised C&L,0.0,H314:0;H301:0;H331:0;H311:0
3484,"[1,1'-biphenyl]-4,4'-dithiol",230-136-8,6954-27-4,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,38.0,H302:38;H413:38
3488,"Amines, tall-oil alkyl",263-138-2,61790-46-3,Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Aquatic Acute 1,Notified C&L,4.0,H314:4;H318:4;H302:4;H400:4
3490,aconitine,206-121-7,302-27-2,Acute Tox. 2;Acute Tox. 2,Harmonised C&L,0.0,H300:0;H330:0
3502,"19-norpregn-4-en-20-yn-3-one, 17-hydroxy-7-methyl, (7alpha, 17alpha-)",601-419-7,1162-60-3,Not Classified,REACH registration C&L,19.0,Not classified:2;H361:17
3504,"Dihydro-3-(tetrapropenyl)furan-2,5-dione, compound with 1H-benzotriazole",265-011-7,64681-12-5,,Notified C&L,1.0,Not classified:1
3505,"1,1'-(2-(N-2-hydroxyethyl-2-hydroxypropylamino)ethylimino)dipropan-2-ol",205-382-4,139-90-2,Eye Irrit. 2,Notified C&L,18.0,H319:18
3507,"2-amino-3-chloro-1,4-naphthoquinone",220-529-2,2797-51-5,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 3;Repr. 2;STOT SE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,136.0,H371:90;H319:136;H361:97;H317:97;H410:96;H400:128;H302:136;H331:128;H373:8;H315:1
3508,"Tagetes patula, ext.",294-431-3,91722-29-1,Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1398.0,H411:1322;H317:1322;H304:1398;H226:112;H315:112
3511,(Z)-hex-3-enyl propionate,251-533-2,33467-74-2,Not Classified,Notified C&L,210.0,Not classified:169;H335:41;H315:41;H319:41
3514,"Phenyl silsesquioxane, trimethylsilyloxy",615-986-3,73559-47-4,Not Classified,Notified C&L,104.0,Not classified:37;H330:37;H413:30;H331:30
3516,"Oils, vegetable, oxidized",919-237-4,,Not Classified,Notified C&L,36.0,Not classified:36
3517,"Diphenyl (methylenedi-4,1-phenylene)-dicarbamate",202-963-4,101-65-5,Skin Sens. 1;Aquatic Chronic 4,Notified C&L,57.0,H413:38;H317:38;Not classified:19
3519,"2H-Tetrazol-5-amine, hydrate (1:1)",604-965-4,15454-54-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H335:42;H315:42;H302:38;H319:42;H240:4;H228:4
3520,"2,4,5-trimethylphenol",207-832-5,496-78-6,,Notified C&L,4.0,H314:4
3525,Scopoline,207-655-3,487-27-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1.0,H332:1;H302:1;H312:1
3527,"α-D-erythro-Pentofuranose, 4-C-(hydroxymethyl)-1,2-O-(1-methylethylidene)-3-O-(phenylmethyl)-",613-267-9,63593-03-3,Not Classified,Notified C&L,1.0,Not classified:1
3531,2-(4-chlorophenyl)propiononitrile,218-569-0,2184-88-5,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1,Notified C&L,38.0,H318:38;H302:38;H317:38
3536,"Butanoic acid, 3,3-bis[(1,1-dimethylpropyl)dioxy]-, ethyl ester",614-080-5,67567-23-1,Flam. Liq. 3;Org. Perox. D;Aquatic Chronic 2,Notified C&L,176.0,H411:176;H226:176;H242:176
3539,"1,3,4,6,8,13-hexahydroxy-10,11-dimethylphenanthro[1,10,9,8-opqra]perylene-7,14-dione",208-941-0,548-04-9,Acute Tox. 3;Skin Sens. 1,Notified C&L,48.0,H301:39;H317:42;H302:6;H300:3
3541,"1-(3,4-dimetossifenil)-2-metilpropanone",604-187-5,14046-55-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H335:1;H315:1;H302:2;H319:1
3542,"Lime (Citrus aurantifolia), ext.",290-010-3,90063-52-8,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,1811.0,H304:1810;H411:110;H317:1784;H226:1783;H315:1810;H410:1512;H400:556;H319:12;H302:11;Not classified:2;H314:1
3544,4-(trimethoxysilyl)butyronitrile,259-646-9,55453-24-2,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,40.0,H318:39;H315:39;H335:39;H319:1;Not classified:1;H304:1;H332:1;H302:1;H312:1
3545,"D-Arginine, N2-[(phenylmethoxy)carbonyl]-",613-387-1,6382-93-0,Not Classified,Notified C&L,1.0,Not classified:1
3547,"(Z,Z)-2-(8-heptadecenyl)-4,5-dihydro-1-methyl-1-[2-[(1-oxo-9-octadecenyl)amino]ethyl]-1H-imidazolium methyl sulphate",274-381-9,70206-24-5,Not Classified,Notified C&L,1.0,Not classified:1
3549,"5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one",928-541-6,146939-27-7,STOT SE 3;Muta. 2,REACH registration C&L,4.0,H336:4;H341:4
3550,"Eucalyptus radiata australiana, ext.",295-995-3,92201-64-4,Not Classified,Notified C&L,146.0,Not classified:51;H319:47;H304:93;H411:56;H317:57;H226:93;H315:51;H334:38;H401:1
3551,"2,2-dimethyl 3-methyl-3-butenyl propanoate",415-610-6,104468-21-5,Skin Irrit. 2;Aquatic Chronic 3,Harmonised C&L,0.0,H412:0;H315:0
3553,Barium diformate,208-780-6,541-43-5,Acute Tox. 4;Acute Tox. 4,Notified C&L,1.0,H302:1;H332:1
3555,Aluminium tri-tert-butanolate,209-146-1,556-91-2,Flam. Sol. 1;Skin Corr. 1B,Notified C&L,43.0,H228:43;H314:43;H318:1
3556,C.I. Acid Orange 144,612-469-4,61814-64-0,,Notified C&L,1.0,H412:1
3563,Cyclooctanecarbaldehyde,229-732-0,6688-11-5,Flam. Liq. 2,Notified C&L,2.0,H225:1;H335:1;H227:1;H315:1;H319:1
3565,"2,6-diamino-3-((pyridine-3-yl)azo)pyridine",421-430-9,28365-08-4,Acute Tox. 4;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0.0,H373:0;H411:0;H302:0
3566,3-phenylcyclohex-2-en-1-one,233-755-1,10345-87-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H302:1;H319:1
3572,"spirotetramat (ISO);(5s,8s)-3-(2,5-dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4,5]dec-3-en-4-yl ethyl carbonate",606-523-6,203313-25-1,Eye Irrit. 2;Skin Sens. 1A;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0.0,H319:0;H361:0;H335:0;H317:0;H410:0;H400:0
3573,1-[4-(1-methylethyl)phenyl]ethan-1-one,211-433-1,645-13-6,Not Classified,REACH registration C&L,90.0,Not classified:89;H335:1;H315:1;H319:1
3574,Ethyl hydrogen succinate,213-973-3,1070-34-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,2.0,H335:2;H315:2;H302:2;H319:2;H317:1;H334:1;H318:1
3575,"1,2:7,8-diepoxyoctane",219-375-9,2426-07-5,Acute Tox. 4;Acute Tox. 3;Muta. 2;Carc. 1B,Notified C&L,44.0,H302:44;H341:43;H350:39;H311:44;H314:4;H315:1;H319:1
3577,Diethylaluminium iodide,218-032-0,2040-00-8,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1A,REACH registration C&L,3.0,H314:3;H260:3;H250:3
3578,(S)-(+)-2-(4-Isobutylphenyl)propionic Acid,610-620-9,51146-56-6,Acute Tox. 4;Repr. 2,Notified C&L,7.0,H361:4;H302:6;H335:3;H319:4;H315:2
3579,"Fluorene-2,7-diyldiamine",208-377-5,525-64-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:38;H315:39;H319:39;H302:1
3581,1-carbamimidoylurea - (nitroamino)(oxo)azane oxide (1:1),451-590-5,,Expl. 1.4;Flam. Sol. 2,Notified C&L,1.0,H228:1;H204:1
3584,"Phosphorodithioc acid,zinc salt.",606-260-7,19210-06-1,Eye Dam. 1,Notified C&L,59.0,H318:35;H410:24;H400:24
3586,Ethyl cyclohexylideneacetate,216-297-7,1552-92-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H302:1;H319:1
3587,"Epoxides, C10-16-alkyl, reaction products with glycerol",287-814-1,85586-12-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,22.0,H315:22;H319:22
3589,"1,4-divinylbenzene",203-266-8,105-06-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,48.0,H411:1;H315:42;H302:42;H319:42;H335:41;H317:40;H372:6;H334:1;H350:1
3590,"5-phenylpenta-2,4-dienoic acid",216-298-2,1552-94-9,,Notified C&L,5.0,H335:5;H315:5;H319:5
3591,2-aminopropanediamide,263-370-4,62009-47-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H335:2;H315:2;H319:2;H302:1
3595,"lead 2,4,6-trinitro-m-phenylene dioxide;lead 2,4,6-trinitroresorcinoxide;lead styphnate;lead 2,4,6-trinitro-m-phenylene dioxide;lead styphnate (≥ 20 % phlegmatiser)",239-290-0,15245-44-0,,,0.0,H332:0;H201:0;H360:0;H373:0;H400:0;H302:0;H410:0
3597,(2H18)octane,241-285-3,17252-77-6,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,43.0,H225:39;H304:39;H336:39;H410:39;H400:39;H315:39;H224:4;Not classified:1
3598,"Benzoic acid, 2-[(carboxymethyl)amino]-6-chloro-",615-872-3,729597-47-1,Not Classified,Notified C&L,7.0,Not classified:7
3599,"Extracts (petroleum), light vacuum gas oil solvent",295-341-7,91995-78-7,Carc. 1B,Harmonised C&L,0.0,H350:0
3601,4-(tert-Butyl)-3-methoxybenzoic acid,616-742-9,79822-46-1,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,39.0,H411:38;H302:38;H335:1;H315:1;H319:1
3602,Sodium metaphosphate,233-343-1,10124-56-8,Not Classified,REACH registration C&L,531.0,Not classified:514;H335:42;H315:43;H319:50;H314:3;H318:3;H316:1;H320:1
3604,α-bromotoluene;benzyl bromide,202-847-3,100-39-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0.0,H335:0;H315:0;H319:0
3606,"2,4,6,6-tetramethyl-5,6,7,7a-tetrahydro-1,3-dioxaindan-5-one",605-300-0,162691-58-9,Not Classified,Notified C&L,84.0,Not classified:83;H335:1;H315:1;H319:1
3608,"Phenol, 4,4'(1-methylethylidene)bis-,polymer with (chloromethyl) oxirane and methyloxirane",609-251-6,36484-54-5,Skin Sens. 1B;Muta. 2;Aquatic Chronic 2;Skin Sens. 1B;Muta. 2;Aquatic Chronic 2,REACH registration C&L,148.0,H411:43;H317:43;H341:1;Not classified:82;H315:64;H319:43
3611,3-chloro-4-fluorophenol,220-042-5,2613-23-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H335:39;H315:42;H319:42;H314:4;H411:4;H302:7;H312:7;H332:3
3612,"2-fenazinol, 8-amino-7-methyl-, reaction products with sodium sulfide (Na2(Sx))",215-503-2,1327-85-1,Not Classified,Notified C&L,5.0,Not classified:5
3613,"carboxin (ISO); 2-methyl-N-phenyl-5,6-dihydro-1,4-oxathiine-3-carboxamide; 5,6-dihydro-2-methyl-1,4-oxathiine-3-carboxanilide",226-031-1,5234-68-4,Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H373:0;H400:0;H317:0
3614,"Absinthium, ext.",284-503-2,84929-19-1,Flam. Liq. 3;Acute Tox. 3;Asp. Tox. 1;Skin Sens. 1;STOT RE 2;Aquatic Chronic 2,Notified C&L,1639.0,H301:1288;H304:1295;H411:1296;H317:1309;H373:1288;H226:1295;H302:348;H412:147;H319:1;Not classified:1
3615,Benzoylurea,210-372-8,614-22-2,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39.0,H302:39;H319:38
3627,"Gases (petroleum), dehexanizer off;Petroleum gas;[A complex combination of hydrocarbons obtained by the fractionation of combined naphtha streams. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]",272-872-2,68919-00-6,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0.0,H220:0;H340:0;H350:0;Not classified:0
3629,3-(methylthio)butyric acid,240-682-9,16630-65-2,Not Classified,Notified C&L,89.0,Not classified:88;H318:1;H315:1;H302:1;H335:1
3631,"9-Octadecenoic acid (9Z)-, (2-hydroxy-1,3,2-dioxaborolan-4-yl)methyl ester",618-262-5,89325-22-4,Not Classified,Notified C&L,6.0,Not classified:6
3635,Tri-n-butyltin hydride,211-704-4,688-73-3,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Repr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,68.0,H301:68;H372:68;H319:68;H360:3;H410:68;H400:67;H315:68;H312:68;H317:1;H226:8;H261:2
3638,"3,3'-[methylenebis(oxymethylene)]bisheptane",244-815-1,22174-70-5,Aquatic Chronic 4,REACH registration C&L,1.0,H413:1
3639,"1-methylethyl 3,4-diethoxyphenylcarbamate",403-870-3,,Eye Irrit. 2,Notified C&L,93.0,H319:92;H412:1
3640,"2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethane-1-sulfonic acid--potassium (1/1)",618-797-4,91893-72-0,Not Classified,REACH registration C&L,2.0,Not classified:2
3642,"Naphthalene-1,5-disulphonic acid",201-317-9,81-04-9,Skin Corr. 1;Eye Dam. 1,REACH registration C&L,8.0,H314:8;H318:7
3645,Polyethyleneimine ethoxylate propoxylate,610-853-6,52501-07-2,Acute Tox. 4;Eye Dam. 1,Notified C&L,57.0,H318:57;H302:57
3646,"3-(2,4-dichloro-5-hydroxyphenyl)-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one",254-638-1,39807-19-7,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1.0,H410:1;H400:1
3647,(benzyloxy)methanol,238-588-8,14548-60-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,547.0,H318:544;H315:544;H302:547;H312:544;H335:98;H317:45
3650,"linuron (ISO);3-(3,4-dichlorophenyl)-1-methoxy-1-methylurea",206-356-5,330-55-2,Acute Tox. 4;Carc. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0.0,H351:0;H360:0;H373:0;H400:0;H302:0;H410:0
3651,Dimethylcyclopentane,249-193-5,28729-52-4,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,3.0,H225:3;H304:3;H336:1
3655,Betazole,203-278-3,105-20-4,,Notified C&L,1.0,H335:1;H315:1;H319:1
3656,ficin,232-599-1,9001-33-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Resp. Sens. 1,Harmonised C&L,0.0,H335:0;H334:0;H315:0;H319:0
3658,"Bicyclo[3.1.1]hept-2-ene, 2,6,6-trimethyl-, phosphosulfurized",267-032-7,67762-73-6,Skin Sens. 1B,REACH registration C&L,571.0,H317:2;Not classified:566;H226:3
3662,"Phenol, 4-(phenylamino)-, sulfurized",215-450-5,1326-96-1,Not Classified,Notified C&L,37.0,Not classified:37
3663,2-(4-{1-hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl}phenyl)-2-methylpropanoic acid hydrochloride,604-906-2,153439-40-8,Skin Sens. 1;Repr. 1B,Notified C&L,6.0,H360:2;H317:2;Not classified:2;H315:1;H319:1;H312:1;H302:1
3665,acifluorfen (ISO);5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoic acid,256-634-5,50594-66-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H318:0;H302:0;H400:0;H315:0
3667,Nonyl mercaptoacetate,223-139-0,3746-40-5,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,38.0,H411:38;H319:38
3669,"tert-Decanoic acid, oxiranylmethyl ester, reaction products with 1,3-benzenedimethanamine",307-226-1,97553-65-6,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 3;Aquatic Chronic 3,Notified C&L,18.0,H317:18;H314:18;H302:18;H412:18;H331:18
3670,Di-tert-dodecyl disulphide,248-468-7,27458-90-8,Skin Sens. 1B,REACH registration C&L,20.0,H317:1;H316:10;H305:10;H320:10;H413:8;H315:1;H319:1
3671,1-Butyl-3-methylimidazolium methyl carbonate solution,618-781-7,916850-37-8,Flam. Liq. 2;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,122.0,H301:84;H225:84;H319:122;H411:83;H315:122;H335:39;H311:1;H370:1;H331:1
3672,Bithionoloxide,212-679-2,844-26-8,Not Classified,Notified C&L,1.0,Not classified:1
3673,"Bis[2,3-bis(hydroxyimino)-N-phenylbutyramidato-N2,N3]nickel",249-503-9,29204-84-0,Not Classified,Notified C&L,88.0,Not classified:88
3675,"Octadecanoic acid, reaction products with diethanolamine",291-704-9,90459-60-2,Not Classified,Notified C&L,6.0,Not classified:5;H412:1;H315:1
3678,Bis(4-chlorobenzoyl) peroxide,202-310-3,94-17-7,Org. Perox. B;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,7.0,H335:4;H241:4;H315:7;H319:7;H242:3
3679,Lanthanum phosphate,237-419-5,13778-59-1,Not Classified,Notified C&L,1.0,Not classified:1
3681,"Poplar, ext.",281-681-3,84012-37-3,Not Classified,REACH registration C&L,2.0,Not classified:2
3687,"disodium 7-(4,6-dichloro-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo) naphthalene-2-sulfonate",404-600-7,129009-88-7,Skin Sens. 1,Harmonised C&L,0.0,H317:0
3691,2-hydroxyethyl hydrogen phthalate,241-676-9,17689-42-8,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
3692,"reaction mass of: 2,4,6-tri(butylcarbamoyl)-1,3,5-triazine;2,4,6-tri(methylcarbamoyl)-1,3,5-triazine;[(2-butyl-4,6-dimethyl)tricarbamoyl]-1,3,5-triazine;[(2,4-dibutyl-6-methyl)tricarbamoyl]-1,3,5-triazine",420-390-1,187547-46-2,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H317:0
3694,2-methylbenzyl alcohol,201-954-2,89-95-2,Acute Tox. 4;Eye Dam. 1,Notified C&L,42.0,H318:38;H302:38;H335:4;H315:4;H319:4
3697,LIGNOSULFONIC ACID,600-691-4,105859-97-0,Eye Irrit. 2,Notified C&L,296.0,H319:192;Not classified:104;H335:1;H315:1
3703,"2,5-Furandione, polymer with ethenylbenzene, sodium salt",607-789-6,25736-61-2,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,40.0,H318:39;H315:39;H335:38;Not classified:1
3706,"Benzenesulfonic acid, mono-C10-14-alkyl derivs., calcium salts",290-647-7,90194-37-9,Not Classified,Notified C&L,3.0,Not classified:3
3709,Dimethyl 2-aminoterephthalate,226-364-2,5372-81-6,Aquatic Chronic 2,REACH registration C&L,182.0,H411:121;H335:60;H315:60;H319:60;Not classified:1
3710,1-chloro-4-ethylbenzene,210-763-3,622-98-0,Flam. Liq. 3;Acute Tox. 4,Notified C&L,39.0,H226:39;H302:38;H315:1;H319:1
3713,"Soaps, stocks, linseed-oil, acidulated",285-103-0,85029-78-3,Not Classified,Notified C&L,2.0,Not classified:2
3714,"1,2-dimethylcyclopentene",212-148-5,765-47-9,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3;Aquatic Chronic 3,Notified C&L,1.0,H225:1;H319:1;H304:1;H335:1;H412:1;H315:1
3716,"Reaction mass of (2S)-2-methyl-4-[(1R)-2,2,3-trimethylcyclopent-3-en-1-yl]pent-4-en-1-ol and (2R)-2-methyl-4-[(1R)-2,2,3-trimethylcyclopent-3-en-1-yl]pent-4-en-1-ol",435-750-1,,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,40.0,H318:4;H410:4;H315:4;H400:4;Not classified:36
3718,DL-Phenylalaninol,605-234-2,16088-07-6,Skin Corr. 1B,Notified C&L,39.0,H314:38;H315:1;H319:1
3719,"Bis(2,3-epoxypropyl) phthalate",230-566-6,7195-45-1,Acute Tox. 4;Skin Sens. 1A;Eye Irrit. 2;Muta. 2;Carc. 1B;Repr. 1B,REACH registration C&L,1.0,H319:1;H317:1;H360:1;H302:1;H341:1;H350:1
3720,"3,3-pentamethylene-4-butyrolactam",451-630-1,64744-50-9,Acute Tox. 4;Eye Irrit. 2,Notified C&L,2.0,H302:1;H319:1;Not classified:1
3725,"Fatty acids, C14-18 and C16-18-unsatd., calcium salts",270-277-2,68424-16-8,,Notified C&L,65.0,Not classified:65
3732,reaction mass of: dodecanoic acid (35-40 %);poly(1-7)lactate esters of dodecanoic acid (60-65 %),412-590-0,58856-63-6,Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H317:0;H410:0;H318:0;H400:0;H315:0
3735,(R)-(-)-α-(trifluoromethyl)benzylamine,244-747-2,22038-85-3,Eye Irrit. 2,Notified C&L,39.0,H319:38;H335:1;H318:1;H302:1;H227:1;H315:1
3736,"Ethyl (3aR,7R,7aR)-2,2-dimethyl-7-[(methylsulfonyl)oxy]-3a,6,7,7a-tetrahydro-1,3-benzodioxole-5-carboxylate",606-548-2,204254-84-2,Aquatic Chronic 3,REACH registration C&L,3.0,H412:3
3738,"2-(β-D-ribofuranosyl)-4-amino-1,3,5-triazin-2-one",206-280-2,320-67-2,Acute Tox. 4;Carc. 1B,Notified C&L,144.0,H302:144;H350:143;H360:3;H340:4;H315:2;H351:1;H361:1;H372:1
3739,Diallyl isophthalate,214-122-9,1087-21-4,Acute Tox. 4;Skin Sens. 1B;Acute Tox. 4;Aquatic Acute 1,REACH registration C&L,3.0,H332:1;H317:1;H410:1;H400:1;H302:3;H315:1;H319:1
3742,"2H-1,2,4-Benzothiadiazine-3-acetic acid, 2-(3-butoxypropyl)-, ethyl ester, 1,1-dioxide",614-093-6,676352-74-2,Aquatic Chronic 2,Notified C&L,33.0,H411:33
3750,α-3-dibromotoluene,212-519-1,823-78-9,Skin Corr. 1B,Notified C&L,48.0,H314:48;H335:1;H318:1;H290:1
3752,Lanthanum nitride,247-245-1,25764-10-7,,Notified C&L,5.0,H335:5;H315:5;H319:5
3755,Trimethylammonium chloride,209-810-0,593-81-7,Skin Irrit. 2;Eye Irrit. 2A,REACH registration C&L,289.0,H315:168;H319:148;Not classified:121;H335:6
3757,Triphenylvinylsilane,242-487-4,18666-68-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H335:42;H315:43;H319:43
3761,N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-.sc.l.sc.-alanyl-N-carboxyanhydride,430-360-8,84793-24-8,Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0.0,H318:0;H317:0
3762,(6L)lithium iodide,244-572-1,21752-61-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,38.0,H315:38;H319:38
3763,Trimethylpropoxysilane,217-371-1,1825-63-4,Flam. Liq. 2,Notified C&L,38.0,H225:38
3764,Chloramphenicol,200-287-4,56-75-7,Eye Dam. 1;Carc. 2;Repr. 2,REACH registration C&L,330.0,H351:132;H361:176;H318:93;H350:191;H317:45;H360:37;Not classified:6;H340:10;H302:7;H362:6;H400:3;H373:2;H341:4;H372:1;H334:2;H370:1;H371:1;H315:1
3767,"2,6-Dibromo-4-(trifluoromethoxy)aniline",618-118-1,88149-49-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H335:39;H315:40;H319:40
3770,"2,4-dinitrophenylacetic acid",211-398-2,643-43-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H335:42;H315:43;H319:43;H272:1
3774,Carbutamide,206-424-4,339-43-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:38;H315:38;H319:38;H412:1
3775,"Residual oils (petroleum), solvent deasphalted;Baseoil - unspecified;[A complex combination of hydrocarbons obtained as the solvent soluble fraction from C",265-096-0,64741-95-3,Carc. 1B,Harmonised C&L,0.0,H350:0
3776,"Hexanedioic acid, polymer with 2-oxiranylmethyl neodecanoate",615-318-0,716336-43-5,Not Classified,Notified C&L,25.0,Not classified:25
3780,2-amino-5-nitrophenol,204-503-8,121-88-0,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,2183.0,H412:2;H302:7;H317:85;H319:2181;H351:2047;H411:2130;H335:2094;H315:2095;H312:87;H341:5;H332:4
3782,Benzyl methyl disulphide,211-826-8,699-10-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,91.0,H335:66;H315:66;H302:91;H319:66
3783,Dodecane-1-thiol,203-984-1,112-55-0,Skin Corr. 1C;Skin Sens. 1A;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1039.0,H317:643;H314:432;H410:453;H318:533;H400:291;H335:282;H334:177;H315:291;H319:283;H332:112;H302:112;H312:112;H304:100;Not classified:13;H412:4;H411:3;H331:1
3784,"4'-nonyl[1,1'-biphenyl]-4-carbonitrile",258-121-1,52709-85-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1.0,H332:1;H319:1;H302:1;H315:1;H312:1
3785,3-[ethyl[4-[(4-nitrophenyl)azo]phenyl]amino]propiononitrile,250-654-8,31482-56-1,Not Classified,REACH registration C&L,282.0,Not classified:240;H332:42;H319:42;H335:42;H302:42;H315:42;H312:40
3786,6-Iodo indazole,607-884-2,261953-36-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H335:40;H315:41;H302:40;H319:41;Not classified:1;H373:1
3787,Isonicotinaldehyde semicarbazone,226-874-5,5526-59-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H302:38;H319:38
3792,"Benzenesulfonic acid, 5-[[4-[bis(2-hydroxyethyl)amino]-6-methoxy-1,3,5-triazin-2-yl]amino]-2-[2-[4-[[4-methoxy-6-[(2-sulfoethyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]ethenyl]-, sodium salt, compd. with 2,2'-iminobis[ethanol]",285-887-4,85154-06-9,Not Classified,Notified C&L,1.0,Not classified:1
3795,"Lubricating oils (petroleum), C",309-877-7,101316-72-7,Carc. 1B,Harmonised C&L,0.0,H350:0
3803,"4,4',4''-(1-methylpropan-1-yl-3-ylidene)tris(2-cyclohexyl-5-methylphenol)",407-460-5,111850-25-0,Aquatic Chronic 2,Harmonised C&L,0.0,H411:0
3807,Magnesium dihydrogen di-L-aspartate,218-191-6,2068-80-6,Not Classified,REACH registration C&L,4.0,Not classified:3;H315:1
3808,Methoxyphenyl(trifluoromethyl)acetonitrile,279-591-4,80866-87-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,45.0,H332:43;H302:43;H312:39;H319:6;H315:6;H311:6;H331:2;H301:2;H335:1
3810,ISOFEMYLE,454-830-7,,Acute Tox. 2;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,1.0,H318:1;H315:1;H300:1;H317:1
3814,N-ethyl-2-nitrobenzylsulfonamide,927-747-3,,Not Classified,REACH registration C&L,1.0,Not classified:1
3815,Benzyl isopentyl ether,204-570-3,122-73-6,Not Classified,Notified C&L,113.0,Not classified:88;H315:25;H319:25
3816,4-methyloxetan-2-one,221-330-3,3068-88-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;Carc. 2,Notified C&L,39.0,H351:39;H226:39;H315:39;H319:38;H341:1
3817,ENTEROL,419-730-1,,Not Classified,Notified C&L,1.0,Not classified:1
3819,2-[[3-acetamido-4-[(2-chloro-4-nitrophenyl)azo]phenyl](2-cyanoethyl)amino]ethyl acetate,249-033-4,28462-17-1,Aquatic Chronic 4,REACH registration C&L,34.0,H413:2;Not classified:32
3821,Luteinizing hormone,232-661-8,9002-67-9,Repr. 1B,Notified C&L,80.0,H360:80
3822,"Alcohols, C13-15, ethoxylated",613-595-2,64425-86-1,Acute Tox. 4;Eye Dam. 1,Notified C&L,753.0,H318:753;H302:714;H400:270;H410:55;H412:39
3828,N-(2-ethylhexyl)-1-[[2-methyl-4-[(2-methylphenyl)azo]phenyl]azo]naphthalen-2-amine,260-124-8,56358-09-9,Skin Irrit. 2;Skin Sens. 1B;STOT RE 2;Aquatic Chronic 4,REACH registration C&L,98.0,H373:9;H315:92;H413:8;H317:9;Not classified:5;H351:1
3830,"1,5(or 1,8)-diamino-2-bromo-4,8(or 4,5)-dihydroxyanthraquinone",268-758-7,68134-65-6,Not Classified,Notified C&L,54.0,Not classified:54
3835,Phentolamine hydrochloride,200-793-5,73-05-2,Acute Tox. 4,Notified C&L,40.0,H302:40
3836,Butylurea,209-748-4,592-31-4,Acute Tox. 4,Notified C&L,77.0,H302:77;H332:1;H335:1;H341:1;H312:1
3837,titanium tetrachloride,231-441-9,7550-45-0,Skin Corr. 1B,Harmonised C&L,0.0,H314:0
3844,propene;propylene,204-062-1,115-07-1,Press. Gas;Flam. Gas 1,Harmonised C&L,0.0,H220:0;Not classified:0
3845,[4-(phenylmethoxy)phenoxy]acetic acid,254-000-2,38559-92-1,,Notified C&L,5.0,H335:5;H315:5;H319:5
3848,"Hydrocarbons, C",295-298-4,91995-38-9,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0.0,H340:0;H350:0;H304:0
3849,2-(ter-butylamino)-1-(3-chloro-4- hydroxyphenyl)ethanone HCl,918-208-3,,Not Classified,REACH registration C&L,1.0,Not classified:1
3851,reaction product of apple aminoacids and lauryl chloride,918-984-3,,Eye Dam. 1,REACH registration C&L,2.0,H318:2
3854,"Benzene, ethenyl-, distn. residues",270-985-1,68512-63-0,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 1;STOT SE 3;STOT RE 1;Aquatic Chronic 2,Notified C&L,1.0,H372:1;H332:1;H319:1;H304:1;H411:1;H335:1;H226:1;H315:1;Not classified:1
3856,"Dinoprost, trometamol salt",254-002-3,38562-01-5,Acute Tox. 4;Repr. 1B,Notified C&L,69.0,H360:68;H302:69;H319:29;H318:1
3860,"3-[[4-[(6,7-dichlorobenzothiazol-2-yl)azo]phenyl]ethylamino]propiononitrile",246-660-5,25150-28-1,Not Classified,Notified C&L,33.0,Not classified:33
3861,"β-d-Glucopyranoside, 1a,1b,2,5a,6,6a-hexahydro-6-[(4-hydroxy-3-methoxybenzoyl)oxy]-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl, [1aS-(1aα,1bβ,2β,5aβ,6β,6aα)]-",254-247-6,39012-20-9,Acute Tox. 4,Notified C&L,3.0,H302:3
3862,"4-Oxazolidinepropanoic acid, 2,5-dioxo-, phenylmethyl ester, (4S)-",608-678-5,3190-71-4,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,REACH registration C&L,41.0,H318:3;H315:3;H335:3;H317:38;H319:38
3863,Methyldiacetoxyisopropoxy silane,442-070-9,,Flam. Liq. 3;Eye Dam. 1,Notified C&L,1.0,H318:1;H226:1
3867,3-methyl-1-p-tolyl-5-pyrazolone,201-708-4,86-92-0,Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,177.0,H412:120;H317:86;H302:38;Not classified:19
3868,"bensulide (ISO);O,O-diisopropyl 2-phenylsulphonylaminoethyl phosphorodithioate",212-010-4,741-58-2,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H400:0;H302:0
3869,"proteinase, microbial neutral",232-966-6,9068-59-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Resp. Sens. 1,Harmonised C&L,0.0,H335:0;H334:0;H315:0;H319:0
3872,4-(1-phenylethyl)-o-xylene,228-249-2,6196-95-8,Aquatic Chronic 1,Notified C&L,100.0,H410:97;H315:4;H319:3;H304:4;H302:2;Not classified:1
3879,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with m-phenylenebis(methylamine)",500-302-7,113930-69-1,Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,343.0,H401:10;H411:134;H317:169;H314:42;H318:13;Not classified:160;H302:98;H332:4;H412:3
3881,sodium 2-benzoyloxy-1-hydroxyethane-sulfonate,410-680-4,,Skin Sens. 1,Harmonised C&L,0.0,H317:0
3888,"Sodium [4-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]benzene-1-sulphonato(3-)]ferrate(1-)",301-445-6,94021-51-9,,Notified C&L,45.0,Not classified:45
3890,"5-isopropyl-1,3,4-thiadiazol-2-amine",248-232-3,27115-74-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,90.0,H335:90;H315:90;H302:90;H319:90
3892,"propyzamide (ISO);3,5-dichloro-N-(1,1-dimethylprop-2-ynyl)benzamide",245-951-4,23950-58-5,Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H351:0;H410:0;H400:0
3893,dipotassium hexachloroplatinate,240-979-3,16921-30-5,Acute Tox. 3;Eye Dam. 1;Skin Sens. 1;Resp. Sens. 1,Harmonised C&L,0.0,H318:0;H334:0;H301:0;H317:0
3895,cartap hydrochloride,239-309-2,15263-52-2,Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H400:0;H302:0;H312:0
3896,Simethicone,617-098-1,8050-81-5,Not Classified,Notified C&L,51.0,Not classified:48;H412:3;H319:3
3897,Sodium octyl sulphate,205-535-5,142-31-4,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,462.0,H318:333;H315:446;H228:89;H335:201;H319:113;H410:16;H400:16;H302:9;H332:6
3901,1-(m-chlorophenyl)piperazine,229-654-7,6640-24-0,Aquatic Chronic 2,REACH registration C&L,57.0,H411:4;H335:52;H315:52;H302:41;H319:52;H361:11;H332:1;Not classified:1
3903,Benzothiazol-2-ylguanidine,219-955-1,2582-07-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H302:38;H319:38
3905,Iron oleate,245-591-8,23335-74-2,Not Classified,Notified C&L,1.0,Not classified:1
3907,"1-(2-carboxylatoethyl)-2-(heptadec-8-enyl)-4,5-dihydro-1-(2-hydroxyethyl)-1H-imidazolium",267-569-7,67892-37-9,Not Classified,REACH registration C&L,10.0,Not classified:10
3913,Octaaluminium zirconium octachloride icosahydroxide,308-576-8,98106-55-9,Not Classified,Notified C&L,1.0,Not classified:1
3914,"2-(2-((2,4-dimethoxyphenyl)amino)vinyl)-1,3,3-trimethyl-3H-indolium chloride",224-132-5,4208-80-4,Not Classified,Notified C&L,3.0,Not classified:3
3919,2-acetyl-1-methylpyrrole,213-247-6,932-16-1,Not Classified,Notified C&L,89.0,Not classified:88;H335:1;H315:1;H319:1
3920,"1,4-dimethylpiperazine",203-412-0,106-58-1,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,307.0,H225:199;H314:303;H318:188;H302:166;H412:3;H226:104;H311:22;Not classified:4
3921,"3,4-dihydroxy-5-(3-methylbut-2-enyl)-2-(3-methyl-1-oxobutyl)-4-(4-methyl-1-oxopent-3-enyl)cyclopent-2-en-1-one",247-072-1,25522-96-7,Not Classified,Notified C&L,1.0,Not classified:1
3925,"Fatty acids, C12-18 and C18-unsatd., 2-sulfoethyl esters, sodium salts",287-024-7,85408-62-4,Not Classified,Notified C&L,3.0,Not classified:2;H303:1;H319:1
3927,"Hedeoma pulegioides, ext.",289-915-6,90045-53-7,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,117.0,H412:91;H302:117;H317:91;H312:26
3929,[No public or meaningful name is available],481-950-7,,Skin Sens. 1B,Notified C&L,24.0,H302:24;H317:24
3930,"Disodium 5,5'-(2-(1,3-dihydro-3-oxo-2H-indazol-2-ylidene)-1,2-dihydro-3H-indol-3-one)disulphonate",212-728-8,860-22-0,Skin Sens. 1,REACH registration C&L,306.0,H317:6;Not classified:215;H302:86;H412:1
3933,"4,4'-bis[[1-[[(4-chloro-2,5-dimethoxyphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-2,2'-disulphonic acid",285-187-9,85030-61-1,Not Classified,Notified C&L,1.0,Not classified:1
3934,"Natural gas, sweetened, liquefied",305-828-9,95046-41-6,Flam. Gas 1;Press. Gas (Ref. Liq.),Notified C&L,1.0,H281:1;H220:1
3937,guanidine;2-hydroxyiminopropanedinitrile,618-892-0,92972-47-9,Not Classified,REACH registration C&L,2.0,Not classified:2
3940,3-(2-(diaminomethyleneamino)thiazol-4-ylmethylthio)propionitrile,403-710-2,76823-93-3,Acute Tox. 4;Skin Sens. 1,Harmonised C&L,0.0,H302:0;H317:0
3944,3-(2-dodecenyl)succinic anhydride,243-296-9,19780-11-1,Skin Irrit. 2;Skin Sens. 1A;Eye Irrit. 2,REACH registration C&L,183.0,H315:180;H317:71;H319:182;H335:55;H413:1;H332:2
3946,Iron tribromide,233-089-1,10031-26-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H335:40;H315:40;H319:40;H314:5;H302:5;H332:1;H312:1
3947,"Fatty acids, C18-unsatd., dimers, oligomeric reaction products with 4,4'-isopropylidenediphenol -1-chloro-2,3-epoxypropane co-oligomer, tall-oil fatty acids, tetraethylenepentamine and triethylenetetramine",500-296-6,106906-26-7,Aquatic Acute 1,Notified C&L,61.0,H400:36;Not classified:23;H314:1;H411:1;H317:1;H412:1;H315:1;H319:1
3949,"Extracts (petroleum), heavy paraffinic distillate solvent, clay-treated;Distillate aromatic extract (treated);[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contact or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C",296-437-1,92704-08-0,Carc. 1B,Harmonised C&L,0.0,H350:0
3953,"Ethyl hexa-2,4-dienoate",219-258-2,2396-84-1,Not Classified,Notified C&L,283.0,Not classified:282;H411:1
3956,"1H-Pyrazole-3-carbonitrile, 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)thio]-",601-662-9,120067-83-6,Not Classified,Notified C&L,5.0,Not classified:3;H301:2;H372:2;H330:2;H400:2;H412:2;H311:2
3962,(acetylthio)succinic anhydride,230-135-2,6953-60-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
3967,"Amides, tall-oil fatty, N-(hydroxyethyl)",268-950-0,68155-22-6,Eye Dam. 1,Notified C&L,35.0,H318:34;Not classified:34
3968,4-fluorophenol,206-736-0,371-41-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,110.0,H332:98;H319:49;H302:108;H412:58;H315:48;H312:104;H335:102;H314:62;H318:55;H301:2;H331:2;H311:2;H413:1;H402:1
3972,2-(methylnitroamino)ethyl nitrate,241-168-7,17096-47-8,Expl. 1.1;Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,5.0,H201:3;H302:2;H319:2;H203:2
3973,"cinerin II;3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)cyclopropanecarboxylate",204-454-2,121-20-0,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H400:0;H302:0
3978,1-(4-fluorophenyl)-4-(4-methylpiperidin-1-yl)butan-1-one,609-173-2,3575-80-2,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,6.0,H332:5;H319:5;H302:6;H312:5
3983,"4,6-di-tert-butylresorcinol",226-366-3,5374-06-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,40.0,H335:39;H315:40;H413:39;H319:40
3984,Trisodium 2-(carboxylatomethyl(2-hydroxyethyl)amino)ethyliminodi(acetate),205-381-9,139-89-9,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,895.0,H318:712;H302:193;H410:443;H315:552;H400:443;H319:180;Not classified:3;H320:1
3988,4-benzyloxyaniline hydrochloride,257-170-6,51388-20-6,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,42.0,H302:1;H317:1;H319:41;H335:40;H315:40;Not classified:1
3989,Thioacetanilide,211-288-4,637-53-6,Acute Tox. 4;Acute Tox. 4,Notified C&L,39.0,H332:38;H312:38;H301:1
3990,"1,2-dichloro-1-[difluoro(trifluoromethoxy)methoxy]-1,2,2-trifluoroethane,",618-014-6,874288-98-9,Aquatic Chronic 4,Notified C&L,1.0,H413:1
3991,"tert-butyl (S)-[1-[[(2,5-dioxopyrrolidin-1-yl)oxy]carbonyl]-2-methylpropyl]carbamate",222-236-5,3392-12-9,,Notified C&L,1.0,Not classified:1
3993,"N,N'-bis(1,3-dimethylbutylidene)ethylenediamine",247-196-6,25707-70-4,Not Classified,Notified C&L,108.0,Not classified:46;H332:46;H315:45;H302:47;H319:45;H317:17;H314:17;H410:15;H334:17;H400:15;H318:2;H312:1;H351:1
3994,Red RN 1946,434-740-4,,Eye Dam. 1,Notified C&L,37.0,H318:37
3995,"Benzamide, N,N'-(9,10-dihydro-4-hydroxy-9,10-dioxo-1,5-anthracenediyl)bis-",613-343-1,6370-96-3,Aquatic Chronic 4,Notified C&L,1.0,H413:1
3998,"2,3,4,6-tetrafluoroaniline",206-659-2,363-73-5,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38.0,H319:38;H332:38;H335:38;H302:38;H226:38;H315:38;H312:38
4000,"Isononanoic acid, isononyl ester",609-993-0,42131-25-9,Not Classified,Notified C&L,6.0,Not classified:6
4001,"2,3-dihydroflavone",207-654-8,487-26-3,,Notified C&L,2.0,H302:1;H335:1;H315:1;H319:1
4002,Pyrimidine-2-thiol,215-917-3,1450-85-7,,Notified C&L,6.0,H335:5;H315:6;H319:6
4003,"3-(decyloxy)tetrahydrothiophene 1,1-dioxide",242-556-9,18760-44-6,Not Classified,Notified C&L,646.0,Not classified:576;H411:70
4005,Isocytosine,203-592-0,108-53-2,Acute Tox. 4;Eye Irrit. 2,Notified C&L,40.0,H302:39;H319:40;H315:1
4006,Methyl 6-oxohexanoate,229-678-8,6654-36-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,2.0,H335:2;H315:2;H319:2
4007,Normorphine,207-381-4,466-97-7,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,Notified C&L,39.0,H310:38;H300:38;H330:38;H301:1
4008,Triammonium hydrogen ethylenediaminetetraacetate,240-073-8,15934-01-7,Acute Tox. 4;STOT RE 2,Notified C&L,130.0,H373:128;H332:84;Not classified:1
4010,Methyllithium,213-026-4,917-54-4,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,34.0,H318:3;H314:34;H260:34;H250:34;H412:25;H336:4;H224:4;H252:4;H302:4
4011,"2-[(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl]-5,12-dihydroquino[2,3-b]acridine-7,14-dione",278-284-2,75641-02-0,Not Classified,Notified C&L,90.0,Not classified:90
4012,4-chloro-2-fluorobenzoic acid,207-162-3,446-30-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47.0,H335:46;H315:47;H319:47
4013,Cyclohex-2-enone,213-223-5,930-68-7,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 2;Acute Tox. 1,REACH registration C&L,140.0,H226:136;H310:137;H330:97;H301:138;H319:93;H331:41;H311:3;H411:2;H302:2;H335:1;H315:1
4014,Ethionamide,208-628-9,536-33-4,Acute Tox. 4;Repr. 2,Notified C&L,46.0,H361:42;H302:44;H335:2;H315:3;H319:3;H341:1
4017,2-ethylhex-1-ene,216-636-9,1632-16-2,Flam. Liq. 3;Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,15.0,H411:12;H226:11;H315:14;H225:4;H319:3;H304:3;Not classified:2;H336:1;H335:2
4023,4-(tert-Butyl)benzenesulphonamide,613-109-9,6292-59-7,Not Classified,Notified C&L,9.0,Not classified:3;H314:1;H302:1;H332:1;H335:3;H315:4;H319:4
4024,Disodium 3-methyl-5-[(4-sulphonatophenyl)azo]salicylate,229-072-3,6408-91-9,Eye Irrit. 2,Notified C&L,1.0,H319:1
4025,THIO PTBT,615-977-4,7340-90-1,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38.0,H319:38;H317:38;H373:38;H400:38;H410:38;H315:38;H336:5;H304:5;H361:5;H226:1
4026,"Soaps, stocks, menhaden-oil, acidulated",296-504-5,92704-68-2,Not Classified,Notified C&L,1.0,Not classified:1
4028,"1,2,3-trichloro-5-(trifluoromethyl)benzene",256-636-6,50594-82-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,8.0,H335:2;H315:8;H319:8
4029,2-methylbutyl acrylate,256-170-3,44914-03-6,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,2.0,H332:1;H319:2;H335:2;H317:1;H412:1;H226:1;H315:2;H411:1
4032,Bis(4-nitrophenyl) hydrogen phosphate,211-434-7,645-15-8,Acute Tox. 2,Notified C&L,40.0,H300:39;H315:1;H319:1
4037,2-bromo-4-(trifluoromethyl)benzonitrile,252-715-4,35764-15-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H332:1;H319:1;H335:1;H302:1;H315:1;H312:1
4038,"Sodium 4-(3,5-dichloro-4-oxocyclohexa-2,5-dienylideneamino)phenoxide",210-640-4,620-45-1,,Notified C&L,7.0,H335:6;H315:6;H319:6;Not classified:1;H302:1
4040,"(S)-2,3-dihydro-1H-indole-2-carboxylic acid",410-860-2,79815-20-6,Skin Sens. 1;STOT RE 2;Repr. 2,Harmonised C&L,0.0,H373:0;H361:0;H317:0
4043,"Fatty acids, tall-oil, sodium salts",263-137-7,61790-45-2,Not Classified,Notified C&L,106.0,Not classified:104;H315:2;H319:2
4044,5-chloroquinolin-8-ol hydrochloride,246-939-1,25395-13-5,Skin Corr. 1C;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2.0,H314:2;H315:2;H335:2;H319:2
4050,"Tar acids, distn. residues;Distillate Phenols;[A residue from the distillation of crude phenol from coal. It consists predominantly of phenols having carbon numbers in the range of C",306-251-5,96690-55-0,Muta. 1B;Carc. 1B,Harmonised C&L,0.0,H340:0;H350:0
4054,4-amino-2-chlorobenzoic acid,219-540-5,2457-76-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48.0,H335:47;H315:48;H319:48
4056,(Z)-hex-3-enyl formate,251-532-7,33467-73-1,Flam. Liq. 3,Notified C&L,1661.0,H226:1661;H315:39;H319:39
4057,"Tetrahydro-5-oxofuran-2,3-dicarboxylic acid",225-178-9,4702-32-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:38;H315:39;H319:39
4059,cyanomethyltrimethylammoniummethylsulfate,433-720-2,286470-26-6,Aquatic Chronic 3,Harmonised C&L,0.0,H412:0
4061,(E)-2-methylbut-2-enal,207-833-0,497-03-0,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1451.0,H411:1287;H315:1448;H319:1448;H335:159;H225:164;H224:1
4062,Alfacalcidol,255-297-1,41294-56-8,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,Notified C&L,46.0,H310:42;H300:46;H330:43;H301:1;H372:2;H311:1;H361:2;H370:2
4066,4H-pyran-4-one,203-634-8,108-97-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
4067,"(2S,4S,5R)-2-Hydroxymethyl-5-ethylquinuclidine",606-879-2,219794-79-3,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38.0,H318:38;H315:38;H335:38
4071,"ammonium [(1-chloro-1,1,2,3,3,3-hexafluoropropan-2-yl)oxy](difluoro)acetate",927-063-5,,Acute Tox. 3;Acute Tox. 3;STOT RE 1;Aquatic Chronic 2,Notified C&L,1.0,H411:1;H301:1;H372:1;H311:1
4076,"Linden, Tilia americana, ext.",290-011-9,90063-53-9,Not Classified,Notified C&L,10.0,Not classified:10
4083,Propylene dinonanoate,255-350-9,41395-83-9,Not Classified,REACH registration C&L,15.0,Not classified:15
4087,Acrylic acid/2-acrylamido-2-methyl-1-propanesulfonic acid copolymer,609-852-3,40623-75-4,Not Classified,Notified C&L,22.0,Not classified:20;H336:1;H335:2;H314:1;H400:1;H302:1;H226:1;H312:1;H315:1;H319:1
4089,"[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]ammonium hydrogen sulphate",230-259-7,6992-38-7,Not Classified,Notified C&L,2.0,Not classified:2
4091,Acid Red 359,612-471-5,61814-65-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4.0,H315:2;H319:4;H411:1;H412:1
4093,Platinum oxide,234-831-7,12035-82-4,Aquatic Chronic 4,Notified C&L,121.0,H413:83;Not classified:38
4097,"12,12-dimethyl-2,5,8,11,13,16,19,22-octaoxa-12-silatricosane",253-973-0,38495-30-6,Not Classified,REACH registration C&L,1.0,Not classified:1
4100,"Dichloromethyl(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)silane",277-551-0,73609-36-6,Flam. Liq. 3;Skin Corr. 1B,REACH registration C&L,9.0,H314:9;H226:7;H318:3;H302:2;H413:2
4101,Zinc bis(O-isobutyl) (O-pentyl) bis(dithiophosphate),238-589-3,14548-63-1,Eye Dam. 1;Aquatic Chronic 2,Notified C&L,1.0,H411:1;H318:1
4102,"tebuthiuron (ISO);1-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea",251-793-7,34014-18-1,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H400:0;H302:0
4103,3-chlorophenyl isocyanate,220-822-5,2909-38-8,Skin Corr. 1C;Skin Sens. 1A;Eye Dam. 1;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,71.0,H330:67;H317:27;H314:67;H410:27;H318:32;H400:27;H334:69;H411:4;H335:5;H315:4
4106,"Gases (petroleum), crude oil fractionation off;Petroleum gas;[A complex combination of hydrocarbons produced by the fractionation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]",272-871-7,68918-99-0,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0.0,H220:0;H340:0;H350:0;Not classified:0
4108,2-[(3-nitrophenyl)sulphonyl]ethanol,255-501-9,41687-30-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,39.0,H335:39;H315:39;H319:39
4109,2-Ethoxy-4-formylphenyl β-D-glucopyranoside,602-769-3,122397-96-0,Not Classified,REACH registration C&L,89.0,Not classified:89
4110,"reaction mass of: 4-allyl-2,6-bis(2,3-epoxypropyl)phenol;4-allyl-6-[3-[6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol;4-allyl-6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol;4-allyl-6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol",417-470-1,,Skin Sens. 1;Muta. 2,Harmonised C&L,0.0,H317:0;H341:0
4111,Morphine tartrate,206-122-2,302-31-8,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,5.0,H302:4;H319:4;H301:1;H362:1;H361:1;H317:1;H334:1;H331:1
4112,"3,3'-dimethoxy[1,1'-biphenyl]-4,4'-bis(diazonium)",243-681-1,20282-70-6,Carc. 2,Notified C&L,38.0,H351:38
4114,N-Fluoro-N-(phenylsulfonyl)benzenesulfonamide,431-940-3,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,1.0,H335:1;H315:1;H319:1
4115,Ethyl hex-2-enoate,216-296-1,1552-67-6,Not Classified,Notified C&L,1.0,Not classified:1
4116,"3,4,5,6-tetrahydrophthalic anhydride",219-374-3,2426-02-0,Eye Dam. 1;Skin Sens. 1;Resp. Sens. 1;Aquatic Chronic 3,Harmonised C&L,0.0,H412:0;H334:0;H318:0;H317:0
4117,"2,3-epoxypropyl o-tolyl ether",218-645-3,2210-79-9,Skin Irrit. 2;Skin Sens. 1;Muta. 2;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H315:0;H317:0;H341:0
4120,2-(4-Chloro-3-methoxy-pyridin-2-ylmethanesulfinyl)-6-difluoromethoxy-1H-benzoimidazole,609-876-4,409098-86-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
4121,"2-butoxy-4,6-dichloro-1,3,5-triazine",237-555-5,13838-32-9,,Notified C&L,4.0,H335:4;H315:4;H319:4
4134,"Extracts (petroleum), light vacuum gas oil solvent, hydrotreated;Distillate aromatic extract (treated);[A complex combination of hydrocarbons, obtained by solvent extraction from light vacuum petroleum gas oils and treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C",295-342-2,91995-79-8,Carc. 1B,Harmonised C&L,0.0,H350:0
4135,"1,4-diethylbenzene",203-265-2,105-05-5,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,1014.0,H304:894;H411:941;H318:894;H226:1014;H315:987;H335:70;H319:91;H332:27;H302:23;H413:2;Not classified:1
4136,N-glycyl-L-aspartic acid,225-140-1,4685-12-5,,Notified C&L,38.0,Not classified:38
4141,p-acetamidobenzenesulphonyl fluoride,206-343-4,329-20-4,Skin Corr. 1B,Notified C&L,38.0,H314:38
4143,"4,4'-(propane-1,3-diyl)dipyridine",241-284-8,17252-51-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,340.0,H332:274;H319:330;H335:277;H302:274;H315:330;H312:274;H301:65
4147,4-vinylcyclohexene,202-848-9,100-40-3,Carc. 2,Harmonised C&L,0.0,H351:0
4150,"1,3,5-triisopropylbenzene",211-941-3,717-74-8,Not Classified,REACH registration C&L,117.0,Not classified:13;H317:1;H319:56;H336:55;H410:55;H318:55;H400:55;H315:56;H311:55;H412:33;H304:14
4151,Tris(2-hydroxyethyl)ammonium hydrogen maleate,255-351-4,41397-50-6,Skin Sens. 1,Notified C&L,83.0,H317:83
4155,Nitrourea,209-144-0,556-89-8,Expl. 1.1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1.0,H319:1;H332:1;H201:1;H302:1;H315:1;H312:1
4156,"2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)acetic acid",600-820-4,107367-98-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H335:2;H315:2;H319:2
4157,β-phenyl-β-alanine,210-371-2,614-19-7,Flam. Sol. 1,Notified C&L,33.0,H228:33
4158,3-Mercapto-1-hexanol,610-721-8,51755-83-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,71.0,H335:42;H315:70;H302:38;H319:45;Not classified:1
4160,"1,1-dimethyl-2-thiourea",230-204-7,6972-05-0,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2.0,H335:2;H315:2;H319:2
4161,"3-(2,4-dimethoxyphenyl)but-2-enoic acid",616-433-9,7706-67-4,Not Classified,Notified C&L,3.0,Not classified:1;H315:2;H319:2;H335:1;H302:1
4162,"1,1-dimethylheptanethiol",246-896-9,25360-10-5,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,525.0,H410:480;H400:480;H226:484;H335:38;H317:39;H319:45;H412:6;H315:7;H332:1;H302:1;H312:1
4166,Tripropyl borate,211-703-9,688-71-1,Flam. Liq. 3,Notified C&L,44.0,H226:44;H335:4;H315:4;H319:5;Not classified:1
4172,"Banana, Musa paradisiaca, ext.",289-602-4,89957-82-4,Not Classified,Notified C&L,129.0,Not classified:76;H226:28;H224:25;H350:1;H319:1
4174,Isopropylidenedi-p-phenylenebis[bis[(3-ethyl-3-oxetanyl)methyl]phosphine],258-419-1,53184-75-1,,Notified C&L,33.0,Not classified:33
4179,o-tolylacetonitrile,244-937-5,22364-68-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45.0,H332:43;H319:43;H335:43;H302:43;H315:43;H312:43;H331:2;H301:2;H311:2
4180,6-aminonaphthalene-1-sulphonic acid,201-318-4,81-05-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H335:1;H315:2;H319:2
4181,Heptan-4-olide,203-279-9,105-21-5,Skin Irrit. 2,REACH registration C&L,1659.0,H315:47;Not classified:1612;H319:2
4184,"2-[[3-[(1-oxoallyl)oxy]-2,2-bis[[(1-oxoallyl)oxy]methyl]propoxy]methyl]-2-[[(1-oxoallyl)oxy]methyl]-1,3-propanediyl diacrylate",249-698-0,29570-58-9,Skin Sens. 1A;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,215.0,H412:62;H317:91;H319:172;Not classified:41;H315:54;H335:12;H318:1;H360:1;H332:1
4188,"Formaldehyde, reaction products with methylamine",291-312-8,90387-40-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,59.0,H332:59;H319:59;H302:59;H315:59;H312:59
4189,1-fluoro-4-phenoxybenzene,206-357-0,330-84-7,,Notified C&L,5.0,H335:5;H315:5;H319:5
4191,Oxitriptan,224-411-1,4350-09-8,Acute Tox. 3,Notified C&L,112.0,H301:109;H335:60;H315:60;H319:60;Not classified:2;H302:3
4195,"1,1'-azobis(1-cyclohexanecarbonitrile)",218-254-8,2094-98-6,Self-react. D;Acute Tox. 4;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,45.0,H335:44;H411:4;H242:44;H332:4;H315:39;H319:41;H412:1
4196,Myrrh,616-981-9,8016-37-3,Flam. Liq. 3;Acute Tox. 4;Asp. Tox. 1,Notified C&L,112.0,H226:85;H302:86;H304:84;H315:25
4197,Bicyclo[2.2.1]heptan-2-ol,216-637-4,1632-68-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2.0,H335:2;H315:2;H319:2
4198,1H-Imidazole-2-carbaldehyde,600-165-4,10111-08-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48.0,H335:47;H315:48;H319:48
4204,Phenethylammonium chloride,205-849-2,156-28-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H335:39;H315:40;H302:40;H319:40
4210,"Oils, licorice",619-286-9,97676-23-8,Not Classified,Notified C&L,26.0,Not classified:26
4214,1-pentafluorobenzoyl-1H-imidazole,278-285-8,75641-06-4,,Notified C&L,5.0,H335:5;H315:5;H319:5
4216,"N1-methyl-4-(methylsulfonyl)benzene-1,2-diamine",615-907-2,73097-51-5,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,39.0,H411:39;H317:39;H302:1
4220,Triacetoxyethylsilane,241-677-4,17689-77-9,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,363.0,H314:357;H318:29;H302:301;H412:28;Not classified:6;H315:1;H319:1
4221,"1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid",413-760-7,93107-30-3,Aquatic Chronic 3;Repr. 2,Harmonised C&L,0.0,H412:0;H361:0
4225,"Benzenesulfonic acid, mono-C10-13-alkyl derivs., calcium salts",290-646-1,90194-36-8,Skin Irrit. 2;Eye Dam. 1,Notified C&L,61.0,H318:61;H315:61;H412:2
4226,"2,5-Dimethylphenylacetyl-chloride",470-780-9,,Skin Corr. 1A;Skin Sens. 1,Notified C&L,1.0,H314:1;H317:1
4227,L-lysine mono[4-isobutyl-α-methylbenzeneacetate],260-751-7,57469-77-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,96.0,H335:84;H315:84;H302:96;H319:84;H412:8;H361:8;H360:1;H372:1;H411:1
4228,Methylenebis[trimethylsilane],218-322-7,2117-28-4,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H335:42;H315:43;H225:43;H319:43
4229,"Ruscus aculeatus, ext.",281-682-9,84012-38-4,Not Classified,REACH registration C&L,13.0,Not classified:10;H226:2;H302:1;H370:1;H318:1
4230,6-methylcyclohex-3-enecarbaldehyde,201-953-7,89-94-1,Eye Dam. 1;Resp. Sens. 1,Notified C&L,38.0,H334:38;H318:38
4232,"3,7,7-trimethylbicyclo[4.1.0]heptane-2-methanol",282-699-4,84304-13-2,Not Classified,REACH registration C&L,1.0,Not classified:1
4240,4-bromobenzonitrile,210-764-9,623-00-7,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,53.0,H412:10;H319:12;H302:2;H312:11;H301:51;H332:6;H335:6;H315:7;Not classified:2;H331:2;H311:2
4241,5-phenyl-o-anisidine,254-639-7,39811-17-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,42.0,H335:41;H315:42;H319:42
4244,"8-aminonaphthalene-1,6-disulphonic acid",204-969-2,129-91-9,,Notified C&L,2.0,H335:2;H315:2;H319:2
4251,Dodecyl mercaptoacetate,223-138-5,3746-39-2,Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,38.0,H413:38;H319:38
4255,"Sodium 5-tert-butyl-2-[[9,10-dihydro-8-hydroxy-4-(isopropylamino)-9,10-dioxoanthryl]amino]benzenesulphonate",280-147-7,83027-44-5,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,9.0,H412:9;H319:9
4261,"Fatty acids, C16 and C18-unsatd. and C18-unsatd. hydroxy",270-276-7,68424-14-6,Not Classified,Notified C&L,8.0,Not classified:8
4268,Ammonium hexafluorophosphate,241-009-1,16941-11-0,Skin Corr. 1B,Notified C&L,46.0,H314:46;H318:1;H332:1;H319:1;H335:2;H302:1;H312:1
4269,"mono-2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl)piperazinium-1-yl]ethoxy)ethanol trans-butenedioate",415-180-1,773058-82-5,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H318:0;H302:0
4272,Methyl oct-2-enoate,219-259-8,2396-85-2,Not Classified,Notified C&L,88.0,Not classified:88
4273,"[2-Chloro-1,2,2-trifluoro-1-(trifluoromethyl)ethoxy]difluoroacetic acid",618-531-7,903523-21-7,Acute Tox. 2;Acute Tox. 2;Skin Corr. 1B,Notified C&L,1.0,H314:1;H310:1;H300:1
4276,"Cymbopogon martini sofia, ext.",296-436-6,92704-07-9,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,83.0,H304:83;H317:83;H410:83;H400:83;H315:83
4278,"Reaction mass of 2-{[2-(2-hydroxyethoxy)ethoxy]carbonyl}benzoic acid and 2,2'-oxydiethanol",608-744-3,32472-85-8,Eye Dam. 1,REACH registration C&L,84.0,H318:2;Not classified:76;H315:6;H319:6
4284,Hexyltrimethoxysilane,221-331-9,3069-19-0,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1B,REACH registration C&L,93.0,H226:2;H315:68;H317:2;H319:43;Not classified:25
4288,(ETHOXY(ETHOXYCARBONYL)METHYL)TRIPHENYLPHOSPHONIUM CHLORIDE,605-517-0,16847-90-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
4289,Crotonoyl chloride,210-889-9,625-35-4,Flam. Liq. 3;Skin Corr. 1B;STOT SE 3,Notified C&L,46.0,H314:46;H226:46;H335:40;H318:1;H290:1
4291,(S)-o-[[(1-phenylethyl)amino]carbonyl]benzoic acid,244-571-6,21752-36-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:38;H315:39;H319:39
4294,Ethoxytrimethylsilane,217-370-6,1825-62-3,Flam. Liq. 2,REACH registration C&L,150.0,H225:95;Not classified:57;H319:69;H335:68;H302:61;H315:69
4300,2-isopropylaniline,211-397-7,643-28-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,90.0,H335:50;H315:55;H302:90;H319:55;H412:33;H332:6;H373:4;H312:6;H314:1;H400:1
4301,2-methylheptane,209-747-9,592-27-8,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H225:0;H304:0;H336:0;H410:0;H400:0;H315:0
4303,"Poly(oxy-1,2-ethanediyl),a-sulfo-w-(octyloxy)-, ammonium salt (1:1)",610-820-6,52286-18-7,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1.0,H318:1;H315:1
4304,"Phosphoric acid, C8-10-branched and linear alkyl esters, potassium salts",306-963-6,97468-12-7,Skin Irrit. 2;Eye Dam. 1,Notified C&L,8.0,H318:6;H315:6;H314:2
4309,3'-nitroacetophenone,204-504-3,121-89-1,Aquatic Chronic 3,REACH registration C&L,7.0,H412:3;Not classified:4;H319:1;H335:1;H315:1;H312:1
4310,Furfuryl Isopropyl Sulfide,606-138-3,1883-78-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,90.0,H315:89;H319:89;Not classified:1
4311,"2,4,6,8,10-pentamethyl-2,4,6,8,10-pentavinylcyclopentasiloxane",241-712-3,17704-22-2,Not Classified,Notified C&L,22.0,Not classified:22
4314,"Disodium 4,4'-methylenebis[3-hydroxy-2-naphthoate]",229-653-1,6640-22-8,Not Classified,REACH registration C&L,6.0,Not classified:6
4316,"4'-propoxy[1,1'-biphenyl]-4-carbonitrile",258-122-7,52709-86-1,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,40.0,H335:38;H410:38;H318:38;H400:38;H315:39;H413:1;Not classified:1;H319:1
4318,"α,α'-dibromo-m-xylene",210-931-6,626-15-3,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,46.0,H334:38;H315:39;H335:39;H319:39;H314:7;H301:1;H331:1;H311:1;H330:2;H318:1;H290:1;H317:1
4320,"4-methoxy-2,5-dimethylfuran-3(2H)-one",223-797-9,4077-47-8,Acute Tox. 4,Notified C&L,1465.0,H302:1376;Not classified:89
4326,2-(2-butoxyethoxy)ethyl thiocyanate,203-985-7,112-56-1,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3,Harmonised C&L,0.0,H311:0;H226:0;H301:0
4330,"Lubricating oils (petroleum), C",309-876-1,101316-71-6,Carc. 1B,Harmonised C&L,0.0,H350:0
4334,"11a-Hydroxy-estr-4-ene-3,17-dione",613-901-4,6615-00-5,Acute Tox. 4,Notified C&L,16.0,H302:16
4336,2-fluoro-6-methylpyridine,206-980-8,407-22-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48.0,H335:47;H315:48;H319:48;H332:2;H302:2;H312:2;H227:1
4341,"3,5-dichlorosalicylic acid",206-281-8,320-72-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,136.0,H335:135;H315:136;H319:136;H302:1
4343,Dacuronium bromide,248-233-9,27115-86-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 3,Notified C&L,16.0,H331:16;H302:16;H312:16
4344,"2-amino-5-hydroxynaphthalene-1,7-disulphonic acid",229-445-0,6535-70-2,Not Classified,REACH registration C&L,11.0,Not classified:11
4346,Vincristine sulphate,218-190-0,2068-78-2,Acute Tox. 2;Muta. 2;Repr. 2,Notified C&L,44.0,H361:41;H300:41;H341:40;H360:2;H335:2;H315:2;H319:2;H301:2;H331:1;H351:1;Not classified:1;H332:1;H373:1
4348,N-(2-ethoxyphenyl)-N'-(2-ethylphenyl)oxamide,245-950-9,23949-66-8,Not Classified,REACH registration C&L,194.0,Not classified:169;H413:25
4349,"(5,6-Dimethyl-9-oxo-9H-xanthen-4-yl)acetic acid",700-141-4,117570-53-3,Acute Tox. 4;Aquatic Acute 1,Notified C&L,39.0,H400:38;H302:39
4350,"Naphtha (petroleum), solvent-refined heavy;Low boiling point modified naphtha;[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C",265-095-5,64741-92-0,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0.0,H340:0;H350:0;H304:0
4351,"1,1-dimethylhydrazine monohydrochloride",209-811-6,593-82-8,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Aquatic Acute 1,Notified C&L,2.0,H301:2;H319:2;H311:1;H335:1;H400:1;H315:2;H331:1;H372:1;H351:1;H361:1;H411:1;H340:1;H370:1;H312:1
4352,"3-acetyl-1-phenyl-pyrrolidine-2,4-dione",421-600-2,719-86-8,STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0.0,H373:0;H411:0
4353,2-Fluoro-5-iodo-benzaldehyde,604-511-5,146137-76-0,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H335:46;H301:40;H315:46;H319:46;H311:1;H331:1
4355,{[3-Acetamido-4-(2-hydroxy-4-nitrophenylazo)phenyl]imino}diethylene diacetate,437-970-3,371921-62-9,Not Classified,REACH registration C&L,38.0,Not classified:38
4358,"Fatty acids, C6-19-branched, zinc salts",271-378-4,68551-44-0,Aquatic Chronic 2,REACH registration C&L,575.0,H411:567;H315:123;H319:25;H400:16;Not classified:1
4359,"2,2'-(1,4-phenylene)bis[4-[(4-methoxyphenyl)methylene]oxazol-5(4H)-one]",257-055-0,51202-86-9,Not Classified,REACH registration C&L,2044.0,Not classified:2044
4360,"Houttuynia Cordata Extract is an extract of the herb, Houttuynia cordata, Saururaceae ",605-355-0,164288-50-0,Skin Sens. 1,Notified C&L,1.0,H317:1
4364,2-hydroxy-6-(isopropyl)-3-methylcyclohex-2-en-1-one,207-704-9,490-03-9,Not Classified,Notified C&L,88.0,Not classified:88
4366,Glucose 6-(dihydrogen phosphate),200-286-9,56-73-5,Skin Corr. 1B,Notified C&L,39.0,H314:39;H318:1
4369,"(3R,4S,6R,7R,9R,11S,12R,13S,14R)-6-{[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-12,13-dihydroxy-4-[(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy]-10-(hydroxyimino)-7-methoxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecan-2-one",918-279-0,,Not Classified,REACH registration C&L,2.0,Not classified:2
4370,"Methyl 3,5-dinitrobenzoate",220-289-9,2702-58-1,Acute Tox. 4,Notified C&L,39.0,H302:39
4373,4-[[2-methoxy-4-[(4-nitrophenyl)azo]phenyl]azo]phenol,243-325-5,19800-42-1,Acute Tox. 4,REACH registration C&L,39.0,H302:7;Not classified:23;H319:9
4374,Fibrinogens,232-598-6,9001-32-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2.0,H332:2;H302:2;H312:2
4377,"2,6-dimethyl-5,7-octadien-2-ol",227-806-7,5986-38-9,Acute Tox. 4,Notified C&L,258.0,H302:258
4381,Tolualdehyde,215-615-1,1334-78-7,Eye Irrit. 2,Notified C&L,263.0,H319:263
4384,Isoflupredone 21-acetate,206-423-9,338-98-7,Repr. 2,Notified C&L,29.0,H361:29
4386,(E)-3-methylpent-2-en-4-yn-1-ol,228-169-8,6153-06-6,Flam. Liq. 3;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,39.0,H318:1;H314:39;H226:1;H301:1
4387,"N-(2,6-dichlorophenyl)-N-phenylacetamide",284-179-2,84803-53-2,,Notified C&L,1.0,H302:1
4392,Phenyl di(p-tolyl) phosphate,252-280-0,34909-69-8,,Notified C&L,33.0,Not classified:33
4394,Diacrylamide,243-912-6,20602-80-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38.0,H332:38;H319:38;H335:38;H302:38;H315:38;H312:38
4395,"3,3-Dimethoxy-8,8,9,9-tetramethyl-2-oxa-7-thia-3,8-disiladecane",700-372-0,1128026-41-4,Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,2.0,H412:2;H317:2;H225:2
4399,Ethyl isothiocyanatoacetate,417-720-1,24066-82-8,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,1.0,H301:1;H319:1;H335:1;H315:1;H331:1
4403,"Pyridine-3,4-dicarboxylic acid",207-705-4,490-11-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49.0,H335:47;H315:48;H319:48;Not classified:1
4409,"trans-4,5-Difluoro-1,3-dioxolan-2-one",608-589-1,311810-76-1,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,4.0,H315:3;H302:3;H317:3;H319:3;H301:1;H341:1;H373:1
4410,Trisodium bis[3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)]chromate(3-),260-906-9,57693-14-8,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,332.0,H411:277;H317:311;H319:291;H412:34;Not classified:13;H315:5;H335:1
4412,"5-(diisopropylamino)-2-[[4-(dimethylamino)phenyl]azo]-3-methyl-1,3,4-thiadiazolium acetate",281-591-4,83969-14-6,Acute Tox. 3;Skin Sens. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,14.0,H301:14;H317:12;H410:12;H318:14;H400:12;H315:6;H411:2
4413,"1,4-bis(4-nitrophenyl)piperazine",240-371-8,16264-05-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
4414,Aluminium trioleate,211-702-3,688-37-9,Not Classified,Notified C&L,1.0,Not classified:1
4416,5-amino-2-(p-toluidino)benzenesulphonic acid,202-060-5,91-31-6,Acute Tox. 4,Notified C&L,38.0,H302:38
4417,"Diammonio(ethyl)[4-[[4-[ethyl(3-sulphonatobenzyl)amino]phenyl](2-sulphonatophenyl)methylene]cyclohexa-2,5-dien-1-ylidene](3-sulphonatobenzyl)ammonium",220-168-0,2650-18-2,Not Classified,REACH registration C&L,239.0,Not classified:238;H317:1
4419,"profluralin (ISO);N-(cyclopropylmethyl)-α,α,α-trifluoro-2,6-dinitro-N-propyl-p-toluidine",247-656-6,26399-36-0,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H400:0;H319:0
4421,"Pregn-4-ene-3,20-dione, 9-bromo-11β,17-dihydroxy-, (11β)-",600-314-3,102445-69-2,STOT RE 2,REACH registration C&L,1.0,H373:1
4425,Manganese orthophosphate,233-341-0,10124-54-6,Not Classified,Notified C&L,40.0,Not classified:27;H373:13;H319:13
4430,"3-(2-dodecenyl)-1-(2,2,6,6-tetramethyl-4-piperidyl)pyrrolidine-2,5-dione",283-121-3,84540-29-4,Skin Corr. 1A;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1.0,H314:1;H410:1;H318:1;H400:1
4439,2-amino-4-(trifluoromethyl)benzenethiol hydrochloride,429-560-8,4274-38-8,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 4;STOT RE 2;Aquatic Acute 1,Harmonised C&L,0.0,H332:0;H317:0;H314:0;H373:0;H400:0;H302:0;H312:0
4440,"N-nitro-5-methyl-tetrahydro-4H-1,3,5-Oxadiazine-4-Imine",604-923-5,153719-38-1,Self-heat. 2;Acute Tox. 4;Skin Sens. 1;STOT RE 2;Aquatic Chronic 3,Notified C&L,157.0,H317:157;H373:156;H252:156;H302:157;H412:157
4444,"(5α)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-one",207-386-1,467-13-0,,Notified C&L,2.0,H302:1;H301:1;H331:1
4445,Yttrium phosphate,237-790-3,13990-54-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H335:43;H315:43;H319:43;Not classified:1
4446,2-cyano-4'-methylbiphenyl,422-310-9,114772-53-1,Acute Tox. 4;Repr. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,36.0,H372:35;H361:35;H410:4;H400:2;H302:36;H411:31;H332:1;H319:1;H315:1;H312:1
4447,"N,N-bis(2,3-epoxypropyl)aniline",218-259-5,2095-06-9,Acute Tox. 4;Skin Sens. 1;Muta. 2;Aquatic Chronic 2,REACH registration C&L,46.0,H319:30;H411:3;H317:31;H302:31;H341:3;H315:30;Not classified:15
4450,"Fatty acids, C10-30, esters with lanolin alcs.",308-121-3,97862-72-1,Not Classified,REACH registration C&L,19.0,Not classified:19
4451,[2-(acryloyloxy)ethyl]trimethylammonium chloride,256-176-6,44992-01-0,Acute Tox. 4,REACH registration C&L,362.0,H302:359;H317:213;H319:236;H332:74
4455,Methyl isonicotinate,219-546-8,2459-09-8,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,57.0,H315:53;H319:57;H335:50
4456,Methyl 12-hydroxyoctadecanoate,205-471-8,141-23-1,Not Classified,REACH registration C&L,47.0,Not classified:41;H319:6
4461,2-ethylhexyl-2-ethylhexanoate,231-057-1,7425-14-1,Repr. 2,Harmonised C&L,0.0,H361:0
4465,"20-oxopregna-5,16-dien-3-β-yl acetate",213-558-7,979-02-2,Not Classified,REACH registration C&L,6.0,Not classified:4;H373:1;H360:1;H410:1;H362:1
4466,4-chloro-2-cyclohexylphenol,235-988-4,13081-17-9,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 4,Notified C&L,40.0,H301:40;H335:39;H318:39;H413:39;H315:39;H331:1;H311:1
4472,1-phenylcyclobutanecarbonitrile,238-351-9,14377-68-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,2.0,H332:2;H319:2;H302:2;H315:2;H312:2;H335:1
4473,3-butylphthalide,228-000-8,6066-49-5,Not Classified,Notified C&L,125.0,Not classified:87;H335:38;H315:38;H319:38
4476,"Tris(pentane-2,4-dionato-O,O')ruthenium",238-193-0,14284-93-6,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,127.0,H302:84;H413:84;H335:40;H315:41;H319:42;H332:1;H361:1;H312:1;H290:1;H301:2;Not classified:1
4477,Lead dilaurate,239-869-8,15773-55-4,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Chronic 1,Notified C&L,1.0,H332:1;H360:1;H373:1;H410:1;H302:1
4482,"tert-Decanoic acid, oxiranylmethyl ester, reaction products with octahydro-4,7-methano-1H-indenedimethanamine",306-647-8,97358-71-9,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1,Notified C&L,18.0,H314:18;H302:18;H317:18;H312:18
4483,3-(4-hydroxy-3-methylphenyl)propanenitrile,607-090-6,22516-99-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H332:1;H319:1;H335:1;H302:1;H315:1;H312:1
4491,4-[(4-methoxyphenyl)amino]benzenediazonium tetrachlorozincate (2:1),261-820-4,59597-61-4,Not Classified,Notified C&L,1.0,Not classified:1
4492,Tetramethyldisiloxane,250-053-0,30110-74-8,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,96.0,H335:55;H315:55;H225:93;H319:55;Not classified:3
4494,ethyl 7-(diethylamino)-2-oxo-2H-chromene-3-carboxylate,419-180-0,,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1.0,H302:1;H317:1;H319:1
4497,2-hydroxy-2-(3-hydroxy-4-methoxyphenyl)acetic acid,223-017-7,3695-24-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
4500,Zirconium tetrabromide,237-417-4,13777-25-8,Skin Corr. 1B,Notified C&L,44.0,H314:43;Not classified:1;H318:1
4501,"1,3-dichloro-5-(trifluoromethyl)benzene",259-337-9,54773-20-5,Skin Corr. 1B,Notified C&L,2.0,H314:2
4504,"3-(phenylmethyl)-9-oxa-3,7-diazabicyclo[3.3.1]nonane, hydrochloride (1:2)",620-106-6,335620-97-8,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,3.0,H411:3;H302:3;H319:3
4508,"Disodium 5-chloro-6-[4,5-dihydro-4-[[2-methoxy-5-[[2-(sulphonatooxy)ethyl]sulphonyl]phenyl]azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]toluene-3-sulphonate",242-710-5,18976-74-4,,Notified C&L,2.0,Not classified:2
4510,"Flue dust, tin-refining",283-887-9,84775-58-6,Not Classified,Notified C&L,1.0,Not classified:1
4513,L-thiazolidine-4-carboxylic acid,256-240-3,45521-09-3,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H301:1;H332:1;H319:1;H335:1;H315:1;H312:1
4518,Piriqualone,217-590-2,1897-89-8,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,38.0,H302:38;H413:38
4520,isobutyl acrylate,203-417-8,106-63-8,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Acute Tox. 4,Harmonised C&L,0.0,H332:0;H317:0;H226:0;H315:0;H312:0
4521,N-(1-oxooctadecyl)sarcosine,205-539-7,142-48-3,Eye Dam. 1,Notified C&L,18.0,H318:18;H315:1
4524,"Hawthorn, Crataegus monogyna, ext.",289-914-0,90045-52-6,Flam. Liq. 3,Notified C&L,3.0,H226:2;Not classified:1
4525,"trans,cis,cis-cyclododeca-1,5,9-triene",220-437-2,2765-29-9,Acute Tox. 3;Aquatic Chronic 2,Notified C&L,38.0,H411:38;H331:38
4526,"N,N,N',N'-tetracyclohexyl-1,3-benzenedicarboxamide",431-040-0,104560-40-9,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H400:0
4530,Cobalt(2+) neodecanoate,257-798-0,52270-44-7,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,178.0,H411:177;H315:178;H302:178;H317:178;H361:1;H412:1
4533,1-(3-allyl-2-hydroxyphenyl)propan-1-one,609-190-5,35888-91-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,1.0,H335:1;H315:1;H319:1
4537,(2-butylbenzofuran-3-yl) (4-hydroxyphenyl) ketone,257-959-5,52490-15-0,Aquatic Chronic 2,REACH registration C&L,63.0,H411:60;H332:1;H312:1;H302:1;Not classified:1
4538,"Hydrogen tetrafluoroborate(1-), compound with ethyl ether (1:1)",267-983-8,67969-82-8,Water-react. 2;Skin Corr. 1B;Eye Dam. 1,Notified C&L,43.0,H261:38;H318:38;H314:43;H336:5;H226:5;H302:5
4544,Nopol,204-890-3,128-50-7,Acute Tox. 4,Notified C&L,281.0,H302:281;H317:1;H315:1;H319:1
4545,Phenyl 4-pyridyl ketone,238-586-7,14548-46-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H335:43;H315:44;H319:44
4547,"4,5-dichlorophthalic acid",260-478-3,56962-08-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H335:39;H315:40;H319:40
4548,L-(+)-lactic acid; (2,201-196-2,79-33-4,Skin Corr. 1C;Eye Dam. 1,Harmonised C&L,0.0,H314:0;H318:0
4551,Ethyl perfluoroheptanoate,255-362-4,41430-70-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1.0,H332:1;H302:1;H312:1
4557,3-methylpentan-2-one,209-282-1,565-61-7,Flam. Liq. 2,REACH registration C&L,124.0,H225:124
4558,N-hexadecyl(or octadecyl)-N-hexadecyl(or octadecyl)benzamide,401-980-6,,Skin Irrit. 2;Skin Sens. 1,Harmonised C&L,0.0,H315:0;H317:0
4559,"(+)-2,2-dimethyl-4,5-((diphenylphosphino)dimethyl)dioxolane",253-307-9,37002-48-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H335:42;H315:43;H319:43
4560,"Distillates (petroleum), solvent-refined heavy paraffinic;Baseoil - unspecified;[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C",265-090-8,64741-88-4,Carc. 1B,Harmonised C&L,0.0,H350:0
4564,3-(p-hydroxyphenyl)propiononitrile,241-393-0,17362-17-3,,Notified C&L,5.0,H332:4;H319:5;H335:5;H302:4;H315:5;H312:4
4565,"Propanoic acid, 2-phenoxy-, (2R)-",601-217-9,1129-46-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:38;H315:38;H319:38;Not classified:1
4568,"Tetrasodium 7,7'-[[6-(morpholin-4-yl)-1,3,5-triazine-2,4-diyl]diimino]bis[4-hydroxy-3-[(4-methoxy-2-sulphonatophenyl)azo]naphthalene-2-sulphonate]",218-566-4,2184-11-4,Not Classified,REACH registration C&L,22.0,Not classified:22
4570,Tris[2-bromo-1-(chloromethyl)ethyl] phosphate,230-814-3,7328-28-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H302:38;H319:38
4571,"Barberry, Berberis aristata, ext.",289-605-0,89957-84-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
4574,Sodium 4-fluorobenzenesulfinate,617-339-0,824-80-6,Not Classified,Notified C&L,2.0,Not classified:1;H335:1;H315:1;H319:1
4581,Levorphanol,201-002-6,77-07-6,Acute Tox. 3;Acute Tox. 4;Skin Sens. 1;Acute Tox. 3;Resp. Sens. 1;STOT SE 3,Notified C&L,1.0,H301:1;H336:1;H317:1;H334:1;H312:1;H331:1
4585,4-nitroso-N-phenylaniline,205-848-7,156-10-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,75.0,H315:72;H302:71;H319:72;Not classified:3
4586,"Hydrocarbons, C",310-013-6,102110-15-6,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0.0,H340:0;H350:0;H304:0
4587,Beryllium sulphate,236-842-2,13510-49-1,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 2;STOT SE 3;Carc. 1B;STOT RE 1;Aquatic Chronic 2,Notified C&L,1.0,H301:1;H372:1;H330:1;H319:1;H411:1;H335:1;H317:1;H350:1;H315:1
4595,Reaction products of maleic anhydride with sodium phosphinate and their sodium salts,443-950-5,,Not Classified,REACH registration C&L,6.0,Not classified:6
4603,"4,4,5,5,5-pentafluoropentan-1-ol",421-360-9,148043-73-6,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0.0,H412:0;H302:0
4604,"1,2-dichloro-1,1,2,3,3,3-hexafluoropropane",211-551-3,661-97-2,Ozone 1,Notified C&L,38.0,H420:38
4611,"1-Piperazineethanol, 4-[(4-chlorophenyl)phenylmethyl]-",600-928-1,109806-71-5,Acute Tox. 4;Skin Corr. 1;Eye Dam. 1,Notified C&L,1.0,H314:1;H318:1;H302:1
4612,3-methylpentyl 2-methylisocrotonate,258-350-7,53082-58-9,Not Classified,Notified C&L,88.0,Not classified:88
4613,"Quaternary ammonium compounds, coco alkylethylbis(hydroxyethyl), Et sulfates (salts)",268-876-9,68153-31-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,11.0,H318:11;H315:11
4615,"1,4-dimethoxybenzene",205-771-9,150-78-7,Not Classified,REACH registration C&L,1724.0,Not classified:1679;H335:40;H315:45;H319:41
4616,[(methylthio)methyl]triphenylphosphonium chloride,217-221-5,1779-54-0,,Notified C&L,4.0,H335:4;H315:4;H319:4
4617,"10-(2,5-Dihydroxyphenyl)-10H-9-oxa-10-phospha-phenantbrene-10-oxide",619-409-6,99208-50-1,Not Classified,Notified C&L,1.0,Not classified:1
4618,"(S)-(-)-2,3-Epoxy-1-propanol",611-976-8,60456-23-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 3;STOT SE 3;Carc. 1B;Repr. 1B,Notified C&L,43.0,H335:40;H360:40;H318:40;H302:41;H350:42;H315:42;H312:41;H331:43;H319:2;H361:2;H341:3;H370:2;H301:2;H311:2;H227:1
4619,"Citric acid, iron(3+) salt",249-117-0,28633-45-6,Not Classified,Notified C&L,2.0,Not classified:2
4624,"Disodium [3-[4,5-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonato(3-)][1-[[2-hydroxy-5-(phenylazo)phenyl]azo]-2-naphtholato(2-)]chromate(2-)",274-492-2,70236-62-3,Aquatic Chronic 3,REACH registration C&L,2117.0,H412:2086;H411:18;H317:22;H410:13;H400:11;H315:7;H319:7;Not classified:2
4625,"1,2,4-triazolo[4,3-a][1,3,5]triazine-3,5,7-triamine",230-448-4,7144-22-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
4630,4-bromophenyl isocyanate,219-662-9,2493-02-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44.0,H332:39;H319:44;H335:44;H315:44;H312:39;H330:4;H334:4;H331:1
4633,"(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone",610-965-5,53123-88-9,Carc. 2;Repr. 2,Notified C&L,168.0,H361:164;H372:162;H351:161;H341:5;H371:1;H373:1;H410:1;H400:1;H360:1
4637,"Petroleum gases, liquefied, sweetened, C4 fraction;[A complex combination of hydrocarbons obtained by subjecting a liquified petroleum gas mix to a sweetening process to oxidize mercaptans or to remove acidic impurities. It consists predominantly of C4 saturated and unsaturated hydrocarbons.]",295-463-0,92045-80-2,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0.0,H340:0;Not classified:0;H350:0;H220:0
4640,"(E,Z)-tetradeca-9,11-dienyl acetate",256-752-7,50767-79-8,Skin Irrit. 2,Notified C&L,5.0,H315:5
4643,"Sanguisorba officinalis, ext.",284-112-7,84787-71-3,Flam. Liq. 3,Notified C&L,1.0,H226:1
4653,Methyldiphenylamine,209-023-2,552-82-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H315:44;H319:44;H335:43
4655,"Spiro[oxazolidine-2,7'-tricyclo[4.2.0.02,4]octane], 3'-(5,5-dimethyl-1,3-dioxan-2-yl)-3,4-dimethyl-5-phenyl-, [1'S-[1'α,2'β,3'α,4'β,6'α,7'β(4R*,5S*)]]-",612-050-6,60895-73-0,Not Classified,Notified C&L,1.0,Not classified:1
4658,1-fluoro-4-[(4-methylphenyl)sulphonyl]benzene,216-702-7,1643-97-6,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38.0,H315:38;H318:38;H335:38
4659,Tetrahydro-6-propyl-2H-pyran-2-one,211-820-5,698-76-0,Not Classified,REACH registration C&L,261.0,Not classified:255;H315:6;H319:6
4660,"2,5-Furandione, dihydro-, monopolyisobutenyl derivs., reaction products with triethanolamine",267-034-8,67762-80-5,Not Classified,Notified C&L,447.0,Not classified:447
4663,Tin dihydroxide,234-710-9,12026-24-3,Not Classified,Notified C&L,1.0,Not classified:1
4665,"2',4'-difluoro[1,1'-biphenyl]-4-ol",261-599-4,59089-68-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H318:1;H302:1
4667,4-Chlorophenethyl bromide,613-774-5,6529-53-9,Acute Tox. 4;Eye Dam. 1,Notified C&L,40.0,H318:39;H302:39;H315:1;H319:1;H335:1
4668,"Protein hydrolyzates, wheat gluten",309-696-3,100684-25-1,Not Classified,Notified C&L,4.0,Not classified:3;H318:1
4669,nickel(II) silicate,244-578-4,21784-78-1,Skin Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0.0,H410:0;H400:0;H372:0;H317:0;H350:0
4670,9H-fluorene-4-carboxylic acid,230-138-9,6954-55-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H315:42;H319:42;H335:42
4671,C.I. Direct Yellow 28,616-870-5,8005-72-9,Not Classified,Notified C&L,6.0,Not classified:6
4678,N-(3-aminopropyl)pyrrolidin-2-one,231-632-7,7663-77-6,Skin Corr. 1B,Notified C&L,39.0,H314:39
4679,rac-Dimethylsilylenebis(2-methyl-4-phenylindenyl)zirconium dimethyl,604-980-6,154827-36-8,Water-react. 2,Notified C&L,3.0,H261:3
4683,Iron titanium oxide,235-828-3,12789-64-9,Not Classified,Notified C&L,25.0,Not classified:25
4686,3-Bromo-4-hydroxybenzaldehyde,608-409-1,2973-78-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H315:45;H319:45;H335:43;H301:1
4689,2'-phenylbenzohydrazide,208-550-5,532-96-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38.0,H319:38;H302:38
4690,3-chloro-6-isothiocyanatotoluene,245-472-0,23165-53-9,,Notified C&L,5.0,H312:5;H314:4;H332:5;H302:5;H315:1;H319:1;H335:1
4691,α-methylpyrrolidine-1-ethanol,255-665-1,42122-41-8,Acute Tox. 3;Eye Irrit. 2,Notified C&L,38.0,H301:38;H319:38
4698,"O,O-tert-butyl O-docosyl monoperoxyoxalate",404-300-6,116753-76-5,Org. Perox. C;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H242:0;H400:0;H410:0
4699,Diethylammonium diethyldithiocarbamate,216-175-3,1518-58-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H315:39;H319:39;H335:38;Not classified:1
4700,Triethylammonium fluoride,277-550-5,73602-61-6,Acute Tox. 2;Acute Tox. 1;Skin Corr. 1A;Acute Tox. 2,REACH registration C&L,52.0,H300:51;H314:52;H310:51;H330:51;H318:2;H341:1;H412:1;H290:1;H372:1;H311:1;H370:1;H331:1;H302:1
4701,"2-Propenoic acid, C18-22-alkyl esters, polymers with maleic anhydride",606-719-1,211763-25-6,Not Classified,Notified C&L,1.0,Not classified:1
4704,"Formaldehyde, oligomeric reaction products with 5,5-dimethyl-2,4-imidazolidinedione",500-052-9,26811-08-5,Not Classified,Notified C&L,11.0,Not classified:11
4706,"Benzene, 1,5-dibromo-2-chloro-3-fluoro-",606-504-2,202925-04-0,,Notified C&L,5.0,H315:5;H319:5;H335:5
4707,"cis-7,8-epoxy-2-methyloctadecane",249-861-6,29804-22-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H315:39;H319:39;H335:39
4710,"5,6,12,13-tetrachloroanthra(2,1,9-def:6,5,10-d'e'f')diisoquinoline-1,3,8,10(2H,9H)-tetrone",405-100-1,115662-06-1,Repr. 2,Harmonised C&L,0.0,H361:0
4711,Calcium hexanoate,254-096-6,38708-95-1,Aquatic Chronic 4,Notified C&L,2.0,H413:2
4712,"Antimony, compound with manganese (1:1)",234-779-5,12032-82-5,,Notified C&L,4.0,H411:4;H332:4;H302:4
4714,(±)-N-[3-acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]acetamide monohydrochloride,277-629-4,73899-76-0,,Notified C&L,1.0,H302:1
4715,4-nitrophenyl β-D-glucopyranoside,219-661-3,2492-87-7,Not Classified,Notified C&L,5.0,Not classified:4;H371:1;H302:1
4723,(E)-3{(S)-1-[2-(2-amino-6-hydroxy-purin-9-ylmethoxy)-ethoxicarbonyl]-2-methyl-propylamino}-but-2-enoic acid methyl ester,606-477-7,202601-67-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H315:1;H319:1;H335:1
4724,"5,6-diethylindan-2-aminium chloride",455-940-8,,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 2;Aquatic Chronic 2,Notified C&L,2.0,H411:2;H401:1;H317:2;H318:2;H302:2
4725,"2,4,7-trinitrofluoren-9-one",204-965-0,129-79-3,Eye Irrit. 2,Notified C&L,1.0,H319:1
4726,"Propanamide, N-[2-(4-phenoxyphenoxy)ethyl]-",600-606-0,104825-66-3,Aquatic Chronic 2,REACH registration C&L,2.0,H411:2
4737,"4-amino-6-[[4-[[4-[[4-(diethylamino)-2-hydroxyphenyl]azo]phenyl]amino]-3-sulphophenyl]azo]-5-hydroxy-3-[(4-nitrophenyl)azo]naphthalene-2,7-disulphonic acid, sodium salt",303-569-6,94200-89-2,Not Classified,Notified C&L,1.0,Not classified:1
4738,"Prostan-1-oic acid, 16,16-difluoro-11-hydroxy-9,15-dioxo-, (11α)-",603-977-7,136790-76-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H315:38;H319:38;H335:38;H361:1;H302:1;H300:1
4740,2-ethyltoluene,210-255-1,611-14-3,Flam. Liq. 3;Asp. Tox. 1,Notified C&L,245.0,H226:244;H304:152;H361:84;H411:85;H319:85;Not classified:1;H315:1;H336:1;H335:1
4741,"2-(1,1-dimethylethyl)-6-[[3-(1,1-dimethylethyl)-2-hydroxy-5-methylphenyl]methyl]-4-methylphenyl acrylate",262-634-6,61167-58-6,Not Classified,REACH registration C&L,126.0,Not classified:122;H317:2;H413:2
4742,"Nuclease, deoxyribo-",232-667-0,9003-98-9,Resp. Sens. 1,REACH registration C&L,23.0,H334:21;Not classified:2;H317:1
4744,"4-decyloxazolidin-2-one;4-decyl-1,3-oxazolidin-2-one",443-770-7,7693-82-5,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H400:0
4745,Aluminium hydroxide sulphate,215-573-4,1332-73-6,Eye Dam. 1,Notified C&L,184.0,H318:116;Not classified:68
4746,Propyl isovalerate,209-148-2,557-00-6,Flam. Liq. 3,Notified C&L,1488.0,H226:1488
4748,4-(aminomethyl)benzonitrile,233-877-5,10406-25-4,Acute Tox. 4,Notified C&L,42.0,H302:40;H315:3;H319:3;H335:3;H312:1;H332:1;H371:1;H314:1;H318:1
4749,Guanine,200-799-8,73-40-5,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,112.0,H315:110;H319:110;H335:104;Not classified:1;H371:1;H302:1
4750,4-ethyltoluene,210-761-2,622-96-8,,Notified C&L,210.0,H226:188;H304:199;H336:12;Not classified:6;H315:4;H319:4;H335:4
4751,"Carbamic acid, butyl ester, polymer with formaldehyde",608-021-2,26935-10-4,Not Classified,Notified C&L,14.0,Not classified:14
4752,Pigment Red 5021B,410-210-8,,Not Classified,Notified C&L,1.0,Not classified:1
4757,"Fatty acids, C14-18 and C16-18-unsatd., ethoxylated (ca.14)",614-330-3,68154-25-6,Aquatic Chronic 4,Notified C&L,56.0,H413:33;H400:22;H318:22;H302:22;H315:22;Not classified:1
4762,Bis(4-octylphenyl)amine,202-965-5,101-67-7,Aquatic Chronic 2,Notified C&L,113.0,H411:85;Not classified:26;H413:2
4763,Safflower oil,232-276-5,8001-23-8,Not Classified,Notified C&L,1468.0,Not classified:1465;H319:3;H315:3
4766,"Origanum compactum, ext.",290-114-9,90082-26-1,Acute Tox. 4;Asp. Tox. 1;Skin Corr. 1C;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,94.0,H302:94;H304:93;H318:92;H317:93;H412:92;H314:93;H411:2;H319:2;H335:1;H311:2;H315:1
4771,6-bromo-2-naphthyl β-D-glucopyranosiduronic acid,245-176-1,22720-35-0,Not Classified,Notified C&L,1.0,Not classified:1
4777,Trichlorocyclopentylsilane,238-621-6,14579-03-4,Skin Corr. 1B,Notified C&L,43.0,H314:43;H290:1;H318:1
4780,Calcium L-aspartate,244-185-8,21059-46-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3.0,H319:2;H335:2;H315:2;Not classified:1
4784,Pentasodium triphosphate,231-838-7,7758-29-4,Not Classified,REACH registration C&L,3491.0,Not classified:1214;H319:2265;H335:2155;H315:2214;H318:12
4786,Pentafluorobenzene,206-658-7,363-72-4,Flam. Liq. 2;Acute Tox. 4,Notified C&L,23.0,H302:19;H225:21;H226:1;H318:1;H335:1;H315:1;H332:1;H312:1;Not classified:1
4787,Trichloropentylsilane,203-515-0,107-72-2,Flam. Liq. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,40.0,H331:39;H311:39;H314:40;H226:38;H312:1;H318:2;H332:1;H224:1;H290:1
4788,Sodium tetradecyl sulfate,205-380-3,139-88-8,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B,Notified C&L,63.0,H302:40;H311:38;H314:39;H318:23;H315:23;H312:1
4789,β-methylstyrene,211-287-9,637-50-3,Flam. Liq. 2,Notified C&L,2.0,H225:1;H226:1
4796,"Reaction mass of 8,18-dichloro-5,15-diethyl-5,15-dihydro-N,N'-bis[3-(2-methylpiperidino)propyl]-7,17-dioxa-5,9,15,19-tetraazadiindeno[1,2-b:1',2'-m]pentacene disulfonamide and 8-chloro-5,15-diethyl-5,15-dihydro-N,N'-bis[3-(2-methylpiperidino)propyl]-7,17-dioxa-5,9,15,19-tetraazadiindeno[1,2-b:1',2'-m]pentacene disulfonamide",426-570-4,186614-87-9,Skin Sens. 1;Eye Irrit. 2,Notified C&L,1.0,H319:1;H317:1
4799,Trisodium citrate,200-675-3,68-04-2,Not Classified,REACH registration C&L,1069.0,Not classified:1005;H319:63;H315:62;H335:39;H302:1
4800,"2-[2-[4-(diethylamino)phenyl]vinyl]-1,3,3-trimethyl-3H-indolium acetate",264-796-3,64346-30-1,Acute Tox. 3;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,51.0,H400:46;H318:46;H301:12;H410:46;H300:35;Not classified:4;H330:2;H411:1;H319:1
4802,"2-benzyl 1-tert-butyl (2S)-5-oxopyrrolidine-1,2-dicarboxylate",601-251-4,113400-36-5,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H319:1;H335:1;H315:1
4803,C.I. 50415,601-023-4,11099-03-9,Not Classified,Notified C&L,6.0,Not classified:5;H319:1;H315:1
4804,1-[4-[[6-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranosyl]oxy]-2-hydroxy-6-methoxyphenyl]-3-(3-hydroxy-4-methoxyphenyl)prop-2-en-1-one,246-128-2,24292-52-2,Not Classified,Notified C&L,2.0,Not classified:2
4806,tert-butylarsine,423-320-6,4262-43-5,Pyr. Liq. 1;Acute Tox. 2,Harmonised C&L,0.0,H250:0;H330:0
4809,C.I. Direct Red 89,601-899-8,12217-67-3,Not Classified,Notified C&L,1.0,Not classified:1
4810,"tolclofos-methyl (ISO);O-(2,6-dichloro-p-tolyl)-O,O-dimethyl thiophosphate",260-515-3,57018-04-9,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H400:0;H317:0;H410:0
4811,"4,5-dichloro-2-nitroaniline",229-657-3,6641-64-1,Acute Tox. 2;Aquatic Chronic 2,REACH registration C&L,49.0,H411:41;H300:41;H310:39;H373:39;H330:39;H302:8;H312:7;H332:8;H319:8;H335:7;H315:8
4813,"2,3-dibromopropyl acrylate",243-208-9,19660-16-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H319:2;H315:2;H335:1
4822,Ethyl hex-3-enoate,219-257-7,2396-83-0,Flam. Liq. 3,Notified C&L,158.0,H226:158
4823,"Anthemis nobilis, ext.",283-467-5,84649-86-5,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1735.0,H411:1516;H317:1696;H304:1723;H226:1728;Not classified:6;H412:1;H319:2;H315:1
4826,"Fatty acids, C12-20",269-807-5,68334-02-1,Not Classified,Notified C&L,1.0,Not classified:1
4828,"Hydrocarbons, C",308-289-8,97926-70-0,Carc. 1B,Harmonised C&L,0.0,H350:0
4830,"trans-2-isopropyl-5-carboxy-1,3-dioxane",445-770-2,42031-28-7,Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0.0,H318:0;H412:0
4832,Nona-2-6-dienenitrile,266-545-3,67019-89-0,Not Classified,Notified C&L,90.0,Not classified:90
4834,Vanadium oxide,234-834-3,12035-98-2,,Notified C&L,176.0,H332:175;H319:176;H335:176;H372:175;H315:1
4835,Trimethylbismuthine,209-817-9,593-91-9,Flam. Liq. 2;Pyr. Liq. 1;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B,Notified C&L,38.0,H302:38;H311:38;H314:38;H250:38;H225:38
4837,Dipotassium hexakis(cyano-C)platinate,240-978-8,16920-94-8,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,42.0,H311:38;H301:38;H319:42;H335:42;H315:42;H331:38;H302:4;H332:4
4840,"[(3,7-dimethyl-6-octenyl)oxy]acetaldehyde",231-324-2,7492-67-3,Not Classified,Notified C&L,1561.0,Not classified:1524;H317:37;H412:24;H319:13;H411:13;H315:13
4841,POLYAMINOAMIDE ADDUCT (R41)(39155),925-499-0,,Eye Dam. 1,Notified C&L,9.0,H318:9
4842,Dicyclohexyl peroxydicarbonate,216-337-3,1561-49-5,Org. Perox. C;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,4.0,H319:4;H412:4;H315:4;H242:4
4846,"Benzoic acid, 2-hydroxy-5-[[4-[[4-[[8-hydroxy-7-[[4-[(8-hydroxy-3,6-disulfo-1-naphthalenyl)azo]-2-methoxy-5-methylphenyl]azo]-3,6-disulfo-1-naphthalenyl]amino]-6-(phenylamino)-1,3,5-triazin-2-yl]amino]phenyl]azo]-, pentasodium salt",228-995-9,6388-26-7,Not Classified,REACH registration C&L,151.0,Not classified:148;H319:2;H373:1;H315:2;H302:1
4852,"Hydrocarbons, C7-9",272-912-9,68920-06-9,Flam. Liq. 2;Asp. Tox. 1;STOT SE 3;Aquatic Chronic 2,Notified C&L,44.0,H336:38;H411:38;H304:39;H225:38;Not classified:5
4853,o-hydroxybenzenesulphonic acid,210-191-4,609-46-1,,Notified C&L,34.0,Not classified:33;H314:1
4860,"(ethyl-3-oxobutanoato-O'1,O'3)(2-dimethylaminoethanolato)(1-methoxypropan-2-olato)aluminium(III), dimerised",402-370-2,149057-70-5,Flam. Liq. 3;Eye Dam. 1,Harmonised C&L,0.0,H318:0;H226:0
4861,"6,10,14-trimethylpentadecan-2-one",207-950-7,502-69-2,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,210.0,H400:84;H410:84;Not classified:88;H413:38
4867,Benzyldodecylbis(2-hydroxypropyl)ammonium chloride,265-345-3,65059-91-8,Skin Corr. 1B;Aquatic Chronic 2,Notified C&L,34.0,H411:34;H314:34
4873,Sodium 5-(sec-butyl)-5-ethylbarbiturate,205-611-8,143-81-7,Acute Tox. 3,Notified C&L,1.0,H301:1
4876,4-methyl-β-methylenecyclohex-3-ene-1-ethyl acetate,239-164-5,15111-97-4,Not Classified,Notified C&L,88.0,Not classified:88
4877,Codeine hydrobromide,204-730-2,125-25-7,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Lact.,REACH registration C&L,7.0,H362:5;H317:6;H302:6;H318:4;H301:1;H334:2;H361:2;H331:1;H336:1;H412:1
4878,"Vacuum distillate (shale oil), light, base and acid",923-317-4,,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1.0,H319:1;H412:1;H315:1;H226:1
4881,trans-1-methyl-4-(1-methylvinyl)cyclohexene,229-977-3,6876-12-6,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H226:0;H400:0;H317:0;H315:0;H410:0
4882,"(2R-cis)-(3-methyloxiranyl)phosphonic acid, compound with 2-amino-2-(hydroxymethyl)propane-1,3-diol (1:1)",279-018-8,78964-85-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1,Notified C&L,68.0,H319:65;H317:65;H334:65;H315:65;Not classified:3
4886,Cerium vanadium tetraoxide,237-044-7,13597-19-8,Not Classified,REACH registration C&L,9.0,Not classified:2;H332:7;H319:7;H335:7;H302:7
4888,(2S)-5-amino-2-{[(2S)-2-aminopropanoyl]amino}-5-oxopentanoic acid,475-290-9,,Not Classified,Notified C&L,1.0,Not classified:1
4891,"9,10-Anthracenedione, 1,4-diamino-, N,N'-mixed 2-ethylhexyl and hexyl and octyl derivs.",297-755-3,93762-42-6,Not Classified,REACH registration C&L,11.0,Not classified:10;H319:1;H315:1
4892,"Fats and Glyceridic oils, shea butter, unsaponifiable fraction",607-097-4,225234-14-0,Not Classified,REACH registration C&L,2.0,Not classified:2
4895,Vinylcyclopentane,223-133-8,3742-34-5,Flam. Liq. 2,Notified C&L,44.0,H225:44
4900,"4,5-Difluoro-2-nitroaniline",616-585-6,78056-39-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H319:41;H335:40;H315:41
4904,"Dihydrogen (ethyl)[4-[4-[ethyl(3-sulphonatobenzyl)amino](4-hydroxy-2-sulphonatobenzhydrylidene]cyclohexa-2,5-dien-1-ylidene](3-sulphonatobenzyl)ammonium, disodium salt",219-091-5,2353-45-9,STOT SE 3,REACH registration C&L,271.0,H335:142;H319:92;H315:92;Not classified:75;H341:55;H351:3
4905,"3,4-Dichloro-N-(5-chloro-4-{[2-({4-[(2-hexyldecyl)oxy]phenyl}sulfonyl)butanoyl]amino}-2-hydroxyphenyl)benzamide",459-290-6,,Not Classified,Notified C&L,1.0,Not classified:1
4908,4-methoxybenzenethiol,211-799-2,696-63-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,55.0,H302:54;H312:43;H332:43;H319:49;H335:46;H315:49;H311:1;H301:1;H331:1
4912,"4-(Cyclopropylcarbonyl)-α,α-dimethyl-ethyl ester benzeneacetic acid",605-546-9,169280-10-8,Aquatic Chronic 2,REACH registration C&L,1.0,H411:1
4915,potassium perfluorooctanesulfonate;potassium heptadecafluorooctane-1-sulfonate,220-527-1,2795-39-3,Acute Tox. 4;Acute Tox. 4;Carc. 2;Lact.;STOT RE 1;Aquatic Chronic 2;Repr. 1B,Harmonised C&L,0.0,H302:0;H360:0;H411:0;H362:0;H332:0;H351:0;H372:0
4916,1-(m-chlorophenyl)piperazine hydrochloride,265-718-0,65369-76-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H319:41;H335:41;H302:41;H315:41;H301:1
4919,Bromocriptine,247-128-5,25614-03-3,Acute Tox. 4;Repr. 2;Lact.,Notified C&L,1.0,H361:1;H362:1;H302:1
4923,Methyl ricinoleate,205-472-3,141-24-2,Not Classified,REACH registration C&L,136.0,Not classified:136
4924,[No public or meaningful name is available],472-020-1,,Not Classified,Notified C&L,1.0,Not classified:1
4925,[No public or meaningful name is available],454-420-8,,Not Classified,Notified C&L,31.0,Not classified:31
4926,"Trimethyl benzene-1,2,4-tricarboxylate",219-547-3,2459-10-1,Aquatic Chronic 2,REACH registration C&L,87.0,H411:87
4929,"Rosin, fumarated",266-040-8,65997-04-8,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 4,REACH registration C&L,411.0,H413:46;H318:197;H317:348;H412:68;Not classified:61;H302:7;H411:1
4934,Bicyclo[2.2.1]hept-5-en-2-ol,235-987-9,13080-90-5,Flam. Sol. 1,Notified C&L,38.0,H228:38
4939,3-(dimethylamino)propyl methacrylate,243-911-0,20602-77-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,32.0,H319:32;H335:32;H315:32
4940,"2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)pent-4-en-2-ol",407-850-5,89544-40-1,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H318:0;H302:0
4942,2-naphthyl isocyanate,218-815-7,2243-54-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,198.0,H302:194;H312:194;H332:194;H319:198;H335:198;H315:198;H334:4;H331:4
4944,Trypsin,607-831-3,,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,1.0,H319:1;H334:1;H371:1;H315:1
4949,Fusafungine,215-737-5,1393-87-9,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,2.0,H317:2;H412:1
4954,2-ethylhexyl oleate,247-655-0,26399-02-0,Not Classified,REACH registration C&L,548.0,Not classified:515;H413:33
4956,"Sodium hydrogen 4-[[4-(ethylamino)-m-tolyl][4-(ethylimino)-3-methylcyclohexa-2,5-dien-1-ylidene]methyl]benzene-1,3-disulphonate",220-167-5,2650-17-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,92.0,H319:92;H335:80;H315:81;Not classified:1
4959,Benzthiazide,202-061-0,91-33-8,Skin Sens. 1;Resp. Sens. 1,Notified C&L,90.0,H334:90;H317:90
4962,Tridecyl phosphate,224-099-7,4200-55-9,Not Classified,Notified C&L,9.0,Not classified:9
4965,2-tert-butylcyclohexyl propionate,255-044-5,40702-13-4,Not Classified,Notified C&L,88.0,Not classified:88
4969,Magnesium thiosulphate,233-340-5,10124-53-5,Not Classified,REACH registration C&L,43.0,Not classified:1;H319:42;H335:42;H315:42
4970,"Extracts (petroleum), light paraffinic distillate solvent, hydrodesulfurized;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained by solvent extraction of a light paraffin distillate and treated with hydrogen to convert the organic sulfur to hydrogen sulfide which is eliminated. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",295-340-1,91995-77-6,Carc. 1B,Harmonised C&L,0.0,H350:0
4975,"Disodium [2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][2-hydroxy-3-[(2-hydroxy-1-naphthyl)azo]-5-nitrobenzenesulphonato(3-)]chromate(2-)",274-491-7,70236-61-2,Aquatic Chronic 3,Notified C&L,13.0,H412:12;H317:1;Not classified:1
4981,Corn oil,617-614-5,84696-06-0,Flam. Liq. 3,Notified C&L,1.0,H226:1
4983,"2,2-diphenyl-1-picrylhydrazyl",217-591-8,1898-66-4,Skin Sens. 1;Resp. Sens. 1,Notified C&L,43.0,H334:38;H317:38;H319:5;H335:4;H315:5;H300:4;H350:1;H302:1;H242:1;H361:1;H372:1;H370:1;H341:1
4987,"Hydrogen [3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2-hydroxy-5-nitrobenzenesulphonato(3-)]hydroxychromate(1-), compound with 3-[(2-ethylhexyl)oxy]propylamine (1:1)",287-257-4,85443-67-0,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,84.0,H411:84;H317:84
4991,"Cyclohexane, oxidized, non-acidic by-products, distn. residues",271-816-4,68609-04-1,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2B;Muta. 2;Aquatic Chronic 3,REACH registration C&L,85.0,H317:85;H412:85;H315:85;H320:2;H341:85;H319:83
4993,6-aminonicotinamide,206-349-7,329-89-5,Repr. 1B,Notified C&L,132.0,H360:132;H331:1;H301:1;H311:1
4996,Barbital sodium,205-613-9,144-02-5,Acute Tox. 4;Repr. 2,REACH registration C&L,41.0,H361:2;H302:40;Not classified:1
4998,4-(1-methylvinyl)cyclohex-1-ene-1-methyl acetate,239-162-4,15111-96-3,Not Classified,Notified C&L,115.0,Not classified:115
4999,Barium diethanolate,220-829-3,2914-19-4,,Notified C&L,4.0,H332:4;H302:4;H314:4;H225:4
5001,"5-[3-(1-ethoxyethoxy)-3-methyl-4-penten-1-ynyl]-2,4,6,6-tetramethyl-5,6,7,7a-tetrahydro-1,3-benzodioxol-5-ol",605-301-6,162691-59-0,Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,84.0,H402:1;H412:84
5004,Sodium bis[4-[(2-chloro-4-nitrophenyl)azo]-2-[[(2-hydroxy-5-nitrophenyl)imino]methyl]phenolato(2-)]chromate(1-),280-929-8,83804-09-5,,Notified C&L,33.0,Not classified:33
5011,"Castor oil, reaction products with 1,2-cyclohexanedicarboxylic acid",298-718-4,93821-32-0,Not Classified,Notified C&L,9.0,Not classified:9
5013,(2-hydroxypropyl)trimethylammonium 2-ethylhexanoate,263-502-0,62314-22-1,Skin Corr. 1C;Eye Dam. 1;Repr. 2,REACH registration C&L,168.0,H361:8;H318:8;H314:8;H319:138;H302:138;Not classified:22
5020,methyl 4-fluoro-3-hydroxybenzoate,606-779-9,214822-96-5,Skin Sens. 1;Eye Irrit. 2;STOT SE 3,REACH registration C&L,7.0,H319:7;H335:5;H317:1;H315:6
5021,2-Azetidinecarboxylic acid,606-432-1,20063-89-2,Acute Tox. 4;Eye Dam. 1,Notified C&L,38.0,H318:38;H302:38
5022,(Dimethoxy(methyl)silyl)methyl 2-methacrylate,479-600-3,,Not Classified,REACH registration C&L,2.0,Not classified:2
5027,[No public or meaningful name is available],460-360-3,,Not Classified,Notified C&L,1.0,Not classified:1
5028,"cis-4,5-difluoro-1,3-dioxolan-2-one",608-588-6,311810-75-0,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,2.0,H319:2;H317:2;H302:2;H315:2;H373:1
5033,Copper diformate,208-865-8,544-19-4,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,44.0,H318:2;H301:2;H400:40;H317:2;H315:4;H410:40;H302:40;H319:2;H332:2;H312:2;Not classified:1
5034,2-Ethoxy-4-{3-[(S)-3-methy-1-(2-piperidin-1-yl-phenyl)-butylamino]-2-oxo-propyl}-benzoic acid ethyl ester,604-604-0,147770-06-7,Aquatic Chronic 4,Notified C&L,1.0,H413:1
5037,"Polygonum bistorta, ext.",281-680-8,84012-36-2,Flam. Liq. 3,Notified C&L,1.0,H226:1
5039,"2,2'-oxydipropanol",203-599-9,108-61-2,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H319:1;H335:1;H315:1
5044,3-phenylpyruvic acid,205-847-1,156-06-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3.0,H319:3;H315:3;H335:2
5046,(E)-4-(1-methylvinyl)cyclohexene-1-carbaldehyde oxime,250-402-7,30950-27-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H319:1;H335:1;H315:1
5047,Hafnium tetrabromide,237-416-9,13777-22-5,Skin Corr. 1B,Notified C&L,39.0,H314:39
5050,"1,2-dichloro-3-(trifluoromethyl)benzene",259-336-3,54773-19-2,Skin Corr. 1B,Notified C&L,1.0,H314:1
5051,"Filipendula ulmaria, ext.",283-886-3,84775-57-5,Not Classified,Notified C&L,39.0,Not classified:37;H226:2
5053,"Fatty acids, C18-unsatd., dimers, oligomeric reaction products with fatty acids, C16-18 and C18-unsatd., branched and linear, tetraethylenepentamine and triethylenetetramine",500-382-3,157707-73-8,Eye Dam. 1,Notified C&L,10.0,H318:9;Not classified:1
5054,nickel zirkonium trioxide,274-755-1,70692-93-2,Skin Sens. 1;STOT RE 1;Carc. 1A,Harmonised C&L,0.0,H372:0;H350:0;H317:0
5058,"1,3-Benzenediamine, 4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-",442-110-5,,Skin Sens. 1;STOT RE 2;Aquatic Chronic 2,Notified C&L,1.0,H411:1;H317:1;H373:1
5060,N-[(p-tolylsulphonyl]-p-toluenesulphonamide,223-016-1,3695-00-9,Eye Irrit. 2,Notified C&L,49.0,H319:49
5061,Isopentyl laurate,228-626-1,6309-51-9,Not Classified,REACH registration C&L,5.0,Not classified:5
5063,Chloroneb,220-222-3,2675-77-6,Aquatic Chronic 2,Notified C&L,131.0,H411:128;Not classified:3
5064,1-methyl-3-sulphonatopyridinium,244-626-4,21876-47-1,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38.0,H318:38;H335:38;H315:38
5065,Oxotris(propan-2-olato)vanadium,226-997-4,5588-84-1,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H319:45;H335:44;H315:45;H226:44
5066,Sodium hydrogen glutamate,205-538-1,142-47-2,Not Classified,REACH registration C&L,380.0,Not classified:375;H332:3;H312:3;H302:3;H319:1;H335:1
5067,"Hydrocarbons, C",308-287-7,97926-68-6,Carc. 1B,Harmonised C&L,0.0,H350:0
5071,"1,4-dinitropiperazine",224-010-1,4164-37-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H335:38;H302:38;H315:38
5072,ALIPHATIC POLYMER DIAMINE,614-773-2,68911-25-1,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,49.0,H318:24;H317:31;H315:31;H314:17;H336:7;H319:7;H400:4;H410:4;Not classified:1
5073,"Lithospermum officinale, ext.",290-017-1,90063-58-4,Flam. Liq. 3,Notified C&L,1.0,H226:1
5074,"(8R,9S,10R,13S,14S,15S)-13-ethyl-15-hydroxy-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-3H-cyclopenta[a]phenanthrene-3,17(2H)-dione",612-051-1,60919-46-2,Not Classified,Notified C&L,2.0,Not classified:1;H362:1;H411:1;H360:1;H351:1
5075,"Gases (petroleum), hydrocracking low-pressure separator;Refinery gas;[A complex combination obtained by the liquid-vapor separation of the hydrocracking process reactor effluent. It consists predominantly of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]",272-182-1,68783-06-2,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0.0,Not classified:0;H350:0;H220:0;H340:0
5080,"2,2,6-trimethyl-4H-1,3-dioxin-4-one",226-403-3,5394-63-8,Flam. Liq. 2;Eye Irrit. 2,REACH registration C&L,84.0,H319:83;H225:83;H315:1
5083,2-carbamoyl-1-methylpyridinium methanesulphonate,289-300-2,87141-87-5,,Notified C&L,1.0,H302:1
5085,Diethyl methyl(3-oxocyclohexyl)malonate,257-797-5,52263-19-1,Not Classified,REACH registration C&L,2.0,Not classified:2
5086,2-phenylethyl hexanoate,228-538-3,6290-37-5,Not Classified,Notified C&L,90.0,Not classified:90
5087,(2-(methylamino)pyridin-3-yl)methyl N-(tert-butoxycabonyl)-N-methylglycinate,928-404-0,1180002-01-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 2,Notified C&L,1.0,H319:1;H371:1;H315:1
5091,Ammonium hexabromoplatinate,241-394-6,17363-02-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42.0,H302:42;H312:38;H332:38;H319:42;H335:42;H315:42
5092,3-bromo-2-fluorotoluene,261-981-0,59907-12-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H319:40;H335:39;H302:39;H315:40
5093,Estradiol valerate,213-559-2,979-32-8,Repr. 1B,Notified C&L,85.0,H360:82;H362:24;H413:25;H351:42;H302:19;H312:18;H332:18;H350:3;H373:2;H334:1;H411:1;H372:1
5095,"[1S-(1α,3α,5α)]-6,6-dimethyl-2-methylenebicyclo[3.1.1]heptan-3-ol",208-927-4,547-61-5,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1.0,H318:1;H315:1
5099,Nopyl acetate,204-891-9,128-51-8,Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1715.0,H319:1396;H411:1396;H317:1396;H412:319
5100,"5-Chloro-1,3-benzodioxole",615-747-3,7228-38-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H319:43;H335:43;H315:43
5106,"Trisodium [3-[[3-[(5-chloro-2,6-difluoro-4-pyrimidinyl)amino]-2-hydroxy-5-sulphophenyl]azo]-4-hydroxynaphthalene-2,7-disulphonato(5-)]cuprate(3-)",273-884-0,69121-24-0,Eye Irrit. 2,Notified C&L,31.0,H319:31
5107,5-chloro-2-(2-chlorophenoxy)aniline,260-479-9,56966-48-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H319:1;H335:1;H315:1
5108,Dioctyltin di(acetate),241-555-0,17586-94-6,Skin Corr. 1A;Eye Dam. 1;Acute Tox. 2;STOT SE 2,REACH registration C&L,90.0,H318:6;H371:27;H314:6;H330:5;H413:62;H373:55;H319:22;H315:22;H301:7
5113,"N-methyl-N-2,4,6-tetranitroaniline;tetryl",207-531-9,479-45-8,Expl. 1.1;Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2,Harmonised C&L,0.0,H373:0;H311:0;H301:0;H331:0;H201:0
5121,"Sulfuric acid, chromium(3+) potassium salt (2:1:1), dodecahydrate",616-539-5,7788-99-0,,Notified C&L,8.0,H319:7;H315:7;Not classified:1
5123,"Thiosulfuric acid(H2S2O3),S-[2-[[3-[[(2R)-2,4-dihydroxy-3,3-dimethyl-1-oxobutyl]amino]-1-oxopropyl]amino]ethyl]ester, calcium salt (2:1)",446-480-9,34644-00-3,Eye Dam. 1,Notified C&L,1.0,H318:1
5124,"7-methyl-3-methyleneocta-1,6-diene",204-622-5,123-35-3,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,2038.0,H304:2015;H226:2033;H411:75;H400:126;H319:1720;H315:1720;H317:47;H412:302;H410:80;Not classified:2;H335:3;H336:1
5125,3-methylpent-3-en-2-one,209-283-7,565-62-8,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,REACH registration C&L,154.0,H302:111;H226:154;H319:154;H335:153;H315:154;H331:31;H312:80;H332:80
5128,Gestonorone caproate,215-010-2,1253-28-7,Carc. 2;Repr. 1A;Lact.,Notified C&L,24.0,H362:24;H360:24;H351:24
5137,2-chloro-N-(hydroxymethyl)acetamide,220-598-9,2832-19-1,Skin Corr. 1B;Eye Dam. 1,Notified C&L,57.0,H318:38;H314:43;Not classified:12;H317:6;H319:2;H302:2;H315:1;H412:1;H341:1
5138,Manganese trihydroxide,215-571-3,1332-62-3,Aquatic Chronic 4,Notified C&L,3.0,H413:3
5140,"α,α-bis(trifluoromethyl)benzyl alcohol",211-943-4,718-64-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H319:45;H335:44;H315:45;H226:44
5141,Phenyl 2-bromo-2-propyl ketone,233-879-6,10409-54-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H335:39;H315:39
5142,2-Fluoro-5-iodobenzonitrile,609-061-3,351003-36-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,45.0,H332:43;H312:43;H302:43;H319:5;H335:4;H315:5;H311:2;H301:2;H331:2
5144,"1H-Imidazole-1-ethanol, α-(2,4-dichlorophenyl)-, (αR)-",608-122-1,27656-21-9,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,1.0,H413:1;H302:1
5145,Ethyl 2-oxocyclopentanecarboxylate,210-253-0,611-10-9,Not Classified,Notified C&L,4.0,Not classified:3;H227:1;H335:1;H319:1;H315:1
5146,"Hydrocarbons, C",310-012-0,102110-14-5,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0.0,H350:0;H304:0;H340:0
5149,"1,4-benzodioxan-6-ylacetic acid",241-286-9,17253-11-1,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39.0,H319:39;H302:39
5150,"4,4'-methylenediphenyl diisocyanate;diphenylmethane-4,4'-diisocyanate",202-966-0,101-68-8,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 4;STOT SE 3;Resp. Sens. 1;Carc. 2;STOT RE 2,Harmonised C&L,0.0,H373:0;H334:0;H351:0;H332:0;H319:0;H335:0;H317:0;H315:0
5152,2-ethylhexyl 4-aminobenzoate,420-170-3,26218-04-2,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H400:0;H410:0
5153,N-methylephedrine,209-022-7,552-79-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H335:38;H315:38
5156,4-cyclohexylmorpholine,229-195-2,6425-41-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38.0,H318:38;H302:38;H335:38;H315:38
5158,Hex-3-enyl 2-methylbutyrate,233-224-4,10094-41-4,Not Classified,Notified C&L,89.0,Not classified:89
5159,"Fatty acids, C18-unsatd., trimers, 2-ethylhexyl esters",605-694-4,173832-46-7,Not Classified,REACH registration C&L,8.0,Not classified:8
5164,"oxadiargyl (ISO);3-[2,4-dichloro-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one",254-637-6,39807-15-3,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0.0,H400:0;H410:0;H361:0;H373:0
5165,"1,3-dichloro-1,1,2,2,3,3-hexafluoropropane",211-552-9,662-01-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H335:38;H315:38
5167,4-(4'-chlorobenzoyl)pyridine,238-587-2,14548-48-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H319:42;H335:42;H315:42
5169,"1,1,2,2-tetrachloroethane",201-197-8,79-34-5,Acute Tox. 1;Acute Tox. 2;Aquatic Chronic 2,Harmonised C&L,0.0,H310:0;H411:0;H330:0
5173,"Tail gas (petroleum), thermal cracked hydrocarbon fractionation stabilizer, petroleum coking;Petroleum gas;[A complex combination of hydrocarbons obtained from the fractionation stabilization of thermal cracked hydrocarbons from petroleum coking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]",273-176-1,68952-82-9,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0.0,Not classified:0;H350:0;H220:0;H340:0
5176,"Benzoic acid, 2-hydroxy-, mono-C>13-alkyl derivs., calcium salts (2:1)",281-018-8,83846-43-9,Aquatic Chronic 3,Notified C&L,934.0,H412:482;H319:447;H315:447;H317:5
5177,"N,N-dimethyl-2,4,6-trinitroaniline",219-663-4,2493-31-4,Ox. Liq. 2;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,38.0,H311:38;H272:38;H301:38;H314:38;H331:38
5178,"Glycerides, animal",309-697-9,100684-26-2,Not Classified,Notified C&L,1.0,Not classified:1
5179,1-nitro-4-(pentafluorosulphanyl)benzene,447-610-7,2613-27-6,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3,Notified C&L,1.0,H311:1;H301:1;H319:1;H315:1;H331:1
5180,1-[trans-4-(trans-4-Ethylcyclohexyl)-cyclohexyl]-3-fluor-4-t rifluormethoxy-benzen,604-127-8,139395-96-3,Aquatic Chronic 4,Notified C&L,1.0,Not classified:1;H413:1
5181,cholest-5-ene-3-β-yl chloroformate,230-447-9,7144-08-3,Skin Corr. 1B,Notified C&L,44.0,H314:44;H318:2;H290:1
5183,"2,4,5-trichloroanisole",228-099-8,6130-75-2,Not Classified,Notified C&L,4.0,Not classified:4
5185,Ammonium bismuth citrate,247-078-4,25530-63-6,,Notified C&L,4.0,H332:4;H312:4;H302:4
5189,5-methoxy-2-methylindole,214-066-5,1076-74-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H319:2;H335:2;H315:2
5190,Copper dibenzoate,208-552-6,533-01-7,Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H335:1;H302:1
5191,"3,3-dimethyl-8,9-dinorbornan-2-ol",216-639-5,1632-73-1,Not Classified,Notified C&L,1630.0,Not classified:1589;H319:39;H335:38;H315:41
5194,4-chloro-8-(trifluoromethyl)quinoline,245-880-9,23779-97-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H319:43;H335:43;H315:43
5196,"Sassafras albidum, ext.",284-113-2,84787-72-4,Acute Tox. 4;Carc. 1B,Notified C&L,98.0,H350:62;H302:62;Not classified:36;H341:24
5197,"Fatty acids, dehydrated castor-oil",263-061-4,61789-45-5,Not Classified,REACH registration C&L,122.0,Not classified:122
5198,"Fatty acids, C18-22, calcium salts",308-821-9,98653-90-8,Not Classified,Notified C&L,1.0,Not classified:1
5199,Humulene,229-816-7,6753-98-6,Not Classified,Notified C&L,132.0,Not classified:78;H319:54;H335:51;H315:54;H304:10
5208,"Amines, rosin",263-139-8,61790-47-4,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1A;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,277.0,H302:271;H318:175;H400:88;H317:88;H315:103;H410:88;H314:169;H319:14;Not classified:5
5209,"Sodium 9,10-dihydroxystearate",243-995-9,20731-55-9,Not Classified,Notified C&L,2.0,Not classified:2
5212,Peroxidase,232-668-6,9003-99-0,Resp. Sens. 1,REACH registration C&L,15.0,H334:13;H317:4;H319:1;H335:1;H315:1;Not classified:2
5213,L-tyrosinohydrazide,231-631-1,7662-51-3,Skin Sens. 1;Eye Irrit. 2,Notified C&L,39.0,H319:39;H317:38;H315:1
5214,"4-amino-5-hydroxy-6-[[4-[[4-[[2-hydroxy-4-[(o-tolyl)amino]phenyl]azo]phenyl]amino]-3-sulphophenyl]azo]-3-[(4-nitrophenyl)azo]naphthalene-2,7-disulphonic acid, sodium salt",303-568-0,94200-88-1,Not Classified,Notified C&L,1.0,Not classified:1
5217,"1H-2,3-benzothiazin-4(3H)-one 2,2-dioxide",244-577-9,21784-53-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2.0,H319:2;H335:2;H302:2;H315:2
5218,"Phosphoric acid, pentyl ester",235-827-8,12789-46-7,Skin Corr. 1B,Notified C&L,21.0,H314:21
5221,Triuret,209-147-7,556-99-0,Acute Tox. 4,Notified C&L,39.0,H302:39
5222,(2-methoxy-2-oxoethyl)triphenylphosphonium bromide,217-222-0,1779-58-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H319:43;H335:42;H315:43
5227,"2-[[3,3'-dichloro-4'-[[1-[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-3-oxo-N-(o-tolyl)butyramide",279-017-2,78952-72-4,Not Classified,Notified C&L,135.0,Not classified:134;H412:1
5228,"2,6-dimethylheptan-2-ol",236-244-1,13254-34-7,Flam. Liq. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1843.0,H227:12;H319:1839;H315:1839;Not classified:4;H335:4
5230,Acide Gamma linolénique,624-740-4,506-26-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H319:41;H335:40;H315:41;Not classified:1
5231,Bromodichlorophenol,255-664-6,42121-92-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1.0,H318:1;H302:1;H335:1;H315:1
5232,"1,2,3,4-tetrahydronaphthalen-2-one",208-498-3,530-93-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H335:39;H315:39
5234,Barium dibenzoate,208-551-0,533-00-6,Acute Tox. 3;Eye Dam. 1;Acute Tox. 4,REACH registration C&L,112.0,H332:28;H318:6;H301:6;H302:105;H319:1;Not classified:1
5237,"Fatty acids, C16 and C18-unsatd., ethoxylated",614-331-9,68154-26-7,Not Classified,Notified C&L,1.0,Not classified:1
5242,"Hydrocarbons, C10-C13, isoalkanes, cyclics, <2% aromatics",918-317-6,,Asp. Tox. 1,Notified C&L,1.0,H304:1
5248,"2-Propenoic acid, polymers with C18-22-alkyl acrylate",606-718-6,211763-24-5,Not Classified,Notified C&L,1.0,Not classified:1
5253,"Zinc, 2-ethylhexanoate naphthenate complexes",288-588-7,85763-74-2,Not Classified,Notified C&L,1.0,Not classified:1
5254,"1,6-Hexanediamine, N,N'-Bis(2,2,6,6-Tetramethyl-4-Piperidinyl)-, polymer with 2,4,6-Trichloro-1,3,5-Triazine, reaction products with 2,4,4-Trimethyl-2-Pentanamine",615-131-4,70624-18-9,Aquatic Chronic 3,Notified C&L,95.0,H412:79;Not classified:13;H400:2;H410:2;H319:1;H411:1
5255,2-chloro-6-fluoroaniline,206-657-1,363-51-9,,Notified C&L,8.0,H302:7;H311:5;H373:5;H332:7;H319:7;H315:7;H331:1;H301:1;H312:3;H335:2
5259,"Carbamic acid, N-[methyl-3-[(phenoxycarbonyl)amino]phenyl]-, C,C'-[2-ethyl-2-[[[[[methyl-3-[(phenoxycarbonyl)amino]phenyl]amino]carbonyl]oxy]methyl]-1,3-propanediyl] ester",608-022-8,26948-92-5,Not Classified,Notified C&L,1.0,Not classified:1
5261,"Fatty acids, castor-oil",263-060-9,61789-44-4,Not Classified,Notified C&L,96.0,Not classified:95;H319:1
5265,"2,4-dichloro-6-methylpyrimidine",226-563-4,5424-21-5,Skin Corr. 1B;Eye Dam. 1,Notified C&L,47.0,H318:38;H314:46;H319:1;H315:1
5267,"Hydrocarbons, C11-C12, isoalkanes, <2% aromatics",918-167-1,,Flam. Liq. 3;Asp. Tox. 1,REACH registration C&L,887.0,H304:887;H226:887;H413:871
5271,"2-[[4-(2,4-Dichlorobenzoyl)-1,3-dimethyl-1H-pyrazol-5-yl]oxy]-1-phenylethanone",615-306-5,71561-11-0,Acute Tox. 4;Aquatic Acute 1,Notified C&L,38.0,H400:38;H302:38
5273,4-chloropyridine-3-sulfonyl chloride,608-853-6,33263-44-4,Acute Tox. 4;Skin Corr. 1B;STOT SE 3,Notified C&L,1.0,H335:1;H302:1;H314:1
5275,"Siloxanes and Silicones, di-Me, 3-(4-hydroxy-3-methoxyphenyl)propyl Me, 3-hydroxypropyl Me, ethers with polyethylene glycol mono-Me ether",605-035-0,156012-96-3,Not Classified,Notified C&L,44.0,Not classified:44
5276,"1,2-Propanediol, monoethyl ether",610-784-1,52125-53-8,Flam. Liq. 3;STOT SE 3,Notified C&L,335.0,H335:178;H226:246;Not classified:73;H336:53;H318:1;H319:1
5278,Indan-2-amine,221-021-3,2975-41-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,56.0,H319:51;H335:51;H315:51;H301:4;H314:5;H318:1
5279,"Trisodium (2R)-2-[(1S)-1,2-dihydroxyethyl]-5-oxo-4-(phosphonooxy)-2,5-dihydrofuran-3-olate",425-180-1,,Not Classified,REACH registration C&L,127.0,Not classified:127
5285,"Artemisia herba-alba, ext.",283-905-5,84775-75-7,Flam. Liq. 4;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;STOT SE 2;Aquatic Chronic 3,REACH registration C&L,1416.0,H227:5;H301:1342;H319:6;H317:92;H371:38;H412:5;H315:6;H373:1286;H411:1375;H304:1291;H226:88;Not classified:36;H302:37;H341:1;H335:1
5288,"Stearic acid, compound with 2,2',2''-nitrilotriethanol (1:1)",224-945-5,4568-28-9,Not Classified,Notified C&L,48.0,Not classified:45;H319:3;H315:2
5292,Methyl 2-furoate,210-254-6,611-13-2,Acute Tox. 3,Notified C&L,1604.0,H301:1579;H312:45;H319:45;H335:44;H315:71;H412:1
5295,"Benzeneethanol, α,α-dimethyl-, 1-formate",600-112-5,10058-43-2,Not Classified,Notified C&L,64.0,Not classified:64
5297,4-methylstyrene,210-762-8,622-97-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,340.0,H226:320;H411:7;H332:251;H319:303;H315:304;H304:251;H335:311;Not classified:20;H373:12;H341:12
5298,5-[(3-methylthiazolidin-2-ylidene)ethylidene]-4-oxo-2-thioxothiazolidin-3-acetic acid,265-567-0,65152-09-2,,Notified C&L,1.0,H315:1
5303,4-methylphthalic acid,224-333-8,4316-23-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H335:38;H315:39
5304,"2,2'-(2,5-cyclohexadiene-1,4-diylidene)bismalononitrile",216-174-8,1518-16-7,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,45.0,H331:39;H301:39;H311:39;H332:6;H312:5;H302:6;H319:1;H335:1;H315:1
5307,dicopper chloride trihydroxide,215-572-9,1332-65-6,Acute Tox. 3;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H400:0;H332:0;H301:0;H410:0
5309,[μ-[carbonato(2-)-O:O']]dihydroxydioxodizirconium,260-633-5,57219-64-4,Not Classified,REACH registration C&L,186.0,Not classified:181;H319:5;H335:5;H315:5
5312,2-ethylbutan-1-ol,202-621-4,97-95-0,Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0.0,H312:0;H302:0
5313,"1,2-Dihydro-2,2,4-trimethylquinoline, oligomers",500-051-3,26780-96-1,Aquatic Chronic 3,REACH registration C&L,842.0,H412:735;H317:69;H411:56;H302:55;Not classified:49;H413:2;H400:1;H410:1
5315,4-(1-methoxy-1-methylethyl)-1-methylcyclohexene,238-620-0,14576-08-0,Skin Irrit. 2;Aquatic Chronic 3,REACH registration C&L,273.0,H412:15;H315:15;Not classified:258
5316,"Sabal serrulatum, ext.",283-292-4,84604-15-9,Not Classified,Notified C&L,60.0,Not classified:58;H319:1;H315:1;H226:1
5319,"2,2'-oxydiethyl diacrylate;diethylene glycol diacrylate",223-791-6,4074-88-8,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0.0,H319:0;H317:0;H311:0;H315:0
5320,Calcium bis(dihydrogenorthophosphate),231-837-1,7758-23-8,Eye Dam. 1,REACH registration C&L,350.0,H318:310;H319:37;H335:34;H315:34;Not classified:3
5323,1-benzo[b]thien-2-ylethan-1-one,245-177-7,22720-75-8,Acute Tox. 4,Notified C&L,57.0,H302:42;Not classified:14;H312:1;H373:1;H360:1;H411:1
5329,Oxydiacetyl dichloride,244-186-3,21062-20-4,Skin Corr. 1B;Eye Dam. 1,Notified C&L,39.0,H318:39;H314:39;H290:1
5337,"(3S,3aS,4S,4aS,6S,8aR,8bR,11S)-6,11-dihydroxy-3-methyl-12-methylene-2-oxo-4a,6-ethano-3,8b-prop-1-enoperhydroindeno[1,2-b]furan-4-carboxylic acid",201-001-0,77-06-5,Not Classified,Notified C&L,147.0,Not classified:93;H319:52;H412:2
5344,"4-iodo-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one",204-966-6,129-81-7,,Notified C&L,5.0,H319:5;H335:4;H315:4;H302:1
5345,"3-Isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate, oligomers, blocked with diethyl malonate",920-219-3,,Not Classified,Notified C&L,83.0,Not classified:83
5351,Cloxacillin sodium,211-390-9,642-78-4,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,8.0,H334:8;H317:7;H302:1;H319:1;H315:1
5352,Cyclopentadecanone,207-951-2,502-72-7,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1409.0,H400:13;H410:13;Not classified:1396
5359,"(2R,4S,5R)-2-Aminomethyl-5-ethylquinuclidine",610-359-0,475160-61-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38.0,H318:38;H302:38;H335:38;H315:38
5360,"Adenosine 5'-(trihydrogen diphosphate), 2'-(dihydrogen phosphate), 5'→5'-ester with 3-(aminocarbonyl)-1-β-d-ribofuranosylpyridinium hydroxide, inner salt, disodium salt",246-129-8,24292-60-2,Not Classified,REACH registration C&L,4.0,Not classified:4
5361,"Distillates (petroleum), alkene-alkyne manuf. pyrolysis oil, mixed with high-temp. coal tar, indene fraction;Redistillates;[A complex combination of hydrocarbons obtained as a redistillate from the fractional distillation of bituminous coal high temperature tar and residual oils that are obtained by the pyrolytic production of alkenes and alkynes from petroleum products or natural gas. It consists predominantly of indene and boils in a range of approximately 160°C to 190°C (320°F to 374°F).]",295-292-1,91995-31-2,Muta. 1B;Carc. 1B,Harmonised C&L,0.0,H350:0;H340:0
5364,Tetraethylammonium iodide,200-676-9,68-05-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,54.0,H319:54;H335:53;H315:54
5366,"Tris(pentane-2,4-dionato-O,O')rhodium",238-192-5,14284-92-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Repr. 2,Notified C&L,44.0,H302:40;H312:40;H361:38;H332:40;H319:44;H335:43;H315:44;H413:1
5367,2-chloro-p-cresol,229-656-8,6640-27-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H319:41;H335:40;H315:41;H332:3;H312:3;H302:3;H311:2;H301:2;H331:2
5369,"Phosphorous acid, 2-[2-[[bis(isodecyloxy)phosphino]oxy]propoxy]-1-methylethyl isodecyl phenyl ester",310-149-6,115035-49-9,Not Classified,Notified C&L,3.0,Not classified:2;H317:1;H315:1
5373,"5-[(3,4-dimethoxyphenethyl)amino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile",266-544-8,67018-85-3,,Notified C&L,1.0,H301:1
5376,Hydrazodicarbothioamide,205-537-6,142-46-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H319:41;H335:40;H315:41;H302:4
5380,"5-bromo-1,2,3-trimethoxybenzene",220-223-9,2675-79-8,Skin Sens. 1,Notified C&L,44.0,H317:38;H319:6;H335:5;H315:6
5382,"Fatty acids, C12-20 and C12-20-unsatd.",269-808-0,68334-03-2,Not Classified,Notified C&L,2.0,Not classified:2
5383,Dipotassium hexabromoplatinate,240-977-2,16920-93-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38.0,H302:38;H312:38;H332:38;H319:38;H335:38;H315:38
5387,(E)-3-(5-nitro-2-furyl)acrylaldehyde,258-078-9,52661-56-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H319:1;H335:1;H302:1;H315:1
5391,"2,4,6-tribromophenyl acrylate",223-132-2,3741-77-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
5394,Dihexadecyl disulphide,216-338-9,1561-75-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H335:38;H315:38
5396,2-chloro-10-(3-chloropropyl)-10H-phenothiazine,220-438-8,2765-59-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
5397,2-[2-[2-(tetradecyloxy)ethoxy]ethoxy]ethyl myristate,261-822-5,59599-55-2,Not Classified,Notified C&L,36.0,Not classified:36
5400,prop-1-en-2-ylbenzene; styrene,618-465-9,9011-11-4,Not Classified,Notified C&L,80.0,Not classified:80
5401,"Formamide, N-(2-amino-4,6-dichloro-5-pyrimidinyl)-",605-623-7,171887-03-9,,Notified C&L,1.0,H319:1;H335:1;H315:1
5403,"Formaldehyde, oligomeric reaction products with 3-aminomethyl-3,5,5-trimethylcyclohexylamine and 4-tert-butylphenol",500-300-6,111411-00-8,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,80.0,H302:3;H312:2;H318:3;H317:3;H412:3;H314:3;Not classified:77
5406,"1,5-dimethylpyrrole-2-carbonitrile",260-120-6,56341-36-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38.0,H332:38;H312:38;H302:38
5409,Barium trifluoromethanesulphonate,220-526-6,2794-60-7,Acute Tox. 4;Acute Tox. 4,Notified C&L,42.0,H332:42;H302:42
5411,Gallium nitride,247-129-0,25617-97-4,Skin Sens. 1,Notified C&L,43.0,H317:42;Not classified:1
5413,"(Â±)-O,O-Diethyl O-(1,2,2,2-tetrachloroethyl) phosphorothioate",611-172-7,54593-83-8,Acute Tox. 1;Acute Tox. 1;Eye Irrit. 2;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,194.0,H310:194;H311:156;H301:156;H400:194;H319:194;H330:194;H410:194;H300:38
5414,Benzylbis(2-hydroxypropyl)octadecylammonium chloride,265-346-9,65059-92-9,Skin Corr. 1B;Aquatic Chronic 2,Notified C&L,1.0,H411:1;H314:1
5417,"N-(3-methyl-3H-thiazol-2-ylidene)-2,5-xylidine",262-890-9,61676-87-7,Acute Tox. 4,Notified C&L,38.0,H302:38
5418,"1-Propene, 1,1,2,3,3,3-hexafluoro-, polymer with 1,1-difluoroethene and 1,1,2,2-tetrafluoroethene",607-638-4,25190-89-0,Aquatic Chronic 2,Notified C&L,108.0,H411:66;Not classified:42
5420,"(2,2,3,3,4,4,5,5,6,6,7,7,7-tridecafluoroheptyl)oxirane",254-004-4,38565-52-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,28.0,H319:28;H335:27;H412:4;H315:28;H302:20;H312:20;H332:20
5423,"Aromatic hydrocarbons, C9-10",298-717-9,93821-31-9,Asp. Tox. 1;STOT SE 3;Aquatic Chronic 2,Notified C&L,1.0,H336:1;Not classified:1;H411:1;H304:1
5425,"2-Deoxy-2,2-difluoro-D-erythro-pentafuranous-1-ulose-3,5-dibenzoate",601-822-8,122111-01-7,Acute Tox. 4,Notified C&L,1.0,H302:1
5428,Tantalum pentaiodide,238-742-4,14693-81-3,Skin Corr. 1B;Acute Tox. 3,Notified C&L,42.0,H331:38;H314:42
5429,"2,6-diphenylpyridine",222-620-2,3558-69-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38.0,H302:38;H318:38;H400:38;H335:38;H315:38;H410:38
5433,"Trisodium 3-[(E)-(4-{[halo-{2-[(halo-[4-substituted-phenyl]aminoheteromonocyclyl) amino]propyl}amino)-heteromonocyclyl]amino}-5-sulfonato-1- naphthyl)diazenyl]-1,5-naphthalenedisulfonate",466-480-2,,Skin Sens. 1,REACH registration C&L,1.0,H317:1
5438,2-cyclododecylpropan-1-ol,411-410-8,118562-73-5,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H400:0;H410:0
5439,"Reaction product of: 3-hydroxy-5,7-di-tert-butylbenzofuran-2-one with o-xylene",417-100-9,,Aquatic Chronic 4,Notified C&L,1286.0,H413:1286
5447,"dioxacarb (ISO);2-(1,3-dioxolan-2-yl)phenyl N-methylcarbamate",230-253-4,6988-21-2,Acute Tox. 3;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H301:0
5450,Methyl hex-3-enoate,219-256-1,2396-78-3,Flam. Liq. 3,Notified C&L,1415.0,H226:1415
5456,"N,N'-dibenzylethylenediammonium di(acetate)",204-572-4,122-75-8,Acute Tox. 4,REACH registration C&L,65.0,H302:65
5457,"Veronica officinalis, ext.",285-571-6,85117-19-7,Flam. Liq. 3,Notified C&L,1.0,H226:1
5464,3-ethoxy-2-methylacrylaldehyde,255-899-4,42588-57-8,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39.0,H332:38;H312:38;H302:38;H226:39;H301:1;H311:1
5465,Gramicidin D,215-738-0,1393-88-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3,Notified C&L,116.0,H302:116;H312:116;H334:116;H319:116;H332:116;H335:116;H317:116;H315:116
5468,"(6S)-6-{propyl[2-(2-thienyl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride (1:1)",603-080-0,125572-93-2,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,41.0,H317:2;H302:41;H412:2;H312:1;H400:1;H332:1;H410:1
5470,Mercury selenide,243-910-5,20601-83-6,,Notified C&L,4.0,H310:4;H373:4;H300:4;H400:4;H330:4;H410:4
5471,"Cis-(2,4-(dichlorophenyl)-2-(1H-1,2,4-triazol-1-yl-methyl)1,3-dioxolan-4-yl]methyl p-Toluenesulfonate)",600-468-1,103661-14-9,Acute Tox. 4,Notified C&L,1.0,H302:1
5472,YELLOW ULK 1438,416-270-1,,Not Classified,Notified C&L,1.0,Not classified:1
5474,Dihydroergotamine mesilate,228-235-6,6190-39-2,Acute Tox. 4;Acute Tox. 4,Notified C&L,50.0,H332:44;H312:43;H317:4;H302:2;H361:2;H362:2;H412:1;H360:1;H373:1
5478,Triethylmethylammonium hydroxide,600-911-9,109334-81-8,Skin Corr. 1A,Notified C&L,38.0,H314:38
5479,"4,11,11-trimethyl-8-methylenebicyclo[7.2.0]undec-3-en-5-yl acetate",250-960-1,32214-91-8,Skin Sens. 1,Notified C&L,140.0,H317:140;H411:25;H315:36;H400:10;H410:10;H319:1;H302:1
5480,4-chlorophenyl pyridin-3-yl ketone,238-584-6,14548-44-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H335:38;H315:38
5481,"4H-1,4-benzothiazin-3-one",226-197-5,5325-20-2,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H319:1;H335:1;H315:1
5483,o-isopropoxyphenol,225-379-1,4812-20-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H319:42;H335:42;H315:42
5484,"5-amino-1H-triazolo[4,5-d]pyrimidin-7-ol",205-148-1,134-58-7,Acute Tox. 4,Notified C&L,129.0,H302:129
5488,2-bromo-3'-chloropropiophenone,252-282-1,34911-51-8,Skin Sens. 1;Eye Irrit. 2,Notified C&L,2.0,H319:2;H317:2;H315:1
5490,Isooctyl diphenyl phosphite,247-658-7,26401-27-4,Not Classified,Notified C&L,22.0,Not classified:20;H411:2
5491,"Soaps, stocks, vegetable-oil, acidulated",273-179-8,68952-95-4,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,20.0,H319:4;H315:4;H318:8;H314:8;H412:4;Not classified:8
5492,"4-nitrophenyl 1,3-thiazol-5-ylmethylcarbonate hydrochloride",414-490-2,,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,1.0,H411:1;H318:1;H317:1;H315:1
5500,N-chloroacetyl-L-leucine,211-700-2,688-12-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H319:2;H315:2
5502,Thiostrepton,215-734-9,1393-48-2,Acute Tox. 4,Notified C&L,40.0,H302:40;H332:1;H312:1
5503,"Aspidospermidine-3-carboxilic acid, 2,3,6,7,-tetradehydro-, methyl ester, monohydrochloride, (5α,12β,19α)-",608-363-2,29479-00-3,Acute Tox. 4;Acute Tox. 4,Notified C&L,2.0,H332:1;H302:2
5513,(R)-thiazolidine-4-carboxylic acid,252-106-3,34592-47-7,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,52.0,H312:46;H301:49;H332:46;H319:51;H335:50;H315:51;H302:3
5516,"2,6-di-tert-butyl-p-benzoquinone",211-946-0,719-22-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H319:46;H335:44;H315:46
5519,"Fatty acids, C18-unsatd., dimers, oligomeric reaction products with fatty acids, C16-18 and C18-unsatd., branched and linear and triethylenetetramine",500-381-8,157707-72-7,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,2.0,H318:2;H317:2;H412:2;H315:2
5520,"Fatty acids, C18-unsatd., reaction products with acrylic acid",287-819-9,85586-17-0,Not Classified,Notified C&L,1.0,Not classified:1
5521,"Yohimbe, ext.",285-574-2,85117-22-2,Acute Tox. 4,Notified C&L,26.0,H302:25;H301:1
5523,Benz[a]acridine,205-929-7,225-11-6,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,12.0,H400:12;H410:12
5524,"2,5-dinitrophenol",206-348-1,329-71-5,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0.0,H373:0;H311:0;H411:0;H301:0;H331:0
5525,2-[2-(Piperazin-1-yl)ethoxy]ethanol,700-022-7,13349-82-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,92.0,H319:7;H335:8;H315:8;H412:83;H320:1;Not classified:1
5526,"(6R)-6-Dimethylamino-4,4-diphenyl-heptan-3-one; compound with 2-(toluene-4-sulfonylamino)-pentanedioic acid",921-925-4,,Acute Tox. 3;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,2.0,H336:2;H301:2;H412:2
5528,Calcium diethanolate,220-828-8,2914-17-2,,Notified C&L,2.0,H314:1;H225:1;H319:1
5530,"2-Propenoic acid, 2-methyl-, methyl ester, polymer with 1,3-butadiene and ethenylbenzene",607-511-3,25053-09-2,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,223.0,H319:172;H317:172;H315:172;Not classified:50;H373:1
5531,"3,7-dimethyloct-7-en-1-ol",205-473-9,141-25-3,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,171.0,H318:132;H317:132;H315:132;H411:61;H319:39
5532,"reaction mass of: 2,2'-[[cis-1,2-cyclohexanediylbis(nitrilomethylidene)]bis[phenolate]](2-)N,N',O,O'-copper complex;2,2'-[[trans-1,2-cyclohexanediylbis(nitrilomethylidyne)]bis[phenolate]](2-)N,N',O,O'-copper complex",419-610-7,171866-24-3,STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H373:0
5533,"trans-1,2-dimethylcyclohexane",229-979-4,6876-23-9,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,51.0,H304:47;H225:47;H336:8;H224:4
5535,"methyl (4S)-2,2-dimethyl-1,3-dioxolane-4-carboxylate",611-975-2,60456-21-5,Acute Tox. 4,Notified C&L,2.0,H302:1;Not classified:1
5538,4-chlorophthalic acid,201-886-3,89-20-3,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1.0,H332:1;H319:1;H312:1;H302:1
5539,Propyl [3-(dimethylamino)propyl]carbamate monohydrochloride,247-125-9,25606-41-1,Skin Sens. 1,Notified C&L,46.0,H317:40;H413:3;H315:3;Not classified:3
5540,"4,4'-[sulphonylbis(4,1-phenyleneoxy)]dianiline",235-986-3,13080-89-2,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,71.0,H311:71;H301:71;H319:71;H335:38;H315:71
5541,Dodecyltriethoxysilane,242-409-9,18536-91-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H319:43;H335:38;H315:43
5542,Diisooctyl succinate,249-282-9,28880-24-2,Not Classified,REACH registration C&L,1.0,Not classified:1
5543,"Methyl 3,3-dimethoxypropionate",231-055-0,7424-91-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,5.0,H319:4;H335:4;H315:4;Not classified:1;H227:1
5548,"ethyl 2-{[3-acetylamino-4-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)phenyl]ethylamino}propionate",430-480-0,221452-67-1,Aquatic Chronic 4,Harmonised C&L,0.0,H413:0
5552,"Spinels, chromium cobalt blue green",306-012-5,95465-96-6,Not Classified,Notified C&L,1.0,Not classified:1
5556,"Disodium [2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)]chromate(2-)",274-490-1,70236-60-1,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,254.0,H411:147;H317:95;H336:83;H412:83;H226:83;Not classified:25;H319:2;H335:1;H315:1
5559,butyl nitrite,208-862-1,544-16-1,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3,Harmonised C&L,0.0,H331:0;H301:0;H225:0
5560,Bis(2-chloro-1-methylethyl) ether,203-598-3,108-60-1,Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,34.0,H319:31;H315:31;H300:20;H335:11;H301:10;H302:2;Not classified:1
5564,Methyl dimethoxyacetate,201-950-0,89-91-8,Flam. Liq. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H227:1;H335:1;H319:1;H315:1
5566,"Oils, passionflower",619-287-4,97676-26-1,Not Classified,Notified C&L,3.0,Not classified:3
5567,Tricyclo[3.3.1.13.7]dec-2-ylamine hydrochloride,234-074-2,10523-68-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47.0,H319:47;H335:46;H315:47;H302:3;H412:1
5568,"2,3-dihydroxypropyl acetate",203-415-7,106-61-6,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1.0,H319:1;H412:1;H315:1
5574,"N,N,N-trimethylanilinium hydroxide",217-592-3,1899-02-1,Skin Corr. 1B,Notified C&L,39.0,H314:39;H318:1
5578,"[3R-(3α,3aβ,7β,8aα)]-1,2,3,7,8,8a-hexahydro-3,6,8,8-tetramethyl-4H-3a,7-methanoazulen-4-one",250-405-3,30960-39-5,Not Classified,Notified C&L,1.0,Not classified:1
5579,"Formaldehyde, oligomeric reaction -products with -(2-aminoethyl)-1,2-ethandiamine, reaction products with bisphenol A, epichlorohydrine, glycidyl tolyl ether",924-329-2,,Not Classified,Notified C&L,9.0,Not classified:9
5583,Trichloro(hexadecyl)silane,227-575-2,5894-60-0,Acute Tox. 4;Skin Corr. 1,REACH registration C&L,66.0,H302:27;H314:65;H318:23;H319:1;H335:1;H315:1;H290:1
5585,Aluminium metaphosphate,237-415-3,13776-88-0,Not Classified,REACH registration C&L,57.0,Not classified:18;H319:38;H335:38;H315:38;H373:1
5589,Ethyl Thiooxamate,605-564-7,16982-21-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48.0,H319:47;H335:46;H315:47;Not classified:1
5590,"Phosphoric acid, ethyl ester, sodium salt",287-378-2,85497-01-4,Eye Irrit. 2,Notified C&L,1.0,H319:1
5594,"3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea",406-690-3,43136-14-7,Aquatic Chronic 4,Harmonised C&L,0.0,H413:0
5596,"α,α,β,β-tetrafluoro-m-nitrophenetole",216-704-8,1644-21-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H335:38;H315:38
5597,Pentadecanal,220-435-1,2765-11-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
5599,Carnidazole,255-663-0,42116-76-7,Skin Sens. 1;Eye Dam. 1,Notified C&L,46.0,H318:38;H317:38;H302:8
5600,"Lyase, citrate",232-740-7,9012-83-3,Not Classified,Notified C&L,1.0,Not classified:1
5602,Tris(2-hydroxyethyl)ammonium chloride,211-284-2,637-39-8,Not Classified,REACH registration C&L,144.0,Not classified:142;H319:2;H315:1
5604,"Fatty acids, castor-oil, polymd.",614-641-4,68604-47-7,Not Classified,Notified C&L,8.0,Not classified:7;H315:1
5605,Sodium perborate monohydrate,600-419-4,10332-33-9,Ox. Sol. 3;Acute Tox. 4;Eye Dam. 1;STOT SE 3;Repr. 1B,Notified C&L,166.0,H302:161;H360:161;H272:161;H318:161;H335:161;H331:39;H332:39;Not classified:5
5612,Disodium naphthyl phosphate,218-564-3,2183-17-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H319:43;H335:42;H315:43
5613,"Naphthalene-1,4-diamine",218-816-2,2243-61-0,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38.0,H319:38;H302:38
5615,1-fluoro-4-(methylsulphonyl)benzene,207-237-0,455-15-2,,Notified C&L,7.0,H319:5;H335:5;H315:5;H302:2
5617,"1,3-Propanediamine, N,N-dimethyl-, reaction products with epichlorohydrin",297-311-9,93384-95-3,Not Classified,Notified C&L,2.0,Not classified:1;H317:1;H302:1;H314:1
5618,Harmaline hydrochloride,206-655-0,363-11-1,Acute Tox. 4,Notified C&L,38.0,H302:38
5625,"Gas oils (petroleum), solvent-refined;Gasoil - unspecified;[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C",265-092-9,64741-90-8,Carc. 1B,Harmonised C&L,0.0,H350:0
5626,"5-chloro-1,10-phenanthroline",224-098-1,4199-89-7,Acute Tox. 4;Eye Dam. 1,Notified C&L,38.0,H318:38;H302:38
5627,Allyl oct-2-ynoate,277-303-1,73157-43-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1,Notified C&L,88.0,H317:88;H312:78;H302:88;H315:88;H311:10
5632,3-(Acetylamino)-4-hydroxy-5-nitrobenzenesulfonic acid,611-797-5,59115-12-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H335:38;H315:38
5635,Mepacrine hydrochloride,200-700-8,69-05-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H319:40;H335:40;H302:41;H315:40
5636,Floctafenine,245-881-4,23779-99-9,Acute Tox. 4,Notified C&L,1.0,H302:1
5642,"Triisononanoic acid, triester with 2,2'-[oxybis(methylene)]bis[2-(hydroxymethyl)propane-1,3-diol] tris(2-ethylhexanoate)",270-560-0,68443-84-5,Not Classified,REACH registration C&L,2.0,Not classified:2
5646,N-(1-cyanocyclopentyl)pentanamide,928-489-4,,Skin Sens. 1,REACH registration C&L,1.0,H317:1
5647,Niobium nitride,246-362-5,24621-21-4,Not Classified,Notified C&L,1.0,Not classified:1
5654,"Siloxanes and Silicones, di-Me, Me vinyl",614-123-8,67762-94-1,Not Classified,Notified C&L,9.0,Not classified:9
5656,o-phenylenediamine,202-430-6,95-54-5,Acute Tox. 3;Acute Tox. 4;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 4;Muta. 2;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H312:0;H301:0;H400:0;H332:0;H319:0;H317:0;H351:0;H410:0;H341:0
5658,Penoxsulam,606-869-8,219714-96-2,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,250.0,H400:250;H410:250
5661,"N,N-dimethyl(2-thienylmethyl)amine",247-410-8,26019-17-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H335:38;H315:38;H226:38
5662,"1-Naphthalenepropanoic acid, 6-[[(4-chlorophenyl)sulfonyl]amino]-5,6,7,8-tetrahydro-2-methyl-, (6R)-",605-410-9,165538-40-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H335:38;H315:38
5663,"Aluminum oxide (Al2O3), solid soln. with barium oxide and magnesium oxide, europium-doped",310-015-7,102110-17-8,Acute Tox. 4;Acute Tox. 4,Notified C&L,90.0,H332:86;H302:86;Not classified:4
5664,"2,2'-[methylenebis(p-phenyleneoxymethylene)]bisoxirane",218-257-4,2095-03-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,56.0,H400:38;H319:53;H335:38;H317:53;H315:53;H410:38;H411:15;Not classified:3
5665,Rubidium perchlorate,236-840-1,13510-42-4,Ox. Sol. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42.0,H302:38;H272:42;H332:38;H319:42;H335:42;H315:42
5670,"Trisodium [7-[[4-[(5-chloro-2,6-difluoro-4-pyrimidinyl)amino]-2-hydroxyphenyl]azo]-8-hydroxynaphthalene-1,3,6-trisulphonato(5-)]cuprate(3-)",273-885-6,69121-25-1,Skin Sens. 1;Resp. Sens. 1,Notified C&L,31.0,H334:31;H317:31
5671,"6,6,7,7,8,8,8-heptafluoro-2,2-dimethyloctane-3,5-dione",241-556-6,17587-22-3,Flam. Liq. 3,Notified C&L,46.0,H226:46;H319:7;H335:7;H315:7
5672,Ethyl fumarate,219-544-7,2459-05-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H319:44;H335:43;H315:44;Not classified:1
5674,p-(epoxyethyl)styrene,233-910-3,10431-61-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,55.0,H319:55;H302:55;H315:55
5682,(2-hydroxypropyl)trimethylammonium formate,263-503-6,62314-25-4,Skin Corr. 1C;Eye Dam. 1,REACH registration C&L,89.0,H318:4;H314:4;H319:85;H302:85
5683,Iron arsenide,234-947-8,12044-16-5,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,209.0,H400:209;H331:209;H301:209;H410:209
5685,"Reaction products of diazotised anthranilic acid coupled with resorcinol and diazotised 5-aminonaphthalene-1-sulphonic acid, metallised with Chromium (III) basic sulphate, sodium salts",400-320-4,94933-05-8,Not Classified,REACH registration C&L,46.0,Not classified:42;H412:4
5686,"(1α,2α,5α)-2,6,6-trimethylbicyclo[3.1.1]heptan-3-one",208-926-9,547-60-4,Acute Tox. 4,Notified C&L,88.0,H302:88
5687,Dipotassium hexacyanocobalt(II)-ferrate(II),603-073-2,12549-23-4,STOT RE 2;Aquatic Chronic 4,REACH registration C&L,5.0,H413:1;H373:1;H332:4;H302:4
5689,"3-methylthiomorpholin-4-amine 1,1-dioxide",247-743-9,26494-77-9,Not Classified,REACH registration C&L,34.0,Not classified:34
5700,4-piperidylmethylamine,230-446-3,7144-05-0,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,46.0,H318:2;H314:46;H302:1;H227:1;H312:1;H332:1;H335:1
5701,propanal;propionaldehyde,204-623-0,123-38-6,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0.0,H319:0;H335:0;H315:0;H225:0
5703,5-(bromoacetyl)salicylamide,277-626-8,73866-23-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,8.0,H319:7;H335:7;H302:7;H315:7;Not classified:1
5704,Family 603: Alcohols and derivatives,451-510-9,,Not Classified,Notified C&L,1.0,Not classified:1
5708,Iron oxide,215-570-8,1332-37-2,Not Classified,Notified C&L,501.0,Not classified:496;H332:4;H372:4;H319:1;H335:1;H315:1
5710,Dinonylphenyl bis(nonylphenyl) phosphite,259-335-8,54771-30-1,Eye Irrit. 2,Notified C&L,14.0,H319:13;Not classified:1
5714,"(octahydro-4,7-methano-1H-indenyl)methyl acrylate",300-723-4,93962-84-6,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,1.0,H411:1;H319:1;H335:1;H317:1;H315:1
5719,"3-[3,3,3-trimethyl-1,1-bis[(trimethylsilyl)oxy]disiloxanyl]propyl methacrylate",241-165-0,17096-07-0,Aquatic Chronic 4,REACH registration C&L,59.0,H413:8;H319:47;H335:46;H315:47;Not classified:4;H373:1
5721,Divinyl adipate,223-792-1,4074-90-2,Skin Sens. 1B,Notified C&L,116.0,H317:83;Not classified:33
5722,Hex-2-enyl acetate,233-223-9,10094-40-3,Not Classified,Notified C&L,113.0,Not classified:88;H226:25
5725,"Orchis mascula, ext.",290-112-8,90082-24-9,Not Classified,Notified C&L,37.0,Not classified:37
5727,"2,2'-dimorpholinyldiethyl ether",229-194-7,6425-39-4,Eye Irrit. 2,REACH registration C&L,689.0,H319:439;Not classified:250;H315:136;H413:2;H302:2;H317:1
5728,Cyclohexylurea,211-822-6,698-90-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H319:40;H335:39;H302:40;H315:40
5733,"2,3-dihydro-5-nitroindole-2,3-dione",210-252-5,611-09-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,43.0,H332:38;H312:38;H302:39;H351:38;H341:4;H319:1;H315:1
5734,L-t-Leu,424-750-7,,Not Classified,Notified C&L,1.0,Not classified:1
5735,"2,3,6-trimethylcyclohexan-1-one",609-995-1,42185-47-7,Flam. Liq. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H227:1;H335:1;H319:1;H315:1
5736,"7H-Pyrrolo[2,3-d]pyrimidine-2,4-diol",609-755-6,39929-79-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H319:1;H335:1;H302:1;H315:1
5737,Cytidine 5'-(disodium phosphate),229-819-3,6757-06-8,Not Classified,Notified C&L,12.0,Not classified:12
5744,"2,3-dimethylpentane",209-280-0,565-59-3,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H304:0;H336:0;H400:0;H315:0;H410:0;H225:0
5746,"β-Alanine, N-coco alkyl derivs.",284-219-9,84812-94-2,Eye Dam. 1;Aquatic Acute 1,REACH registration C&L,57.0,H400:25;H318:4;H319:23;H315:44;Not classified:9;H411:1
5747,3-(difluoromethyl)-1-methyl-,620-041-3,907204-31-3,Lact.;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H362:0;H400:0;H410:0
5749,"6-nitro-1H,3H-naphtho[1,8-cd]pyran-1,3-dione",229-659-4,6642-29-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H335:38;H315:38
5754,2-Chloro-4-(4-methoxyphenylethinyl)-phenol,928-662-4,,Not Classified,Notified C&L,1.0,Not classified:1
5755,"Rosin, maleated, polymer with sorbitol",917-954-7,,Not Classified,Notified C&L,1.0,Not classified:1
5756,4-(2-cyano-3-phenylamino-acryloyloxymethyl)-cyclohexyl-methyl 2-cyano-3-phenylamino)-acrylate,413-510-7,147374-67-2,Skin Sens. 1;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H317:0;H373:0
5759,"Ethyl (S)-α-[(4-aminophenyl)methyl]-1,3-dihydro-1,3-dioxo-2H-isoindole-2-acetate monohydrochloride",306-598-2,97338-03-9,Skin Sens. 1;Eye Dam. 1,Notified C&L,1.0,H318:1;H317:1
5760,"3-morpholinopropane-1,2-diol",229-193-1,6425-32-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
5761,Dotetracontafluoroicosane,253-557-9,37589-57-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H335:39;H315:39
5763,"Fatty acids, C16-18 and C18-unsatd., branched and linear, esters with trimethylolpropane",609-825-6,403507-18-6,Not Classified,Notified C&L,6.0,Not classified:6
5764,Barium metasilicate,236-245-7,13255-26-0,Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,40.0,H332:40;H302:40;H314:40
5765,Dipotassium hexachloroiridate,240-976-7,16920-56-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,41.0,H302:40;H312:40;H332:40;H319:40;H335:39;H315:41;H290:2;H317:1
5766,"benzyl 2,4-dibromobutanoate",420-710-8,23085-60-1,Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0.0,H400:0;H361:0;H317:0;H315:0;H410:0
5768,Triethylborane,202-620-9,97-94-9,Pyr. Liq. 1;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 2,REACH registration C&L,196.0,H250:192;H301:124;H314:196;H330:86;H360:83;H318:84;H225:42
5772,"1,2,3,4-tetrahydronaphthalen-2-ol",208-497-8,530-91-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H319:1;H335:1;H302:2;H315:1
5776,"erythromycin A9-oxime (E);(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-.sc.d.sc.-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E)",437-070-0,13127-18-9,Aquatic Chronic 2,Harmonised C&L,0.0,H411:0
5777,Phenyl acetate,204-575-0,122-79-2,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,217.0,H319:21;H302:108;H412:2;Not classified:88;H315:20
5784,"Reaction product of 4,4'-methylenediphenyl diisocyanate (MDI) (101-68-8) and p-Toluidine (106-49-0)",926-809-7,,Flam. Sol. 1,REACH registration C&L,2.0,H228:2
5785,"N-(2,6-dimethylphenyl)piperidine-2-carboxamide",605-165-8,15883-20-2,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,40.0,H301:38;H319:1;H335:1;H315:1;Not classified:1
5788,Sodium 4-(4-dimethylaminophenylazo)benzenesulphonate,208-925-3,547-58-0,Acute Tox. 3,Notified C&L,121.0,H301:120;H331:1;H311:1;Not classified:1
5790,Hentricontan-16-one,207-952-8,502-73-8,Not Classified,Notified C&L,20.0,Not classified:20
5793,"2,3-dimethylbutane",201-193-6,79-29-8,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Chronic 2,Harmonised C&L,0.0,H304:0;H411:0;H336:0;H315:0;H225:0
5798,Butadiene-Acrylonitrile Copolymers,618-357-1,9003-18-3,Not Classified,Notified C&L,256.0,Not classified:248;H317:8;H332:1
5804,DL-3-(3-thienyl)-β-alanine,305-042-6,94333-62-7,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H319:1;H335:1;H315:1
5806,Bis((C10-13)alkylphenyl)iodonium hexafluoroantimonate,608-253-4,288094-79-1,Flam. Liq. 3;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,2.0,H302:2;H226:1;H411:1;H332:1;H317:2;H400:1;H410:1
5812,"4-[[5-[[4-chloro-6-[(3-sulphophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulphophenyl]azo]-4,5-dihydro-5-oxo-1-(4-sulphophenyl)-1H-pyrazole-3-carboxylic acid",299-257-1,93858-25-4,Not Classified,REACH registration C&L,3.0,Not classified:3
5813,4-(4-chlorophenyl)-1-imidazol-1-ylbutan-2-ol,925-590-5,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,2.0,H332:2;H312:2;H302:2
5814,"N-[[4-[2-[[(3-ethyl-2,5-dihydro-4-methyl-2-oxo-1H-pyrrol-1-yl)carbonyl]amino]ethyl]phenyl]sulfonyl]-methyl ester carbamic acid",601-579-8,119018-30-3,Not Classified,REACH registration C&L,4.0,Not classified:2;H302:2;H332:1;H312:1
5816,Propyl acetoacetate,217-223-6,1779-60-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H319:2;H315:2;H335:1
5817,Trospium chloride,233-875-4,10405-02-4,Acute Tox. 4,Notified C&L,6.0,H302:5;Not classified:1;H412:2;H332:2;H312:1
5818,"4,4'-bis[[1-[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-2,2'-disulphonic acid",279-016-7,78952-69-9,Not Classified,Notified C&L,152.0,Not classified:152
5822,"2,2,3,3,4,4,4-heptafluorobutyramide",211-553-4,662-50-0,,Notified C&L,5.0,H319:5;H335:5;H315:5;H302:1
5825,"1-bromo-2,4-dimethoxybenzene",241-717-0,17715-69-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H319:44;H335:43;H315:44
5827,Kinoprene,255-898-9,42588-37-4,Flam. Liq. 3;Aquatic Acute 1,Notified C&L,38.0,H400:38;H226:38
5828,C.I. Acid Orange 89,602-819-4,12269-95-3,Not Classified,Notified C&L,1.0,Not classified:1
5834,Dinoprostone,206-656-6,363-24-6,Acute Tox. 4;Repr. 1B,Notified C&L,77.0,H302:77;H360:75;H361:1
5835,"(8S-cis)-10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride",246-818-3,25316-40-9,Acute Tox. 4;Carc. 1B,Notified C&L,154.0,H350:144;H302:119;H319:49;H315:42;H340:53;H360:50;H361:10;H318:2;H335:2;Not classified:1;H373:2;H351:1;H312:2;H332:2;H341:1
5836,"N,N'-bis(6-fluoro-4-(3-(1-ethyl-6-hydroxy-3,4-dimethyl-heteromonocyl-5-ylazo)-phenylamino)- 1,3,5-triazine-2-yl)-phenylenediamine, polysulfonate sodium salt",421-910-8,,Skin Sens. 1B,Notified C&L,1.0,H317:1
5840,"Antimony, compound with nickel (1:3)",235-676-8,12503-49-0,,Notified C&L,4.0,H302:4;H411:4;H334:4;H332:4;H317:4;H351:4
5842,Soybean oil,232-274-4,8001-22-7,Not Classified,Notified C&L,1115.0,Not classified:1095;H319:20
5843,p-toluenesulphonyl fluoride,207-238-6,455-16-3,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,43.0,H332:39;H312:39;H302:43;H314:43
5845,"Benzoic acid, 2-amino-3,5-dibromo-, methyl ester",611-997-2,606-00-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H319:42;H335:42;H315:42
5848,3-mercapto-L-valine hydrochloride,247-077-9,25526-04-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H335:38;H315:38
5849,"4,6-Dichloro-5-fluoropyrimidine",606-739-0,213265-83-9,,Notified C&L,4.0,H312:2;H318:1;H335:1;H315:1;H314:2;H332:1;H302:1
5850,nickel disilicide,235-379-3,12201-89-7,Skin Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0.0,H350:0;H400:0;H317:0;H372:0;H410:0
5851,Sodium D-gluconate,238-976-7,14906-97-9,Not Classified,Notified C&L,2.0,Not classified:2
5852,Dimethyl (2-acetoxyethyl)phosphonate,254-301-9,39118-50-8,Not Classified,Notified C&L,1.0,Not classified:1
5858,"Coleus barbatus, ext.",607-025-1,223748-52-5,Acute Tox. 4,Notified C&L,1.0,H312:1
5860,"Anthracene-9,10-dicarbaldehyde",230-322-9,7044-91-9,Acute Tox. 4,Notified C&L,39.0,H302:38;H319:1;H315:1
5861,Poly Alpha-méthylstyrène,607-482-7,25014-31-7,Not Classified,Notified C&L,2.0,Not classified:1;H319:1;H411:1;H335:1
5863,"2,3,6,7-tetrahydro-1H,5H-benzo[ij]quinolizine",207-535-0,479-59-4,Muta. 2,Notified C&L,1.0,H341:1
5865,Phenylpropiolic acid,211-285-8,637-44-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48.0,H319:48;H335:47;H315:48
5867,potassium N-(1-methoxy-1-oxobut-2-en-3-yl)valinate,427-240-2,134841-35-3,Skin Sens. 1,Harmonised C&L,0.0,H317:0
5875,"(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(1-tert-butoxy-2-methyl-1-oxopropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",600-349-4,102772-66-7,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,4.0,H334:4;H317:4;H400:1;H228:1;H410:1
5880,[2-[(2-methyl-1-oxoallyl)oxy]ethyl] hydrogen maleate,257-569-5,51978-15-5,Skin Corr. 1B;Skin Sens. 1,Notified C&L,53.0,H317:39;H314:38;H302:14;H318:14;H312:13;H332:13;H315:14;H319:1;H335:1
5882,colecalciferol; cholecalciferol; Vitamin D,200-673-2,67-97-0,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2;STOT RE 1,Harmonised C&L,0.0,H310:0;H372:0;H330:0;H300:0
5883,"Phosphoric acid, butyl ester",235-826-2,12788-93-1,Skin Corr. 1B,REACH registration C&L,187.0,H314:114;Not classified:73;H318:6;H290:1;H400:1;H351:1
5884,"N,N-Dibutyl-3-aminophenol",610-109-0,43141-69-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
5889,Pentaammonium triphosphate,238-741-9,14693-67-5,Not Classified,Notified C&L,2.0,Not classified:2
5892,"Undaria pinnatifida, ext.",607-058-1,223751-81-3,Flam. Liq. 3,Notified C&L,1.0,H226:1
5897,"Sulfuric acid, ammonium iron(3+) salt (2:1:1), dodecahydrate",616-517-5,7783-83-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,40.0,H319:40;H315:40
5902,Trimethylarsine,209-815-8,593-88-4,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,107.0,H400:107;H331:107;H301:107;H410:107;H261:38;H225:38;H226:14;H260:14;H319:14;H335:14;H315:14
5903,"2,4-dihydro-4-methyl-5-(trifluoromethyl)-3H-1,2,4-triazole-3-thione",250-288-9,30682-81-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H335:39;H302:39;H315:39;H312:1;H332:1
5904,Palladium dioxide,234-836-4,12036-04-3,Ox. Sol. 3;Aquatic Chronic 4,Notified C&L,84.0,H413:84;H272:84
5906,"Fatty acids, tall-oil, compds. with 2-(diethylamino)ethanol",269-809-6,68334-10-1,Not Classified,Notified C&L,72.0,Not classified:72
5911,4-tert-butylbenzenethiol,219-255-6,2396-68-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H319:44;H335:39;H315:44;H302:6;H332:2;H312:1
5916,"2,4,6-tris(heptafluoropropyl)-1,3,5-triazine",213-023-8,915-76-4,Acute Tox. 4,Notified C&L,39.0,H332:39;H312:1;H302:1
5919,"(5α)-7,8-didehydro-4,5-epoxy-3-hydroxy-17-methylmorphinan-6-one",207-384-0,467-02-7,Acute Tox. 3;Skin Sens. 1;Acute Tox. 3;Resp. Sens. 1,Notified C&L,2.0,H331:2;H317:2;H301:2;H334:2
5920,"Methyl N-(2,6-dimethylphenyl)-DL-alaninate",258-237-2,52888-49-0,Aquatic Chronic 2,REACH registration C&L,192.0,H411:192
5922,Disodium (Z)-[2-[(1-oxooctadec-9-enyl)amino]ethyl] 2-sulphonatosuccinate,270-864-3,68479-64-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,45.0,H319:43;H315:45;H318:2
5926,"Amines, coco alkyl, reaction products with epichlorohydrin and formaldehyde",305-947-6,95370-82-4,Not Classified,Notified C&L,1.0,Not classified:1
5929,"Saffron, ext.",283-295-0,84604-17-1,Flam. Liq. 3;Carc. 2,Notified C&L,116.0,H351:88;H226:78;H315:25;H317:1;H225:2
5932,Citronellyl 3-methylcrotonate,244-019-4,20770-40-5,Not Classified,Notified C&L,1523.0,Not classified:1523
5933,Cinnamyl phenylacetate,231-322-1,7492-65-1,Not Classified,Notified C&L,88.0,Not classified:88
5938,"lead sulfochromate yellow;C.I. Pigment Yellow 34;[This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77603.]",215-693-7,1344-37-2,Carc. 1B;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1A,Harmonised C&L,0.0,H350:0;H373:0;H360:0;H400:0;H410:0
5942,Methyl 2-Acetamidoacrylate,609-121-9,35356-70-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H319:44;H335:43;H315:44
5943,"5-(benzoylamino)-3-[[5-[[(5-chloro-2,6-difluoro-4-pyrimidinyl)amino]methyl]-1-sulpho-2-naphthyl]azo]-4-hydroxynaphthalene-2,7-disulphonic acid, lithium sodium salt",280-427-9,83400-12-8,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,53.0,H411:1;H317:15;Not classified:38
5944,Altizide,226-994-8,5588-16-9,Not Classified,Notified C&L,1.0,Not classified:1
5947,"Amines, N-tallow alkyltrimethylenedi-, octanoates",298-714-2,93821-28-4,Skin Corr. 1B;STOT RE 1;Aquatic Acute 1,Notified C&L,1.0,H400:1;H372:1;H314:1
5949,"4-chloro-α,α,α-trifluoro-3-nitrotoluene",204-451-6,121-17-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,52.0,H319:46;H335:45;H302:50;H315:46;H332:4;H312:4;H301:2;H331:1;H311:1;H400:2;H410:2
5955,"2,4-dichloro-1,3-dinitro-5-(trifluoromethyl)benzene",249-420-8,29091-09-6,,Notified C&L,6.0,H302:6;H400:4;H319:6;H335:5;H315:6;H410:4;H312:1;H332:1;H242:1
5958,4-benzyloxy-3-methoxybenzaldehyde,219-379-0,2426-87-1,,Notified C&L,4.0,H319:4;H335:4;H315:4
5959,"3-ethoxyandrosta-3,5-dien-17-one",619-264-9,972-46-3,Not Classified,REACH registration C&L,3.0,Not classified:2;H361:1;H301:1
5961,Fusidic acid,230-256-0,6990-06-3,Acute Tox. 4,REACH registration C&L,118.0,H302:64;H319:55;H335:56;H412:2;H315:55;H411:52
5962,Epinephrine,200-098-7,51-43-4,Acute Tox. 3;Acute Tox. 2;Acute Tox. 3,Notified C&L,100.0,H310:96;H331:93;H301:97;H330:5;H311:3;H373:3;H319:3;H335:2;H412:4;H315:2;H360:1;H300:2;H341:1
5963,1-methoxy-2-nitro-4-phenylbenzene,605-152-7,15854-73-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,REACH registration C&L,2.0,H318:1;H302:1;H335:1;H315:1;H341:1
5964,hexadecyl 3-amino-4-isopropoxybenzoate,424-830-1,,Aquatic Chronic 4,Harmonised C&L,0.0,H413:0
5967,"2-chloro-N,N-dimethylacetamide",220-224-4,2675-89-0,Acute Tox. 4;Skin Corr. 1B,Notified C&L,47.0,H302:39;H314:40;H319:7;H335:5;H315:7
5968,(2-hydroxyethyl)dimethylammonium hydrogen tartrate,227-809-3,5988-51-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H319:2;H335:2;H315:2
5969,"2-Propanol, 1-(3,5-dimethylphenoxy)-3-[(phenylmethyl)amino]-",610-515-8,502605-82-5,Not Classified,REACH registration C&L,2.0,Not classified:2
5970,N-(2-(5-methoxyindol-3-yl)ethyl)acetamide,200-797-7,73-31-4,Not Classified,Notified C&L,277.0,Not classified:273;H361:1;H332:1;H312:1;H302:2;H360:1;H228:1
5972,Zinc sulphite,237-046-8,13597-44-9,,Notified C&L,1.0,H318:1;H302:1
5978,"Resin acids and Rosin acids, tall-oil, esters with pentaerythritol",287-660-5,85566-49-0,Not Classified,Notified C&L,3.0,Not classified:3
5982,(-)-propylhexedrine hydrochloride,228-246-6,6192-98-9,Acute Tox. 3;Eye Dam. 1;Acute Tox. 2;Aquatic Chronic 2,Notified C&L,83.0,H411:83;H318:83;H301:83;H330:83
5983,"Piperazine-1,4-dicarbaldehyde",224-011-7,4164-39-0,Not Classified,Notified C&L,87.0,Not classified:83;H319:4;H335:4;H315:4
5987,Sodium dihydridobis(2-methoxyethanolato)aluminate(1-),245-178-2,22722-98-1,Flam. Sol. 1;Water-react. 2;Skin Corr. 1B;Eye Dam. 1;STOT SE 3;STOT SE 3,REACH registration C&L,200.0,H318:43;H335:97;H228:67;H314:167;H261:42;H312:55;H302:55;H260:68;Not classified:33;H332:26;H373:5;H336:5;H361:5;H224:4;H225:1;H304:1
5989,"Licorice, Glycyrrhiza uralensis, ext., hydrolyzed",309-343-3,100209-35-6,Not Classified,Notified C&L,1.0,Not classified:1
5990,(Z)-oct-3-en-1-yl propionate,302-769-0,94134-03-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H319:1;H335:1;H315:1
5991,"2-(2-chlorophenyl)-2,4-dihydro-5-methyl-3H-pyrazol-3-one",238-623-7,14580-22-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
5992,Eleutheroside E,609-679-3,39432-56-9,Acute Tox. 4,Notified C&L,39.0,H302:39
5993,"iso-octyl 4-amino-3,5,6-trichloropyridine-2-carboxylate",608-024-9,26952-20-5,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,55.0,H317:55;H412:55;H315:55
5994,"2-allyl-1,4-bis[[3-(3,4-dihydroxyphenyl)-1-oxo]oxy]-3,5-dihydroxycyclohexanecarboxylic acid",214-655-7,1182-34-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H319:2;H335:2;H315:2
6004,2-Dimethylamino-1-hydroxy-ethanesulfonic acid natrium salt,929-207-2,,,Notified C&L,1.0,Not classified:1
6005,"N-(2-methoxy-5-octadecanoylaminophenyl)-2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxopentanoic acidamide",431-330-7,142776-95-2,Aquatic Chronic 4,Harmonised C&L,0.0,H413:0
6007,"Disodium 1,2-ethanedisulphonate",226-198-0,5325-43-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H319:43;H335:42;H315:43
6010,"Lime (chemical), hydraulic",285-561-1,85117-09-5,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,REACH registration C&L,34.0,H318:34;H335:34;H315:34
6012,"Linden, Tilia vulgaris, ext.",290-015-0,90063-56-2,Not Classified,Notified C&L,1.0,Not classified:1
6015,Methyl pyridine-2-carboxylate,219-545-2,2459-07-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H319:40;H335:39;H315:40
6016,"Cyclopentanol, 2-(2-hexen-1-yl)-",609-019-4,34686-67-4,Not Classified,Notified C&L,113.0,Not classified:113
6019,"N,N-diethyl-m-toluamide;diethyltoluamide (ISO): N,N-diethyl-m-toluamide; [deet]",205-149-7,134-62-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Harmonised C&L,0.0,H319:0;H302:0;H315:0
6020,"Hexasodium 6,13-dichloro-3,10-bis[[2-[[4-chloro-6-[(2,4-disulphonatophenyl)amino]-1,3,5-triazin-2-yl]amino]ethyl]amino]triphenodioxazine-4,11-disulphonate",282-850-4,84434-51-5,Skin Sens. 1B,REACH registration C&L,110.0,H317:99;H334:37;H335:34;H320:19;H319:18;Not classified:11;H315:4
6023,"Sodium 3,5,5-trimethylhexanoate",220-169-6,2650-30-8,Acute Tox. 4;Skin Corr. 1;Eye Dam. 1,REACH registration C&L,74.0,H318:2;H302:2;H314:2;Not classified:72
6031,N-methylformamide,204-624-6,123-39-7,Acute Tox. 4;Repr. 1B,Harmonised C&L,0.0,H312:0;H360:0
6032,"tert-Decanoic acid, oxiranylmethyl ester, reaction products with triethylenetetramine",306-648-3,97358-72-0,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,30.0,H319:30;H411:30;H317:30;H315:30
6033,Annatto,215-735-4,1393-63-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,37.0,H319:29;H315:29;Not classified:8
6039,Zinc selenite,237-048-9,13597-46-1,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,68.0,H373:56;H301:66;H400:51;H331:50;H410:66;H332:16;Not classified:2;H362:2
6041,2-methyl-5-phenyl-3-(3-sulphonatopropyl)benzoxazolium,266-175-2,66142-15-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H335:38;H315:38
6043,m-nitrobenzamide oxime,225-709-4,5023-94-9,,Notified C&L,4.0,H319:4;H335:4;H315:4
6050,"Naphthalenesulfonic acid, methyl-, polymer with formaldehyde, sodium salt",617-192-2,81065-51-2,Eye Dam. 1,Notified C&L,158.0,H318:157;Not classified:1
6052,"Sulfur, homopolymer",618-540-6,9035-99-8,Not Classified,Notified C&L,37.0,Not classified:33;H319:4;H315:4
6054,Racepinefrine,206-347-6,329-65-7,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H319:39;H335:39;H311:40;H315:39;H301:1
6057,"2-ethylhexyl dihydrogen phosphate, compound with tert-dodecylamine",267-037-4,67763-14-8,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,9.0,H319:9;H411:9;H315:9
6059,4-chloro-2-nitroanisole,201-887-9,89-21-4,Acute Tox. 4,Notified C&L,44.0,H302:38;H319:6;H335:5;H315:6
6060,"1,2-diphenylethylamine",247-126-4,25611-78-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H335:38;H315:39;H302:1;H312:1;H332:1
6062,"3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl nicotinate",289-227-6,86362-36-9,Not Classified,REACH registration C&L,38.0,Not classified:38
6063,"reaction product of 2,2',2''-nitrilotriethanol and 6,6',6''-(1,3,5-triazine-2,4,6-triyltriimino)trihexanoic acid",924-140-5,,Not Classified,Notified C&L,1.0,Not classified:1
6064,Aluminium oxide,215-691-6,1344-28-1,Not Classified,REACH registration C&L,2894.0,Not classified:2692;H370:72;H335:98;H372:59;H350:8;H361:8;H317:8;H412:8;H341:8;H220:4;H332:7;H302:5;H373:2;H319:9;H315:9;H225:2
6065,"Heptane-3,5-dione",231-054-5,7424-54-6,Flam. Liq. 3,Notified C&L,45.0,H226:44;H302:2;H331:1;H311:1
6068,Calcium diformate,208-863-7,544-17-2,Eye Dam. 1,REACH registration C&L,566.0,H318:431;H319:98;Not classified:35;H335:8;H315:10;H413:2;H317:3
6069,Dimethyl malonate,203-597-8,108-59-8,Eye Irrit. 2,REACH registration C&L,1823.0,H319:290;Not classified:1532;H335:57;H315:61
6071,Ethyl piperidine-1-propionate,243-205-2,19653-33-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,41.0,H319:41;H335:40;H315:41
6075,"Spinels, chromium green",306-013-0,95465-97-7,Not Classified,Notified C&L,6.0,Not classified:6
6076,Lithium ethoxide,628-773-5,2388-07-0,Self-heat. 1;Skin Corr. 1B,Notified C&L,38.0,H251:38;H314:38
6083,2-(2-hydroxypropoxy)propanol,203-416-2,106-62-7,Not Classified,Notified C&L,1.0,Not classified:1
6085,"Dimethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate",244-628-5,21881-77-6,,Notified C&L,2.0,H302:2
6088,"6-methyl-1H,3H-pyrimidine-2,4-dithione",228-624-0,6308-38-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H335:38;H315:38
6090,"3,6,9,12-tetraoxatridecylamine",285-182-1,85030-56-4,Skin Corr. 1C;Eye Dam. 1,Notified C&L,1.0,H318:1;H314:1
6092,"4-Cyclohexene-1,2-dicarboxylic acid, reaction products with glycidyl tolyl ether, hexahydro-1,3-isobenzofurandione, phthalic anhydride and 3a,4,7,7a-tetrahydro-1,3-isobenzofurandione",616-002-5,73612-25-6,Not Classified,Notified C&L,9.0,Not classified:9
6093,Ammonium ferrous sulfate hexahydrate,616-518-0,7783-85-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H319:42;H335:42;H315:42
6094,"Fatty acids, C18-unsatd., dimers, oligomeric reaction products with fatty acids, C16-18 and C18-unsatd., branched and linear, 4,4'-isopropylidenediphenol-1-chloro-2,3-epoxypropane co-oligomer and triethylenetetramine",500-380-2,157707-71-6,Not Classified,Notified C&L,55.0,Not classified:55
6098,Trisodium tetrathioantimonate,237-414-8,13776-84-6,Acute Tox. 4;Acute Tox. 4,Notified C&L,1.0,H332:1;H302:1
6101,Tetradecyl benzoate,274-753-0,70682-72-3,Not Classified,Notified C&L,1.0,Not classified:1
6111,"Ethyl 2,4-dimethyl-1,3-dioxolane-2-acetate",228-536-2,6290-17-1,Not Classified,REACH registration C&L,269.0,Not classified:268;H319:1;H335:1;H315:1;H226:1
6112,2-hydroxyethyl carbamate,226-405-4,5395-01-7,Eye Irrit. 2,Notified C&L,92.0,H319:84;Not classified:8;H335:1;H315:1
6118,"Fatty acids, C16-18 and C16-18-unsatd., mixed with C14-19-alkenes and vegetable oil, sulfurized",308-120-8,97862-71-0,Not Classified,Notified C&L,566.0,Not classified:566
6120,Magnesium bis(2-ethylbutanoate),700-021-1,79992-76-0,Skin Sens. 1;Aquatic Acute 3,Notified C&L,1.0,H402:1;H317:1
6123,Proguanil hydrochloride,211-283-7,637-32-1,Acute Tox. 3,Notified C&L,48.0,H301:45;H361:4;H412:4;H302:2;Not classified:1;H413:1;H317:1;H400:1;H411:1
6126,"(2E,6E)-nona-2,6-dien-1-al",241-557-1,17587-33-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1401.0,H319:1288;H315:1288;Not classified:113
6127,Pentaamminechlororuthenium dichloride,242-408-3,18532-87-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42.0,H302:38;H312:38;H332:38;H319:42;H335:42;H315:42
6130,2-Ethylphenylhydrazine Hydrochloride,611-735-7,58711-02-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
6133,Isobutyl 2-bromopropionate,273-886-1,69122-46-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H335:38;H315:38;H226:38
6134,"Acetic acid, lead salt, basic",257-175-3,51404-69-4,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,43.0,H302:4;H373:40;H360:42;H400:42;H332:4;H410:42;H318:2;H362:2;H351:40;H372:2;Not classified:1
6136,"N,N,N',N'-tetraethylethylenediamine",205-770-3,150-77-6,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,79.0,H314:79;H226:65;H302:5;H318:2;H332:1
6138,DL-4-hydroxymandelic acid,230-569-2,7198-10-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
6139,"1,5-naphthylenediamine",218-817-8,2243-62-1,Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H400:0;H410:0;H351:0
6140,4-Isonicotinic acid anilide,608-466-2,3034-31-9,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38.0,H319:38;H302:38
6144,"Benzamide, N-(2,3-dichlorophenyl)-4-(ethoxymethoxy)-",616-701-5,79540-50-4,Aquatic Chronic 2,Notified C&L,38.0,H411:38
6145,"Oils, menhaden, stearins",272-751-4,68910-69-0,Not Classified,Notified C&L,1.0,Not classified:1
6146,"4,4'-[isopropylidenebis(4,1-phenyleneoxy)]dianiline",235-985-8,13080-86-9,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 4,REACH registration C&L,92.0,H413:34;H317:2;H302:92;H319:40;H335:40;H315:40;H400:1;H410:1
6149,Hyoscyamine sulphate,210-644-6,620-61-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1.0,H331:1;H301:1;H311:1
6150,Didecyl phenyl phosphite,215-012-3,1254-78-0,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,3.0,H317:3;H410:2;H315:3;H411:1
6153,Potassium nitridotrioxoosmate(1-),244-575-8,21774-03-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H335:38;H315:38
6155,"Spinels, chromium iron manganese zinc brown",269-058-4,68186-96-9,Not Classified,Notified C&L,8.0,Not classified:8
6157,"5-nitro-1,10-phenanthroline",224-097-6,4199-88-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H319:43;H335:43;H315:43;H332:1;H312:1;H302:1
6160,"Potassium (1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate and Potassium (1S,3S)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate",617-365-2,82597-69-1,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,1.0,H318:1;H314:1
6164,"Disodium hydrogen 5-acetamido-4-hydroxy-3-[(m-phosphonatophenyl)azo]naphthalene-2,7-disulphonate",268-512-9,68110-24-7,Not Classified,Notified C&L,1.0,Not classified:1
6176,"Petrolatum (petroleum), oxidized, sodium salt",295-462-5,92045-79-9,,Notified C&L,1.0,Not classified:1
6180,"Tetrasodium 4-amino-5-hydroxy-3,6-bis[[4-[[2-(sulphonatooxy)ethyl]sulphonyl]phenyl]azo]naphthalene-2,7-disulphonate",241-164-5,17095-24-8,Skin Sens. 1;Resp. Sens. 1,Notified C&L,218.0,H334:211;H317:208;H335:17;H320:17;Not classified:6;H412:4;H332:1;H319:1;H302:1;H315:1;H318:1
6183,2-[bis(2-hydroxyethyl)amino]-5-nitrophenol,258-002-4,52551-67-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H319:2;H335:2;H315:2
6185,"(S)-(+)-butane-1,3-diol",246-363-0,24621-61-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H335:38;H315:38
6186,"1,1,1,2,3,3-hexafluoro-2-(heptafluoropropoxy)-3-[(trifluorovinyl)oxy]propane",216-703-2,1644-11-7,Flam. Liq. 3,REACH registration C&L,5.0,H226:2;H319:3;H335:2;H315:3
6187,Ethyl 3-cyclohexylpropionate,233-222-3,10094-36-7,Flam. Liq. 3,Notified C&L,40.0,H226:39;H411:1
6189,Potassium di-tert-butyl phosphate,619-702-9,33494-80-3,Eye Dam. 1,REACH registration C&L,54.0,H318:10;H319:44;H335:42;H315:45;H412:2
6191,N-(4-methoxyphenyl)-p-anisidine,202-968-1,101-70-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 2,Notified C&L,44.0,H351:38;H319:44;H335:42;H315:44;H412:2
6192,"Fatty acids, C12-18, α-sulfo, disodium salts",286-085-7,85186-99-8,Skin Irrit. 2;Eye Dam. 1,Notified C&L,3.0,H318:3;H315:2
6200,"1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one;hydrate;hydrochloride",615-173-3,7081-53-0,Acute Tox. 4,Notified C&L,54.0,H302:53;H301:1
6202,"Alcohols, C16-18 and C18-unsatd., ethoxylated, phosphate, potassium salt",921-088-5,,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,42.0,H319:36;H411:36;H315:42;H318:6
6208,Methyl N6-benzyloxycarbonyl-L-lysinate hydrochloride,248-715-9,27894-50-4,Not Classified,Notified C&L,1.0,Not classified:1
6212,isobutyric acid,201-195-7,79-31-2,Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0.0,H312:0;H302:0
6213,"reaction mass of: 5-(N-methylperfluorooctylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one;5-(N-methylperfluoroheptylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one",413-640-4,,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H400:0;H410:0;H373:0
6214,"Distillates (petroleum), solvent-refined light paraffinic;Baseoil - unspecified;[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C",265-091-3,64741-89-5,Carc. 1B,Harmonised C&L,0.0,H350:0
6222,Geranyl acetate,203-341-5,105-87-3,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,2198.0,H317:1710;H412:1705;H315:1758;H411:449;H319:47;H335:42;H401:1
6225,"1,1'-[(6-phenyl-1,3,5-triazine-2,4-diyl)diimino]bis[3-acetyl-4-aminoanthraquinone]",250-961-7,32220-82-9,Not Classified,REACH registration C&L,20.0,Not classified:20
6230,Dimethyl undecanedioate,224-943-4,4567-98-0,Not Classified,Notified C&L,25.0,Not classified:25
6232,"metaflumizone (ISO); (EZ)-2'-[2-(4-cyanophenyl)-1-(α,α,α -trifluoro-m-tolyl)ethylidene]-[4-(trifluoromethoxy)phenyl]carbanilohydrazide [E-isomer > 90%, Z-isomer <10% relative content]",604-167-6,139968-49-3,Lact.;STOT RE 2;Repr. 2,Harmonised C&L,0.0,H362:0;H361:0;H373:0
6234,Dolomite,240-440-2,16389-88-1,Not Classified,Notified C&L,786.0,Not classified:752;H319:34
6240,"Fatty acids, soybean oil, conjugated",917-780-1,,Not Classified,REACH registration C&L,1.0,Not classified:1
6241,"Soaps, stocks, vegetable-oil",273-178-2,68952-94-3,Not Classified,Notified C&L,54.0,Not classified:54
6245,2-[2-(2-methoxyethoxy)ethoxy]ethyl acrylate,256-348-0,48067-72-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
6247,"4-[2,4-bis(1,1-dimethylpropyl)phenoxy]butyryl chloride",256-755-3,50772-29-7,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,88.0,H314:88;H225:88;H318:36
6249,"2-((2,6-Dichlorophenyl)amino)benzeneacetic acid",616-599-2,78213-16-8,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,62.0,H311:55;H301:61;H319:54;H335:54;H315:54;Not classified:1;H331:1;H361:3;H373:2;H412:5;H362:1;H332:1;H372:2;H370:1;H360:1
6253,1-methylpiperidine-2-ethanol,208-554-7,533-15-3,Acute Tox. 4;Skin Corr. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,35.0,H318:1;H302:2;H412:1;H314:2;Not classified:33;H312:1
6257,"Cyclohexane-1,4-dicarboxylic acid",214-068-6,1076-97-7,Eye Irrit. 2,REACH registration C&L,367.0,H319:151;Not classified:216;H302:44;H335:6;H315:9
6259,4-formyl-N-isopropylbenzamide,236-247-8,13255-50-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,1.0,H319:1;H335:1;H302:1;H315:1
6265,"1,2-vinylenebis(triphenylphosphonium) dibromide",259-334-2,54770-27-3,,Notified C&L,4.0,H319:4;H335:4;H315:4
6266,Trisilver arsenate,236-841-7,13510-44-6,Acute Tox. 3;Acute Tox. 3;Carc. 1A;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42.0,H350:42;H301:42;H400:42;H331:42;H410:42
6269,Ethyl α-oxothiophen-2-acetate,223-793-7,4075-58-5,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H319:1;H335:1;H315:1
6273,Epoxy Modified Polydimethylsiloxane,680-212-3,67762-95-2,Eye Irrit. 2,Notified C&L,25.0,H319:20;Not classified:5
6276,"Phenol, 2-bromo-4-fluoro-",610-467-8,496-69-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50.0,H319:50;H335:49;H302:47;H315:50;H225:1;H312:1;H332:1
6281,"Hexamethylene diisocyanate, trimers, reaction products with butanone oxime",923-136-0,162491-94-3,Skin Irrit. 2;Skin Sens. 1;STOT RE 2,Notified C&L,83.0,H317:83;H373:83;H315:83
6285,Dipotassium sebacate,257-932-8,52457-55-3,Not Classified,Notified C&L,33.0,Not classified:33
6286,Titanium dihydroxide oxide,234-711-4,12026-28-7,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;STOT RE 2,Notified C&L,1.0,H373:1;H318:1;H335:1;H315:1
6291,3-methylpentan-2-ol,209-281-6,565-60-6,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,40.0,H319:40;H226:40
6292,"Butanedioic acid, 2-methylene-, polymer with 1,3-butadiene and ethenylbenzene",608-451-0,30174-67-5,Not Classified,Notified C&L,33.0,Not classified:33
6301,"Esterification product of fatty polyalcohols, C-18-36-54 branched, linear and cyclic and sulfanylalkanoic acid",600-642-7,1052719-65-9,Not Classified,Notified C&L,1.0,Not classified:1
6302,"4-[2,4-bis(tert-pentyl)phenoxy]butyric acid",256-756-9,50772-35-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H335:39;H315:39
6304,L-isoleucine,200-798-2,73-32-5,Not Classified,REACH registration C&L,152.0,Not classified:151;H319:1;H335:1;H315:1
6307,"1,2-Benzenedicarboxylic acid, isodecyl ester, manuf. of, by-products from",271-079-9,68515-38-8,Flam. Liq. 3;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,2.0,H319:2;H411:2;H226:2
6308,"21,23-Dioxa[13]cytochalasa-13,19-diene-1,17,22-trione, 6,7-epoxy-18-hydroxy-16,18-dimethyl-10-phenyl-, (7S,13E,16S,18R,19E)-",252-835-7,36011-19-5,Acute Tox. 2;Acute Tox. 2;Acute Tox. 1;Repr. 2,Notified C&L,39.0,H310:39;H330:39;H361:39;H300:39
6309,"1-amino-3-[4-[4-(4-hydroxyphenyl)piperazin-1-yl]phenyl]-1-[(2S,3S)-2-methyl-1-phenoxypentan-3-yl]urea",608-998-5,345217-02-9,STOT RE 2;Aquatic Chronic 4,Notified C&L,12.0,H413:12;H373:12
6311,2-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenol hydrochloride,220-595-2,2829-92-7,,Notified C&L,1.0,H302:1
6314,1H-pyrimidin-2-one,209-149-8,557-01-7,,Notified C&L,1.0,H319:1;H335:1;H315:1
6315,4-methyloctanoic acid,259-404-2,54947-74-9,Skin Corr. 1B,Notified C&L,1463.0,H314:1461;H318:76;Not classified:2;H290:1
6316,"5-[[4-chloro-6-[(3-sulphophenyl)amino]-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[[4-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]azo]naphthalene-2,7-disulphonic acid, sodium salt",279-015-1,78952-61-1,Not Classified,REACH registration C&L,29.0,Not classified:24;H412:5
6318,2-thiazolin-2-ylamine,217-224-1,1779-81-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H319:43;H335:43;H315:43
6319,(E)-3-(2-chlorophenyl)-2-(4-fluorophenyl)propenal,410-980-5,112704-51-5,Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0.0,H319:0;H317:0
6327,Linalyl phenylacetate,230-444-2,7143-69-3,Not Classified,Notified C&L,280.0,Not classified:280
6334,Nicotinonitrile 1-oxide,238-975-1,14906-64-0,,Notified C&L,5.0,H319:5;H335:4;H302:5;H315:5;H312:1;H332:1
6340,"Sodium 4-(2,4-dihydroxyphenylazo)benzenesulphonate",208-924-8,547-57-9,Not Classified,Notified C&L,12.0,Not classified:12
6341,Photoactive compound,433-600-1,,Expl. 1.4;Flam. Sol. 1;Aquatic Chronic 4,Notified C&L,1.0,H204:1;H413:1;H228:1
6344,5-nitrobenzimidazolium nitrate,248-716-4,27896-84-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H335:38;H315:39;H302:1;H312:1;H332:1
6345,"(2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,9-heptadecafluorononyl)oxirane",254-006-5,38565-53-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4.0,H319:4;H335:3;H315:4
6346,1-[(2-ethylhexyl)amino]-4-(methylamino)anthraquinone,278-219-8,75476-94-7,Not Classified,Notified C&L,81.0,Not classified:81
6348,(E)-But-2-ene,618-356-6,9003-17-2,,Notified C&L,52.0,Not classified:41;H412:11
6349,isobutyryl chloride,201-194-1,79-30-1,Flam. Liq. 2;Skin Corr. 1A,Harmonised C&L,0.0,H314:0;H225:0
6350,2-aminoethyldiethylamine,202-844-7,100-36-7,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,136.0,H302:87;H311:130;H226:135;H318:89;H314:136;H334:1;H317:84;H225:1;H332:41;H312:6
6351,"2-Benzofurancarboxamide, 6-methoxy-N-methyl-N-[2-(methylamino)-4-(methylsulfonyl)phenyl]-",616-155-8,74878-47-0,Not Classified,Notified C&L,31.0,Not classified:31
6353,Daidzin,611-245-3,552-66-9,Not Classified,Notified C&L,2.0,Not classified:1;H319:1;H335:1;H315:1
6356,Dodecyl-2-naphthol,288-872-0,85927-01-1,,Notified C&L,1.0,Not classified:1
6357,"3-[4-(acetyloxy)-3,5-dimethoxyphenyl]-prop-2-enoic acid",618-691-8,90985-68-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H319:1;H335:1;H315:1
6359,"6-Hydroxy-7-isopropylamino-6,7,8,9-tetrahydro-2H-2,9a-diazabenzo[cd]azulen-1-one hydrochloride",601-619-4,119520-06-8,Acute Tox. 4;Acute Tox. 4;STOT RE 1,Notified C&L,47.0,H332:36;H302:36;H372:36;H331:11;H301:11
6360,"Artemisia annua, ext.",283-903-4,84775-74-6,Skin Sens. 1;Acute Tox. 4;STOT SE 2,Notified C&L,278.0,H332:230;H317:241;H371:240;Not classified:36;H412:55;H400:1;H410:1
6361,2-nitrobenzaldehyde,209-025-3,552-89-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,100.0,H319:99;H335:97;H302:97;H315:99;H412:36;H312:1;H332:1
6366,N-benzylphenethylammonium diacetate,302-174-6,94094-72-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,2.0,H319:1;H302:2;H315:2;H318:1;H335:1
6377,"2,3,4,5-tetrachlorobenzoyl chloride",609-997-2,42221-52-3,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1,REACH registration C&L,4.0,H290:2;H317:4;H302:4;H314:4
6378,"Aniline, oligomeric reaction products with 1-chloro-2,3-epoxypropane",500-053-4,26838-74-4,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2B;Muta. 2;Aquatic Chronic 3,Notified C&L,1.0,H302:1;H319:1;H317:1;H412:1;H315:1;H341:1
6382,1-butylimidazole,224-335-9,4316-42-1,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,48.0,H318:47;H335:46;H315:47;H330:8;H310:2;H300:2;H314:1
6383,1-bromo-3-methylcyclohexane,237-675-8,13905-48-1,Flam. Liq. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H227:1;H335:1;H319:1;H315:1
6385,1-(bromomethyl)-4-chlorobenzene,210-760-7,622-95-7,Skin Corr. 1B,Notified C&L,47.0,H314:47;H290:1;H318:1;H331:1;H301:1;H311:1
6387,"Nona-1,8-diyne",219-254-0,2396-65-8,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H319:43;H335:42;H315:43;H226:43
6389,3-((bis(diisopropylamino)phosphanyl)oxy)propanenitrile,600-337-9,102691-36-1,Flam. Liq. 3;Acute Tox. 4;Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,166.0,H317:163;H302:6;H412:3;H226:163;H334:160;H319:161;H315:161;H312:2;H332:2;H335:3
6392,"9-fluoro-11β,17,21-trihydroxy-16-methylenepregna-1,4-diene-3,20-dione 21-acetate",215-013-9,1255-35-2,Skin Sens. 1;Resp. Sens. 1;Repr. 2,Notified C&L,2.0,H361:2;H334:1;H317:1;H412:1
6394,"ACETIC ACID, C6- 8-BRANCHED ALKYL ESTERS",618-553-7,90438-79-2,Aquatic Chronic 2,Notified C&L,265.0,H411:194;H319:45;H332:21;H312:21;H302:21;Not classified:5
6395,Benzyltributylammonium bromide,246-819-9,25316-59-0,,Notified C&L,8.0,H319:6;H335:5;H302:5;H315:6;Not classified:2;H312:1;H332:1
6396,"α,α,α-trifluoro-4-toluonitrile",207-239-1,455-18-5,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,84.0,H332:46;H312:48;H228:39;H302:81;H319:9;H315:9;Not classified:2;H311:3;H301:3;H331:3;H335:3
6402,Sodium benzothiazol-2-yl sulphide,219-660-8,2492-26-4,Met. Corr. 1;Skin Corr. 1C;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,844.0,H290:65;H400:635;H317:626;H314:801;H410:751;H318:497;H302:38;H319:1;H315:1;Not classified:1
6407,"2,2-dimethoxyethyl(dimethyl)amine",254-097-1,38711-20-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3.0,H319:3;H315:3;H226:3;H335:1
6409,Sodium 4-hydroxybutyrate,207-953-3,502-85-2,Not Classified,Notified C&L,1.0,Not classified:1
6410,"Saccharomyces cerevisiae, ext.",283-294-5,84604-16-0,Not Classified,REACH registration C&L,23.0,Not classified:23
6413,tert-butyl peracetate,203-514-5,107-71-1,Flam. Liq. 3;Org. Perox. C;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 3;Aquatic Chronic 2,REACH registration C&L,556.0,H226:2;H411:2;H319:524;H317:56;H331:2;H242:19;H302:54;H240:38;H335:54;H315:54;H341:32;H241:21;H350:1;H304:1
6416,Piperidolate hydrochloride,204-964-5,129-77-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2.0,H332:2;H312:2;H302:2
6421,"Ethanone, 1-(1-cycloocten-1-yl)-",466-270-0,17339-74-1,Skin Irrit. 2;Skin Sens. 1,Notified C&L,1300.0,H317:1300;H315:1300
6423,1-(3-nitro-4-phenylmethoxyphenyl)ethanone,604-357-9,14347-05-8,Aquatic Chronic 3,Notified C&L,1.0,H412:1
6424,2-methylundecane,230-323-4,7045-71-8,Asp. Tox. 1,Notified C&L,1.0,H304:1
6425,(E)-3-{(S)-1-[2-(2-Amino-6-hydroxy-purin-9-ylmethoxy)-ethoxycarbonyl]-2-methyl-propylamino}-but-2-enoic acid mehylester,606-478-2,202601-68-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H319:1;H335:1;H315:1
6430,"4-methoxy-N,N'-bis(3-pyridylmethyl)isophthaldiamide",251-245-7,32828-81-2,Not Classified,Notified C&L,2.0,Not classified:2
6433,(Z)-[(octadec-9-enyloxy)methyl]oxirane,262-268-7,60501-41-9,Not Classified,REACH registration C&L,84.0,Not classified:84
6434,"2,2,2-trichloroethyl dichlorophosphite",262-021-3,60010-51-7,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38.0,H318:38;H314:38
6435,"flusilazole (ISO);bis(4-fluorophenyl)(methyl)(1H-1,2,4-triazol-1-ylmethyl)silane",617-717-5,85509-19-9,Acute Tox. 4;Carc. 2;Aquatic Chronic 2;Repr. 1B,Harmonised C&L,0.0,H411:0;H302:0;H360:0;H351:0
6436,p-tert-butoxybenzaldehyde,260-909-5,57699-45-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H319:43;H335:42;H315:43
6438,"(3R,4S,5S,6R,7R,9R,10Z,11S,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione 10-oxime",603-883-6,134931-01-4,Aquatic Chronic 2,REACH registration C&L,1.0,H411:1
6441,"2,4-dinitro-N',N'-dipropyl-6-(trifluoromethyl)benzene-1,3-diamine",249-421-3,29091-21-2,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,194.0,H400:194;H410:194;H332:38
6447,"Spirulina platensis, ext.",607-057-6,223751-80-2,Not Classified,Notified C&L,1.0,Not classified:1
6448,Silver p-toluenesulphonate,240-859-0,16836-95-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H335:42;H315:42;H319:42;H400:4
6450,"Distillates (petroleum) catalytic reformer, heavy arom. conc.;Gasoil - unspecified;[A complex combination of hydrocarbons obtained from the distillation of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C",295-294-2,91995-34-5,Carc. 1B,Harmonised C&L,0.0,H350:0
6457,3-Ethyl-3-(2-,608-424-3,298695-60-0,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 2,Notified C&L,14.0,H411:13;H400:13;H315:13;H410:14;H314:1
6458,"2,4,5-trichlorophenyl isothiocyanate",245-471-5,23165-46-0,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;STOT SE 3;Aquatic Chronic 4,Notified C&L,43.0,H332:42;H335:39;H318:38;H317:38;H413:38;H312:42;H315:39;H314:4;H302:4;H319:1
6461,Tetradecyl propionate,228-300-9,6221-95-0,Not Classified,Notified C&L,47.0,Not classified:47
6462,Ethylene oxide - propylene oxide copolymer mono(nonylphenyl) ether,609-376-6,37251-69-7,Aquatic Chronic 3,Notified C&L,240.0,H412:240;H315:1;H319:1
6467,2-nitrothiophene,210-190-9,609-40-5,Muta. 2,REACH registration C&L,7.0,H341:6;H332:2;H302:2;H312:2
6468,"(1α,2β,5α)-2,6,6-trimethylbicyclo[3.1.1]heptane",229-978-9,6876-13-7,Flam. Liq. 3;Asp. Tox. 1,REACH registration C&L,258.0,H226:258;H304:225;H335:33;H315:33;H319:33
6469,Tripotassium hexakis(nitrito-N)rhodate,241-716-5,17712-66-2,,Notified C&L,4.0,H335:4;H315:4;H319:4
6473,"Vanadate(1-), oxo(phosphato(3-)-kappaO)-, hydrogen, hydrate (2:1)",424-390-0,93280-40-1,Acute Tox. 3;Skin Sens. 1B;Eye Dam. 1;Acute Tox. 4;STOT SE 3;Muta. 2;Repr. 2;STOT RE 1;Aquatic Chronic 2,Notified C&L,83.0,H301:83;H341:83;H332:83;H335:83;H318:83;H411:83;H317:83;H372:83;H361:83
6475,"Trisodium 3-hydroxy-4-(4'-sulphonatonaphthylazo)naphthalene-2,7-disulphonate",213-022-2,915-67-3,Eye Irrit. 2,REACH registration C&L,264.0,H319:119;Not classified:144;H335:74;H315:74;H412:1
6481,m-phenylene di(acetate),203-596-2,108-58-7,Skin Sens. 1B;Eye Irrit. 2;Aquatic Acute 1,REACH registration C&L,50.0,H400:6;H317:6;H319:49;H335:43;H315:44;H318:1
6482,"2H-Imidazo[4,5-b]pyridin-2-one, 1,3-dihydro-1-(4-piperidinyl)-, hydrochloride (1:2)",616-591-9,781649-84-1,Acute Tox. 4;Eye Irrit. 2,Notified C&L,35.0,H302:35;H319:35
6484,Sunflower oil,232-273-9,8001-21-6,Not Classified,Notified C&L,1565.0,Not classified:1565
6485,Barium manganate,232-109-6,7787-35-1,Ox. Sol. 2;Acute Tox. 4;Acute Tox. 4,Notified C&L,43.0,H332:43;H302:43;H272:43
6487,4-methylhexanoic acid,216-336-8,1561-11-1,Not Classified,Notified C&L,128.0,Not classified:89;H226:39;H314:39
6488,"2,2'-(heptylimino)bisethanol",258-238-8,52891-01-7,Skin Sens. 1B,Notified C&L,1.0,H317:1
6489,"(5α)-6,7,8,14-tetradehydro-4,5-epoxy-6-methoxy-17-methylmorphinan-3-ol",207-385-6,467-04-9,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Acute Tox. 3;Resp. Sens. 1;Repr. 2,REACH registration C&L,11.0,H301:9;H311:8;H331:9;H334:10;H317:10;H361:10;H302:2
6493,"Dibromo-16,17-dimethoxyanthra[9,1,2-cde]benzo[rst]pentaphene-5,10-dione",247-192-4,25704-81-8,Not Classified,Notified C&L,3.0,Not classified:3
6504,tetraammine palladium (II) hydrogen carbonate,425-270-0,134620-00-1,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H373:0;H318:0;H302:0;H410:0;H400:0;H317:0
6506,"Amines, N-tallow alkyltrimethylenedi-, reaction products with epichlorohydrin",298-715-8,93821-29-5,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3;Aquatic Chronic 4,REACH registration C&L,7.0,H335:2;H318:2;H317:2;H413:2;H315:2;Not classified:5
6507,"Pregna-1,4-diene-3,20-dione, 11,21-bis(acetyloxy)-16,17-dihydroxy-, (11β, 16α)-",611-417-8,56723-09-2,Not Classified,REACH registration C&L,2.0,Not classified:2
6508,2-methyl-DL-serine,226-565-5,5424-29-3,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
6510,"2,4-dinitrotoluene",204-450-0,121-14-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Muta. 2;Carc. 1B;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0.0,H373:0;H341:0;H301:0;H311:0;H331:0;H410:0;H400:0;H361:0;H350:0
6513,"Reaction products of 2-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-hydroxyphenol with ((C10-16, rich in C12-13 alkyloxy)methyl)oxyrane",410-560-1,,Not Classified,REACH registration C&L,22.0,Not classified:7;H413:13;H400:2;H410:2
6514,2-naphthyl dihydrogen phosphate,236-011-4,13095-41-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H302:38;H315:38;H319:38
6517,"N,N,N',N',N'',N''-hexamethylsilanetriamine",239-165-0,15112-89-7,Flam. Liq. 2;Water-react. 2;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 1,Notified C&L,66.0,H314:62;H311:60;H302:62;H330:38;H261:38;H225:38;H260:23;H331:22;H226:24;Not classified:4;H332:2;H318:1;H312:2
6518,Chloro(phenyl)acetyl chloride,220-826-7,2912-62-1,Flam. Liq. 3;Skin Corr. 1B;STOT SE 3,Notified C&L,39.0,H335:39;H226:39;H314:39
6520,"Currant, Ribes nigrum, ext.",271-749-0,68606-81-5,Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1519.0,H411:1307;H304:1306;H317:1308;H412:181;H302:114;H315:26;H226:4;H319:2;H225:1;H410:1;H400:1
6522,2-(diethylamino)ethyl acrylate,219-378-5,2426-54-2,Acute Tox. 4;Acute Tox. 2;Skin Corr. 1B;Skin Sens. 1,Notified C&L,39.0,H310:38;H302:38;H317:38;H314:39
6524,"Phosphoric acid, mixed decyl and octyl esters, compds. with diethanolamine",619-536-7,68425-57-0,Skin Corr. 1;Eye Dam. 1,REACH registration C&L,20.0,H314:3;H318:20;H315:17
6526,Calcium bis[5-(1-cyclohexen-1-yl)-5-ethylbarbiturate],205-610-2,143-76-0,Acute Tox. 4,Notified C&L,1.0,H302:1
6527,1-Methylbenzimidazole,605-321-5,1632-83-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,43.0,H335:43;H318:39;H302:39;H315:43;H319:5
6528,"3,4-dichlorobenzoic acid",200-099-2,51-44-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48.0,H335:44;H315:45;H319:45;Not classified:3
6529,"1,3-dihydro-1-oxoisobenzofuran-5-carbonitrile",279-900-2,82104-74-3,Not Classified,REACH registration C&L,42.0,Not classified:3;H332:39;H302:39;H312:39;H319:1;H315:1
6536,Zirconium oxide,234-835-9,12036-01-0,Aquatic Chronic 4,Notified C&L,3.0,H413:3
6538,(2-methoxymethylethoxy)propanol,252-104-2,34590-94-8,Not Classified,REACH registration C&L,5071.0,Not classified:5000;H319:39;H411:23;H318:23;H335:14;H302:4;H336:5;H315:1
6539,"Siloxanes and Silicones, di-Me, polymers with Me silsesquioxanes",614-226-8,68037-74-1,Not Classified,Notified C&L,5.0,Not classified:5
6540,"1,3-Bis(vinylsulfonylacetamido)propane",428-350-3,93629-90-4,Eye Dam. 1;Skin Sens. 1;Muta. 2;Aquatic Chronic 3,Harmonised C&L,0.0,H412:0;H341:0;H318:0;H317:0
6542,"Hydrogen [3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2-hydroxy-5-nitrobenzenesulphonato(3-)]hydroxychromate(1-)",287-254-8,85443-63-6,Not Classified,Notified C&L,83.0,Not classified:83
6544,"1-chloro-N,N,N',N',N'',N''-hexamethylsilanetriamine",236-331-4,13307-05-6,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,38.0,H226:38;H314:38
6547,"1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-, N-babassu-oil acyl derivs., inner salts",607-007-3,223704-95-8,,Notified C&L,2.0,H318:1;Not classified:1
6551,Bis(chloromethyldimethylsilanyl)amine,238-622-1,14579-91-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:38;H315:38;H319:38;H314:1;H318:1
6552,"Extracts (petroleum), solvent-refined heavy paraffinic distillate solvent;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained as the extract from the re-extraction of solvent-refined heavy paraffinic distillate. It consists of saturated and aromatic hydrocarbons having carbon numbers predominantly in the range of C",272-180-0,68783-04-0,Carc. 1B,Harmonised C&L,0.0,H350:0
6555,Trimethylborane,209-816-3,593-90-8,Flam. Gas 1;Press. Gas (Liq.);Skin Corr. 1B,Notified C&L,128.0,H280:106;H220:68;H314:128;H250:22
6558,"Glycerides, C16-18 and C18-unsatd., deodorizer distillates",272-911-3,68920-03-6,Not Classified,REACH registration C&L,56.0,Not classified:56
6559,"1,1-diethoxy-3,7-dimethylocta-2,6-diene",231-323-7,7492-66-2,Aquatic Chronic 2,REACH registration C&L,1483.0,H411:2;Not classified:1380;H412:52;H315:66;H413:35
6560,"1-Propanone, 2-hydroxy-2-methyl-, 1-(4-C10-13-alkylphenyl) derivs.",600-033-6,1001416-18-7,Aquatic Chronic 1,REACH registration C&L,4.0,H410:3;Not classified:1
6561,"1(3H)-Isobenzofuranone, 3,3-bis(6-hydroxy[1,1'-biphenyl]-3-yl)-",617-599-5,84627-12-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,1.0,H335:1;H400:1;H315:1;H319:1
6562,"Methyl 3α-[(ethoxycarbonyl)oxy]-7,12-dioxo-5β-cholan-24-oate",244-184-2,21059-42-7,Aquatic Chronic 4,Notified C&L,38.0,H413:38
6563,Phenylacetaldehyde,204-574-5,122-78-1,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1B;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,1710.0,H314:1318;H318:1317;H302:1707;H317:1653;H412:31;H335:46;H315:48;H319:48;H225:1
6568,"Octasodium 2-(3,4-bis(sulfonatooxy)-2,5-bis(sulfonatooxymethyl)tetrahydrofuran-2-yloxy)-3,5-bis(sulfonatooxy)-6-sulfonatooxymethyltetrahydropyran-4-oxysulfonate",420-660-7,,Not Classified,REACH registration C&L,3.0,Not classified:3
6572,1-(2-propenyl)pyridinium chloride,412-740-5,25965-81-5,Acute Tox. 4;Skin Sens. 1,Harmonised C&L,0.0,H302:0;H317:0
6573,"3-azaspiro[5.5]undecane-2,4-dione",214-459-1,1130-32-1,Acute Tox. 3;Aquatic Chronic 2,REACH registration C&L,42.0,H411:2;H301:2;H335:40;H302:40;H315:40;H319:40
6574,Fluphenazine,200-702-9,69-23-8,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 2,Notified C&L,204.0,H330:204;H318:204;H301:204;H315:204;H370:10
6576,"Disodium 2,2'-(1-triazene-1,3-diyldi-p-phenylene)bis[6-methylbenzothiazole-7-sulphonate]",217-377-4,1829-00-1,Not Classified,Notified C&L,4.0,Not classified:4
6580,Zirconium vanadium blue zircon,269-057-9,68186-95-8,Not Classified,REACH registration C&L,102.0,Not classified:102
6581,"3,3-dichlorobutan-2-one",220-164-9,2648-57-9,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1.0,H332:1;H302:1;H319:1
6583,"1,2-Bis(tosyloxy)ethane",613-165-4,6315-52-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H335:43;H315:44;H319:44
6585,"Amines, N-C12-18-alkyltrimethylenedi-",268-957-9,68155-37-3,Acute Tox. 3;Skin Corr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,35.0,H314:35;H301:35;H410:35;H400:35;H372:35
6592,Decan-2-ol,214-296-6,1120-06-5,Eye Irrit. 2,Notified C&L,38.0,H319:38
6596,"3,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-4-benzopyrone",207-709-6,490-31-3,Not Classified,Notified C&L,1.0,Not classified:1
6601,N-(N6-trifluoroacetyl-L-lysyl)-L-proline,402-920-1,,Not Classified,Notified C&L,1.0,Not classified:1
6603,Phenyl propionate,211-282-1,637-27-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H302:1;H315:1;H319:1
6609,"4,4'-dihydroxy-7,7'-ureylenedi(naphthalene-2-sulphonic acid)",205-142-9,134-47-4,Not Classified,REACH registration C&L,10.0,Not classified:7;H315:3;H319:3;H335:1
6610,"1,1,2,2,3,3,4,4,4-nonafluoro-N,N-bis(2-hydroxyethyl)butane-1-sulphonamide",252-044-7,34455-00-0,STOT RE 2;Aquatic Chronic 3,REACH registration C&L,4.0,H412:3;H373:3;Not classified:1
6613,sodium 3-(2H-benzotriazol-2-yl)-5-sec-butyl-4-hydroxybenzenesulfonate,403-080-9,92484-48-5,Eye Dam. 1,Harmonised C&L,0.0,H318:0
6614,"Naphthenic acids, cobalt salts",263-064-0,61789-51-3,Skin Sens. 1;STOT RE 1;Aquatic Chronic 3,REACH registration C&L,225.0,H412:28;H372:18;H317:182;H411:74;H334:66;H361:26;H302:19;H315:30;H228:16;H351:30;H319:27;H341:16;H360:17;H410:40;H400:30;H312:16;H350:16;H226:14;Not classified:6;H304:4;H335:1;H330:1;H300:1;H310:1
6617,Metampicillin,229-365-6,6489-97-0,Skin Sens. 1;Resp. Sens. 1,Notified C&L,38.0,H334:38;H317:38
6622,"1,1,2,2-tetrafluoro-2-(1,1,2,2-tetrafluoro-2-iodoethoxy)ethanesulphonyl fluoride",266-172-6,66137-74-4,Skin Corr. 1B;Eye Dam. 1,Notified C&L,41.0,H314:41;H318:39;H290:1
6624,"Alcohols, C16-20-branched",274-758-8,70693-04-8,Not Classified,Notified C&L,78.0,Not classified:78
6625,Bis(N-phenylbenzene-p-diamine) sulphate,225-173-1,4698-29-7,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,34.0,H319:32;H317:30;H302:27;H410:24;H400:17;H301:6;H315:4;H335:4;Not classified:1;H332:1
6626,Sodium N-methyltaurinate,224-339-0,4316-74-9,Skin Corr. 1C;Eye Dam. 1,REACH registration C&L,156.0,H318:154;H314:93;H315:63
6629,2'-chloroacetanilide,208-555-2,533-17-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H319:43;H315:43;H335:42
6632,"Sodium 4-chloro-3-[4-[[2-[(2-chlorophenoxy)sulphonyl]phenyl]azo]-2,5-dihydro-5-imino-3-methyl-1H-pyrazol-1-yl]benzenesulphonate",274-496-4,70247-68-6,Skin Sens. 1,Notified C&L,2.0,H317:2
6634,"3,6,9,12-tetraoxotridecanol",245-883-5,23783-42-8,Not Classified,REACH registration C&L,170.0,Not classified:166;H319:4
6645,Sodium tetradecyl sulphate,214-737-2,1191-50-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,66.0,H319:43;H315:66;H335:43;H318:23;H302:1
6655,"Decanol, branched",289-094-4,85995-86-4,Skin Irrit. 2;Aquatic Chronic 3,Notified C&L,3.0,H319:3;H412:3;H315:3
6656,"Formaldehyde, reaction products with N,N-dimethylbenzenamine and N-ethyl-2-methylbenzenamine, oxidized, molybdatephosphates",291-297-8,90367-47-8,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,84.0,H410:84;H400:84
6661,"Vincaleukoblastine, 3-(aminocarbonyl)-O4-deacetyl-3-de(methoxycarbonyl)-, sulfate (1:1) (salt)",261-984-7,59917-39-4,Acute Tox. 2;Eye Dam. 1;Repr. 2,Notified C&L,1.0,H318:1;H300:1;H361:1
6667,"1,12-bis (diisopropyl phosphoryl) dodecane",919-645-2,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,0.0,No data
6670,"Cement, portland, chemicals",266-043-4,65997-15-1,Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,787.0,H318:667;H317:576;H315:700;H335:481;H319:80;Not classified:40;H351:1
6673,Bis(1-methylpropyl)magnesium,241-558-7,17589-14-9,Flam. Sol. 1;Water-react. 1;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,26.0,H228:26;H318:1;H314:26;H260:26
6675,Dihydroxyaluminium stearate,230-325-5,7047-84-9,Not Classified,Notified C&L,55.0,Not classified:55
6676,"Fatty acids, C14-18 and C16-18-unsatd., 2-phenoxyethyl esters, maleated",292-835-4,91001-64-8,Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,2.0,H319:2;H317:2
6679,5-nitrouracil,210-250-4,611-08-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,92.0,H319:92;H315:92;H335:92
6683,Isobutyl decanoate,250-281-0,30673-38-2,Not Classified,Notified C&L,88.0,Not classified:88
6690,"Ethanedioic acid, lithium salt (1:[?])",608-551-4,30903-87-8,,Notified C&L,4.0,H302:4;H312:4
6694,"Phenol, isopropylated",291-826-2,90480-88-9,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 3;Muta. 2;STOT RE 2;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,10.0,H314:10;H373:10;H411:5;H341:10;H331:10;H317:3;H302:3;H311:10;H301:7;H318:2
6696,Di-tert-butyl phosphate,608-874-0,33494-81-4,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,0.0,No data
6698,N-isopropyl-N'-phenyl-p-phenylenediamine,202-969-7,101-72-4,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H302:0;H410:0;H317:0;H400:0
6699,"5-(Trimethylsilyl)-1,3-cyclopentadiene",609-148-6,3559-74-8,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,69.0,H319:69;H226:69;H315:69;H335:68
6701,Methyl 2-[(phenylmethylene)amino]benzoate,254-307-1,39129-16-3,Not Classified,Notified C&L,1286.0,Not classified:1286
6710,"Thujopsis dolabrata, ext.",294-437-6,91722-39-3,Asp. Tox. 1,Notified C&L,1386.0,H304:1386
6714,"2,2-bis[[(1-oxodocosyl)oxy]methyl]propane-1,3-diyl didocosanoate",262-895-6,61682-73-3,Not Classified,Notified C&L,37.0,Not classified:37
6715,"N,N-dimethylnicotinamide",230-209-4,6972-69-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H302:38;H315:39;H319:39;H335:38
6717,"carbosulfan (ISO);2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate",259-565-9,55285-14-8,Acute Tox. 3;Skin Sens. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H317:0;H330:0;H301:0;H410:0;H400:0
6723,Diacetoxydimethylsilane,218-562-2,2182-66-3,Skin Corr. 1B,Notified C&L,43.0,H314:43;H318:3;H226:1;H290:1
6728,"[2-[[[1,1'-bicyclohexyl]-1-ylcarbonyl]oxy]ethyl]diethylammonium chloride",200-671-1,67-92-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,94.0,H302:94;H315:91;H319:91;H335:91
6729,"Bromelain, stem",253-387-5,37189-34-7,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,950.0,H319:950;H334:950;H315:950;H335:950
6733,Praseodymium dioxide,234-838-5,12036-05-4,Not Classified,Notified C&L,3.0,Not classified:3
6735,"Lipopolysaccharides, Escherichia coli",297-473-0,93572-42-0,Acute Tox. 2,Notified C&L,39.0,H300:39
6745,Sodium octane-1-sulphonate monohydrate,226-195-4,5324-84-5,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,736.0,H314:8;H318:8;H319:685;H315:684;H335:454;Not classified:43;H320:1
6747,Sodium bisulfate monohydrate,600-069-2,10034-88-5,Eye Dam. 1,Notified C&L,210.0,H318:209;H314:1;H335:1
6749,TOXEPYRON,453-120-4,,Aquatic Chronic 1,Notified C&L,1.0,H410:1
6751,Cobalt(2+) propionate,216-333-1,1560-69-6,Acute Tox. 4;Skin Sens. 1A;Eye Irrit. 2;Acute Tox. 4;Repr. 1B;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,188.0,H319:8;H317:188;H332:12;H400:12;H411:8;H302:12;H360:6;H410:4;H361:2
6758,A mixture of: calcium bis(C10-14 branched alkylsalicylate); calcium bis(C18-30 alkyl salicylate); calcium bis(C18-30 alkyl phenolate); calcium bis(C10-14 branched alkyl phenolate); lubrificating oil (C15-30),455-880-2,,Skin Sens. 1;Repr. 1B;Aquatic Chronic 4,Notified C&L,2.0,H360:2;H413:2;H317:2
6762,N-methylhyoscinium bromide,205-844-5,155-41-9,Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1,Notified C&L,41.0,H312:38;H400:38;H332:38;H330:2;H300:2;H310:2;H301:1
6763,"Plastics, wastes, pyrolyzed, pyrolysis oil",309-755-3,100801-72-7,Not Classified,Notified C&L,1.0,Not classified:1
6770,"1H-Imidazolium, 3-ethyl-1-methyl-, octanoate (1:1)",620-043-4,1154003-55-0,Skin Corr. 1C;Eye Dam. 1,Notified C&L,83.0,H314:83;H318:83
6772,"4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecanoic acid",252-108-4,34598-33-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H319:40;H315:40;H335:39
6773,(2-cyano-1-methylethyl)dodecylethylsulphonium tetrafluoroborate(1-),276-380-9,72140-65-9,Acute Tox. 4;Skin Sens. 1B;Repr. 2;STOT RE 1;STOT RE 2,REACH registration C&L,2.0,H361:2;H317:2;H373:2;H372:2;H302:2
6776,(S)-α-amino-1H-indole-3-propionamide monohydrochloride,225-708-9,5022-65-1,Not Classified,Notified C&L,1.0,Not classified:1
6777,(quinolin-8-olato)lithium,246-932-3,25387-93-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H319:2;H315:2
6779,"1-(4-methoxyphenyl)piperazine-1,4-diylium dichloride",254-166-6,38869-47-5,,Notified C&L,5.0,H319:5;H315:5;H335:4;H301:1
6781,4-bromo-2-fluoroanisole,219-096-2,2357-52-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H319:45;H315:45;H335:44
6784,Propionanilide,210-649-3,620-71-3,Acute Tox. 4,Notified C&L,52.0,H302:52
6788,"N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-hydroxy-4-[(2-methoxy-4-nitrophenyl)azo]naphthalene-2-carboxamide",230-250-8,6985-95-1,Not Classified,Notified C&L,6.0,Not classified:6
6789,3-(dodecylthio)propionic acid,215-967-6,1462-52-8,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,195.0,H318:194;H315:195;H335:194;H319:1
6791,Triacetoxyphenylsilane,241-952-9,18042-54-1,Not Classified,Notified C&L,1.0,Not classified:1
6796,2-chlorobenzamide,210-195-6,609-66-5,Acute Tox. 4;Acute Tox. 2,Notified C&L,78.0,H302:78;H330:38;H319:5;H315:5;H335:4
6797,2-ethyl-2-oxazoline,233-912-4,10431-98-8,Flam. Liq. 3;Skin Corr. 1A;Skin Sens. 1,REACH registration C&L,50.0,H314:8;H226:49;H317:6;H318:1;H302:38;H332:38;H312:38;H319:3;H315:3;H335:1;Not classified:1
6798,"Naphtha, thermal cracked, residues, naphthalene cut",285-562-7,85117-10-8,Skin Irrit. 2;Eye Irrit. 2;Muta. 1B;Carc. 1B;Aquatic Chronic 2,Notified C&L,83.0,H319:83;H315:83;H340:83;H350:83;H411:83
6800,"Acetic acid, C9-11-branched alkyl esters, C10-rich",600-871-2,108419-34-7,Not Classified,Notified C&L,176.0,Not classified:176
6801,Benzofuran-2-yl methyl ketone,216-706-9,1646-26-0,Skin Sens. 1B,REACH registration C&L,111.0,H317:110;H332:3;H361:2;H319:1;H315:1;H335:1;H302:1
6804,"1,4-Bis((4'-(4-acryloyloxybutoxy)phenyl)carbonyloxy)benzene",454-650-9,132694-65-6,Aquatic Chronic 4,Notified C&L,2.0,H413:1;H411:1
6805,Neodymium(3+) acetate,228-244-5,6192-13-8,Not Classified,REACH registration C&L,4.0,Not classified:2;H319:2;H315:2;H335:2
6808,4-(trans-4-Propylcyclohexyl)-benzoic acid,613-780-8,65355-29-5,Acute Tox. 4,Notified C&L,3.0,H302:2;Not classified:1;H315:2;H335:1;H317:1;H319:1
6810,"Ethanaminium, 2-hydroxy-N-(2-hydroxyethyl)-N,N-dimethyl-, methanesulfonate (1:1)",604-846-7,152390-17-5,Not Classified,Notified C&L,1.0,Not classified:1
6811,"(2R,3R)-2,3-dimethylbutanedioic acid",607-861-7,26099-09-2,Eye Irrit. 2,Notified C&L,130.0,H319:65;H290:50;H314:63;H318:50;H315:7;H371:1;H373:1
6812,sodium carbonate,207-838-8,497-19-8,Eye Irrit. 2,Harmonised C&L,0.0,H319:0
6814,Cocodimonium Hydroxypropyl Hydrolyzed Wheat Protein,603-409-8,130381-04-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H319:1;H315:1;Not classified:1
6818,"2,6-Dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid",610-580-2,50887-69-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49.0,H319:45;H315:45;H335:44;Not classified:2;H302:3;H332:1;H312:1
6823,"Guar gum, carboxymethyl ether, sodium salt",609-654-7,39346-76-4,Eye Dam. 1,Notified C&L,2.0,H318:2
6824,"Magnesium, bis(2-hydroxybenzoato-O1,O2)-, ar,ar'-di-C>13-alkyl derivs.",284-578-1,84929-98-6,Aquatic Chronic 3,Notified C&L,17.0,H412:17
6825,Quinoline derivative,452-210-0,,Not Classified,Notified C&L,1.0,Not classified:1
6827,"Trisodium 2,4-bis[[2,4-diamino-5-[(3-sulphonatophenyl)azo]phenyl]azo]benzenesulphonate",229-206-0,6428-26-8,Not Classified,Notified C&L,1.0,Not classified:1
6829,"m-Hydroxyphenol, oligomers",500-056-0,26982-54-7,Eye Irrit. 2,Notified C&L,1.0,H319:1
6830,Piperazin-4-ylacetophenone,257-332-6,51639-48-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H319:39;H315:39;H335:39;H314:4
6838,5-METHYL-1H-TETRAZOLE,609-862-8,4076-36-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H319:42;H315:42;H335:41;H228:5
6840,Disodium sulphonatoacetate,226-752-1,5462-60-2,Not Classified,Notified C&L,3.0,Not classified:2;H314:1;H335:1
6841,"Dipotassium hydrogen 7-aminonaphthalene-1,3,6-trisulphonate",284-333-9,84852-23-3,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,2.0,H314:2;H318:2
6844,"Anthemis nobilis, ext.",616-968-8,8015-92-7,Flam. Liq. 3;Asp. Tox. 1;Aquatic Chronic 2,REACH registration C&L,218.0,H226:169;H304:169;H411:169;H317:166;H315:38;H412:31;Not classified:10;H319:1
6846,2-[[3-(4-hydroxyphenyl)-1-oxo-2-propen-1yl]amino]-benzoic acid,920-437-9,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 1B,REACH registration C&L,1.0,H360:1;H319:1;H315:1;H335:1
6849,L-ornithine L-aspartate,221-772-7,3230-94-2,Not Classified,Notified C&L,7.0,Not classified:7
6852,"Starch, hydrogen 2-(octen-1-yl)butanedioate, aluminum salt",618-671-9,9087-61-0,Not Classified,Notified C&L,124.0,Not classified:124
6854,"3-(2,3-dichlorophenyl)-1,1-dimethylurea",233-645-3,10290-37-6,,Notified C&L,33.0,Not classified:33
6857,"Methyl (Z,Z)-8,8-dioctyl-3,6,10-trioxo-2,7,9-trioxa-8-stannatrideca-4,11-dien-13-oate",262-265-0,60494-19-1,Skin Irrit. 2;Eye Irrit. 2;STOT RE 2;Aquatic Chronic 4,Notified C&L,7.0,H319:7;H413:6;H315:7;H373:7;H410:1;H400:1
6863,"Exo-(-)-4,7,7-trimethyl-6-thiabicyclo[3.2.1]octane",227-219-6,5718-75-2,Aquatic Chronic 2,Notified C&L,38.0,H411:38
6865,"leucomalachite green;N,N,N',N'-tetramethyl-4,4'-benzylidenedianiline",204-961-9,129-73-7,Muta. 2;Carc. 2,Harmonised C&L,0.0,H351:0;H341:0
6866,Manganese oxide,215-695-8,1344-43-0,Not Classified,REACH registration C&L,595.0,Not classified:256;H302:268;H332:267;H312:185;H319:168;H315:168;H335:168;H311:1
6869,"Glycine, N,N'-1,3-propanediylbis[N-(carboxymethyl)-",606-302-4,1939-36-2,Acute Tox. 4;Eye Dam. 1;Repr. 2,Notified C&L,39.0,H302:39;H318:39;H361:38;H312:1
6871,Diethyl ethylphosphonate,201-111-9,78-38-6,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,152.0,H302:151;H318:148;H411:151;H319:5;H315:1;H335:1
6873,4-Bromo-3-chloroanisole,610-550-9,50638-46-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H319:2;H315:2;H335:2
6874,3-dodecylaminopropionic acid,215-968-1,1462-54-0,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1.0,H318:1;H315:1
6876,Reaction product of potassium hydroxide and phosphorous acid,923-751-4,,Not Classified,Notified C&L,2.0,Not classified:2
6881,"Reaction products of behenic acid, Eicosadioic acid and Polyglyceryl-10",478-920-0,,Not Classified,REACH registration C&L,1.0,Not classified:1
6883,"2-methoxy-5-nitrobenzenediazonium chloride, compound with zinc chloride",271-309-8,68540-75-0,Not Classified,Notified C&L,1.0,Not classified:1
6887,"(E,E)-3,7,11,15-tetramethylhexadeca-1,6,10,14-tetraen-3-ol",214-201-8,1113-21-9,Skin Irrit. 2,REACH registration C&L,306.0,H315:305;H319:38;H335:38;Not classified:1
6890,"(R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile",430-780-1,103146-25-4,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0.0,H302:0;H411:0;H317:0
6891,"1-(1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethyl-2-naphthyl)ethan-1-one",259-174-3,54464-57-2,,Notified C&L,1792.0,H410:1415;H315:1494;H317:1586;H411:377;H400:34;Not classified:1;H318:1
6892,Pentacosane,211-123-6,629-99-2,Not Classified,Notified C&L,6.0,Not classified:4;H304:2
6897,"8,9-didehydro-6,8-dimethylergoline",208-947-3,548-42-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38.0,H302:38;H332:38;H312:38
6898,"Tris(2,5-xylyl) phosphate",242-799-0,19074-59-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,38.0,H319:38;H413:38;H315:38;H335:38
6899,"(1S)-2,2-dimethyl-3-methylenebicyclo[2.2.1]heptane",227-337-8,5794-04-7,Flam. Liq. 3;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,158.0,H400:79;H319:119;H226:89;H410:115;H228:70
6900,3-bromobutan-2-one,212-404-6,814-75-5,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B,Notified C&L,43.0,H302:39;H314:43;H226:39;H312:43;H301:4;H331:4
6902,Butyl myristate,203-759-8,110-36-1,Skin Irrit. 2,Notified C&L,40.0,H315:39;Not classified:1
6903,"Phenol, 4-[(4-amino-3-methylphenyl)amino]-, reaction products with sodium sulfide (Na2(Sx)), thiosulfonated",215-577-6,1332-88-3,Not Classified,Notified C&L,34.0,Not classified:34
6905,"4,4'-oxybis(benzene-1,2-diamine)",220-226-5,2676-59-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38;H334:38;H302:38
6906,"Hydrocarbons, steam-cracking tar middle",289-222-9,86290-83-7,Asp. Tox. 1;Skin Irrit. 2;Muta. 1B;Carc. 1B;Aquatic Chronic 2,REACH registration C&L,41.0,H304:13;H315:25;H340:25;H350:25;H411:13;H319:12;H361:15;H373:18;H332:6;H335:6;H226:12;Not classified:1;H410:12;H302:12;H400:12;H336:5
6908,"Trimethoxy(2,4,4-trimethylpentyl)silane",251-995-5,34396-03-7,Flam. Liq. 3,REACH registration C&L,172.0,H226:143;H412:89;H318:38;Not classified:29
6917,Ethyl linoleate,208-868-4,544-35-4,Skin Irrit. 2,REACH registration C&L,494.0,H315:108;Not classified:386
6921,"Octasodium 2,2'-[(2,2'-disulphonato[1,1'-biphenyl]-4,4'-diyl)bis[imino(6-chloro-1,3,5-triazine-4,2-diyl)imino(1-hydroxy-3-sulphonatonaphthalene-6,2-diyl)azo]]bisnaphthalene-1,5-disulphonate",268-519-7,68110-30-5,Not Classified,REACH registration C&L,54.0,Not classified:43;H319:11;H317:2
6922,"(4aR,4bS,6aS,9aS,9bR,11aR)-4a,6a-Dimethyltetradecahydro-1H-indeno[5,4-f]quinoline-2,7-dione",616-323-0,76318-69-9,Skin Sens. 1B;STOT RE 2;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,1.0,H401:1;H411:1;H373:1;H317:1
6926,Steel,603-109-7,12597-69-2,Not Classified,Notified C&L,83.0,Not classified:83
6929,"3-amino-2,2-dimethylpropan-1-ol",247-948-3,26734-09-8,,Notified C&L,7.0,H319:5;H315:5;H335:5;H314:2;H318:1
6935,N-ethyl-1-(4-(phenylazo)phenylazo)-2-naphthylamine,228-862-5,6368-72-5,Not Classified,Notified C&L,84.0,Not classified:46;H302:38
6941,Magnesium silicate,237-413-2,13776-74-4,Not Classified,Notified C&L,87.0,Not classified:87
6944,"Poly(oxy-1,2-ethanediyl), .alpha.-[1,1'-biphenyl]yl-.omega.-hydroxy-, benzylated",614-292-8,68130-72-3,Aquatic Chronic 3,Notified C&L,25.0,H412:25
6946,"Cusparia febrifuga, ext.",283-883-7,84775-53-1,Not Classified,Notified C&L,88.0,Not classified:88
6950,4-trans-Propylcyclohexancarbonic acid-(4-trans-pentylcyclohexyl)ester,616-676-0,79284-92-7,Aquatic Chronic 4,Notified C&L,1.0,H413:1;Not classified:1
6951,3-Cyclohexyl-2-cyclohexylimino-5-(4-diethylamino-2-methoxyphenyl)methylenoxazolidine-4-one,457-890-2,,Aquatic Chronic 4,Notified C&L,1.0,H413:1
6954,"phenyl (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-piperidinecarboxylate",924-743-3,253768-88-6,Aquatic Chronic 4,REACH registration C&L,2.0,H413:2;Not classified:2
6959,(Z)-4-[3-(2-chloro-9H-thioxanthen-9-ylidene)propyl]piperazine-1-ethanol dihydrochloride,261-080-2,58045-23-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,25.0,H302:25;H319:25;H315:25;H335:25
6960,4-chloro-6-(2-chlorophenoxy)-5-fluoropyrimidine,606-738-5,213265-81-7,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1.0,H302:1;H411:1;H317:1
6962,Bromo(2H5)benzene,224-013-8,4165-57-5,Flam. Liq. 3;Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,47.0,H226:47;H315:47;H411:47
6963,Difluoromethane,200-839-4,75-10-5,Press. Gas (Liq.),REACH registration C&L,250.0,H221:60;H280:249;H220:189;H350:3;H340:3;H312:1
6965,Tung oil,232-272-3,8001-20-5,Not Classified,Notified C&L,585.0,Not classified:552;H317:32;H332:1;H319:1;H315:1;H335:1
6966,N-methyl-N-(trimethylsilyl)acetamide,231-217-0,7449-74-3,Flam. Liq. 3;Repr. 1B,REACH registration C&L,11.0,H360:2;H226:10;H319:6;H315:7;H335:7;Not classified:1;H318:2;H314:1;H412:1
6972,C.I. REACTIVE BLACK 47,403-940-3,,Not Classified,Notified C&L,1.0,Not classified:1
6973,"3,3,4,4,4-pentafluorobutan-1-ol",259-405-8,54949-74-5,Flam. Liq. 3,Notified C&L,3.0,H226:2;H225:1
6978,Dipotassium hexachloropalladate,240-974-6,16919-73-6,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,44.0,H318:2;H315:6;H317:2;H410:2;H302:2;H400:2;H319:42;H335:4
6983,Methyl 2-[cinnamylideneamino]benzoate,305-271-1,94386-48-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,259.0,H319:259;H315:259;H317:259
6985,"Hepta-1,6-diyne",219-253-5,2396-63-6,Flam. Liq. 2,Notified C&L,44.0,H225:44;H304:5;H319:1;H315:1
6989,"1-(5,6,7,8-tetrahydro-2-naphthyl)ethan-1-one",212-266-7,774-55-0,Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,288.0,H411:16;H315:16;H317:2;Not classified:233;H302:40
6992,2-(2-butoxyethoxy)ethyl acrylate,230-810-1,7328-16-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
6995,"Disodium 4,4'-isopropylidenediphenolate",219-488-3,2444-90-8,,Notified C&L,1.0,H302:1;H319:1;H315:1;H335:1
6997,"N,N'-dioctadecylsebacamide",252-352-1,35081-84-6,Not Classified,Notified C&L,1.0,Not classified:1
6998,2-amino-α-oxothiazol-4-acetic acid,277-301-0,73150-67-1,,Notified C&L,1.0,H302:1;H319:1;H315:1;H335:1
7005,4-tert-butylbenzonitrile,224-137-2,4210-32-6,Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,46.0,H302:7;H411:2;H312:43;H319:39;H332:43;H301:1;H331:1;H311:1
7008,Benzylbis(2-hydroxypropyl)tetradecylammonium chloride,265-349-5,65059-94-1,,Notified C&L,34.0,Not classified:33;H314:1;H411:1
7009,"1,4-dioxane-2,5-dione",207-954-9,502-97-6,Skin Corr. 1C;Eye Dam. 1,REACH registration C&L,53.0,H314:11;H318:10;H302:40;H319:42;H315:2;H335:1
7011,"Paraffin waxes and Hydrocarbon waxes, oxidized",268-871-1,68153-22-0,Not Classified,REACH registration C&L,15.0,Not classified:15
7017,"α-D-Xylofuranose, 1,2-O-(1-methylethylidene)-",606-426-9,20031-21-4,,Notified C&L,1.0,H302:1
7023,Dimethylammonium 2-(4-chloro-2-methylphenoxy)propionate,251-008-8,32351-70-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1.0,H318:1;H315:1;H410:1;H302:1;H400:1
7024,"Hickory, Carya ovata, ext.",294-553-7,91723-46-5,Skin Corr. 1B,Notified C&L,112.0,H314:76;Not classified:36
7026,2-fluoroethylamine hydrochloride,207-302-3,460-08-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4.0,H319:4;H315:4;H335:3
7028,4-chloro-1H-indole-2-carboxylic acid,246-364-6,24621-73-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2.0,H302:2;H319:2;H315:2;H335:2
7031,"Aluminum oxide (Al2O3), solid soln. with cerium oxide (CeO2) and magnesium oxide, terbium-doped",310-017-8,102110-19-0,Not Classified,Notified C&L,2.0,Not classified:1;H318:1
7037,"Fats, animal, mixed with vegetable oils, deodorizer distillates",272-916-0,68920-10-5,Not Classified,Notified C&L,1.0,Not classified:1
7038,4'-ethoxyacetoacetanilide,204-577-1,122-82-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,34.0,H302:33;H332:33;H312:33;H301:1
7039,"4-methylpentane-2,3-dione",231-328-4,7493-58-5,Flam. Liq. 3;Skin Sens. 1,Notified C&L,88.0,H226:88;H317:88
7045,Cyclopropylamine,212-142-2,765-30-0,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4,REACH registration C&L,166.0,H314:166;H318:40;H317:36;H225:166;H332:41;H302:165;H412:33;H312:5
7052,tert-butyl N-hydroxycarbamate,252-836-2,36016-38-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H302:2;H319:2;H315:2;H335:2
7054,"Disodium hydrogen aminomethyl[[4-[(sulphonatophenyl)amino]phenyl][4-[(sulphonatophenyl)imino]cyclohexa-2,5-dien-1-ylidene]methyl]benzenesulphonate",249-113-9,28631-66-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,24.0,H319:24;H315:24;H335:23;H301:1;H317:1
7060,Citronellyl acetate,205-775-0,150-84-5,Skin Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1971.0,H315:1971;H411:1924;H319:291;H335:4;H302:2;H317:2;Not classified:1;H400:1
7063,hafnium tetra-n-butoxide,411-740-2,22411-22-9,Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0.0,H318:0;H317:0
7065,4-chloro-1'-(4-methoxyphenyl)benzohydrazide,240-441-8,16390-07-1,Not Classified,REACH registration C&L,39.0,Not classified:4;H341:35;H351:35;H317:35
7072,"4-chloro-3,5-dinitrobenzamide",243-998-5,20731-63-9,Skin Sens. 1,Notified C&L,38.0,H317:38
7073,"1-Propanamine, 3-(triethoxysilyl)-, reaction products with trimethoxymethylsilane and 2-[[3-(trimethoxysilyl)propoxy]methyl]oxirane",610-348-0,474530-85-3,Eye Irrit. 2,Notified C&L,36.0,H319:36
7076,3-(dichloromethylsilyl)propyl acetate,226-126-8,5290-24-4,Acute Tox. 4;Skin Corr. 1A;STOT SE 3;Aquatic Chronic 3,Notified C&L,9.0,H302:9;H314:9;H412:9;H335:9;H318:1
7077,"3,3-dichloro-2,2-dimethylpropionic acid",265-252-8,64855-18-1,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38.0,H314:38;H318:38
7078,"Alcohols, C18-22",307-144-6,97552-91-5,Not Classified,Notified C&L,527.0,Not classified:527
7079,(2H6)benzene,214-061-8,1076-43-3,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;Muta. 1B;Carc. 1A;STOT RE 1,Notified C&L,55.0,H319:42;H304:46;H340:41;H315:42;H225:54;H350:50;H372:46;H330:4;H301:4;H311:4;Not classified:2;H336:1;H341:1;H361:1;H411:1;H370:1;H302:1
7081,"(2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-henicosafluoroundecyl)oxirane",254-007-0,38565-54-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H319:2;H315:2;H335:2
7084,N-methyl-m-toluidine,211-795-0,696-44-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0.0,H373:0;H331:0;H412:0;H301:0;H311:0
7090,"Juniper, Juniperus virginiana, ext., epoxidized",309-341-2,100209-33-4,Not Classified,Notified C&L,113.0,Not classified:103;H411:10
7093,benz[a]anthracene,200-280-6,56-55-3,Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H350:0;H400:0;H410:0
7100,"tert-butyl 4-{2-oxo-1H,2H,3H-imidazo[4,5-b]pyridin-1-yl}piperidine-1-carboxylate",616-594-5,781649-87-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1.0,H302:1;H332:1;H312:1
7101,"Disodium 3-hydroxy-4-[(4-nitrophenyl)azo]naphthalene-2,7-disulphonate",230-443-7,7143-21-7,,Notified C&L,4.0,H319:4;H315:4;H335:4
7104,Nafoxidine hydrochloride,439-520-1,,Acute Tox. 3;Skin Sens. 1;Eye Dam. 1;Repr. 1B,Notified C&L,1.0,H360:1;H301:1;H318:1;H317:1
7107,"Dihydronicotinamide-adenine dinucleotide phosphate, tetrasodium salt",220-163-3,2646-71-1,Not Classified,Notified C&L,3.0,Not classified:3
7113,Chlorprothixene hydrochloride,229-289-3,6469-93-8,Acute Tox. 3,Notified C&L,40.0,H301:40;H319:2;H315:2;H335:2
7114,Manganese ferrite black spinel,269-056-3,68186-94-7,Not Classified,REACH registration C&L,486.0,Not classified:486
7117,Chlorpromazine hydrochloride,200-701-3,69-09-0,Acute Tox. 3;Acute Tox. 2,Notified C&L,100.0,H301:99;H330:93;H318:3;H317:3;H410:3;H332:2;H362:3;H319:1;H300:1;H315:1;H310:1;H335:1;H311:1
7119,2-[[4-[bis[2-(1-oxopropoxy)ethyl]amino]-2-chlorophenyl]azo]-5-nitrobenzonitrile,277-625-2,73862-12-1,Not Classified,Notified C&L,16.0,Not classified:16
7122,Nonan-1-amide,214-297-1,1120-07-6,Acute Tox. 4,Notified C&L,38.0,H302:38
7127,"Imidazolium compounds, 1-benzyl-4,5-dihydro-2-nortall-oil alkyl-1-(2-tall-oil aminoethyl), chlorides",272-753-5,68910-70-3,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B,Notified C&L,79.0,H312:59;H314:79;H318:79;H332:59;H302:59;H315:20;H335:20
7129,"(E)-3,7-dimethylocta-2,6-dienal",205-476-5,141-27-5,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,317.0,H319:274;H315:317;H317:317
7133,"Fatty acids, tall-oil, cobalt salts",263-065-6,61789-52-4,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,141.0,H302:141;H411:131;H317:141;H315:39;H361:14
7136,Tropacocaine hydrochloride,211-281-6,637-23-0,Acute Tox. 4,Notified C&L,1.0,H312:1
7139,"Pentane-1,2,5-triol",238-747-1,14697-46-2,Eye Irrit. 2,Notified C&L,1.0,H319:1
7142,N-ethyltridecafluoro-N-(2-hydroxyethyl)hexanesulphonamide,252-045-2,34455-03-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H335:1
7143,(4-fluorophenyl)-isopropylamine,448-100-7,,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Acute Tox. 4;Muta. 2;Aquatic Chronic 2,REACH registration C&L,4.0,H315:4;H341:4;H317:4;H332:4;H411:4;H302:4
7144,"(10aS)-methyl 10a-methoxy-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxylate",607-239-5,23495-64-9,Skin Sens. 1B;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,3.0,H412:1;H318:1;H317:1;H302:1;H332:1;H312:1;Not classified:1
7153,2-aminop-cresol hydrochloride,221-026-0,2977-71-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
7154,"Reaction product of: 2,4-diamino-6-[2-(2-methyl-1H-imidazol-1-yl)ethyl]-1,3,5-triazine and cyanuric acid",428-190-4,68490-66-4,Not Classified,REACH registration C&L,27.0,Not classified:27
7155,"Hexanedioic acid, polymer with 1,3-butanediol, hexadecanoate",614-418-1,68332-62-7,Not Classified,Notified C&L,64.0,Not classified:64
7157,"Formaldehyde, reaction products with N,N-dimethylbenzenamine and N-ethyl-2-methylbenzenamine, oxidized, molybdatetungstatephosphates",291-298-3,90367-48-9,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,83.0,H400:83;H318:83;H410:83
7158,"1-(4-Amino-6,7-dimethoxyquinazolin-2-yl)-4-[[(2RS)-tetrahydrofuran-2-yl]carbonyl]piperazine hydrochloride dihydrate",629-697-5,70024-40-7,Eye Irrit. 2,Notified C&L,90.0,H319:51;H302:40;H315:7;H335:7;H361:7;H370:1
7159,Veralipride,266-435-5,66644-81-3,,Notified C&L,1.0,H302:1;H332:1;H312:1
7160,Sodium 3-(allyloxy)-2-hydroxypropanesulphonate,258-004-5,52556-42-0,Skin Irrit. 2;Eye Dam. 1;Repr. 2,REACH registration C&L,53.0,H318:6;H315:45;H361:6;H319:39;H335:38;Not classified:8
7161,5-tert-butyl-3-isoxazolylamine hydrochloride,404-840-2,164578-13-6,Acute Tox. 4;Eye Dam. 1;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0.0,H302:0;H318:0;H412:0;H373:0
7162,4-chloro-3-nitrobenzoic acid,202-550-9,96-99-1,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;STOT SE 3,REACH registration C&L,50.0,H319:50;H315:50;H335:49;H317:3;H334:1
7166,"Trisodium bis[3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-4-hydroxy-5-nitrobenzenesulphonato(3-)]chromate(3-)",260-892-4,57674-14-3,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,75.0,H412:48;H319:67;Not classified:8
7168,Sodium sarcosinate,224-338-5,4316-73-8,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,196.0,H314:163;H318:155;Not classified:33
7169,"4'-(decyloxy)[1,1'-biphenyl]-4-carbonitrile",274-495-9,70247-25-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1.0,H312:1;H319:1;H315:1;H332:1;H302:1
7175,Disodium 4-[1-methyl-2-[(1-oxooctadec-9-enyl)amino]ethyl] 2-sulphonatosuccinate,267-199-6,67815-88-7,Eye Irrit. 2,Notified C&L,152.0,H319:91;H318:56;H315:9;Not classified:5
